<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">PJjC79yRvgyGqtwGVWCNvpv</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2019000600809</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20190106</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Statement</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Simone Nascimento dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alcantara</surname>
            <given-names>Monica Luiza de</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freire</surname>
            <given-names>Cl&#225;udia Maria Vilas</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cantisano</surname>
            <given-names>Armando Luis</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teodoro</surname>
            <given-names>Jos&#233; Aldo Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porto</surname>
            <given-names>Carmen Lucia Lascasas</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amaral</surname>
            <given-names>Salomon Israel do</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Veloso</surname>
            <given-names>Orlando</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albricker</surname>
            <given-names>Ana Cristina Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">11</xref>
          <xref ref-type="aff" rid="aff12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Petisco</surname>
            <given-names>Ana Cl&#225;udia Gomes Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>Fanilda Souto</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>M&#225;rcio Vin&#237;cius Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleh</surname>
            <given-names>Mohamed Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>Marcelo Luiz Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">16</xref>
          <xref ref-type="aff" rid="aff17">17</xref>
          <xref ref-type="aff" rid="aff18">18</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Hospital Bras&#237;lia</institution>
        <addr-line>
          <city>Bras&#237;lia</city>
          <state>DF</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Bras&#237;lia, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Eccos Diagn&#243;stico Cardiovascular</institution>
        <addr-line>
          <city>Bras&#237;lia</city>
          <state>DF</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Eccos Diagn&#243;stico Cardiovascular, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution content-type="orgname">Americas Medical City</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Americas Medical City, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution content-type="orgname">Hospital Samaritano</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Samaritano, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution content-type="orgname">Ecovitall</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Ecovitall, Rio de Janeiro, RJ - Brazil </institution>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <institution content-type="orgname">Hospital Barra Dor</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Barra Dor, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff8">
        <label>8</label>
        <institution content-type="orgname">Provato Medicina Diagn&#243;stica</institution>
        <addr-line>
          <city>Ribeir&#227;o Preto</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Provato Medicina Diagn&#243;stica, Ribeir&#227;o Preto, SP - Brazil</institution>
      </aff>
      <aff id="aff9">
        <label>9</label>
        <institution content-type="orgname">Hospital Universit&#225;rio Pedro Ernesto</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Universit&#225;rio Pedro Ernesto, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff10">
        <label>10</label>
        <institution content-type="orgname">US DOPPLER</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">USDOPPLER, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff11">
        <label>11</label>
        <institution content-type="orgname">Instituto de Ultrassom</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">IMEDE, Instituto de Ultrassom, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff12">
        <label>12</label>
        <institution content-type="orgname">UniBH</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">UniBH, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff13">
        <label>13</label>
        <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff14">
        <label>14</label>
        <institution content-type="orgname">Angiolab</institution>
        <institution content-type="orgdiv1">Laborat&#243;rio Cardiovascular</institution>
        <addr-line>
          <city>Vit&#243;ria</city>
          <state>ES</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Angiolab, Laborat&#243;rio Cardiovascular, Vit&#243;ria, ES - Brazil</institution>
      </aff>
      <aff id="aff15">
        <label>15</label>
        <institution content-type="orgname">Hospital Mater Dei</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Mater Dei, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff16">
        <label>16</label>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff17">
        <label>17</label>
        <institution content-type="orgname">Hospital Israelita Albert Einstein</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff18">
        <label>18</label>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina</institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas da Faculdade de Medicina da USP, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c1"><bold>Correspondence:</bold> Sociedade Brasileira de Cardiologia - Av. Marechal C&#226;mara, 360/330 - Centro - Rio de Janeiro - Postal Code: 20020-907. E-mail: <email>sbc@cardiol.br</email>.</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>15</day>
        <month>07</month>
        <year>2019</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>06</month>
        <year>2019</year>
      </pub-date>
      <volume>112</volume>
      <issue>6</issue>
      <fpage>809</fpage>
      <lpage>849</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <table-wrap id="t29">
      <label/>
      <caption>
        <title/>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
        </colgroup>
        <thead>
          <tr>
            <th colspan="8" style="border-bottom-width:thin;border-bottom-style:solid">Declaration of potential conflict of interest of authors/collaborators of the Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology &#8211; 2019</th>
          </tr>
          <tr>
            <th colspan="8" style="border-bottom-width:thin;border-bottom-style:solid">If the last three years the author/developer of the Statement:</th>
          </tr>
          <tr>
            <th align="left">Names Members of the Statement</th>
            <th align="center">Participated in clinical studies and/or experimental trials supported by pharmaceutical or equipment related to the guideline in question</th>
            <th align="center">Has spoken at events or activities sponsored by industry related to the guideline in question</th>
            <th align="center">It was (is) advisory board member or director of a pharmaceutical or equipment</th>
            <th align="center">Committees participated in completion of research sponsored by industry</th>
            <th align="center">Personal or institutional aid received from industry</th>
            <th align="center">Produced scientific papers in journals sponsored by industry</th>
            <th align="center">It shares the industry</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Cl&#225;udia Maria Vilas Freire</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Jos&#233; Aldo Ribeiro Teodoro</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Carmen Lucia Lascasas Porto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Orlando Veloso</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Ana Cl&#225;udia Gomes Pereira Petisco</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Fanilda Souto Barros</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">M&#225;rcio Vin&#237;cius Lins Barros</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Mohamed Hassan Saleh</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Marcelo Luiz Campos Vieira</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Simone Nascimento dos Santos</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Monica Luiza de Alcantara</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Salomon Israel do Amaral</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Ana Cristina Lopes Albricker</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Armando Luis Cantisano</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <sec sec-type="intro">
      <title>1. Introduction and Equipment</title>
      <sec>
        <title>1.1. Introduction</title>
        <p>The use of ultrasound (US) in Medicine started in the decade of 1940 and, since then, it has played a significant role in the diagnosis of cardiovascular diseases (CVD). It is a diverse technology that follows the physical principles of propagation of US waves in different media. Due to its broad applicability, relatively low-cost, and reproducibility, US has a secure place in diagnostic aid. Members of the Department of Cardiovascular Imaging (DCI) - experts in vascular ultrasound (VUS) - prepared this guideline to indicate the best use of this technique, according to recommendations from the current medical literature. We included the main aspects related to equipment components, software, transducers, and their evolution since the last guideline, and addressed the most relevant topics in the field of diagnosis of vascular diseases. The foundation behind using VUS to diagnose important pathologies, such as carotid atherosclerotic disease, diseases in vertebral arteries, abdominal aorta and its branches, was based on recommendations from the DCI panel of experts in 2015 and 2016.<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B2">2</xref>
				</p>
        <p>This guideline does not aim to compare VUS with other imaging examination methods or expound on the use of VUS in the follow-up of vascular diseases after the initial diagnosis. For this content, the reader should consult more extensive and specific publications on the subject. </p>
        <p>Our goal is to disseminate the best practices in VUS to various services in the country, standardize the interpretation of examinations, and contribute to the proper use of this non-invasive, widely available, and low-cost tool.</p>
      </sec>
      <sec>
        <title>1.2. Equipment</title>
        <p>In a country with continental dimensions and different economic realities like Brazil, it is difficult to determine what ideal equipment is. We cannot demand from a small laboratory in the interior of the country to work with equipment that has the same technological resources needed for a laboratory that assists a large number of patients. This standardization intends to suggest the appropriate minimum resources of equipment and the ideal way to perform, with safety and accuracy, the examinations whose protocols will be described below, always remembering that this area is in constant evolution. </p>
        <sec>
          <title>1.2.1. Machine</title>
          <p>The equipment must be capable of delivering the following types of image and Doppler: (a) two-dimensional image; (b) color flow imaging (CFI); (c) pulsed wave Doppler; (d) continuous wave Doppler (for some types of transducers, but not required for vascular examinations); (e) power Doppler, also known as power angio and Doppler energy - way of mapping the flow without indicating the direction, based on the amplitude of the signal (ideal resource, but not essential to the examination).</p>
          <p>More advanced tools, such as second-harmonic imaging, B-Flow, inversion recovery pulse sequences - for the use of microbubble contrast -, and even transducers capable of producing three-dimensional images, are useful in complex examinations, but not yet part of our daily practice. They will also be covered for information purposes as a way to encourage the technological progress that brings additional benefits to patients.</p>
        </sec>
        <sec>
          <title>1.2.2. Applications (Software)</title>
          <p>Among the application options, the equipment must have specific presets to each type of study to expedite and facilitate the task of the examiner. </p>
        </sec>
        <sec>
          <title>1.2.3. Multi-frequency or Broadband Transducers</title>
          <p><bold>Linear transducer</bold>: ideal frequency between 5 and 10 MHz (in some cases, frequencies of 4 or 12 MHz can be useful); for studies of superficial structures, since transducers of higher frequency have better axial image resolution, but their use is limited due to the large sound damping when traveling through tissues.</p>
          <p><bold>Convex transducer</bold>: ideal frequency between 2 and 5 MHz; used in studies of deeper structures, such as abdominal ones, with the advantage of covering a larger area compared to sector transducers of similar frequencies.</p>
          <p><bold>Low-frequency sector transducer</bold>: 2 to 4 MHz; useful when the examiner needs continuous Doppler in studies of abdominal arteries.</p>
          <p><bold>High-frequency sector transducer</bold>: 4 to 10 MHz; useful when the acoustic window is limited by bone structures. </p>
          <p><bold>Micro-convex transducer</bold>: frequency between 4 and 8 MHz; adaptable to sites with limited window, such as bone structures, dressings, wounds, or other situations in which the contact surface available for the probe is reduced, without loss of lateral resolution in distal fields, as presented by sector transducers.</p>
          <p>
            <bold>
              <italic>1.2.3.1. Image Orientation</italic>
            </bold>
          </p>
          <p>In longitudinal images, most vascular imaging guides recommend displaying cranial structures on the left side of the screen, and caudal structures on the right. In transverse planes, structures on the left side of the screen must correspond to the marking on the upper left corner of the monitor. That way, transverse planes will display right lateral structures, as well as left medial structures on the left side of the monitor screen.<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B4">4</xref>
					</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>2. Carotid and Vertebral Arteries</title>
      <p>According to the World Health Organization (WHO), CVDs are the main causes of morbidity and mortality worldwide. In 2012, 17.5 million people died from CVDs, the equivalent to 31% of all deaths occurred in the period, with estimates that 7.4 million resulted from coronary artery disease (CAD) and 6.7 million from cerebrovascular accident (CVA).<xref ref-type="bibr" rid="B5">5</xref>
			</p>
      <p>Ultrasound of carotid arteries is valuable and widely used in cardiovascular risk assessment, as it measures the intima-media thickness (IMT), detects atherosclerotic plaques, and can evaluate the morphology of plaques and degree of stenosis, characteristics associated with cerebrovascular events.</p>
      <sec>
        <title>2.1. Intima-media Thickness and Detection of Carotid Artery Plaques for Cardiovascular Risk Assessment</title>
        <p>With the publication of the Brazilian Guidelines for Dyslipidemia and Atherosclerosis Prevention in 2007 and 2013,<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B6">6</xref><sup>-</sup><xref ref-type="bibr" rid="B8">8</xref> the Mannheim consensus documents of 2004-2011,<xref ref-type="bibr" rid="B9">9</xref> and the American Society of Echocardiography consensus,<xref ref-type="bibr" rid="B10">10</xref> Brazilian experts in the VUS field joined forces to disseminate the correct way to measure IMT and detect atherosclerotic plaques in carotid arteries. In the latest update of the Brazilian guideline in 2017,<xref ref-type="bibr" rid="B8">8</xref> IMT measurement was not included separately in the stratification of cardiovascular risk, but in the characterization of atherosclerotic plaque as IMT &gt; 1.5 mm. Another aspect that shows the importance of correctly measuring IMT is its use in several research protocols. Since the American and European expert consensuses use IMT as an aggravating factor for cardiovascular risk, we decided to include the measurement technique in this guideline. This section aims to standardize the technique to measure IMT and detect carotid plaques.</p>
      </sec>
      <sec>
        <title>2.2. Ultrasound Definition of Intima-media Thickness and Carotid Plaque</title>
        <p>In two-dimensional images, IMT is characterized by a double line with defined intima-lumen and media-adventitia interfaces. IMT is the distance between the two acoustic interfaces. The atheromatous carotid plaque (CP) can be defined as a focal structure that spreads at least 0.5 mm into the arterial lumen, and/or measures more than 50% of the surrounding IMT value, and/or has an IMT &gt; 1.5 mm.<xref ref-type="bibr" rid="B9">9</xref>
					<xref ref-type="fig" rid="f1">Figure 1</xref> schematically illustrates the IMT measurement and the three ways to define CP. </p>
        <p>
          <fig id="f1">
            <label>Figure 1</label>
            <caption>
              <title>Schematic illustration showing examples of IMT and plaque measurements. IMT measurement (A). Different measurements of 3 carotid plaques: encroaching &#8805; 0.5 mm on the arterial lumen (B); measurement &gt; 50% of the surrounding IMT value (C); large plaque (D).</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf01.jpg"/></fig>
        </p>
        <sec>
          <title>2.2.1. Indications</title>
          <p>The European and American consensuses<xref ref-type="bibr" rid="B9">9</xref><sup>,</sup><xref ref-type="bibr" rid="B10">10</xref> recommend measuring IMT in specific groups (<xref ref-type="table" rid="t1">Table 1</xref>). In these groups of individuals, IMT is considered increased when above the 75 percentile for their age, gender, and ethnicity, according to one of the normative tables, assisting in the discussion of clinical treatment and change in lifestyle. If a CP is found, regardless of the obstruction degree, IMT measurement does not need to be reported, except for exams explicitly requested for this purpose. In these cases, if the CP is located in the IMT measurement, it should be included in the value. </p>
          <table-wrap id="t1">
            <label>Table 1</label>
            <caption>
              <title>When to measure the intima-media thickness</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="100%"/>
              </colgroup>
              <tbody>
                <tr>
                  <td align="left">1. Intermediate cardiovascular risk: use the IMT measurement as an aggravating factor for high risk reclassification<xref ref-type="bibr" rid="B10">10</xref>
									</td>
                </tr>
                <tr>
                  <td align="left">2. Patients known to have a higher cardiovascular risk and hard clinical classification:</td>
                </tr>
                <tr>
                  <td align="left"> &#8226; Patients with familial hypercholesterolemia<xref ref-type="bibr" rid="B11">11</xref>
									</td>
                </tr>
                <tr>
                  <td align="left"> &#8226; Patients with autoimmune diseases or who use immunosuppressants, corticosteroids, antiretroviral drugs, or other medicines that induce elevation of cholesterol<xref ref-type="bibr" rid="B12">12</xref>
									</td>
                </tr>
                <tr>
                  <td align="left"> &#8226; History of early cardiovascular disease in first-degree relatives<xref ref-type="bibr" rid="B10">10</xref>
									</td>
                </tr>
                <tr>
                  <td align="left"> &#8226; Individuals &lt; 60 years with a severe abnormality in a risk factor<xref ref-type="bibr" rid="B10">10</xref>
									</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Women &lt; 60 years with at least two risk factors<xref ref-type="bibr" rid="B10">10</xref>
									</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1">
                <p>
                  <italic>IMT: intima-media thickness.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>2.2.2. Measurement Protocol</title>
          <p>The recommended protocol is similar to the one described by the ELSA-Brasil study<xref ref-type="bibr" rid="B13">13</xref> (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
          <table-wrap id="t2">
            <label>Table 2</label>
            <caption>
              <title>Protocol to measure intima-media thickness</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="100%"/>
              </colgroup>
              <tbody>
                <tr>
                  <td align="left">&#8226; Two-dimensional fundamental imaging</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Do not zoom</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Transducer with frequency &gt; 7 MHz</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Proper gain adjustment; depth between 3.0 and 4.0 cm</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Longitudinal plane of the common carotid and carotid bifurcation</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Capture images in the anterior and posterior accesses or the sternocleidomastoid muscle, with the most rectilinear image possible and with a well-defined double-line pattern, and choose the best one</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>After collecting numerical IMT data, the average values will be compared with existing reference numbers, according to normative tables of the studies ELSA Brasil,<xref ref-type="bibr" rid="B13">13</xref> CAPS,<xref ref-type="bibr" rid="B14">14</xref> or MESA.<xref ref-type="bibr" rid="B15">15</xref> The decision about which table to use will depend on the gender, age, and ethnicity of the individual.</p>
          <p>Although the manual point-to-point measurement is less reproducible - considering the differences in ultrasound equipment used in our country -, the consensus was that it could be used if the equipment does not automatically measure IMT, strictly respecting the technical recommendations. The examiner should pay special attention when placing the cursor in the intima-lumen and media-adventitia interfaces and be very cautious not to overestimate the values. In this case, measure each side at least five times to obtain the mean value (mean IMT).<xref ref-type="bibr" rid="B16">16</xref>
					</p>
        </sec>
        <sec>
          <title>2.2.3. Interpretation of Results</title>
          <p>Mean IMT [mean of measurements in the right or left common carotid artery (RCCA and LCCA, respectively)]: most types of equipment provide this measurement automatically or semi-automatically (in the latter case, the examiner can make small adjustments based on the automatic one). After calculating the mean IMT values from each side, compare them to the table to find the equivalent percentile. The individual under study is classified in the highest percentile. </p>
          <p>To determine the percentile of IMT measurement, consult <xref ref-type="table" rid="t3">tables 3</xref> to <xref ref-type="table" rid="t5">5</xref>, according to the age group of the individual under study.</p>
          <table-wrap id="t3">
            <label>Table 3</label>
            <caption>
              <title>ELSA Brasil:<xref ref-type="bibr" rid="B13">13</xref> individuals of both genders, aged 40 to 65 years, of white, multiracial, or black ethnicity</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="1%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
                <col width="6%"/>
              </colgroup>
              <thead>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <th align="left" colspan="9">Mean IMT LCCA (mm)</th>
                  <th align="center">
									</th>
                  <th align="center" colspan="9">Mean IMT RCCA (mm)</th>
                </tr>
              </thead>
              <tbody>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left" style="border-bottom:hidden">
									</td>
                  <td align="left">
                    <bold>Ethnicity</bold>
                  </td>
                  <td align="center">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center">
                    <bold>40y</bold>
                  </td>
                  <td align="center">
                    <bold>45y</bold>
                  </td>
                  <td align="center">
                    <bold>50y</bold>
                  </td>
                  <td align="center">
                    <bold>55y</bold>
                  </td>
                  <td align="center">
                    <bold>60y</bold>
                  </td>
                  <td align="center">
                    <bold>65y</bold>
                  </td>
                  <td align="center">
									</td>
                  <td align="center" rowspan="13" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Man</bold>
                  </td>
                  <td align="left">
                    <bold>Ethnicity</bold>
                  </td>
                  <td align="center">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center">
                    <bold>40y</bold>
                  </td>
                  <td align="center">
                    <bold>45y</bold>
                  </td>
                  <td align="center">
                    <bold>50y</bold>
                  </td>
                  <td align="center">
                    <bold>55y</bold>
                  </td>
                  <td align="center">
                    <bold>60y</bold>
                  </td>
                  <td align="center">
                    <bold>65y</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="12" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Man</bold>
                  </td>
                  <td align="left" rowspan="4">White</td>
                  <td align="center">P 25</td>
                  <td align="center">0.47</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.54</td>
                  <td align="center">0.57</td>
                  <td align="center">0.60</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4">White</td>
                  <td align="center">P 25</td>
                  <td align="center">0.45</td>
                  <td align="center">0.48</td>
                  <td align="center">0.51</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.57</td>
                  <td align="center">0.60</td>
                  <td align="center">0.64</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.51</td>
                  <td align="center">0.54</td>
                  <td align="center">0.58</td>
                  <td align="center">0.61</td>
                  <td align="center">0.65</td>
                  <td align="center">0.69</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.60</td>
                  <td align="center">0.65</td>
                  <td align="center">0.69</td>
                  <td align="center">0.73</td>
                  <td align="center">0.77</td>
                  <td align="center">0.81</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">0.75</td>
                  <td align="center">0.79</td>
                </tr>
                <tr>
                  <td align="center">P 90</td>
                  <td align="center">0.70</td>
                  <td align="center">0.75</td>
                  <td align="center">0.80</td>
                  <td align="center">0.85</td>
                  <td align="center">0.90</td>
                  <td align="center">0.95</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.66</td>
                  <td align="center">0.71</td>
                  <td align="center">0.76</td>
                  <td align="center">0.81</td>
                  <td align="center">0.85</td>
                  <td align="center">0.90</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">Multiracial</td>
                  <td align="center">P 25</td>
                  <td align="center">0.48</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.58</td>
                  <td align="center">0.61</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4">Multiracial</td>
                  <td align="center">P 25</td>
                  <td align="center">0.44</td>
                  <td align="center">0.47</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.60</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.57</td>
                  <td align="center">0.61</td>
                  <td align="center">0.65</td>
                  <td align="center">0.69</td>
                  <td align="center">0.73</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.50</td>
                  <td align="center">0.54</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.66</td>
                  <td align="center">0.69</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.60</td>
                  <td align="center">0.65</td>
                  <td align="center">0.70</td>
                  <td align="center">0.75</td>
                  <td align="center">0.80</td>
                  <td align="center">0.85</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.58</td>
                  <td align="center">0.63</td>
                  <td align="center">0.68</td>
                  <td align="center">0.73</td>
                  <td align="center">0.77</td>
                  <td align="center">0.82</td>
                </tr>
                <tr>
                  <td align="center">P 90</td>
                  <td align="center">0.69</td>
                  <td align="center">0.75</td>
                  <td align="center">0.80</td>
                  <td align="center">0.86</td>
                  <td align="center">0.92</td>
                  <td align="center">0.97</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.69</td>
                  <td align="center">0.74</td>
                  <td align="center">0.79</td>
                  <td align="center">0.84</td>
                  <td align="center">0.89</td>
                  <td align="center">0.94</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4" style="border-bottom-width:thin;border-bottom-style:solid">Black</td>
                  <td align="center">P 25</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.55</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.65</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4" style="border-bottom-width:thin;border-bottom-style:solid">Black</td>
                  <td align="center">P 25</td>
                  <td align="center">0.46</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.57</td>
                  <td align="center">0.60</td>
                  <td align="center">0.64</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">0.75</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.54</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.66</td>
                  <td align="center">0.70</td>
                  <td align="center">0.74</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.64</td>
                  <td align="center">0.68</td>
                  <td align="center">0.72</td>
                  <td align="center">0.77</td>
                  <td align="center">0.81</td>
                  <td align="center">0.86</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.61</td>
                  <td align="center">0.67</td>
                  <td align="center">0.73</td>
                  <td align="center">0.78</td>
                  <td align="center">0.84</td>
                  <td align="center">0.90</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center">P 90</td>
                  <td align="center">0.71</td>
                  <td align="center">0.78</td>
                  <td align="center">0.84</td>
                  <td align="center">0.91</td>
                  <td align="center">0.97</td>
                  <td align="center">1.03</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.70</td>
                  <td align="center">0.77</td>
                  <td align="center">0.83</td>
                  <td align="center">0.89</td>
                  <td align="center">0.95</td>
                  <td align="center">1.02</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left" rowspan="13">
                    <bold>Woman</bold>
                  </td>
                  <td align="left">
                    <bold>Etnia</bold>
                  </td>
                  <td align="center">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center">
                    <bold>40y</bold>
                  </td>
                  <td align="center">
                    <bold>45y</bold>
                  </td>
                  <td align="center">
                    <bold>50y</bold>
                  </td>
                  <td align="center">
                    <bold>55y</bold>
                  </td>
                  <td align="center">
                    <bold>60y</bold>
                  </td>
                  <td align="center">
                    <bold>65y</bold>
                  </td>
                  <td align="center">
									</td>
                  <td align="center" rowspan="13">
                    <bold>Woman</bold>
                  </td>
                  <td align="left">
                    <bold>Etnia</bold>
                  </td>
                  <td align="center">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center">
                    <bold>40y</bold>
                  </td>
                  <td align="center">
                    <bold>45y</bold>
                  </td>
                  <td align="center">
                    <bold>50y</bold>
                  </td>
                  <td align="center">
                    <bold>55y</bold>
                  </td>
                  <td align="center">
                    <bold>60y</bold>
                  </td>
                  <td align="center">
                    <bold>65y</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">White</td>
                  <td align="center">P 25</td>
                  <td align="center">0.44</td>
                  <td align="center">0.47</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4">White</td>
                  <td align="center">P 25</td>
                  <td align="center">0.44</td>
                  <td align="center">0.47</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.55</td>
                  <td align="center">0.58</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.66</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.48</td>
                  <td align="center">0.52</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.66</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.54</td>
                  <td align="center">0.58</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">0.75</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.53</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.66</td>
                  <td align="center">0.70</td>
                  <td align="center">0.75</td>
                </tr>
                <tr>
                  <td align="center">P 90</td>
                  <td align="center">0.61</td>
                  <td align="center">0.66</td>
                  <td align="center">0.71</td>
                  <td align="center">0.76</td>
                  <td align="center">0.81</td>
                  <td align="center">0.86</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.59</td>
                  <td align="center">0.64</td>
                  <td align="center">0.69</td>
                  <td align="center">0.74</td>
                  <td align="center">0.79</td>
                  <td align="center">0.84</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">Multiracial</td>
                  <td align="center">P 25</td>
                  <td align="center">0.45</td>
                  <td align="center">0.48</td>
                  <td align="center">0.51</td>
                  <td align="center">0.54</td>
                  <td align="center">0.57</td>
                  <td align="center">0.60</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4">Multiracial</td>
                  <td align="center">P 25</td>
                  <td align="center">0.44</td>
                  <td align="center">0.47</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.50</td>
                  <td align="center">0.53</td>
                  <td align="center">0.57</td>
                  <td align="center">0.60</td>
                  <td align="center">0.64</td>
                  <td align="center">0.67</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.56</td>
                  <td align="center">0.60</td>
                  <td align="center">0.64</td>
                  <td align="center">0.68</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.56</td>
                  <td align="center">0.60</td>
                  <td align="center">0.64</td>
                  <td align="center">0.68</td>
                  <td align="center">0.72</td>
                  <td align="center">0.77</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.55</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.68</td>
                  <td align="center">0.72</td>
                  <td align="center">0.76</td>
                </tr>
                <tr>
                  <td align="center">P 90</td>
                  <td align="center">0.63</td>
                  <td align="center">0.68</td>
                  <td align="center">0.73</td>
                  <td align="center">0.78</td>
                  <td align="center">0.83</td>
                  <td align="center">0.88</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.62</td>
                  <td align="center">0.67</td>
                  <td align="center">0.72</td>
                  <td align="center">0.77</td>
                  <td align="center">0.82</td>
                  <td align="center">0.87</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">Black</td>
                  <td align="center">P 25</td>
                  <td align="center">0.46</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.55</td>
                  <td align="center">0.58</td>
                  <td align="center">0.61</td>
                  <td align="center">
									</td>
                  <td align="left" rowspan="4">Black</td>
                  <td align="center">P 25</td>
                  <td align="center">0.46</td>
                  <td align="center">0.49</td>
                  <td align="center">0.53</td>
                  <td align="center">0.56</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                </tr>
                <tr>
                  <td align="center">P 50</td>
                  <td align="center">0.51</td>
                  <td align="center">0.55</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.70</td>
                  <td align="center">
									</td>
                  <td align="center">P 50</td>
                  <td align="center">0.51</td>
                  <td align="center">0.55</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                </tr>
                <tr>
                  <td align="center">P 75</td>
                  <td align="center">0.57</td>
                  <td align="center">0.62</td>
                  <td align="center">0.66</td>
                  <td align="center">0.70</td>
                  <td align="center">0.75</td>
                  <td align="center">0.79</td>
                  <td align="center">
									</td>
                  <td align="center">P 75</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">0.76</td>
                  <td align="center">0.80</td>
                </tr>
                <tr>
                  <td align="center">P 90</td>
                  <td align="center">0.64</td>
                  <td align="center">0.70</td>
                  <td align="center">0.76</td>
                  <td align="center">0.82</td>
                  <td align="center">0.88</td>
                  <td align="center">0.94</td>
                  <td align="center">
									</td>
                  <td align="center">P 90</td>
                  <td align="center">0.64</td>
                  <td align="center">0.71</td>
                  <td align="center">0.77</td>
                  <td align="center">0.83</td>
                  <td align="center">0.90</td>
                  <td align="center">0.96</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN3">
                <p>
                  <italic>RCCA: right common carotid artery; LCCA: left common carotid artery; IMT: intima-media thickness.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="t4">
            <label>Table 4</label>
            <caption>
              <title>CAPS table:<xref ref-type="bibr" rid="B14">14</xref> individuals of both genders, aged 25 to 45 years. There is no ethnic classification</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="1%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
              </colgroup>
              <tbody>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left" rowspan="5">
                    <bold>Man</bold>
                  </td>
                  <td align="center" rowspan="2">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center" colspan="7">
                    <bold>Age</bold>
                  </td>
                  <td align="center">
									</td>
                  <td align="center" rowspan="5">
                    <bold>Woman</bold>
                  </td>
                  <td align="center" rowspan="2">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center" colspan="7">
                    <bold>Age</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center">
                    <bold>25</bold>
                  </td>
                  <td align="center">
                    <bold>35</bold>
                  </td>
                  <td align="center">
                    <bold>45</bold>
                  </td>
                  <td align="center">
                    <bold>55</bold>
                  </td>
                  <td align="center">
                    <bold>65</bold>
                  </td>
                  <td align="center">
                    <bold>75</bold>
                  </td>
                  <td align="center">
                    <bold>85</bold>
                  </td>
                  <td align="center">
									</td>
                  <td align="center">
                    <bold>25</bold>
                  </td>
                  <td align="center">
                    <bold>35</bold>
                  </td>
                  <td align="center">
                    <bold>45</bold>
                  </td>
                  <td align="center">
                    <bold>55</bold>
                  </td>
                  <td align="center">
                    <bold>65</bold>
                  </td>
                  <td align="center">
                    <bold>75</bold>
                  </td>
                  <td align="center">
                    <bold>85</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center">%25</td>
                  <td align="center">0.515</td>
                  <td align="center">0.585</td>
                  <td align="center">0.634</td>
                  <td align="center">0.68</td>
                  <td align="center">0.745</td>
                  <td align="center">0.814</td>
                  <td align="center">0.83</td>
                  <td align="center">
									</td>
                  <td align="center">%25</td>
                  <td align="center">0.524</td>
                  <td align="center">0.575</td>
                  <td align="center">0.619</td>
                  <td align="center">0.665</td>
                  <td align="center">0.718</td>
                  <td align="center">0.771</td>
                  <td align="center">0.807</td>
                </tr>
                <tr>
                  <td align="center">%50</td>
                  <td align="center">0.567</td>
                  <td align="center">0.633</td>
                  <td align="center">0.686</td>
                  <td align="center">0.746</td>
                  <td align="center">0.83</td>
                  <td align="center">0.914</td>
                  <td align="center">0.937</td>
                  <td align="center">
									</td>
                  <td align="center">%50</td>
                  <td align="center">0.567</td>
                  <td align="center">0.615</td>
                  <td align="center">0.665</td>
                  <td align="center">0.719</td>
                  <td align="center">0.778</td>
                  <td align="center">0.837</td>
                  <td align="center">0.880</td>
                </tr>
                <tr>
                  <td align="center">%75</td>
                  <td align="center">0.633</td>
                  <td align="center">0.682</td>
                  <td align="center">0.756</td>
                  <td align="center">0.837</td>
                  <td align="center">0.921</td>
                  <td align="center">1.028</td>
                  <td align="center">1.208</td>
                  <td align="center">
									</td>
                  <td align="center">%75</td>
                  <td align="center">0.612</td>
                  <td align="center">0.66</td>
                  <td align="center">0.713</td>
                  <td align="center">0.776</td>
                  <td align="center">0.852</td>
                  <td align="center">0.921</td>
                  <td align="center">0.935</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <table-wrap id="t5">
            <label>Table 5</label>
            <caption>
              <title>MESA table:15 individuals of both genders, aged 65 to 84 years, of white, black, Chinese, or Hispanic ethnicity</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
                <col width="5%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" colspan="17">Mean IMT RCCA</th>
                </tr>
              </thead>
              <tbody>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left" rowspan="3" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>White man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>White woman</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Black man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Black woman</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">%25</td>
                  <td align="center">0.52</td>
                  <td align="center">0.57</td>
                  <td align="center">0.65</td>
                  <td align="center">0.72</td>
                  <td align="center">0.51</td>
                  <td align="center">0.55</td>
                  <td align="center">0.65</td>
                  <td align="center">0.72</td>
                  <td align="center">0.58</td>
                  <td align="center">0.61</td>
                  <td align="center">0.71</td>
                  <td align="center">0.74</td>
                  <td align="center">0.55</td>
                  <td align="center">0.60</td>
                  <td align="center">0.65</td>
                  <td align="center">0.71</td>
                </tr>
                <tr>
                  <td align="left">%50</td>
                  <td align="center">0.62</td>
                  <td align="center">0.68</td>
                  <td align="center">0.77</td>
                  <td align="center">0.83</td>
                  <td align="center">0.58</td>
                  <td align="center">0.65</td>
                  <td align="center">0.75</td>
                  <td align="center">0.83</td>
                  <td align="center">0.67</td>
                  <td align="center">0.74</td>
                  <td align="center">0.85</td>
                  <td align="center">0.85</td>
                  <td align="center">0.64</td>
                  <td align="center">0.71</td>
                  <td align="center">0.76</td>
                  <td align="center">0.83</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">%75</td>
                  <td align="center">0.71</td>
                  <td align="center">0.81</td>
                  <td align="center">0.92</td>
                  <td align="center">0.97</td>
                  <td align="center">0.67</td>
                  <td align="center">0.76</td>
                  <td align="center">0.87</td>
                  <td align="center">0.93</td>
                  <td align="center">0.80</td>
                  <td align="center">0.92</td>
                  <td align="center">0.99</td>
                  <td align="center">1,02</td>
                  <td align="center">0.74</td>
                  <td align="center">0.81</td>
                  <td align="center">0.92</td>
                  <td align="center">0.96</td>
                </tr>
                <tr>
                  <td align="left" rowspan="3" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Chinese man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Chinese woman</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Hispanic man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Hispanic woman</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">%25</td>
                  <td align="center">0.54</td>
                  <td align="center">0.56</td>
                  <td align="center">0.62</td>
                  <td align="center">0.66</td>
                  <td align="center">0.55</td>
                  <td align="center">0.54</td>
                  <td align="center">0.59</td>
                  <td align="center">0.67</td>
                  <td align="center">0.53</td>
                  <td align="center">0.60</td>
                  <td align="center">0.65</td>
                  <td align="center">0.71</td>
                  <td align="center">0.51</td>
                  <td align="center">0.57</td>
                  <td align="center">0.65</td>
                  <td align="center">0.63</td>
                </tr>
                <tr>
                  <td align="left">%50</td>
                  <td align="center">0.64</td>
                  <td align="center">0.70</td>
                  <td align="center">0.73</td>
                  <td align="center">0.79</td>
                  <td align="center">0.60</td>
                  <td align="center">0.63</td>
                  <td align="center">0.71</td>
                  <td align="center">0.77</td>
                  <td align="center">0.62</td>
                  <td align="center">0.67</td>
                  <td align="center">0.78</td>
                  <td align="center">0.81</td>
                  <td align="center">0.58</td>
                  <td align="center">0.69</td>
                  <td align="center">0.76</td>
                  <td align="center">0.78</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">%75</td>
                  <td align="center">0.73</td>
                  <td align="center">0.83</td>
                  <td align="center">0.92</td>
                  <td align="center">0.98</td>
                  <td align="center">0.70</td>
                  <td align="center">0.77</td>
                  <td align="center">0.84</td>
                  <td align="center">0.96</td>
                  <td align="center">0.73</td>
                  <td align="center">0.82</td>
                  <td align="center">0.90</td>
                  <td align="center">0.92</td>
                  <td align="center">0.67</td>
                  <td align="center">0.77</td>
                  <td align="center">0.87</td>
                  <td align="center">0.92</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center" colspan="17">
                    <bold>Mean IMT LCCA</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="3" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Percentile</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>White man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>White woman</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Black man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Black woman</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">%25</td>
                  <td align="center">0.54</td>
                  <td align="center">0.57</td>
                  <td align="center">0.67</td>
                  <td align="center">0.71</td>
                  <td align="center">0.50</td>
                  <td align="center">0.55</td>
                  <td align="center">0.63</td>
                  <td align="center">0.70</td>
                  <td align="center">0.56</td>
                  <td align="center">0.63</td>
                  <td align="center">0.69</td>
                  <td align="center">0.72</td>
                  <td align="center">0.54</td>
                  <td align="center">0.59</td>
                  <td align="center">0.63</td>
                  <td align="center">0.68</td>
                </tr>
                <tr>
                  <td align="left">%50</td>
                  <td align="center">0.63</td>
                  <td align="center">0.69</td>
                  <td align="center">0.81</td>
                  <td align="center">0.85</td>
                  <td align="center">0.58</td>
                  <td align="center">0.64</td>
                  <td align="center">0.73</td>
                  <td align="center">0.80</td>
                  <td align="center">0.69</td>
                  <td align="center">0.75</td>
                  <td align="center">0.82</td>
                  <td align="center">0.85</td>
                  <td align="center">0.63</td>
                  <td align="center">0.67</td>
                  <td align="center">0.76</td>
                  <td align="center">0.78</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">%75</td>
                  <td align="center">0.78</td>
                  <td align="center">0.82</td>
                  <td align="center">0.95</td>
                  <td align="center">1,00</td>
                  <td align="center">0.67</td>
                  <td align="center">0.75</td>
                  <td align="center">0.85</td>
                  <td align="center">0.94</td>
                  <td align="center">0.81</td>
                  <td align="center">0.92</td>
                  <td align="center">0.99</td>
                  <td align="center">1,02</td>
                  <td align="center">0.73</td>
                  <td align="center">0.80</td>
                  <td align="center">0.90</td>
                  <td align="center">0.91</td>
                </tr>
                <tr>
                  <td align="left" rowspan="3" style="border-bottom-width:thin;border-bottom-style:solid">
                    <bold>Percentil</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Chinese man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Chinese woman</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Hispanic man</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Hispanic woman</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                  <td align="center" colspan="4">
                    <bold>Age</bold>
                  </td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <td align="left">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                  <td align="center">
                    <bold>45-54</bold>
                  </td>
                  <td align="center">
                    <bold>55-64</bold>
                  </td>
                  <td align="center">
                    <bold>65-74</bold>
                  </td>
                  <td align="center">
                    <bold>75-84</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">%25</td>
                  <td align="center">0.55</td>
                  <td align="center">0.57</td>
                  <td align="center">0.62</td>
                  <td align="center">0.69</td>
                  <td align="center">0.49</td>
                  <td align="center">0.52</td>
                  <td align="center">0.58</td>
                  <td align="center">0.64</td>
                  <td align="center">0.55</td>
                  <td align="center">0.61</td>
                  <td align="center">0.68</td>
                  <td align="center">0.72</td>
                  <td align="center">0.51</td>
                  <td align="center">0.58</td>
                  <td align="center">0.62</td>
                  <td align="center">0.68</td>
                </tr>
                <tr>
                  <td align="left">%50</td>
                  <td align="center">0.63</td>
                  <td align="center">0.70</td>
                  <td align="center">0.72</td>
                  <td align="center">0.84</td>
                  <td align="center">0.58</td>
                  <td align="center">0.63</td>
                  <td align="center">0.71</td>
                  <td align="center">0.76</td>
                  <td align="center">0.64</td>
                  <td align="center">0.72</td>
                  <td align="center">0.80</td>
                  <td align="center">0.86</td>
                  <td align="center">0.58</td>
                  <td align="center">0.68</td>
                  <td align="center">0.72</td>
                  <td align="center">0.77</td>
                </tr>
                <tr>
                  <td align="left">%75</td>
                  <td align="center">0.73</td>
                  <td align="center">0.84</td>
                  <td align="center">0.86</td>
                  <td align="center">0.97</td>
                  <td align="center">0.67</td>
                  <td align="center">0.72</td>
                  <td align="center">0.87</td>
                  <td align="center">0.94</td>
                  <td align="center">0.75</td>
                  <td align="center">0.85</td>
                  <td align="center">0.98</td>
                  <td align="center">0.97</td>
                  <td align="center">0.68</td>
                  <td align="center">0.79</td>
                  <td align="center">0.86</td>
                  <td align="center">0.91</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN4">
                <p>
                  <italic>RCCA: right common carotid artery; LCCA: left common carotid artery; IMT: intima-media thickness.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>2.2.4. How to Prepare a Report</title>
          <p>Describe the mean IMT on each side, in mm, in the body of the report. Also, include in conclusion if the value is above or below the 75 percentile and the table used, with its bibliographic reference.</p>
          <p>Inform the presence of carotid plaques, with their specific characteristics and quantification, according to the criteria recommended by the recent Brazilian consensus.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
        </sec>
      </sec>
      <sec>
        <title>2.3. Morphological Evaluation of Carotid Atherosclerotic Plaques</title>
        <p>CP morphology plays an essential role in the incidence of cerebrovascular events and can also be an important predictor of events.<xref ref-type="bibr" rid="B17">17</xref><sup>,</sup><xref ref-type="bibr" rid="B18">18</xref>
				</p>
        <p>Recognizing the ultrasound characteristics of the plaque can help to identify unstable ones. Describe the following properties: location, extension, echogenicity, texture, surface, presence of movable components, and anechoic areas next to the fibrotic capsule. Report these characteristics for the most important plaques, particularly those with more than 50% stenosis.</p>
        <p>&#8226; <bold>Location:</bold> we recommend subdividing the carotids into distal and proximal common carotid, bifurcation, external branch, and proximal and medial internal branch (<xref ref-type="fig" rid="f2">Figure 2</xref>). </p>
        <p>
          <fig id="f2">
            <label>Figure 2</label>
            <caption>
              <title>Right carotid and its anatomical subdivisions recommended by the group (adapted from the Mannheim study).9 CC: common carotid; IB: internal branch; BCA: brachiocephalic artery.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf02.jpg"/></fig>
        </p>
        <p>&#8226; <bold>Extension</bold>: must be measured, as it can be correlated with events and affects the choice of surgical and endovascular treatment.<xref ref-type="bibr" rid="B19">19</xref>
				</p>
        <p>&#8226; <bold>Echogenicity</bold>: defined by comparing the plaque echogenicity to that of adjacent structures (blood, muscle, adventitia of the vessel, and bone), and classified into:<xref ref-type="bibr" rid="B20">20</xref>
				</p>
        <p>- Hypoechoic or echolucent: darker, that is, echogenicity similar to that of blood and less echogenic than the sternocleidomastoid muscle.</p>
        <p>- Isoechoic: echogenicity close to that of muscle.</p>
        <p>- Hyperechoic: lighter than the adjacent muscle.</p>
        <p>- Calcified: very echogenic, creating acoustic shadowing due to calcium deposition. Echogenicity is comparable to that of the bone.</p>
        <p>&#8226; <bold>Echotexture</bold>: Reilly et al.<xref ref-type="bibr" rid="B21">21</xref> classified the texture of the plaque as homogeneous or heterogeneous.</p>
        <p>- Homogeneous: uniform in both low and high echo levels.</p>
        <p>- Heterogeneous: a mixture of high, medium, and low echo levels.</p>
        <p>&#8226; <bold>Surface</bold>: lumen surface is categorized into three classes:<xref ref-type="bibr" rid="B20">20</xref><sup>,</sup><xref ref-type="bibr" rid="B22">22</xref>
				</p>
        <p>- Smooth: irregularities of less than 0.4 mm depth.</p>
        <p>- Irregular: from 0.4 to 2 mm depth.</p>
        <p>- Ulcerated: crater greater than 2.0 mm depth.</p>
      </sec>
      <sec>
        <title>2.4. Quantification of Carotid Artery Stenosis</title>
        <p>Several institutions published evaluation criteria for carotid stenosis, with some differences in interpretation.<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B23">23</xref><sup>-</sup><xref ref-type="bibr" rid="B25">25</xref> However, in 2003, a consensus document was published in the USA to make recommendations on the performance of VUS of carotid arteries. The United Kingdom followed them in 2009, and the DCI of the Brazilian Society of Cardiology (BSC) in 2015.<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B4">4</xref>
				</p>
        <sec>
          <title>2.4.1. Measurement Techniques to Quantify Stenosis</title>
          <p>The assessment of carotid stenosis with VUS is based on measurements of flow velocity and their relationships using spectral Doppler, associated with the evaluation of two-dimensional and color Doppler imaging. With the patient in the supine position, use transverse and longitudinal ultrasound planes that allow the visualization of the right and left carotid system.</p>
          <p><xref ref-type="fig" rid="f3">Figure 3</xref> shows the recommendation from DCI-BSC for the sequence of evaluation of carotid stenosis.</p>
          <p>
            <fig id="f3">
              <label>Figure 3</label>
              <caption>
                <title>Recommendation from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology for the sequence of evaluation of carotid stenosis. PSV: peak systolic velocity.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf03.jpg"/></fig>
          </p>
          <p>
            <bold>
              <italic>2.4.1.1. Quantification of Carotid Stenosis with Hemodynamic Parameters</italic>
            </bold>
          </p>
          <p>Arterial flow velocity measured by Doppler is presented as flow velocity waveforms (spectrum) for each site examined. Wave characteristics depend on the type of local flow, as well as changes in blood velocity resulting from conditions proximal and distal to the measurement site. In the internal carotid artery (ICA), the resistance of flow velocity waveforms is usually of low. In the external carotid artery (ECA), the resistance of velocity waveform is high, while in the common carotid artery (CCA), it is intermediate between ICA and ECA<xref ref-type="bibr" rid="B13">13</xref>(<xref ref-type="fig" rid="f4">Figure 4</xref>).</p>
          <p>
            <fig id="f4">
              <label>Figure 4</label>
              <caption>
                <title>Normal flow patterns of carotid arteries. (A) Common carotid artery. (B) Internal carotid artery. (C) External carotid artery.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf04.jpg"/></fig>
          </p>
          <p>Measure the velocities in the proximal and distal segments of CCA. To evaluate the velocity ratio in the quantification of ICA stenosis, assess CCA at approximately 2 cm from the bifurcation, preferably in a rectilinear segment, without plaques.<xref ref-type="bibr" rid="B4">4</xref> Analyze ICA in the proximal and middle segments, since atherosclerotic lesions usually affect the proximal 2 cm. The cursor must be parallel to the vessel wall, with a volume sample smaller than the lumen, and positioned in its center and toward the flow, so the insonation angle is &#8804; 60&#186; (<xref ref-type="fig" rid="f5">Figure 5</xref>).<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B26">26</xref>
					</p>
          <p>
            <fig id="f5">
              <label>Figure 5</label>
              <caption>
                <title>(1) Diagram illustrating the placement of the cursor and the insonation angle. (A) Parallel to the jet in case of stenosis. (B) Parallel to the vessel. (2) Cursor and insonation angle toward the flow jet in case of stenosis (arrow).</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf05.jpg"/></fig>
          </p>
          <p>After identifying the stenosis with B-scan and/or color Doppler, document the spectral tracing in this point, and pre-stenotic and post-stenotic regions. The velocity evaluation given by the spectral tracing must include the peak systolic velocity (PSV) and end-diastolic velocity (EDV) in CCA and ICA. Systolic and diastolic velocities provide the following relationships (ratios): PSV ICA/PSV CCA, PSV ICA/EDV CCA, and EDV ICA/EDV CCA. </p>
          <p>Subocclusions are diagnosed based on the narrowing of the vessel lumen using color/power Doppler, with thin flow (string sign or trickle flow); however, it might be associated with high, low, or undetectable velocities, which occasionally hinders the diagnosis.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
          <p>In turn, carotid occlusions can be diagnosed with ultrasound as the absence of patent lumen in grayscale and undetected flow with color/power Doppler and/or spectral Doppler, in addition to the presence of high-resistance flow in CCA and staccato flow - flow with minimal velocity and very high-resistance at the occlusion or pre-occlusion site.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
          <p>The study group from DCI-BSC suggests the use of <xref ref-type="table" rid="t6">table 6</xref> to quantify ICA stenosis.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
          <table-wrap id="t6">
            <label>Table 6</label>
            <caption>
              <title>Quantification of internal carotid artery stenosis (Department of Cardiovascular Imaging of the Brazilian Society of Cardiology)</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="16%"/>
                <col width="16%"/>
                <col width="16%"/>
                <col width="16%"/>
                <col width="16%"/>
                <col width="16%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">% Anat Dist St (Nascet)</th>
                  <th align="center">PSV cm/s</th>
                  <th align="center">EDV cm/s</th>
                  <th align="center">PSV lC/ PSV CC</th>
                  <th align="center">PSV IC / EDV CC</th>
                  <th align="center">EDV IC / EDV CC</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">&lt; 50%</td>
                  <td align="center" style="background-color:#339C6D">&lt; 140</td>
                  <td align="center" style="background-color:#ffff00">&lt; 40</td>
                  <td align="center" style="background-color:#ffff00">&lt; 2.0</td>
                  <td align="center" style="background-color:#FFC926">&lt; 8</td>
                  <td align="center" style="background-color:#FFC926">&lt; 2.6</td>
                </tr>
                <tr>
                  <td align="left">50 to 59%</td>
                  <td align="center" style="background-color:#339C6D">140 to 230</td>
                  <td align="center" style="background-color:#ffff00">40 to 69</td>
                  <td align="center" style="background-color:#ffff00">2.0 to 3.1</td>
                  <td align="center" style="background-color:#FFC926">8 to 10</td>
                  <td align="center" style="background-color:#FFC926">2.6 to 5.5</td>
                </tr>
                <tr>
                  <td align="left">60 to 69%</td>
                  <td align="center" style="background-color:#339C6D">&#8211;</td>
                  <td align="center" style="background-color:#ffff00">70 to 100</td>
                  <td align="center" style="background-color:#ffff00">3.2 to 4.0</td>
                  <td align="center" style="background-color:#FFC926">11 to 13</td>
                  <td align="center" style="background-color:#FFC926">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">70 to 79%</td>
                  <td align="center" style="background-color:#339C6D">&gt; 230</td>
                  <td align="center" style="background-color:#ffff00">&gt; 100</td>
                  <td align="center" style="background-color:#ffff00">&gt; 4.0</td>
                  <td align="center" style="background-color:#FFC926">14 to 21</td>
                  <td align="center" style="background-color:#FFC926">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">80 to 89%</td>
                  <td align="center" style="background-color:#339C6D">&#8211;</td>
                  <td align="center" style="background-color:#ffff00">&gt; 140</td>
                  <td align="center" style="background-color:#ffff00">&#8211;</td>
                  <td align="center" style="background-color:#FFC926">22 to 29</td>
                  <td align="center" style="background-color:#FFC926">&gt; 5.5</td>
                </tr>
                <tr>
                  <td align="left">&gt; 90%</td>
                  <td align="center" style="background-color:#339C6D">&gt; 400</td>
                  <td align="center" style="background-color:#ffff00">&#8211;</td>
                  <td align="center" style="background-color:#ffff00">&gt; 5.0</td>
                  <td align="center" style="background-color:#FFC926">&gt; 30</td>
                  <td align="center" style="background-color:#FFC926">
									</td>
                </tr>
                <tr>
                  <td align="left">Subocclusion</td>
                  <td align="center">Variable &#8211; thin flow</td>
                  <td align="center">Variable &#8211; thin flow</td>
                  <td align="center">Variable &#8211; thin flow</td>
                  <td align="center">Variable &#8211; thin flow</td>
                  <td align="center">Variable &#8211; thin flow</td>
                </tr>
                <tr>
                  <td align="left">Occlusion</td>
                  <td align="center">Lack of flow</td>
                  <td align="center">Lack of flow</td>
                  <td align="center">Not applicable</td>
                  <td align="center">Not applicable</td>
                  <td align="center">Not applicable</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN5">
                <p><italic>The colors represent, from left to right, the most relevant criteria according to the literature. CC: common carotid; IC: internal carotid; EDV: end-diastolic velocity; PSV: peak systolic velocity</italic>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>
            <bold>
              <italic>2.4.1.2. Quantification of Carotid Stenosis with Anatomic Parameters</italic>
            </bold>
          </p>
          <p>The anatomical criterion (<xref ref-type="fig" rid="f6">Figure 6</xref>) is based on the assessment of lumen reduction and should be used to characterize, in particular, stenosis below 50% (without hemodynamic repercussion); however, it is also a great contributor in stenosis greater than 50%, in which the hemodynamic criterion can fail to quantify stenosis accurately (e.g., severe aortic stenosis, significant contralateral carotid stenosis, among others). Lumen reduction is preferentially measured by diameter, and the result of the carotid stenosis range should be reported in intervals of 10%. It is recommended not to measure plaques smaller than 20% to avoid possible differences in the measurement of diameter reduction when the thickened intima is included or stopped being included.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
          <p>
            <fig id="f6">
              <label>Figure 6</label>
              <caption>
                <title>Measurement of lumen reduction. (A) Smooth atheromatous plaque in the lumen. (B) Irregular atheromatous plaque in the lumen.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf06.jpg"/></fig>
          </p>
        </sec>
        <sec>
          <title>2.4.2. Circumstances that Can Change the Measurement of Flow Velocities and Anatomic Evaluation</title>
          <p>Velocity evaluation can be compromised in some situations that affect measurements of spectral analysis. They can be located in the carotid bifurcation - distal or proximal - or even, in the contralateral carotid. Among the conditions proximal to the bifurcation, we underline aortic valve diseases (stenosis or insufficiency), atherosclerotic stenosis, or arteritis with involvement of the aortic arch, branches, and common carotid<xref ref-type="bibr" rid="B1">1</xref> (<xref ref-type="table" rid="t7">Table 7</xref>).</p>
          <table-wrap id="t7">
            <label>Table 7</label>
            <caption>
              <title>Circumstances that can change the measurement of flow velocities</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Pathology</th>
                  <th align="center">Abnormalities in VUS</th>
                  <th align="center">Assessment alternatives</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Stenosis proximal to the common carotid artery or brachiocephalic artery</td>
                  <td align="center">Reduced absolute flow velocities (PSV and EDV)</td>
                  <td align="center">Using the velocity ratio and evaluation by the anatomical criterion</td>
                </tr>
                <tr>
                  <td align="left">Significant stenosis or contralateral carotid occlusion</td>
                  <td align="center">Compensatory increase in flow velocities</td>
                  <td align="center">Using the velocity ratio and evaluation by the anatomical criterion</td>
                </tr>
                <tr>
                  <td align="left">Arrhythmias (atrial fibrillation)</td>
                  <td align="center">Variable velocity peaks</td>
                  <td align="center">Waiting for the most regular period, or using an average of five beats and anatomical criterion</td>
                </tr>
                <tr>
                  <td align="left">Aortic valve stenosis</td>
                  <td align="center">Reduced absolute flow velocities (PSV and EDV)</td>
                  <td align="center">Using the velocity ratio and evaluation by the anatomical criterion</td>
                </tr>
                <tr>
                  <td align="left">Aortic valve insufficiency</td>
                  <td align="center">Increase in PSV flow, with the possibility of retrograde diastolic flow</td>
                  <td align="center">Using anatomical criterion or velocity ratio that does not involve EDV</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN6">
                <p>
                  <italic>VUS: Vascular Ultrasound; EDV: end-diastolic velocity; PSV: peak systolic velocity.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Anatomic evaluation can be affected in circumstances such as arterial calcification with acoustic shadowing, improper adjustment of equipment, among others.</p>
        </sec>
        <sec>
          <title>2.4.3. Report Description</title>
          <p>Relevant information for the report: </p>
          <p>Specify the type of transducer used.</p>
          <p>Inform the technical quality of the examination (report situations that can lower its quality - e.g., presence of catheters). </p>
          <p>Describe the presence of atherosclerotic plaques, their location, extension, morphological characteristics, and degree of stenosis - quantified in deciles according to the DCI-BSC recommendation.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
          <p>Report other findings of or related to carotid arteries (e.g., tortuosities, dissections, tumors, arteritis). </p>
        </sec>
      </sec>
      <sec>
        <title>2.5. Ultrasound Assessment After Carotid Intervention</title>
        <p>Treatment of symptomatic and asymptomatic carotid atherosclerotic disease has been the subject of multidisciplinary debate. Interventional treatment can be done by carotid endarterectomy or carotid stenting.</p>
        <p>Ultrasound is the examination of choice for the follow-up after carotid intervention, and its protocol has the same sequence of the examination of carotid arteries without intervention, with some peculiarities in the intervention site. For more information about what to report on the vascular intervention site, the basic protocol of ultrasound follow-up, and velocity parameter tables, we suggest consulting the DCI recommendations recently published.<xref ref-type="bibr" rid="B1">1</xref>
				</p>
      </sec>
      <sec>
        <title>2.6. Ultrasound Evaluation of Vertebral Arteries</title>
        <p>The VUS evaluation of extracranial vertebral arteries contributes to the carotid study. It is divided into four segments: three extracranial and one intracranial (<xref ref-type="fig" rid="f7">Figure 7</xref>).<xref ref-type="bibr" rid="B27">27</xref><sup>,</sup><xref ref-type="bibr" rid="B28">28</xref>
				</p>
        <p>
          <fig id="f7">
            <label>Figure 7</label>
            <caption>
              <title>Extracranial segments of the vertebral artery (V0-V3).</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf07.jpg"/></fig>
        </p>
        <sec>
          <title>2.6.1. Methodology to Perform the Examination</title>
          <p>The patient&#8217;s position is the same as that adopted for the carotid study. </p>
          <p>To evaluate the extracranial part of vertebral arteries, start the examination by the V2 segment. At this point, with the aid of color Doppler and small angulation movements, try to identify the artery (as well as its vein) and record the spectral curves, adapting the scale and insonation angle of the vessel. Past this point, the artery is displayed toward its origin. The V3 segment of the vertebral artery lies below the mastoid process of the temporal bone (anatomic mark for the study). This region presents the vessel end of the transverse foramen and its course around the mastoid process (also called &#8220;atlas loop&#8221; due to its anatomical relationship with this vertebral body).<xref ref-type="bibr" rid="B3">3</xref> The typical parameters expected are:</p>
          <p>Diameter: ranges from 2 to 4 mm. Caliber asymmetry among vertebral arteries is common (73% of cases), and the left one has a more dilated caliber in 50% of cases.<xref ref-type="bibr" rid="B28">28</xref><sup>,</sup><xref ref-type="bibr" rid="B29">29</xref> The normal standard with pulsed wave Doppler is waveforms with laminar antegrade flow of low-resistance, PSV between 20 and 60 cm/s in the V2 segment, and that can range from 30 to 100 cm/s in the origin of the vertebral artery. Due to the frequent diameter asymmetry, there is a considerable difference in PSV and resistance index (RI) among the normal vertebral arteries of an individual.<xref ref-type="bibr" rid="B27">27</xref>
					</p>
          <p>Vertebral artery hypoplasia is defined as a vessel diameter equal to or lower than 2.0 mm (or caliber asymmetry among vertebral arteries with ratio &gt; 1:1.7).<xref ref-type="bibr" rid="B28">28</xref>
					</p>
        </sec>
        <sec>
          <title>2.6.2. Quantification of Stenosis</title>
          <p>Proximal stenosis (V0-V1) diagnosis results from the increase in flow velocities at the lesion site. The DCI-BSC standardization<xref ref-type="bibr" rid="B3">3</xref> suggests the values presented in <xref ref-type="table" rid="t8">table 8</xref>, adapted from the study by Hua et al.<xref ref-type="bibr" rid="B30">30</xref> Evaluate stenosis in the remaining segments with VUS based on multi-parameter analysis, such as turbulent flow with color Doppler, local increase in flow velocities, increase in velocity rates, and distal flow damping, since there are no tables of quantification of stenosis for these segments.</p>
          <table-wrap id="t8">
            <label>Table 8</label>
            <caption>
              <title>Cut-off velocity values for proximal vertebral artery stenosis</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Stenosis</th>
                  <th align="center">&lt; 50%</th>
                  <th align="center">50 to 69%</th>
                  <th align="center">70 to 99%</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">V<sub>max</sub></td>
                  <td align="center">&#8805; 85 cm/s</td>
                  <td align="center">&#8805; 140 cm/s</td>
                  <td align="center">&#8805; 210 cm/s</td>
                </tr>
                <tr>
                  <td align="left">VVR</td>
                  <td align="center">&#8805; 1.3</td>
                  <td align="center">&#8805; 2.1</td>
                  <td align="center">&#8805; 4</td>
                </tr>
                <tr>
                  <td align="left">EDV</td>
                  <td align="center">&#8805; 27 cm/s</td>
                  <td align="center">&#8805; 35 cm/s</td>
                  <td align="center">&#8805; 55 cm/s</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN7">
                <p><italic>VVR: maximum velocity rate at the stenosis site and the V2 segment; EDV: end-diastolic velocity</italic>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>3. Abdominal Aorta and Branches</title>
      <sec>
        <title>3.1. Abdominal Aortic Aneurysm</title>
        <sec>
          <title>3.1.1. General Considerations</title>
          <p>Aneurysms are defined as a local dilation equal to or greater than 50% of the proximal or normal arterial diameter, necessarily involving all vessel layers. Even though the diameter of the abdominal aorta changes with age, gender, and biotype, the mean diameter of the infrarenal aorta is approximately 2.0 cm, with upper normal limit &lt; 3.0 cm. Thus, abdominal aortic aneurysm (AAA) is defined as an aorta that measures &gt; 3.0 cm. AAAs are located between the diaphragm and the aortic bifurcation and can be classified as suprarenal, juxtarenal, and infrarenal. Approximately 85% of AAAs are infrarenal, and 5% involve the suprarenal aorta.<xref ref-type="bibr" rid="B31">31</xref> About 25% of patients with AAA have associated iliac artery aneurysm.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>Aneurysms can be fusiform, saccular, or with eccentric shapes. The type of asymmetry can significantly influence the risk of rupture and, as aneurysms grow, they can form laminated thrombi that preserve the arterial lumen.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>VUS is the most used examination to screen and diagnose asymptomatic patients in emergency units without a prior diagnosis and symptomatic ones. Computed tomography angiography (CTA) is the examination of choice for pre- and postoperative assessment; however, VUS does not lose its value for being more accessible, costing less, and not using nephrotoxic contrast. The current availability of microbubble contrast makes VUS quite attractive, particularly in postoperative assessments.<xref ref-type="bibr" rid="B32">32</xref>
					</p>
        </sec>
        <sec>
          <title>
            <bold>3.1.2. Clinical Indications</bold>
            <xref ref-type="bibr" rid="B2">2</xref>
          </title>
          <p>Screening (<xref ref-type="table" rid="t9">Table 9</xref>).</p>
          <table-wrap id="t9">
            <label>Table 9</label>
            <caption>
              <title>Recommendation from the Department of Cardiovascular Imaging for screening and follow-up of abdominal aortic aneurysm</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="100%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Screening</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">&#8226; Men aged 65 to 75 years</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Men aged 55 to 75 years with a family history of AAA and/or who smokes</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Women aged 55 to 75 years with a family history of AAA and/or who smokes</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid;border-top-width:thin;border-top-style:solid">
                  <td align="left">
                    <bold>Follow-up interval</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">&#8226; 2.6 to 2.9 cm &#8211; reevaluate in 5 years (sub-aneurysmal dilation)</td>
                </tr>
                <tr>
                  <td align="left">&#8226; 3.0 to 3.9 cm &#8211; 24 months</td>
                </tr>
                <tr>
                  <td align="left">&#8226; 4.0 to 4.5 cm &#8211; 12 months</td>
                </tr>
                <tr>
                  <td align="left">&#8226; 4.6 to 5.0 cm &#8211; 6 months</td>
                </tr>
                <tr>
                  <td align="left">&#8226; &gt; 5.0 cm &#8211; 3 months</td>
                </tr>
                <tr style="border-bottom-width:thin;border-bottom-style:solid;border-top-width:thin;border-top-style:solid">
                  <td align="left">
                    <bold>Indication for intervention</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">&#8226; &#8805; 5.5 cm</td>
                </tr>
                <tr>
                  <td align="left">&#8226; AAA-related symptoms</td>
                </tr>
                <tr>
                  <td align="left">&#8226; Growth rate &gt; 1.0 cm per year</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN8">
                <p>
                  <italic>AAA: abdominal aortic aneurysm.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Follow-up: monitor the growth and determine the appropriate time for surgery.<xref ref-type="bibr" rid="B33">33</xref>
					</p>
          <p>Evaluation of pulsating abdominal mass, signs of rupture, or growth. </p>
          <p>Preoperative AAA examination: report data on the access route, abnormalities in iliac arteries, fixation site of the endoprosthesis, aspect and measurements of the aneurysmal sac, and presence of parietal thrombi.</p>
          <p>Postoperative AAA examination.</p>
        </sec>
        <sec>
          <title>3.1.3. Examination Instructions and Protocols (<xref ref-type="table" rid="t10">Table 10</xref>)</title>
          <table-wrap id="t10">
            <label>Table 10</label>
            <caption>
              <title>Examination instructions and protocols for the study of abdominal aorta and branches</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="30%"/>
                <col width="17%"/>
                <col width="17%"/>
                <col width="17%"/>
                <col width="17%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Examination instructions</th>
                  <th align="center">Abdominal aorta</th>
                  <th align="center">Aortoiliac segment</th>
                  <th align="center">Mesenteric arteries and celiac trunk</th>
                  <th align="center">Renal arteries</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Low-frequency convex or sector transducers (2 to 5 MHz)</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Preferentially in the morning with 6- to 8-h fasting</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">The patient should not smoke, chew gums, or consume carbonated beverages</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Optional antiflatulent</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Supine position with head raised at 30<sup>o</sup></td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Lateral position</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">&#8211;</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Transverse, coronal, and longitudinal planes</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">What to evaluate:</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">B-scan:</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left"> Dimensions</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> Anatomic changes</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> Morphology of walls and plaques</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> Presence of thrombi</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">&#8211;</td>
                  <td align="center">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">Color Doppler:</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left"> Aliasing</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> Lack of flow (occlusion)</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left">Spectral Doppler:</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left"> PSV</td>
                  <td align="center">&#8211;</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> PSV ratio (V2/V1)</td>
                  <td align="center">&#8211;</td>
                  <td align="center">x</td>
                  <td align="center">&#8211;</td>
                  <td align="center">&#8211;</td>
                </tr>
                <tr>
                  <td align="left"> EDV</td>
                  <td align="center">&#8211;</td>
                  <td align="center">&#8211;</td>
                  <td align="center">x</td>
                  <td align="center">x</td>
                </tr>
                <tr>
                  <td align="left"> Renal aortic ratio</td>
                  <td align="center">&#8211;</td>
                  <td align="center">&#8211;</td>
                  <td align="center">&#8211;</td>
                  <td align="center">x</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN9">
                <p>
                  <italic>EDV: end-diastolic velocity; PSV: peak systolic velocity.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>
            <bold>3.1.4. Examination Protocol for Abdominal Aortic Aneurysm According to Recommendations from the Department of Cardiovascular Imaging</bold>
            <xref ref-type="bibr" rid="B2">2</xref>
          </title>
          <p>The examination must be conducted from the subxiphoid region to the aortic bifurcation, followed by the study of right and left common iliac arteries and their external and internal branches.</p>
          <p>The evaluation uses B-scan, with transverse, coronal, and longitudinal planes to detect atheroma plaques and measure the diameters, especially if dilations are found. Take the anteroposterior (AP) measurement of the aneurysm during the peak systolic expansion, reporting if it was made from outer wall to outer wall (OTO) or inner wall to inner wall (ITI).</p>
          <p>&#8226; <bold>Screening</bold>: use the B-scan during the subxiphoid part of the echocardiogram or in routine abdominal ultrasound.</p>
          <p>&#8226; <bold>Diagnosis and follow-up</bold>: screen the aorta from the subxiphoid region to its bifurcation, followed by the study of iliac arteries and branches. </p>
          <p>&#8226; <bold>Preoperative assessment</bold>: descriptions, necessary measurements, and relevant data are described in <xref ref-type="fig" rid="f8">figure 8</xref>.</p>
          <p>
            <fig id="f8">
              <label>Figure 8</label>
              <caption>
                <title>Preoperative assessment of abdominal aortic aneurysm (AAA).</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf08.jpg"/></fig>
          </p>
          <p>&#8226; <bold>Postoperative assessment</bold>: inform the surgical techniques used. They are described in detail in the DCI recommendations.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>Essential information to include in the medical report (<xref ref-type="fig" rid="f8">Figure 8</xref>):</p>
          <p>&#8226; <bold>Diagnostic examination:</bold></p>
          <p>- Report technical difficulties.</p>
          <p>- Measure the largest diameter of the aorta.</p>
          <p>- Inform the presence of tortuosities or enlargement of the aorta.</p>
          <p>- Define the location of the aneurysm: supra-, juxta-, or infrarenal.</p>
          <p>- Describe the anatomical shape of the aneurysm: saccular, fusiform, or other. </p>
          <p>- Inform the presence or absence of wall thrombi, the intraluminal diameter, and signs of rupture.</p>
          <p>&#8226; Additional information for the preoperative examination:</p>
          <p>- Diameters:</p>
          <p>&#9675; Neck in the lowest renal artery plane.</p>
          <p>&#9675; Neck 15 mm below the origin of the lowest renal artery.</p>
          <p>&#9675; Maximum AAA - AP transverse plane (ITI or OTO).</p>
          <p>&#9675; Bifurcation plane (when present).</p>
          <p>&#9675; Both common iliac arteries.</p>
          <p>&#9675; Iliac artery bifurcation.</p>
          <p>- Longitudinal extension of the proximal neck.</p>
          <p>- Neck angle with aneurysm axis.</p>
          <p>- Longitudinal extension of AAA.</p>
        </sec>
      </sec>
      <sec>
        <title>3.2. Aortoiliac Atherosclerotic Disease</title>
        <p>VUS allows the identification, localization, and anatomic extension of atherosclerotic lesions, and evaluates the aortic wall to register not only the presence of atherosclerotic lesion but of ulceration, calcification, thrombus, dissection, and dilation. When performed by trained and experienced professionals, this technique has good diagnostic accuracy for aortoiliac atherosclerotic disease, with 86% sensitivity and 97% specificity for lesions &gt; 50% stenosis.<xref ref-type="bibr" rid="B34">34</xref>
				</p>
        <sec>
          <title>3.2.1. Clinical Indications for Venous Ultrasound in Cases of Aortoiliac Atherosclerotic Disease</title>
          <p>Symptoms of acute ischemia (distal embolism) and intermittent claudication with decreased or absent femoral pulse, gluteal claudication, erectile dysfunction, and pain at rest.</p>
          <p>Clinical signs such as abdominal bruit and reduced ankle-brachial index.</p>
          <p>Prior VUS showing abnormalities in the velocity curve pattern of femoral arteries.</p>
          <p>Follow-up of grafts and endoprostheses for the treatment of aortoiliac obstruction.</p>
          <p>Suspected diagnosis of aortic dissection.</p>
          <p>Suspected diagnosis of arteritis.</p>
        </sec>
        <sec>
          <title>3.2.2. Examination Protocol for Aortoiliac Atherosclerotic Disease According to DCI Recommendations (<xref ref-type="table" rid="t10">Table 10</xref>)</title>
          <p>
            <bold>
              <italic>3.2.2.1. Diagnostic Criteria</italic>
            </bold>
          </p>
          <p>&#8226; <bold>Stenosis</bold>: measure PSV at the lesion site (V2) and 1 to 2 cm proximal to the lesion (V1) and calculate the velocity ratio (V2/V1). Determine the spectral curve with an angle &#8804; 60&#186; parallel to the turbulent flow axis (<xref ref-type="fig" rid="f9">Figure 9</xref>). The degree of stenosis should be classified according to <xref ref-type="table" rid="t11">table 11</xref>.</p>
          <p>
            <fig id="f9">
              <label>Figure 9</label>
              <caption>
                <title>Color flow imaging showing the flow proximal to the lesion in red and the turbulent flow at the lesion site (arrow). The diagrams A and C demonstrate the velocity spectrum with Doppler. (A) Cursor proximal to the lesion to measure V1. (B) Cursor at the lesion site to measure V2. (C) Cursor distal to the lesion with damped waveform.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf09.jpg"/></fig>
          </p>
          <table-wrap id="t11">
            <label>Table 11</label>
            <caption>
              <title>Classification of the degree of stenosis with pulsed wave Doppler</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="50%"/>
                <col width="50%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Classification</th>
                  <th align="center">Systolic velocity ratio</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Stenosis &lt; 50%</td>
                  <td align="center">V2/V1 &lt; 2.0</td>
                </tr>
                <tr>
                  <td align="left">Stenosis &#8805; 50%</td>
                  <td align="center">V2/V1 &#8805; 2.0</td>
                </tr>
                <tr>
                  <td align="left">Stenosis &#8805; 70%</td>
                  <td align="center">V2/V1 &#8805; 4.0</td>
                </tr>
                <tr>
                  <td align="left">Occlusion</td>
                  <td align="center">Lack of flow</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>&#8226; <bold>Occlusion</bold>: lack of flow in any aortoiliac segment, even with scan parameters that detect low-velocity flows. Presence of typical preocclusive waveform (high peripheral resistance, low peak systolic velocity, and lack of diastolic flow). Collateral vessels can be found in occluded pre- and post-segment (re-entry point). The post-occlusive spectrum is characterized by monophasic waveform, with reduced PSV and prolonged acceleration time - <italic>parvus/tardus</italic> (<xref ref-type="fig" rid="f9">Figure 9</xref>). Hypoechoic image with a concave interface in colored flow and spectrum in preocclusive <italic>staccato</italic> pattern suggests thromboembolic occlusion. </p>
          <p>&#8226; Essential information to include in the medical report:</p>
          <p>- Diagnostic examination: </p>
          <p>&#9675; Report if there were technical difficulties during the examination.</p>
          <p>&#9675; In case of dilations, inform the largest diameter of the aorta and/or iliac arteries.</p>
          <p>- Additional information for the preoperative examination: </p>
          <p>&#8226; Inform the presence, aspect, and location of atherosclerotic plaques, as well as the degree of stenosis of lesions. <xref ref-type="table" rid="t12">Table 12</xref> lists the general limitations of VUS examination.</p>
          <table-wrap id="t12">
            <label>Table 12</label>
            <caption>
              <title>General limitations of vascular ultrasound in the evaluation of abdominal aorta and branches</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Aorta and iliacs</th>
                  <th align="left">Mesenteric arteries/Celiac trunk</th>
                  <th align="left">Renal arteries</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">&#9679; Hostile abdomen</td>
                  <td align="left">&#9679; Hostile abdomen</td>
                  <td align="left">&#9679; Hostile abdomen</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Obesity</td>
                  <td align="left">&#9679; Obesity</td>
                  <td align="left">&#9679; Obesity</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Intestinal meteorism</td>
                  <td align="left">&#9679; Intestinal meteorism</td>
                  <td align="left">&#9679; Intestinal meteorism</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Examiner-dependent</td>
                  <td align="left">&#9679; Patient with severe abdominal pain &#8211; in acute ischemia</td>
                  <td align="left">&#9679; Anatomic changes</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Low-quality equipment</td>
                  <td align="left">&#9679; Examiner-dependent</td>
                  <td align="left">&#9679; Examiner-dependent</td>
                </tr>
                <tr>
                  <td align="left">
									</td>
                  <td align="left">&#9679; Low-quality equipment</td>
                  <td align="left">&#9679; Low-quality equipment</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
      </sec>
      <sec>
        <title>3.3. Mesenteric Arteries</title>
        <sec>
          <title>3.3.1. General Considerations</title>
          <p>Mesenteric vessels are represented by the celiac trunk (CT) and superior and inferior mesenteric arteries (SMA and IMA, respectively). Anatomically, CT starts just below the aortic hiatus of the diaphragm and originates the splenic and hepatic arteries. </p>
          <p>SMA and IMA begin approximately 0.5 to 2 cm below CT and 4 to 5 cm above the aortic bifurcation, respectively (<xref ref-type="fig" rid="f10">Figure 10</xref>).<xref ref-type="bibr" rid="B35">35</xref>
					</p>
          <p>
            <fig id="f10">
              <label>Figure 10</label>
              <caption>
                <title>Abdominal aorta and branches. SA: splenic artery; HA: hepatic artery; RCIA: right common iliac artery; LCIA: left common iliac artery; IMA: inferior mesenteric artery; RRA: right renal artery; LRA: left renal artery; SMA: superior mesenteric artery; CT: celiac trunk.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf10.jpg"/></fig>
          </p>
          <p>Mesenteric artery obstructive disease progresses chronically and asymptomatically. The clinical manifestation represented by postprandial abdominal pain (mesenteric angina) and/or progressive weight loss occurs when two or more mesenteric vessels are involved. Older men are more frequently affected. Atherosclerosis is responsible for more than 90% of diseases that strike mesenteric arteries and is usually dissemination of the atheromatous process that involves the entire aorta.<xref ref-type="bibr" rid="B36">36</xref>
					</p>
          <p>Arteriography is the standard diagnostic method; however, VUS is the first examination indicated for the study of symptomatic chronic intestinal ischemia for being non-invasive and risk-free.<xref ref-type="bibr" rid="B37">37</xref>
					</p>
          <p>The objective of VUS is to determine the presence, location, extension, and severity of the stenotic lesion. The study must include the SMA, CT, and IMA, with the evaluation of SMA and CT being more important.<xref ref-type="bibr" rid="B38">38</xref>
					</p>
        </sec>
        <sec>
          <title>3.3.2. Clinical Indications</title>
          <p>Recurrent postprandial abdominal pain (mesenteric angina).</p>
          <p>Weight loss without a known cause.</p>
          <p>Abdominal bruit.</p>
          <p>The DCI recommendations describe in detail the protocols of follow-up after surgical or endovascular treatment and assessment of compression syndromes.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
        </sec>
        <sec>
          <title>3.3.3. Examination Preparation and General Protocol (Table 10)</title>
          <p>&#8226; <bold>Specific examination protocol:</bold><xref ref-type="bibr" rid="B39">39</xref><sup>,</sup><xref ref-type="bibr" rid="B40">40</xref>
					</p>
          <p>- Place the transducer in the epigastric region; using the transverse plane, identify the SMA anteriorly, the aorta posteriorly, and the right renal vein between these two vessels (<xref ref-type="fig" rid="f11">Figure 11A</xref>). In this same location, using the longitudinal plane of the aorta, find the CT and SMA (<xref ref-type="fig" rid="f11">Figure 11B</xref>).</p>
          <p>
            <fig id="f11">
              <label>Figure 11</label>
              <caption>
                <title>Mesenteric vessels and abdominal aorta. (A) Transverse plane with B-scan showing the superior mesenteric artery (SMA) anteriorly and the abdominal aorta (AA) posteriorly. (B) Longitudinal plane of the abdominal aorta and emergence of the celiac trunk and SMA.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf11.jpg"/></fig>
          </p>
          <p>- B-scan: evaluates the presence of atherosclerotic or aneurysmal disease.</p>
          <p>- Color flow imaging: assesses vessel patency and indicates flow turbulence, suggesting the probable stenosis site. </p>
          <p>- Spectral analysis: used to analyze PSV and EDV. Measure these velocities in the origin of the vessel and/or in places with suspicion of stenosis. Position the insonation angle toward the blood flow. </p>
          <p>- Velocities of mesenteric vessels are influenced by respiration; therefore, patients should hold their breath during the measurement. </p>
          <p>&#8226; <xref ref-type="table" rid="t13">Table 13</xref> presents the ultrasonographic criteria to assess flow in CT and SMA.<xref ref-type="bibr" rid="B2">2</xref><sup>,</sup><xref ref-type="bibr" rid="B41">41</xref><sup>-</sup><xref ref-type="bibr" rid="B43">43</xref>
					</p>
          <table-wrap id="t13">
            <label>Table 13</label>
            <caption>
              <title>Ultrasonographic criteria to assess the native celiac trunk and superior mesenteric artery</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="20%"/>
                <col width="20%"/>
                <col width="20%"/>
                <col width="20%"/>
                <col width="20%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Artery</th>
                  <th align="center">Normal Doppler</th>
                  <th align="center">Stenosis &#8805; 50%</th>
                  <th align="center">Stenosis &#8805; 70%</th>
                  <th align="center">Occlusion</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">CT</td>
                  <td align="center">Low-resistance</td>
                  <td align="center">PSV &gt; 240 cm/s EDV &gt; 40 cm/s</td>
                  <td align="center">PSV &gt; 320 cm/s EDV &gt; 100 cm/s</td>
                  <td align="center">Lack of flow Retrograde CHA flow</td>
                </tr>
                <tr>
                  <td align="left">SMA Fasting</td>
                  <td align="center">High-resistance</td>
                  <td align="center">PSV &gt; 295 cm/s EDV &gt; 45 cm/s</td>
                  <td align="center">PSV &gt; 400 cm/s EDV &gt; 70 cm/s</td>
                  <td align="center">Lack of flow</td>
                </tr>
                <tr>
                  <td align="left">SMA Postprandial</td>
                  <td align="center">Low-resistance</td>
                  <td align="center">PSV &gt; 295 cm/s EDV &gt; 45 cm/s</td>
                  <td align="center">PSV &gt; 400 cm/s EDV &gt; 70 cm/s</td>
                  <td align="center">Lack of flow</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN10">
                <p>
                  <italic>CHA: common hepatic artery; SMA: superior mesenteric artery; CT: celiac trunk; EDV: end-diastolic velocity; PSV: peak systolic velocity.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>3.3.4. Essential Information to Include in the Medical Report</title>
          <p>Report if there were technical difficulties during the examination.</p>
          <p>Presence or absence of atherosclerotic disease.</p>
          <p>Lesion site.</p>
          <p>Measurement of stenosis.</p>
          <p>Measurement of PSV and EDV.</p>
        </sec>
        <sec>
          <title>3.3.5. Examination Limitations</title>
          <p><xref ref-type="table" rid="t12">Table 12</xref> lists the examination limitations.</p>
        </sec>
      </sec>
      <sec>
        <title>3.4. Renal Arteries</title>
        <sec>
          <title>3.4.1. General Considerations</title>
          <p>Prevalence of renal artery stenosis (RAS) changes according to the population studied. RAS is the most common cause of secondary hypertension among the general population of hypertensive patients, representing approximately 1 to 6% of cases.<xref ref-type="bibr" rid="B44">44</xref><sup>,</sup><xref ref-type="bibr" rid="B45">45</xref>
					</p>
          <p>The most frequent cause of RAS is atherosclerosis (85% to 90% of cases), which often strikes the origin of and/or the segment proximal to the renal artery and can be unilateral or bilateral. Its prevalence increases with age, diabetes, and atherosclerosis in other arterial sites. It is considered an independent predictor of adverse events such as acute myocardial infarction, CVA, and death due to cardiovascular causes.<xref ref-type="bibr" rid="B45">45</xref><sup>,</sup><xref ref-type="bibr" rid="B46">46</xref>
					</p>
          <p>Fibromuscular dysplasia - a non-inflammatory disease - is responsible for 10% of RAS cases. Its frequency among the general population is unknown, but it is more usually reported in young women. Renal artery involvement occurs in its mid-distal segment and is often bilateral.<xref ref-type="bibr" rid="B47">47</xref>
					</p>
          <p>With the quality improvement of imaging methods, RAS diagnosis became feasible and of great interest, aiming to identify patients who would benefit not only from drug therapy but also from renal revascularization procedures. Among the imaging examinations, VUS is the initial method of choice to investigate RAS due to its advantages, such as being non-invasive, low-cost, having no risk of radiation, and, mainly, the lack of contraindications related to the use of nephrotoxic contrast. Ultrasound evaluation of renal arteries has high specificity in competent laboratories, demonstrating that, when the vessels are correctly assessed, its results rarely differ from those obtained by arteriography.<xref ref-type="bibr" rid="B45">45</xref><sup>,</sup><xref ref-type="bibr" rid="B48">48</xref><sup>-</sup><xref ref-type="bibr" rid="B50">50</xref>
					</p>
          <p><xref ref-type="table" rid="t14">Table 14</xref> shows the main indications to investigate RAS, according to the principal American guidelines.<xref ref-type="bibr" rid="B51">51</xref><sup>,</sup><xref ref-type="bibr" rid="B52">52</xref>
					</p>
          <table-wrap id="t14">
            <label>Table 14</label>
            <caption>
              <title>Clinical indications to investigate renal artery stenosis</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="100%"/>
              </colgroup>
              <tbody>
                <tr>
                  <td align="left">&#9679; Onset of hypertension in patients aged &#8804; 30 years</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Onset of severe hypertension in patients aged &#8805; 55 years</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with accelerated hypertension (sudden or persistent worsening of previously controlled hypertension)</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with resistant hypertension (treatment failure with full doses of three antihypertensive drug classes, including diuretics)</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with malignant hypertension (with target-organ damage: acute renal failure, acute congestive heart failure, new visual or neurological disorder, and/or advanced retinopathy)</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with worsening of renal function after administration of angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with unexplained renal atrophy or discrepancy &gt; 1.5 cm from kidney sizes</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with sudden and unexplained pulmonary edema (flash pulmonary edema)</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with renal failure or unexplained congestive heart failure</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with refractory angina</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with multiple vessel coronary artery disease</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Patients with abdominal aortic aneurysm</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>The principal objectives of the study of renal arteries are:</p>
          <p>Identify the main renal arteries and, if possible, the accessory ones.</p>
          <p>Locate and grade stenotic lesions resulting from atherosclerotic disease or not.</p>
          <p>Monitor the progression of RAS.</p>
          <p>Follow-up after renal artery revascularization.</p>
        </sec>
        <sec>
          <title>3.4.2. Examination Protocol (<xref ref-type="table" rid="t10">Table 10</xref>)</title>
          <p>Patient&#8217;s position: Supine, using transverse and longitudinal ultrasound planes to analyze the abdominal aorta and origin of renal arteries.</p>
          <p>Lateral, using the coronal plane to assess all middle and distal segments of renal arteries. Use this plane to measure the longitudinal diameter of the kidney and analyze the intrarenal flow in segmental or interlobular arteries.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>B-scan: used to identify atheroma plaques in the renal artery and evaluate the echogenicity and size of the kidney.</p>
          <p>Color flow imaging and/or power Doppler: evaluate artery patency. Power Doppler indicates possible stenosis sites through flow turbulence or reduction in the vessel lumen.</p>
          <p>Spectral analysis: Essential to measure systolic and diastolic velocities (PSV and EDV). Use the transverse or coronal plane, keeping the cursor directed at the flow jet, with an insonation angle &lt; 60&#176; in the renal artery and 0&#176; in intraparenchymatous arteries.<xref ref-type="bibr" rid="B53">53</xref>
					</p>
          <p>Measure PSV and EDV at the origin of the renal artery or in any segment with suspicion of stenosis.</p>
          <p>Use the longitudinal plane of the aorta, near the origin of the SMA, to measure its PSV and calculate the renal aortic ratio (RAR).</p>
        </sec>
        <sec>
          <title>3.4.3. Diagnostic Criteria for Renal Artery Stenosis</title>
          <p>Diagnostic criteria for RAS are classified as direct and indirect. The first consists of evaluating the renal artery from its origin in the aorta and, if possible, in all its extension. The second analyzes the hemodynamic repercussion of the proximal lesion of the renal artery on intraparenchymatous arteries.</p>
          <p>The direct criterion comprises renal artery PSV and EDV and aortic PSV to calculate RAR (renal artery PSV/aortic PSV). The low-resistance waveform is considered normal for the renal artery. PSV is the most accurate parameter to grade RAS, with values that range between 180 and 250 m/s from study to study. EDV and RAR are used to aid the RAS evaluation. According to several studies, RAR ranges from 3.2 to 3.7 to estimate hemodynamically significant stenosis. Situations such as aortic coarctation, severe left ventricular dysfunction, aortic dissection or aneurysm, and systolic aortic velocities &gt; 100 cm/s or &lt; 40 cm/s can change the velocities in renal arteries and their relationships.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>Indirect criteria, represented by the measurement of the kidney size and analysis of intraparenchymatous artery flow, should be combined with direct criteria to optimize the results. A difference of 1.5 cm in kidney size can result from hemodynamically significant stenosis or even renal artery occlusion. Regarding the analysis of intraparenchymatous artery flow, initially, there is a reduction in the first systolic peak (FSP), prolonged acceleration time (AT) with decreased acceleration rate (AR), and flattening of the systolic wave until the <italic>parvus/tardus</italic> pattern is found. AT &gt; 70 ms is associated with 60% RAS, while the <italic>parvus/tardus</italic> flow is present in more severe stenosis (80%).<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p><xref ref-type="table" rid="t15">Table 15</xref> summarizes the criteria recommended by DCI-BSC for hemodynamically significant RAS (&gt; 60%). All references to these criteria are detailed in the guideline.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <table-wrap id="t15">
            <label>Table 15</label>
            <caption>
              <title>Velocity criteria to quantify renal artery stenosis both native and after stenting</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="14%"/>
                <col width="14%"/>
                <col width="14%"/>
                <col width="14%"/>
                <col width="14%"/>
                <col width="14%"/>
                <col width="14%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Degree of stenosis</th>
                  <th align="center">Renal artery PSV</th>
                  <th align="center">Renal aortic ratio</th>
                  <th align="center">Renal artery EDV</th>
                  <th align="center">Intrarenal flow</th>
                  <th align="center">Renal artery PSV after stenting</th>
                  <th align="center">Renal aortic ratio after stenting</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Normal</td>
                  <td align="center">&lt; 200 cm/s</td>
                  <td align="center">&lt; 3.5</td>
                  <td align="center">&lt; 150 cm/s</td>
                  <td align="center">AT &lt; 70 ms</td>
                  <td align="center">&lt; 390 cm/s</td>
                  <td align="center">&lt; 5</td>
                </tr>
                <tr>
                  <td align="left">&lt; 60%</td>
                  <td align="center">&#8805; 200 cm/s</td>
                  <td align="center">&lt; 3.5</td>
                  <td align="center">&lt; 150 cm/s</td>
                  <td align="center">AT &lt; 70 ms</td>
                  <td align="center">&lt; 390 cm/s</td>
                  <td align="center">&lt; 5</td>
                </tr>
                <tr>
                  <td align="left">&#8805; 60%</td>
                  <td align="center">&#8805; 200 cm/s</td>
                  <td align="center">&#8805; 3.5</td>
                  <td align="center">&lt; 150 cm/s</td>
                  <td align="center">AT &lt; or &#8805; 70ms</td>
                  <td align="center">&gt; 390 cm/s</td>
                  <td align="center">&#8805; 5</td>
                </tr>
                <tr>
                  <td align="left">&#8805; 80%</td>
                  <td align="center">&#8805; 200 cm/s</td>
                  <td align="center">&#8805; 3.5</td>
                  <td align="center">&#8805; 150 cm/s</td>
                  <td align="center">AT &#8805; 70 ms <italic>tardus/parvus</italic> flow</td>
                  <td align="center">&#8805; 390 cm/s</td>
                  <td align="center">&#8805; 5</td>
                </tr>
                <tr>
                  <td align="left">Occlusion</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">Might have <italic>tardus/parvus</italic> flow</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN11">
                <p>
                  <italic>AT: acceleration time; EDV: end-diastolic velocity; PSV: peak systolic velocity.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Renal artery occlusion might be suggested if the vessel flow is not seen during color flow imaging and/or power Doppler, and not detected with pulsed wave Doppler, associated with a longitudinal diameter of the ipsilateral kidney &lt; 8.5 cm. </p>
          <p>Follow-up after renal revascularization is not part of the scope of this publication and can be found in the DCI guidelines.<xref ref-type="bibr" rid="B2">2</xref>
					</p>
        </sec>
        <sec>
          <title>3.4.4. Limitations of the Renal Artery Study</title>
          <p>Listed on table 12. </p>
        </sec>
        <sec>
          <title>3.4.5. Essential Information to Include in the Medical Report</title>
          <p>Report if there were technical difficulties during the examination.</p>
          <p>Inform the presence or absence of atherosclerotic disease or signs of fibromuscular dysplasia.</p>
          <p>Lesion site. </p>
          <p>Measurement of stenosis.</p>
          <p>Measurement of renal artery PSV and EDV.</p>
          <p>Measurement of aortic PSV.</p>
          <p>Measurement of pulsatility index (PI) and RI in intraparenchymatous arteries (preferably the segmental artery).</p>
          <p>Measurement of kidney size.</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>4. Lower-Limb Arteries</title>
      <p>VUS can evaluate peripheral arterial diseases (PADs) with high accuracy, enabling the anatomical and functional assessment of arterial lesions, in addition to identifying the location, extension, and hemodynamic repercussion of stenosis or occlusion.<xref ref-type="bibr" rid="B54">54</xref><sup>,</sup><xref ref-type="bibr" rid="B55">55</xref>
			</p>
      <sec>
        <title>4.1. Clinical Indications</title>
        <p>Anatomic diagnosis of stenosis or occlusion in the stenotic PAD in symptomatic patients considered for revascularization.<xref ref-type="bibr" rid="B56">56</xref><sup>-</sup><xref ref-type="bibr" rid="B59">59</xref>
				</p>
        <p>Follow-up of the progression of stenotic disease previously diagnosed.</p>
        <p>Surgical therapeutic planning for patients diagnosed with PAD.<xref ref-type="bibr" rid="B60">60</xref><sup>,</sup><xref ref-type="bibr" rid="B61">61</xref>
				</p>
        <p>Diagnosis and follow-up of peripheral arterial aneurysms.<xref ref-type="bibr" rid="B62">62</xref>
				</p>
        <p>Diagnosis, follow-up, and treatment of pseudoaneurysms.<xref ref-type="bibr" rid="B63">63</xref><sup>,</sup><xref ref-type="bibr" rid="B64">64</xref>
				</p>
        <p>Evaluation of autogenous or synthetic vascular grafts, with follow-up and diagnosis of complications.<xref ref-type="bibr" rid="B65">65</xref><sup>-</sup><xref ref-type="bibr" rid="B67">67</xref>
				</p>
        <p>Monitoring of arterial sites submitted to percutaneous intervention, such as angioplasty, thrombolysis, thrombectomy, atherectomy, and stenting<italic>.</italic><xref ref-type="bibr" rid="B68">68</xref><sup>-</sup><xref ref-type="bibr" rid="B71">71</xref>
				</p>
        <p>Confirmation of significant arterial abnormalities detected by another imaging method.</p>
        <p>Evaluation of vascular and perivascular abnormalities, such as masses, aneurysms, pseudoaneurysms, dissections, thrombosis, embolism, vascular malformation, and arteriovenous fistula (AVF).</p>
        <p>Evaluation of arterial integrity in trauma.</p>
        <p>Evaluation of artery compression syndromes, such as popliteal artery entrapment.</p>
      </sec>
      <sec>
        <title>4.2. Examination Protocol (<xref ref-type="table" rid="t16">Table 16</xref>)</title>
        <table-wrap id="t16">
          <label>Table 16</label>
          <caption>
            <title>Protocol for diagnostic examination and preoperative mapping</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="5%"/>
              <col width="19%"/>
              <col width="19%"/>
              <col width="19%"/>
              <col width="19%"/>
              <col width="19%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="2">Artery</th>
                <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">B-scan</th>
                <th align="center" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid">Pulsed Wave Doppler</th>
                <th align="center">Color Imaging</th>
              </tr>
              <tr>
                <th align="center">
                  <bold>Normal</bold>
                </th>
                <th align="center">
                  <bold>Abnormal</bold>
                </th>
                <th align="center">
                  <bold>Normal</bold>
                </th>
                <th align="center">
                  <bold>Abnormal</bold>
                </th>
                <th>
								</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">CFA</td>
                <td align="center" rowspan="9">Transverse: evaluate the diameter and aspect of the wall<break/>Longitudinal: evaluate the aspect of the wall and intraluminal diameter</td>
                <td align="center" rowspan="9">Transverse: measure the dilations and, if possible, the intraluminal stenosis<break/>Longitudinal: measure the lesion extent</td>
                <td align="center" rowspan="9">Longitudinal: use an angle &#8804; 60 degrees, laminar flow, and multiphase curve (triphase)</td>
                <td align="center" rowspan="9">Longitudinal: evaluate the flow in the stenosis, and proximal and distal to the stenosis<break/>Use the peak systolic velocity in the site of highest velocity (V2), with angle &#8804; 60 degrees, and 1 to 4 cm proximal to the lesion (V1) to calculate the velocity ratio (V2/V1)<break/>Flow in the post-stenotic segment: velocity turbulence or decrease<break/>Post-stenotic velocity curve of the parvus/tardus type indicates hemodynamic repercussion</td>
                <td align="center" rowspan="9">Assess vessel patency with intraluminal color filling<break/>Occlusion: lack of color filling<break/>Shows flow turbulence &#8211; mosaic aspect (aliasing)<break/>Guide the volume scan of the sample to detect the point of highest velocity</td>
              </tr>
              <tr>
                <td>Proximal SFA</td>
              </tr>
              <tr>
                <td>Mid SFA</td>
              </tr>
              <tr>
                <td>Distal SFA</td>
              </tr>
              <tr>
                <td>PA</td>
              </tr>
              <tr>
                <td>PTA</td>
              </tr>
              <tr>
                <td>ATA</td>
              </tr>
              <tr>
                <td>FA</td>
              </tr>
              <tr>
                <td>TFT</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN12">
              <p>
                <italic>FA: fibular artery; CFA: common femoral artery; DFA: deep femoral artery; SFA: superficial femoral artery; PA: popliteal artery; ATA: anterior tibial artery; PTA: posterior tibial artery; TFT: tibial-fibular trunk.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>4.3. Diagnostic Criteria</title>
        <p>Stenosis: measure PSV at the lesion site (V2) and 1 to 4 cm proximal to the lesion (V1) and calculate the velocity ratio (V2/V1). Obtain the spectral curve with an angle &#8804; 60&#186; parallel to the turbulent flow axis (<xref ref-type="fig" rid="f9">Figure 9</xref>). The degree of stenosis should be classified according to <xref ref-type="table" rid="t17">table 17</xref>.<xref ref-type="bibr" rid="B60">60</xref><sup>,</sup><xref ref-type="bibr" rid="B61">61</xref> Other criteria that can assist in grading stenosis are: prolonged AT in distal arteries, which could indicate hemodynamically significant lesions in proximal segments.</p>
        <table-wrap id="t17">
          <label>Table 17</label>
          <caption>
            <title>Classification of the degree of stenosis in native arteries with pulsed wave Doppler</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="50%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Classification</th>
                <th align="center">Systolic velocity ratio</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Stenosis &lt; 50%</td>
                <td align="center">V2/V1 &lt; 2.0</td>
              </tr>
              <tr>
                <td align="left">Stenosis &#8805; 50%</td>
                <td align="center">V2/V1 &#8805; 2.0</td>
              </tr>
              <tr>
                <td align="left">Stenosis &#8805; 70%</td>
                <td align="center">V2/V1 &#8805; 4.0</td>
              </tr>
              <tr>
                <td align="left">Occlusion</td>
                <td align="center">Lack of flow</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Occlusion: lack of flow in any lower-limb arterial segment, even with scan parameters that detect low-velocity flows. Presence of typical preocclusive waveform (high peripheral resistance, low peak systolic velocity, and lack of diastolic flow). Collateral vessels can be found in occluded pre- and post-segment (refilling point). The post-occlusive spectrum is characterized by monophasic waveform, with reduced PSV and prolonged AT (<italic>parvus/tardus</italic> pattern). Hypoechoic image with concave interface in colored flow and spectrum in standard pre-occlusive staccato suggests thromboembolism (<xref ref-type="table" rid="t18">Table 18</xref>).</p>
        <table-wrap id="t18">
          <label>Table 18</label>
          <caption>
            <title>Arterial flow patterns in various situations</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
            </colgroup>
            <thead>
              <tr>
                <th> ;</th>
                <th align="center">Name</th>
                <th align="center">Clinical meaning</th>
                <th align="center">Occurrence situation</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/76977a150911bb41ab50317a131cc79993f3cd8b.svg"/>
                </td>
                <td align="center">Triphasic</td>
                <td align="center">Found in young and normal individuals</td>
                <td align="center">Normal</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/ec84c375d51345d487f1131797119e6616c8c0bf.svg"/>
                </td>
                <td align="center">Triphasic without the elastic component</td>
                <td align="center">Found in old adults with reduced vessel elasticity</td>
                <td align="center">&#9679; Normal old adults<break/>&#9679; Bad US beam alignment</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/ec8838c62c30edc22258d3eee21922f3a8d8a8d0.svg"/>
                </td>
                <td align="center">Biphasic hyperemic</td>
                <td align="center">Without retrograde component, but reaches the baseline. Increased velocities</td>
                <td align="center">&#9679; Inflammatory process<break/>&#9679; Normal reactive vasodilation</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/7ed059cb57f6ed320af1a8a61ae0e7bc411ee1e0.svg"/>
                </td>
                <td align="center">Biphasic post-obstructive</td>
                <td align="center">Without retrograde component, but reaches the baseline. Low velocities</td>
                <td align="center">After moderate obstructions</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/1b38285d05f02be1ae36092d59559a59ea7931e9.svg"/>
                </td>
                <td align="center">Biphasic with retrograde pandiastolic component</td>
                <td align="center">Retrograde pandiastolic component. Usually with normal velocities</td>
                <td align="center">Vessels that provide collateral to other stenotic arteries. In most cases, vessels without proximal lesions</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/799ef9565031b74d3a08858589fcf857b32a5c87.svg"/>
                </td>
                <td align="center">Biphasic "to-and-fro"</td>
                <td align="center">Pronounced retrograde pandiastolic component</td>
                <td align="center">&#9679; Pseudoaneurysm<break/>&#9679; Type II endoleak</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/05b2598f1714fbad183c4229ec8758b551ef85e7.svg"/>
                </td>
                <td align="center">Acute monophasic</td>
                <td align="center">Low velocity, with little increase in acceleration time</td>
                <td align="center">Moderate and moderate to severe post-stenosis, WITH vasodilation reserve</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/670d2d45cceac2d554ec51435c43cd1b5131d962.svg"/>
                </td>
                <td align="center">Damped monophasic</td>
                <td align="center">Low velocity, with increased acceleration time</td>
                <td align="center">Severe post-stenosis or post-occlusion, WITH vasodilation reserve</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/2675061efa705bef5ab6b945609e89addd2d1943.svg"/>
                </td>
                <td align="center">Extremely damped monophasic</td>
                <td align="center">Very low velocity, with high increase in acceleration time</td>
                <td align="center">Post-occlusion, WITH vasodilation reserve</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/5210a9b50ebdee5ec85077bf7c318785f3bc0260.svg"/>
                </td>
                <td align="center">Monophasic without diastole</td>
                <td align="center">Extremely low velocity, with increased acceleration time, without diastole flow</td>
                <td align="center">Post-occlusion, WITHOUT vasodilation reserve. Severe multisegmental lesions</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/400e092d959accae3a957cd4c2b9d96c45bbdf48.svg"/>
                </td>
                <td align="center">Continuous</td>
                <td align="center">Extremely low velocity, with acceleration time so increased that it is not possible to differentiate PSV from EDV</td>
                <td align="center">Post-occlusion, WITH vasodilation reserve. Severe multisegmental lesions</td>
              </tr>
              <tr>
                <td align="left">
                  <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/45bdf9e66ef847fd40d90b11ede69ac4be85957c.svg"/>
                </td>
                <td align="center">Retrograde</td>
                <td align="center">Low velocity, can be damped or not, and can even have a retrograde component</td>
                <td align="center">Retrograde filling of a vessel with proximal occlusion</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN13">
              <p>
                <italic>EDV: end-diastolic velocity; PSV: peak systolic velocity.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Aneurysm: report the identification and location of the aneurysm. Measure the largest diameter including the adventitial layer (out-out) with two-dimensional image in transverse plane. Investigate and document the presence of intraluminal thrombus with color flow imaging.</p>
        <p>Pseudoaneurysm: characterized by dilation that does not compromise all arterial layers and having a connecting channel with the arterial lumen. Evaluate all of these structures with two-dimensional image and color imaging, measuring the calibers. Use spectral Doppler in the connecting channel, where the typical &#8220;to-and-fro&#8221; flow can be found (<xref ref-type="table" rid="t18">Table 18</xref>). Therapeutic interventions should use color imaging and pulsed wave Doppler as a guide, evaluating blood flow in the native artery, aiding in the puncture - in cases of thrombin treatment -, and verifying the thrombosis of the pseudoaneurysm in all treatment modalities.<xref ref-type="bibr" rid="B63">63</xref>
				</p>
        <p><xref ref-type="table" rid="t18">Table 18</xref> presents the different patterns of arterial flow, with their names, clinical meanings, and main occurrence situations.</p>
      </sec>
      <sec>
        <title>4.4. Essential Information to Include in the Medical Report</title>
        <p>Report if there were technical difficulties during the examination.</p>
        <p>Wall aspect and diameter of all arteries studied, when necessary.</p>
        <p>Presence, aspect, location, and degree of stenosis of atherosclerotic plaques.</p>
        <p>Stenosis velocity and characteristics of velocity curves in the post-stenotic segment.</p>
        <p>Signs of segmental or complete arterial occlusion.</p>
      </sec>
      <sec>
        <title>4.5. General Limitations of the Peripheral Artery Ultrasound</title>
        <p>Examiner-dependent.</p>
        <p>Equipment of low technical quality.</p>
        <p> Lower-limb edema.</p>
        <p>Unhealed ulcer.</p>
      </sec>
    </sec>
    <sec>
      <title>5. Arteriovenous Fistulas for Hemodialysis</title>
      <sec>
        <title>5.1. Introduction</title>
        <p>AVFs can be congenital, traumatic, or specifically created for hemodialysis. This guideline will cover only the technical aspects of VUS evaluation of AVF for hemodialysis (AVFH), which can be of two types: </p>
        <p>1. Autogenous - radiocephalic or brachiocephalic (Brescia-Cimino) fistula. <xref ref-type="fig" rid="f12">Figure 12</xref> shows the latero-lateral connection between artery and vein in A; the terminal connection between the artery and lateral of the vein in B; the terminal connection between the vein and lateral of the artery in C; and the termino-terminal connection between artery and vein in D.<xref ref-type="bibr" rid="B72">72</xref>
				</p>
        <p>
          <fig id="f12">
            <label>Figure 12</label>
            <caption>
              <title>Types of brachiocephalic fistulas (Brescia-Cimino). (A) Latero-lateral between artery and vein. (B) Terminal artery &#8211; lateral vein. (C) Terminal vein &#8211; lateral artery. (D) Termino-terminal between artery and vein.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf12.jpg"/></fig>
        </p>
        <p>2. Polytetrafluorethylene (PTFE) grafts. <xref ref-type="fig" rid="f13">Figure 13</xref> shows an example of a straight PTFE graft between the basilic vein and radial artery in A; a loop PTFE graft between the basilic vein and radial artery in B; a curved PTFE graft between the artery and brachial vein in C; and a loop PTFE graft between the great saphenous vein and femoral artery in the lower limb in D.<xref ref-type="bibr" rid="B73">73</xref>
				</p>
        <p>
          <fig id="f13">
            <label>Figure 13</label>
            <caption>
              <title>Types of polytetrafluoroethylene (PTFE) grafts. (A) Straight PTFE graft between the basilic vein and radial artery. (B) Loop PTFE graft between the basilic vein and radial artery. (C) Curved PTFE graft between the brachial artery and vein. (D) Loop PTFE graft between the great saphenous vein and femoral artery.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf13.jpg"/></fig>
        </p>
        <p>The most common AVFH types are the radiocephalic and brachiocephalic;<xref ref-type="bibr" rid="B73">73</xref> however, as an alternative, they can be created between other vessels, such as the ulnar artery and basilic vein, or the brachial artery and basilic vein, but they must be superficialized.</p>
      </sec>
      <sec>
        <title>5.2. Examination Indications</title>
        <p>The main indications for VUS in cases of AVFH are:</p>
        <p>Preoperative vascular mapping, with planning for the procedure, including evaluation of central vessels.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B75">75</xref>
				</p>
        <p>Maturation assessment, especially in obese patients. Maturation occurs when AVFH can withstand repeated venous punctures with large-caliber needles. This process can fail in up to 60% of cases.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B76">76</xref><sup>,</sup><xref ref-type="bibr" rid="B77">77</xref>
				</p>
        <p>Functional follow-up of AVFH to detect complications early.</p>
        <p>Recommendation: perform an examination before the procedure for planning and two after to reduce its failure rate.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B78">78</xref>
				</p>
        <p>Contraindications for the procedure: Paget-Schroetter syndrome and deep venous thrombosis (DVT).</p>
      </sec>
      <sec>
        <title>
          <bold>5.3. Technique</bold>
          <xref ref-type="bibr" rid="B79">79</xref>
        </title>
        <p>High-tech equipment - with high-frequency and/or variable frequency linear probe.</p>
        <p>Patient at rest in a room at ambient temperature, with the upper limb extended parallel to the body.</p>
        <p>Measure the anteroposterior diameters of vessels in transverse planes.</p>
        <p>Possible sites to measure flow volume: afferent - in the artery, 1 to 2 cm before the anastomosis; and efferent - in the vein, 1 to 2 cm after the anastomosis.</p>
        <p>Observe the abnormalities in two-dimensional planes and analyze turbulent flows with color flow imaging</p>
        <p>The Doppler angulation should be parallel to the blood flow (closer to 60&#176;).<xref ref-type="bibr" rid="B79">79</xref>
				</p>
        <p>Spectral Doppler characteristics: artery - low-resistance flow; vein - arterialized flow pattern.</p>
      </sec>
      <sec>
        <title>5.4. Diagnostic Criteria</title>
        <sec>
          <title>5.4.1. Protocol to Create Arteriovenous Fistulas for Hemodialysis</title>
          <p>&#8226; Choose the non-dominant member, if possible.</p>
          <p>&#8226; Follow the order: 1<sup>st</sup> option - wrist; 2<sup>nd</sup> option - elbow; 3<sup>rd</sup> option - prosthesis.</p>
          <p>&#8226; Measure the arterial and venous diameter (a tourniquet can be used in the member to evaluate venous distensibility).<xref ref-type="bibr" rid="B80">80</xref><sup>,</sup><xref ref-type="bibr" rid="B81">81</xref>
					</p>
          <p>- Ideal venous or arterial diameter: elbow - 4 mm; wrist - 3 mm.</p>
          <p>- Minimum functional diameter: elbow - 2 mm; wrist - 1.8 mm.<xref ref-type="bibr" rid="B72">72</xref>
					</p>
          <p>&#8226; Measure the depth between vessels and skin surface; the ideal for puncture is &lt; 5 mm. <xref ref-type="bibr" rid="B79">79</xref>
					</p>
          <p>&#8226; Measure the distance between artery and vein to be used (<xref ref-type="fig" rid="f14">Figure 14</xref>).</p>
          <p>
            <fig id="f14">
              <label>Figure 14</label>
              <caption>
                <title>Measurement of the distance between the brachial artery and basilic vein before the creation of alternative arteriovenous fistulas.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf14.jpg"/></fig>
          </p>
        </sec>
        <sec>
          <title>5.4.2. Protocol after Procedure<xref ref-type="bibr" rid="B77">77</xref><sup>,</sup><xref ref-type="bibr" rid="B79">79</xref><sup>,</sup><xref ref-type="bibr" rid="B81">81</xref>
					</title>
          <p>&#8226; Measurements of artery, vein, and anastomosis; </p>
          <p>- Ideal venous or arterial diameter: elbow - 4 mm; wrist - 3 mm</p>
          <p>- Minimum functional diameter: 2 mm </p>
          <p>&#8226; Flow volume: to obtain the effective flow volume through an AVFH, measure the diameter of the drainage vein by its inner edges (in cm), preferably with a transverse plane, to calculate its radius (R) and, consequently, its area (in cm&#178;). Take this measurement farther from the anastomosis site of the fistula, where the color flow imaging shows no flow turbulence, usually 2 to 5 cm from the anastomosis. Find the flow in the same place of the vein where the diameter was assessed with pulsed wave Doppler. Locate the sample volume in the center of the vessel and correct the Doppler flow angle to up to 60&#176;. Determine the mean flow velocity (V<sub>MEAN</sub>) in cm/s with pulsed wave Doppler. Calculate the mean of 3 to 5 cardiac cycles. Apply the following formula:</p>
          <disp-formula id="e1">
            <mml:math id="e01">
              <mml:semantics>
                <mml:mstyle mathsize="12.0pt">
                  <mml:menclose notation="box">
                    <mml:mrow>
                      <mml:mi>Mean</mml:mi>
                      <mml:mspace width="0.33em"/>
                      <mml:mi>flow</mml:mi>
                      <mml:mspace width="0.33em"/>
                      <mml:mfenced close=")" open="(">
                        <mml:mrow>
                          <mml:mi>ml</mml:mi>
                          <mml:mo>/</mml:mo>
                          <mml:mi>min</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>=</mml:mo>
                      <mml:msub>
                        <mml:mi>V</mml:mi>
                        <mml:mi>mean</mml:mi>
                      </mml:msub>
                      <mml:mfenced close=")" open="(">
                        <mml:mrow>
                          <mml:mi>cm</mml:mi>
                          <mml:mo>/</mml:mo>
                          <mml:mi>s</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>&#215;</mml:mo>
                      <mml:msup>
                        <mml:mi>R</mml:mi>
                        <mml:mn>2</mml:mn>
                      </mml:msup>
                      <mml:mfenced close=")" open="(">
                        <mml:msup>
                          <mml:mi>cm</mml:mi>
                          <mml:mn>2</mml:mn>
                        </mml:msup>
                      </mml:mfenced>
                      <mml:mo>&#215;</mml:mo>
                      <mml:mo>&#960;</mml:mo>
                      <mml:mo>&#215;</mml:mo>
                      <mml:mn>60</mml:mn>
                      <mml:mspace width="0.33em"/>
                      <mml:mfenced close=")" open="(">
                        <mml:mi>s</mml:mi>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:menclose>
                </mml:mstyle>
              </mml:semantics>
            </mml:math>
          </disp-formula>
          <p>The values below are used for normal flow volume of homologous and heterologous AVFH:</p>
          <p>Brescia-Cimino fistula (radiocephalic) = 614 &#177; 242 ml/min.</p>
          <p>PTFE = 464 &#177; 199 ml/min. </p>
          <p>Mean normal value = 514 ml/min.</p>
          <p>Fistulas with flow volume &lt; 450 ml/min have a high risk of thrombosis in 2 to 6 weeks.</p>
          <p>The minimum functional flow volume for AVFH in the elbow is &#8805; 200 ml/min, and in the wrist is &#8805; 150 ml/min.</p>
          <p>Hyperflow is considered when the flow volume is &gt; 3,000 ml/min.</p>
          <p>Maturation protocol:<xref ref-type="bibr" rid="B73">73</xref><sup>,</sup><xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B77">77</xref> AVFH maturation consists of an increase in caliber and flow of the vessels used. </p>
          <p>Assess vessel diameter and structure (&#8805; 6 mm), flow volume (&#8805; 600 ml/min), and the distance between the vein and skin surface &#8804; 6 mm. </p>
          <p>Wait at least 14 days; the ideal scenario is individualization with follow-up for each patient and interval superior to 30 days. If possible, wait 60 or even 90 days before the first canalization. </p>
          <p><xref ref-type="table" rid="t19">Table 19</xref> summarizes the main objectives of VUS findings.</p>
          <table-wrap id="t19">
            <label>Table 19</label>
            <caption>
              <title>Objectives of arteriovenous fistulas for proper hemodialysis (95%)<xref ref-type="bibr" rid="B77">77</xref>
							</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="100%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">&#9679; Vascular diameter: &gt; 4 mm </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">&#9679; Flow volume: &gt; 500 ml/min</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Maturation time: &gt; 30 days</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Diameters &lt; 3mm and flow volume &lt; 400 ml/min = high probability of failure</td>
                </tr>
                <tr>
                  <td align="left">&#9679; Vessel diameter should increase with time</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>5.4.3. Causes and Types of Failures (Autogenous and Prosthetic)<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B76">76</xref><sup>,</sup><xref ref-type="bibr" rid="B79">79</xref><sup>,</sup><xref ref-type="bibr" rid="B82">82</xref>
					</title>
          <p>Arterial: diabetes mellitus and significant atheromatosis.</p>
          <p>Venous: fibrosis.</p>
          <p>Anastomosis site: turbulence and intimal hyperplasia.</p>
          <p>Significant escape through tributary veins.</p>
          <p>Steal phenomenon, in which retrograde flow is found in the radial artery distal to AVFH (<xref ref-type="fig" rid="f15">Figure 15</xref>).</p>
          <p>
            <fig id="f15">
              <label>Figure 15</label>
              <caption>
                <title>Steal phenomenon with retrograde flow in the radial artery (in blue), in the segment distal to the anastomosis of arteriovenous fistulas for hemodialysis.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf15.jpg"/></fig>
          </p>
          <p>Pronounced tortuosities.</p>
          <p>Intimal hyperplasia (valves).</p>
          <p>Thrombosis (dissection by puncture).</p>
          <p>Idiopathic: puncture and surgical technique.</p>
          <p>Significant stenosis with V2/V1 &#8805; 4 (if &#8805; 2 indicates stenosis &gt; 50%; angioplasty is recommended in case of clinical and/or hemodynamic abnormalities associated).</p>
          <p>Occlusion.</p>
          <p>Aneurysm, dilation due to prosthesis degeneration and pseudoaneurysm.</p>
          <p>Infection.</p>
          <p>Hematoma, seroma, and lymphocele.</p>
        </sec>
        <sec>
          <title>5.4.4. Examination Limitations</title>
          <p>Inexistent, with rare exceptions in highly significant edemas, fibrotic scars, and presence of orthopedic devices.</p>
        </sec>
        <sec>
          <title>5.4.5. Suggestions to Elaborate the Report and Conclusion</title>
          <p>1. Examination before the procedure (<xref ref-type="table" rid="t20">Table 20</xref>): </p>
          <table-wrap id="t20">
            <label>Table 20</label>
            <caption>
              <title>Mapping of arteriovenous fistulas for hemodialysis before the procedure</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
              </colgroup>
              <thead>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <th align="left">
									</th>
                  <th align="center" colspan="3">Arterial diameter &#8211; mm</th>
                  <th align="center" colspan="5">Venous diameter &#8211; mm</th>
                </tr>
                <tr>
                  <th align="left">
                    <bold>Axillary</bold>
                  </th>
                  <th align="center">
                    <bold>Brachial</bold>
                  </th>
                  <th align="center">
                    <bold>Radial</bold>
                  </th>
                  <th align="center">
                    <bold>Ulnar</bold>
                  </th>
                  <th align="center">
                    <bold>Brachial</bold>
                  </th>
                  <th align="center">
                    <bold>Radial</bold>
                  </th>
                  <th align="center">
                    <bold>Ulnar</bold>
                  </th>
                  <th align="center">
                    <bold>Cephalic</bold>
                  </th>
                  <th align="center">
                    <bold>Basilic</bold>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Proximal arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Mid arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Distal arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Elbow/wrist</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Skin-vessel depth</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Distance A-V</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Report deep and superficial venous thrombosis; abnormalities in the arterial system; and anomalous anatomic changes, such as the number of vessels, paths, and forearm vessels that continue in the arm</p>
          <p>Inform the measurements of calibers and proper flows.</p>
          <p>2. Examination after the procedure (<xref ref-type="table" rid="t21">Table 21</xref>):</p>
          <table-wrap id="t21">
            <label>Table 21</label>
            <caption>
              <title>Mapping of arteriovenous fistulas for hemodialysis after the procedure</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
              </colgroup>
              <thead>
                <tr style="border-bottom-width:thin;border-bottom-style:solid">
                  <th align="left">Anastomosis:</th>
                  <th align="center" colspan="3">Arterial diameter &#8211; mm</th>
                  <th align="center" colspan="5">Venous diameter &#8211; mm</th>
                </tr>
                <tr>
                  <th align="left">
                    <bold>Axillary:</bold>
                  </th>
                  <th align="center">
                    <bold>Brachial</bold>
                  </th>
                  <th align="center">
                    <bold>Radial</bold>
                  </th>
                  <th align="center">
                    <bold>Ulnar</bold>
                  </th>
                  <th align="center">
                    <bold>Brachial</bold>
                  </th>
                  <th align="center">
                    <bold>Radial</bold>
                  </th>
                  <th align="center">
                    <bold>Ulnar</bold>
                  </th>
                  <th align="center">
                    <bold>Cephalic</bold>
                  </th>
                  <th align="center">
                    <bold>Basilic</bold>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Proximal arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Mid arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Distal arm/forearm</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Elbow/wrist</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">Skin-vessel depth</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                  <td align="center">
									</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Describe the type of AVFH and its location; inform if it is functional, dysfunctional, or non-functional, mentioning the cause, location, and extension of the involvement</p>
          <p>Report the afferent and efferent volumes (ml/min).</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>6. Deep Venous Thrombosis</title>
      <sec>
        <title>6.1. Introduction</title>
        <p>DVT and pulmonary embolism (PE) are part of the same disease spectrum: venous thromboembolism (VTE). DVT represents approximately two-thirds of the cases and PE, one-third. Between 85% and 90% of DVT cases occur in the lower limbs.<xref ref-type="bibr" rid="B83">83</xref>
				</p>
        <p>VTE is a severe, preventable, and high-incidence disease - the third most common CVD, after acute myocardial infarction and CVA. Therefore, VTE is a serious and potentially lethal condition that can affect both inpatients and outpatients. After the first VTE episode, the chance of recurrence is high.<xref ref-type="bibr" rid="B84">84</xref><sup>,</sup><xref ref-type="bibr" rid="B85">85</xref>
				</p>
        <p>The venous thrombus often begins at the venous cuspid level (<xref ref-type="fig" rid="f16">Figure 16</xref>) - either superficial or deep veins - and extends proximally in 13% of cases, retrogradely in 4%, and in both directions in 10%.<xref ref-type="bibr" rid="B86">86</xref><sup>-</sup><xref ref-type="bibr" rid="B88">88</xref> It can be partial - when occupying part of the lumen of the vein involved - or total. Thrombus located in the superficial system indicates superficial venous thrombosis, while DVT involves the deep venous system, and can strike one or more veins.<xref ref-type="bibr" rid="B89">89</xref> DVT in lower limbs is considered proximal if it affects the popliteal vein and/or proximal veins, with or without the involvement of other leg veins, and distal if it affects deep infrapatellar veins.<xref ref-type="bibr" rid="B87">87</xref><sup>,</sup><xref ref-type="bibr" rid="B90">90</xref>
				</p>
        <p>
          <fig id="f16">
            <label>Figure 16</label>
            <caption>
              <title>Two-dimensional image of a recent partial thrombus (acute) located in the valve sinus of the common femoral vein, shown through longitudinal (A) and transverse (B) planes. There is no complete collapse of the vein during compression (C).</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf16.jpg"/></fig>
        </p>
        <p>The objective examination is crucial as the clinical diagnosis alone is not reliable. The consequences of diagnostic error are severe. At an early stage, it can result in death and, at a later stage, depending on the pathophysiology (obstruction, reflux, or both), it can cause chronic venous hypertension, leading to debilitating conditions, such as post-thrombotic syndrome (PTS) and, in case of pulmonary involvement, pulmonary hypertension.<xref ref-type="bibr" rid="B83">83</xref><sup>,</sup><xref ref-type="bibr" rid="B85">85</xref><sup>,</sup><xref ref-type="bibr" rid="B91">91</xref> Furthermore, although effective, the unnecessary use of anticoagulant therapy results in higher costs and risk of hemorrhage.<xref ref-type="bibr" rid="B92">92</xref>
				</p>
      </sec>
      <sec>
        <title>6.2. Post-Thrombotic Syndrome</title>
        <p>PTS is defined as a combination of symptoms and objective findings in patients with DVT in lower or upper limbs. PTS is a debilitating disease and the most common and less known consequence of DVT.<xref ref-type="bibr" rid="B93">93</xref><sup>,</sup><xref ref-type="bibr" rid="B94">94</xref> One to five years after the DVT episode, approximately 30% to 50% of patients develop PTS, with 5% to 10% of them being severe cases, even when treated correctly.<xref ref-type="bibr" rid="B94">94</xref><sup>,</sup><xref ref-type="bibr" rid="B95">95</xref>
				</p>
        <p>PTS is a combination of venous hypertension secondary to flow obstruction or valvular incompetence and microcirculation and lymphatic abnormalities.</p>
        <sec>
          <title>6.2.1. Deep Venous Thrombosis Diagnosis</title>
          <p>As the accuracy of the clinical diagnosis of DVT is low (&lt; 50%), few patients with suspicion of DVT effectively have the disease (12% to 31%). Therefore, the recommendation is to perform an accurate and objective examination that can confirm or rule out DVT.<xref ref-type="bibr" rid="B87">87</xref><sup>,</sup><xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B96">96</xref> The current gold standard examination to diagnose DVT is compression VUS.<xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B97">97</xref>
					</p>
          <p>Three categories of examinations are used to determine the probability of DVT:<xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B98">98</xref>
					</p>
          <p>1. Clinical probability based on anamnesis and clinical examination </p>
          <p>2. D-dimer levels </p>
          <p>3. Imaging studies - the most commonly used is venous VUS, and the less used are venography, CTA, and venous magnetic resonance angiography. This guideline will cover only VUS.</p>
        </sec>
        <sec>
          <title>6.2.2. Vascular Ultrasound</title>
          <p>VUS is considered the current gold standard examination to diagnose acute DVT.<xref ref-type="bibr" rid="B99">99</xref> The PIOPED II study showed 95.5% agreement between CTA and ultrasound in diagnosing or ruling out DVT. In addition, we must remember that VUS is useful not only in diagnosing DVT in symptomatic or asymptomatic (with a high risk of DVT) patients but also in identifying other conditions that cause signs and symptoms indistinguishable from DVT. </p>
          <p>Knowledge about vascular anatomy and its variations is crucial since the frequency of variability in the number of veins is high, with the possibility of only one of them being involved, in addition to the different levels of confluences and paths.</p>
          <p>To diagnose thrombosis, we adopt several criteria, listed below.</p>
          <p>1. Venous compression: the normal vein has thin, smooth, and regular walls, and is completely collapsible with transducer compression (<xref ref-type="fig" rid="f17">Figure 17</xref>).</p>
          <p>
            <fig id="f17">
              <label>Figure 17</label>
              <caption>
                <title>Venous compression maneuver. (A) Artery and vein without compression. (B) Normal vein with total compression. (C) Dilated and incompressible vein, with recent thrombus. (D) Incompressible vein, with old thrombus (chronic). (E) Rethrombosis.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf17.jpg"/></fig>
          </p>
          <p>Incompressibility is the main criterion for DVT diagnosis (<xref ref-type="fig" rid="f16">Figure 16</xref>).</p>
          <p>A few conditions might hinder this compressibility, and sometimes special maneuvers are necessary. They are: </p>
          <p>Presence of a strong muscle group in the path to be compressed; for instance, the adductor canal requires compression in the external side of the thigh.</p>
          <p>Neurogenic bladder needs draining through urinary catheterization.</p>
          <p>Proximity to bone structures; for example, compression is limited in infrapatellar veins due to the size of the transducer.</p>
          <p>2. Vein caliber: usually the vein has twice the caliber of the adjacent artery. Acute venous thrombosis presents great distension of the vessel wall, with an increase in vein caliber and loss of this relationship. Over time, with the process of recanalization, the vein caliber decreases disorderly in some segments, losing the uniformity usually observed along the vessels. In the most chronic stage, a complete vein retraction might occur, with calibers becoming smaller than those of arteries, at times, hindering their recognition during the examination.</p>
          <p>3. Characteristics of the venous wall: parietal irregularities or diffuse parietal thickening, intraluminal trabeculations or synechia, structural valve abnormalities, loss of anatomical relationship with adjacent structures, even if tenuous, which can mean a previous DVT already recanalized. </p>
          <p>Intraluminal echoes indicate presence of thrombus and its echogenicity can characterize or not its age.</p>
          <p>4. Color imaging: color flow imaging is an important tool for venous thrombosis.</p>
          <p>While color flow filling all lumen in longitudinal and transverse planes indicates normality, the lack of color or flaws in filling the vessel can point to partial or complete thrombosis, particularly in recent partial thrombi with low echogenicity.</p>
          <p>Flow around the vessel strongly suggests acute DVT. Flow permeating the thrombus indicates recanalization and chronicity of the process.</p>
          <p>Take precautions regarding the scale and gain of the equipment, and the proper performance of maneuvers that increase venous flow, generating a color signal.</p>
          <p>5. Spectral analysis: the normal venous flow with spectral Doppler is spontaneous and phasic with respiration, increases with distal compression maneuvers, and ceases with Valsalva maneuvers (proximal veins) or proximal compression.<xref ref-type="bibr" rid="B85">85</xref> The spontaneity of the flow might not be observed in distal veins of patients in the supine position, and distal compression maneuvers and/or mobilization of the limb to displace the blood column become necessary. Loss of phasicity, with continuous flow pattern, is an indirect sign of occlusion or proximal compression. Damped response to distal compression indicates obstruction between the compression site and the location of the sample flow.</p>
          <p>Retrograde flow occurs when there is valve damage. Thus, valve regurgitation is a pathological sign, which can warn to the presence of previous thrombosis, and valve agenesia or venous reflux secondary to hyperflow should be ruled out.</p>
          <p><xref ref-type="table" rid="t22">Table 22</xref> describes VUS characteristics that assist in the identification of stages of venous thrombosis.</p>
          <table-wrap id="t22">
            <label>Table 22</label>
            <caption>
              <title>Characteristics of different stages of deep venous thrombosis observed in vascular ultrasound</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Stage</th>
                  <th align="center">Acute</th>
                  <th align="center">Intermediate (subacute)</th>
                  <th align="center">Chronic</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Event time</td>
                  <td align="center">Up to 14 days</td>
                  <td align="center">14 to 28 days</td>
                  <td align="center">&gt; 28 days</td>
                </tr>
                <tr>
                  <td align="left">Vessel caliber</td>
                  <td align="center">Dilated</td>
                  <td align="center">Still dilated, normal, or slightly reduced</td>
                  <td align="center">Usually reduced</td>
                </tr>
                <tr>
                  <td align="left">Incompressibility</td>
                  <td align="center">Total or partial</td>
                  <td align="center">Total or partial</td>
                  <td align="center">Partial or absent</td>
                </tr>
                <tr>
                  <td align="left">Thrombus aspect</td>
                  <td align="center">Hypoechoic</td>
                  <td align="center">Isoechoic</td>
                  <td align="center">Hyperechoic<break/>Parietal irregularities<break/>Fibrotic residues<break/>Residual thrombus: caliber &gt; 2 mm after maximum compression in 6 months or &gt; 3 mm in two consecutive examinations</td>
                </tr>
                <tr>
                  <td align="left">Flow</td>
                  <td align="center">Absent or partial</td>
                  <td align="center">Flow channels permeating the thrombotic mass Can have microfistula</td>
                  <td align="center">Multiple flow channels permeating the thrombus<break/>Complete lumen filling<break/>Presence of collaterals<break/>Continuous flow or reduced amplitude spectrum<break/>Can have orthostatic reflux</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Valsalva and inspiration and expiration maneuvers help and add information (<xref ref-type="table" rid="t23">Table 23</xref>). </p>
          <table-wrap id="t23">
            <label>Table 23</label>
            <caption>
              <title>Venous flow variation according to the phase of the respiratory cycle</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Flow</th>
                  <th align="center">Inspiration</th>
                  <th align="center">Expiration</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Lower limbs</td>
                  <td align="center">&#8595;</td>
                  <td align="center">&#8593;</td>
                </tr>
                <tr>
                  <td align="left">Upper limbs</td>
                  <td align="center">&#8593;</td>
                  <td align="center">&#8595;</td>
                </tr>
                <tr>
                  <td align="left">Subclavians</td>
                  <td align="center">&#8593;</td>
                  <td align="center">&#8595;</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
      </sec>
      <sec>
        <title>6.3. Rethrombosis</title>
        <p>High risk of recurrent venous thromboembolic disease persists after DVT treatment, with a cumulative incidence of these complications close to 30% in eight years of follow-up; among them, mortality reaches 30%, mainly due to malignant diseases.<xref ref-type="bibr" rid="B100">100</xref><sup>,</sup><xref ref-type="bibr" rid="B101">101</xref> Relevant predictive factors for risk of recurrence are male gender, thrombus location, and D-dimer.<xref ref-type="bibr" rid="B102">102</xref> Other less known risk factors are residual thrombus occupying 50% of the vessel lumen diameter after treatment and failure in normalization of compression with VUS.<xref ref-type="bibr" rid="B101">101</xref>
				</p>
        <p>As the non-invasive diagnosis of recurrence is difficult, some ultrasound criteria can be used, such as:</p>
        <p>Measurement of the residual thrombus mass.</p>
        <p>Abnormalities in the thrombus extension.</p>
        <p>Ultrasound characteristics of the thrombus - low echogenicity, slight compressibility, presence of tail, adhesion to the wall, and increase in venous diameter (&#8805; 2 times the contralateral vein, or compared to the diameter of the adjacent artery).<xref ref-type="bibr" rid="B100">100</xref><sup>,</sup><xref ref-type="bibr" rid="B101">101</xref><sup>,</sup><xref ref-type="bibr" rid="B103">103</xref>
				</p>
      </sec>
      <sec>
        <title>6.4. Examination Technique</title>
        <p>Some protocols assess only the proximal segment (femoropopliteal) or the compression VUS of two points (common femoral vein and popliteal vein). These protocols, known as point of care, facilitate the examination by emergency physicians and are proving to be an alternative in the emergency room.<xref ref-type="bibr" rid="B106">106</xref> However, evaluating the entire venous system is important for a proper DVT diagnosis, better assessment in case of recurrence, and to assist in the differential diagnosis with other pathologies. This guideline recommends always performing a full examination.<xref ref-type="bibr" rid="B107">107</xref><sup>,</sup><xref ref-type="bibr" rid="B108">108</xref>
				</p>
        <p>In lower limbs, the patient should be in a comfortable supine position with the torso and head elevated up to 30&#176;, close to the edge of the bed, on the same side of the examiner, with a slight lateral rotation of the hip and slight knee flexion. </p>
        <p>In upper limbs, the patient should be in the supine position, with the limb stretched alongside and slightly away from the body.</p>
        <p>Examine the deep venous system starting with the inguinal fold, gently compressing the veins with the transducer, using transverse planes.<xref ref-type="bibr" rid="B85">85</xref><sup>,</sup><xref ref-type="bibr" rid="B104">104</xref><sup>,</sup><xref ref-type="bibr" rid="B105">105</xref> The goal is to confirm the absence or presence of recent or residual thrombi, every 5 cm, throughout the venous trunk in the femoropopliteal segment by the medial thigh, the infrapatellar segment for the popliteal and trifurcation, the posteromedial leg for calf muscle veins (gastrocnemius, soleus, intergemellar), posterior tibial and fibular veins up to the ankle, as well as superficial veins (great and small saphenous veins along its entire extension). </p>
        <p>The fibular and soleus veins can be seen in the lateral leg, using the fibula as an anatomical reference. In this case, fibular veins are more superficial in relation to the transducer and posterior tibial veins, deeper. To that end, the patient should change positions, flexing the knee and placing the foot on the bed. Do not neglect this maneuver even in hospitalized patients due to the high prevalence of DVT in segments proximal to fibular veins in this group of individuals.</p>
        <p>Anterior tibial and foot veins are rarely studied unless there is a sign of local involvement. </p>
        <p>Investigate iliac veins when the patient has DVT in common femoral veins, and it is not possible to identify the end of the thrombus, or when the flow detected in these veins is continuous or has low amplitude.</p>
        <p>Alternate between transverse and longitudinal images using color imaging to evaluate flow and, when necessary, spectral Doppler. </p>
        <p>Save all stages of the examination (videos and still images) digitally. Currently, clinical research protocols of international multicenter studies recommend recording the maneuver of compressing the vein - with and without compression - in the same picture (dual image). In case of thrombus, measure the venous diameter, in determined sites, to evaluate the residual thrombotic mass.<xref ref-type="bibr" rid="B107">107</xref>
				</p>
        <p>Follow the same evaluation protocol for deep and superficial venous systems in upper limbs, middle and distal segments of subclavian veins, and jugular veins.</p>
        <p>During the follow-up of patients with DVT and recanalization, they preferably should stay in the orthostatic position or, when not possible, sitting for the study of venous reflux.</p>
        <p>Do not forget that the temperature in the room can significantly influence the performance of these examinations. Cold induces vasoconstriction and should be avoided. The ideal temperature is 22 to 25&#176;C.</p>
        <sec>
          <title>6.4.1. Transducers</title>
          <p>In general, high-frequency (5 to 12 MHz) linear transducers are used for normal-weight and thin patients. In overweight/obese patients, the study of the adductor canal and even of leg veins in individuals with moderate/severe edema can use transducers of greater depth range, such as convex abdominal ones, whose frequency varies from 3 to 5 MHz.<xref ref-type="bibr" rid="B108">108</xref>
					</p>
        </sec>
        <sec>
          <title>6.4.2. Information for the Report</title>
          <p>Presence or lack of signs of deep and/or superficial venous thrombosis. </p>
          <p>Information about the characteristics of the thrombus. </p>
          <p>Extension of thrombosis: essential and, if possible, with approximate measurements of anatomical reference points, such as the anterior-superior iliac spine, inguinal fold, knee, malleolar or plantar region, axillary fold, elbow fold, and wrist fold.</p>
          <p>In case of chronic thrombosis:</p>
          <p>- Measurements of residual thrombotic masses can be included in the report and/or images, with their locations so that they can be compared later.</p>
          <p>- Presence of orthostatic reflux.</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>7. Transcranial Doppler</title>
      <p>The main purpose of the study called transcranial Doppler (TCD) is to gather hemodynamic information from intracranial trunk arteries non-invasively, using flow insonation with pulsed wave Doppler.<xref ref-type="bibr" rid="B109">109</xref><sup>,</sup><xref ref-type="bibr" rid="B110">110</xref> The skull has always represented a barrier to reach the vessels since US does not penetrate the calcium in bone tissue and there are limited areas (transorbital and transtemporal windows, and foramen magnum) for examination. Also, arteries are located in deeper parts of the brain, making it difficult to obtain proper images and safely collect a sample capable of providing the spectral curves needed to interpret the hemodynamic status registered at a given moment. These unfavorable characteristics determine that a transducer capable of insonating flow in all trunk arteries of anterior and posterior circulations needs to be small and have a low frequency (2.0 MHz or less). CFI safely identifies vessels and analyzes flows.</p>
      <sec>
        <title>7.1. Types of Transcranial Doppler</title>
        <p>&#8220;<bold><italic>Blind&#8221; TCD</italic></bold>: only uses transducer with pulsed wave Doppler, without B-scan image (<xref ref-type="table" rid="t24">Table 24</xref>).</p>
        <table-wrap id="t24">
          <label>Table 24</label>
          <caption>
            <title>Identification of intracranial trunk arteries with "blind" transcranial Doppler<xref ref-type="bibr" rid="B114">114</xref>
						</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Artery</th>
                <th align="center">Depth</th>
                <th align="center">Flow Vm</th>
                <th align="center">Flow direction in relation to the transducer</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Carotid siphon</td>
                <td align="center">55 to 70 mm</td>
                <td align="center">40 to 50 cm/s</td>
                <td align="center">Positive or negative</td>
              </tr>
              <tr>
                <td align="left">Ophthalmic</td>
                <td align="center">40 to 60 mm</td>
                <td align="center">20 cm/s</td>
                <td align="center">Positive</td>
              </tr>
              <tr>
                <td align="left">Distal internal carotid</td>
                <td align="center">55 to 70 mm</td>
                <td align="center">45 cm/s</td>
                <td align="center">Positive</td>
              </tr>
              <tr>
                <td align="left">Anterior cerebral</td>
                <td align="center">60 to 70 mm</td>
                <td align="center">60 cm/s</td>
                <td align="center">Negative</td>
              </tr>
              <tr>
                <td align="left">Middle cerebral</td>
                <td align="center">35 to 60 mm</td>
                <td align="center">70 cm/s</td>
                <td align="center">Positive</td>
              </tr>
              <tr>
                <td align="left">Posterior cerebral</td>
                <td align="center">55 to 70 mm</td>
                <td align="center">40 cm/s</td>
                <td align="center">Positive (P1), negative (P2)</td>
              </tr>
              <tr>
                <td align="left">Vertebral</td>
                <td align="center">55 to 70 mm</td>
                <td align="center">40 cm/s</td>
                <td align="center">Negative</td>
              </tr>
              <tr>
                <td align="left">Basilar</td>
                <td align="center">70 to 120 mm</td>
                <td align="center">45 cm/s</td>
                <td align="center">Negative</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold><italic>TCD with color Doppler</italic></bold>: transducer with image from B-scan, pulsed wave Doppler, and CFI associated. </p>
        <p><bold><italic>TCD with microbubble contrast</italic></bold>: color TCD associated with intravenous infusion of microbubble contrast.</p>
        <p><bold><italic>TCD with macrobubbles</italic></bold>: color TCD associated with peripheral intravenous infusion of saline or glucose solution mixed with ambient air and shaken (macrobubbles).</p>
      </sec>
      <sec>
        <title>7.2. Examination Technique and Protocol</title>
        <p>The main focus of any TCD examination must be identifying all trunk arteries safely and recording the spectral flow curve of each vessel. Therefore, the usefulness of CFI is indisputable. Currently, using devices exclusively dedicated to &#8220;blind&#8221; Doppler is warranted in the monitoring of continuous flow during surgeries and in neurointensive units.</p>
        <p>The basic TCD protocol should include the use of all possible windows to transmit US to intracranial arteries:<xref ref-type="bibr" rid="B109">109</xref>a) <italic>transorbital (right and left)</italic>, to insonate carotid siphons and ophthalmic arteries; b) <italic>transtemporal (right and left)</italic>, to visualize distal internal carotids, anterior cerebral (A1 and A2 segments), middle cerebral (throughout M1 segments and at the beginning of M2), top basilar, and posterior cerebral arteries (throughout P1 and P2 segments); c) <italic>transforaminal,</italic> to study V4 segments of vertebral and basilar arteries (proximal and middle segments), with the possibility of insonating posterior-inferior cerebellar branches of vertebral arteries.</p>
        <p>The patient can be in a supine position or sitting. The head should be turned according to the window used at the time. The examiner can follow any sequence and must record images of spectral flow curves of each vessel examined - with identification -, according to the international standard. Including pictures or videos done with CFI ensures safety in confirming identification and possible anatomical variants (very common) or technical difficulties during the examination.</p>
        <p>Visualizing brain structures with B-scan determines the ability of the US in penetrating the bone wall in the window chosen and its usability for the examination. CFI will show (or not) flow in lumens of regional arteries, guiding the sample volume of pulsed wave Doppler with precision up to the lumen segment to be insonated to obtain the spectral flow curve. In addition to flow waveform morphology of each vessel, the routine of integral measurement of velocities has to be followed to ensure the collection of essential data to the hemodynamic analysis required in various pathologies with suspicion of DTC: PSV, EDV, mean velocity, RI, and PI (make sure that the equipment preset includes these calculations).</p>
        <p><xref ref-type="table" rid="t25">Table 25</xref> lists the clinical indications for TCD.</p>
        <table-wrap id="t25">
          <label>Table 25</label>
          <caption>
            <title>Clinical indications for transcranial Doppler115,116</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="20%"/>
              <col width="26%"/>
              <col width="26%"/>
              <col width="26%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Pathology</th>
                <th align="center">Objective</th>
                <th align="center">Observation</th>
                <th align="center">Findings</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Brain death*</td>
                <td align="center">Additional examination judicially valid to confirm cerebral circulatory arrest</td>
                <td align="center">Standard study of anterior and posterior circulation arteries is mandatory. In case of residual blood flow, repeat after 12 hours</td>
                <td align="center">Spectral curve with short peak systolic (&lt; 50 cm/s) pattern and lack of diastolic flow; or "alternating" pattern (antegrade systolic and retrograde diastolic flow)</td>
              </tr>
              <tr>
                <td align="left">Intracranial hypertension<sup>111</sup></td>
                <td align="center">Adjuvant indirect monitoring, including after decompressive craniectomy</td>
                <td align="center">Qualitative analysis of the curve pattern, which can vary dynamically (inversion of the diastolic component delimits the irreversible stage)</td>
                <td align="center">Progressive reduction of the diastolic component of the spectral flow curve according to the severity of hypertension</td>
              </tr>
              <tr>
                <td align="left">Ischemic CVA (acute phase)<xref ref-type="bibr" rid="B112">112</xref><sup>,</sup><xref ref-type="bibr" rid="B113">113</xref>
								</td>
                <td align="center">Monitoring of vessel reperfusion in case of thrombolysis (up to 4.5 hours after the start of the event), which lasts approximately 40 minutes (but can take more than 1 hour)</td>
                <td align="center">Monitoring can be intermittent (conventional equipment) or continuous (transducer with "blind" Doppler fixed to a helmet adjustable to the patient's head)</td>
                <td align="center">Reappearance of gradual flow according to the degree of reperfusion (TIBI scale of spectral curve pattern)</td>
              </tr>
              <tr>
                <td align="left">Subarachnoid hemorrhage** <xref ref-type="bibr" rid="B114">114</xref> (<xref ref-type="table" rid="t26">Table 26</xref>)</td>
                <td align="center">Diagnosis, assessment of severity, and monitoring of vasospasm, recommending early intervention</td>
                <td align="center">Perform the examination at hospital admission and repeat it daily in case of vasospasm (critical period: 4 to 14 days after the event). Insonate all arteries at each examination</td>
                <td align="center">Increase in mean flow velocity, according to the severity. Lindegaard ratio (velocity ratio between the middle cerebral artery and ipsilateral internal carotid) differentiates true spasm from hyperemia</td>
              </tr>
              <tr>
                <td align="left">Patent foramen ovale*** <xref ref-type="bibr" rid="B115">115</xref>
								</td>
                <td align="center">Shunt study in patients with ischemic CVA (transient or permanent)</td>
                <td align="center">Intravenous infusion of shaken saline solution ("macrobubbles") associated with the Valsalva maneuver</td>
                <td align="center">HITS (gaseous emboli) recorded in spectral curves are counted and classified according to the Spencer scale</td>
              </tr>
              <tr>
                <td align="left">Sickle cell disease**** <xref ref-type="bibr" rid="B116">116</xref><sup>-</sup><xref ref-type="bibr" rid="B118">118</xref> (<xref ref-type="table" rid="t27">Table 27</xref>)</td>
                <td align="center">Diagnosis and grading of intraluminal stenosis to stratify the risk of ischemic CVA and define the therapeutic approach. Monitoring of therapeutic response</td>
                <td align="center">Mandatory in patients aged 2 to 16 years</td>
                <td align="center">Mean flow velocity defines the periodicity of follow-up and approach (blood exchange)</td>
              </tr>
              <tr>
                <td align="left">Migraine<xref ref-type="bibr" rid="B119">119</xref>
								</td>
                <td align="center">Support for clinical diagnosis and differentiation from other headaches</td>
                <td align="center">It can be performed in the intercritical period or during a painful crisis (different results)</td>
                <td align="center">Measurement of pulsatility index and mean flow velocity in all vessels</td>
              </tr>
              <tr>
                <td align="left">Transoperative monitoring<xref ref-type="bibr" rid="B120">120</xref><sup>,</sup><xref ref-type="bibr" rid="B121">121</xref>
								</td>
                <td align="center">Preoperative assessment of CVA risk (monitoring of spontaneous microemboli; study of cerebral flow reserve) and peroperative monitoring of emboli and cerebral flow reduction during neurological and cardiovascular surgeries</td>
                <td align="center">Continuous flow monitoring of middle cerebral arteries using two transducers with "blind" Doppler fixed to a helmet adjustable to the patient's head. Monitoring should continue in the postoperative (due to microemboli during this period)</td>
                <td align="center">Report of emboli rate (solid and/or gaseous) and reduction in mean flow velocity compared to the baseline value (&gt; 15%) determine the risk of ischemic CVA in the immediate postoperative period*****</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN14">
              <p>
                <italic>CVA: cerebrovascular accident; HITS: high-intensity transient signals; TIBI: thrombolysis in brain ischemia (scale). Information followed by asterisks (*) have additional data, presented in the text below.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="t26">
          <label>*Table 26</label>
          <caption>
            <title>Vasospasm classification</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="33%"/>
              <col width="33%"/>
              <col width="33%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Artery: MCA</th>
                <th align="center">MFV (cm/s)</th>
                <th align="center">Lindegaard ratio</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Mild</bold>
                </td>
                <td align="center">120 to 130</td>
                <td align="center">3 to 6</td>
              </tr>
              <tr>
                <td align="left">Moderate</td>
                <td align="center">130 to 200</td>
                <td align="center">3 to 6</td>
              </tr>
              <tr>
                <td align="left">Severe</td>
                <td align="center">&gt; 200</td>
                <td align="center">&gt; 6</td>
              </tr>
              <tr>
                <td align="left">Artery: ACA</td>
                <td align="center">&gt; 50% of MFV in 24h</td>
                <td align="center">&#8211;</td>
              </tr>
              <tr>
                <td align="left">Artery: PCA</td>
                <td align="center">&gt; 110</td>
                <td align="center">&#8211;</td>
              </tr>
              <tr>
                <td align="left">Artery: VA</td>
                <td align="center">&gt; 80</td>
                <td align="center">&#8211;</td>
              </tr>
              <tr>
                <td align="left">Artery: basilar</td>
                <td align="center">
								</td>
                <td align="center">Soustiel ratio</td>
              </tr>
              <tr>
                <td align="left">Mild</td>
                <td align="center">80 to 95</td>
                <td align="center">2 to 2.49</td>
              </tr>
              <tr>
                <td align="left">Moderate</td>
                <td align="center">&gt; 85</td>
                <td align="center">2.5 to 2.99</td>
              </tr>
              <tr>
                <td align="left">Severe</td>
                <td align="center">&gt; 115</td>
                <td align="center">&gt; 3</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN15">
              <p>
                <italic>MCA: middle cerebral artery; ACA: anterior cerebral artery; PCA: posterior cerebral artery; VA: vertebral artery. Note: Lindegaard ratio is the ratio between the highest mean flow velocity (MFV) in the middle cerebral artery (M1) and MFV in the ipsilateral extracranial internal carotid. Soustiel ratio is the ratio between vertebral MFV and basilar MFV.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="t27">
          <label>****Table 27</label>
          <caption>
            <title>Recommendations of the Brazilian Guidelines for Transcranial Doppler in Children and adolescents with Sickle Cell Disease (2010)<xref ref-type="bibr" rid="B123">123</xref>
						</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="25%"/>
              <col width="25%"/>
              <col width="50%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Mean flow velocity</th>
                <th align="center">CVA risk group</th>
                <th align="center">Approach</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Inadequate ultrasonic windows</td>
                <td align="center">Inconclusive</td>
                <td align="center">Use another imaging method to assess cerebrovascular events</td>
              </tr>
              <tr>
                <td align="left">Difficult execution: uncooperative patient</td>
                <td align="center">Inconclusive</td>
                <td align="center">Repeat in 3 months, with a different examiner if possible</td>
              </tr>
              <tr>
                <td align="left">&lt; 70 cm/s</td>
                <td align="center">Low flow</td>
                <td align="center">Repeat the examination in 30 days</td>
              </tr>
              <tr>
                <td align="left">&lt; 170 cm/s</td>
                <td align="center">Normal</td>
                <td align="center">Repeat the examination in 12 months</td>
              </tr>
              <tr>
                <td align="left">170 to 184 cm/s</td>
                <td align="center">"Low conditional"</td>
                <td align="center">Repeat the examination in 3 months: if &lt; 170 cm/s, repeat in 12 months</td>
              </tr>
              <tr>
                <td align="left">184 to 199 cm/s</td>
                <td align="center">"High conditional"</td>
                <td align="center">Repeat the examination in 30 days: if &lt; 170 cm/s, repeat TCD every 3 months; if two consecutive examinations are abnormal, consider long-term blood exchange</td>
              </tr>
              <tr>
                <td align="left">200 to 220 cm/s</td>
                <td align="center">Abnormal</td>
                <td align="center">Repeat the examination in 30 days: if &gt; 200 cm/s, blood exchange; if "high conditional", repeat TCD in 3 months; if "low conditional", repeat it in 6 months</td>
              </tr>
              <tr>
                <td align="left">&gt; 220 cm/s</td>
                <td align="center">Abnormal</td>
                <td align="center">Imminent risk of CVA, consider long-term blood exchange</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN16">
              <p>
                <italic>CVA: cerebrovascular accident; TCD: transcranial Doppler.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>*According to the <bold>Brazilian Guidelines for the Application of Transcranial Ultrasound as a Diagnostic Test for the Confirmation of Brain Death</bold> (defined by a group of experts from the Department of Neurosonology of the Brazilian Academy of Neurology in 2012), the criteria<xref ref-type="bibr" rid="B122">122</xref> are:</p>
        <p>&#8226; A single TCD is enough to confirm brain death.</p>
        <p>&#8226; TCD should be performed only in patients with previously established clinical diagnosis, in accordance with the current Brazilian regulations; moreover, the patient needs to have stable hemodynamic conditions (with or without the use of drugs), and minimum systemic systolic blood pressure of 90 mmHg (below this value, the examination will not have diagnostic validity).</p>
        <p>&#8226; A full standard TCD study is mandatory, with images in B-scan and color flow imaging (if available), and spectral flow curves of all intracranial trunk arteries.</p>
        <p>&#8226; Characteristic TCD findings in <italic>cerebral circulatory arrest</italic>: spectral flow curves with low-amplitude systolic wave (velocity &lt; 50 cm/s) or curves with an <italic>alternating flow</italic> pattern (waves with antegrade systolic component followed by retrograde diastolic component).</p>
        <p>&#8226; Lack of flow in intracranial trunk arteries is not a criterion for brain death, except in cases in which a prior TCD was performed during the same hospitalization, with a record of flow in the arteries analyzed.</p>
        <p>&#8226; Anterior circulation: in case of inadequate transtemporal windows, reporting criteria for &#8220;vascular collapse&#8221; in both carotid siphons becomes mandatory to diagnose brain death.</p>
        <p>&#8226; Posterior circulation: if it is not possible to detect flow in the basilar artery, findings of &#8220;vascular collapse&#8221; in both intracranial vertebral arteries are crucial to diagnosing brain death; on the other hand, findings related to basilar &#8220;vascular collapse&#8221; in the presence of residual blood flow in at least one vertebral artery will invalidate the conclusive diagnosis of the examination as an indication of brain death in this region.</p>
        <p>&#8226; Residual blood flow can be detected in almost 20% of patients, especially in intracranial carotid arteries and in patients who underwent craniotomy (but this finding tends to disappear in a few hours). </p>
        <p>&#8226; The examination report must have a detailed account of the findings in each anterior and posterior circulation artery and be conclusive regarding the presence or lack of criteria for <italic>cerebral circulatory arrest</italic> that corroborate the clinical diagnosis of brain death.</p>
        <p>
          <bold>***Spencer scale</bold>
        </p>
        <p>The number of embolic spikes shown in the device screen is also useful information since the greater the number of macrobubbles, more significant the size of the shunt(s) through the foramen ovale (Spencer scale): <italic>grade 0 -</italic> lack of HITS; <italic>grade 1 -</italic> 1 to 10 HITS; <italic>grade 2 -</italic> 11 to 30 HITS; <italic>grade 3 -</italic> 31 to 100 HITS; <italic>grade 4 -</italic> 101 to 300; <italic>grade 5 -</italic> &gt; 300 HITS (&#8220;curtain effect&#8221;). Above grade 2, the right-left cardiac shunt is significant. In case of countless spikes (&#8220;curtain effect&#8221;), consider the possibility of pulmonary AVF.</p>
        <p>Examination protocol: peripheral intravenous infusion of solution with &#8220;macrobubbles&#8221; (8 ml of saline or glucose solution mixed with 2 ml of ambient air and shaken until it becomes homogeneous), followed immediately by vigorous Valsalva maneuver performed by the patient for 5 seconds and simultaneous insonation of spectral flow curves (pulsed wave Doppler) in cerebral and basilar arteries. The examination must be conducted in basal conditions (flow record with Valsalva maneuver in the right and left middle cerebral arteries and basilar arteries) and after the infusion of macrobubbles (that is, six times in total). In the event of a record with &#8220;curtain&#8221; pattern, stop the study (which will be considered positive).</p>
        <p><bold>*****</bold>Microembolic signals are detected in up to 70% of cases during the first hour after endarterectomy. A rate of 50 &#8220;microembolic signals&#8221;/hour occurs in up to 10% of cases and is predictive of ipsilateral focal ischemia.<xref ref-type="bibr" rid="B121">121</xref>
				</p>
      </sec>
      <sec>
        <title>7.3. Limitations of Transcranial Color Doppler</title>
        <p>Limitations of TCD basically result from the barrier the cranial bone represents to US. The use of contrast agents (&#8220;microbubbles&#8221;) greatly reduced the cases of inconclusive examinations due to a &#8220;lack of adequate windows.&#8221; The inexperience of the examining physician is also a crucial limiting factor; the learning curve is relatively long and requires dedication.</p>
        <sec>
          <title>7.3.1. Essential Information to Include in Transcranial Doppler Reports</title>
          <p>The basic structure of any additional examination must have:</p>
          <p>&#8226; Patient&#8217;s identification (full name and age).</p>
          <p>&#8226; Clinical indication (the purpose of the examination will determine the type of TCD needed).</p>
          <p>&#8226; Technical quality of the examination (reporting possible issues that interfere in obtaining the necessary images for the study).</p>
          <p>&#8226; Record of all ultrasound windows used, and vessels examined (justifying the cases that were impossible to study).</p>
          <p>&#8226; Description of specific characteristics found in each technical resource used:</p>
          <p>- Color flow imaging - lumen patency or occlusion, laminar or turbulent (&#8220;mosaic&#8221;) pattern, direction (antegrade or retrograde).</p>
          <p>- Pulsed wave Doppler - laminar or turbulent pattern, direction (antegrade or retrograde), velocities of spectral flow curves (peak systolic, end-diastolic, and mean), and PI and resistance according to the clinical indication of the examination (e.g., sickle cell disease requires mean velocity).</p>
          <p>- Contrast solution with &#8220;macrobubbles&#8221; - record and count of HITS in the study of patent foramen ovale and paradoxical embolism.</p>
          <p>- Use of contrast agent with &#8220;microbubbles&#8221; (SonoVue&#174;).</p>
          <p>- In the intraoperative monitoring, report the occurrence and count of HITS/hour and variations in flow velocities with potential risk for ischemic CVA in the postoperative period.</p>
          <p><bold>Conclusion</bold>: avoid etiological diagnosis (TCD is a study of cerebral hemodynamics and findings should be correlated to the clinical indication of examination: for instance, the presence or lack of criteria for vasospasm, with grade classification and time reference to the onset of symptoms of subarachnoid hemorrhage). </p>
          <p><italic>Note</italic>: in cases of sickle cell disease, it is mandatory to specify, after the conclusion, the recommended date to repeat the reassessment examination (following the Brazilian Guidelines for Transcranial Doppler in Children and Adolescents with Sickle Cell Disease, 2010).<xref ref-type="bibr" rid="B123">123</xref> In other pathologies, this suggestion is prohibited due to professional ethics.</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>8. Contrast in Vascular Ultrasound</title>
      <p>The introduction of contrast agents in ultrasound examinations considerably expanded the clinical value of this method. B-scan ultrasound is an excellent method to demonstrate the anatomical and morphological characteristics of parenchymal tissue but does not provide any information about the viability and integrity of microcirculation. Color Doppler ultrasound (CDUS) added data about blood flow velocity but is not able to quantify the volume and show with enough sensitivity the blood flow in microcirculation,<xref ref-type="bibr" rid="B124">124</xref><sup>-</sup><xref ref-type="bibr" rid="B126">126</xref> where velocity is too low to be detected without artifacts created by tissue and transducer maneuvers. Also, the spatial resolution of CDUS is limited, the representation of velocity is angle-dependent, and numerous artifacts can influence the diagnostic interpretation of images. Contrast-enhanced Doppler ultrasound substantially increased the sensitivity of CDUS and reduced some limitations.</p>
      <p>The technical innovation was the introduction of specific image components for contrast in US equipment, allowing direct visualization of signals emitted by microbubble contrast agents, regardless of their velocities. Due to typical characteristics of microbubble signals (which are fundamentally different from those originating in tissues), &#8220;specific microbubble&#8221; images (contrast only) are created, which can show volume and perfusion of the parenchymal tissue with extremely high sensitivity and spatial resolution.<xref ref-type="bibr" rid="B124">124</xref> The creation of each &#8220;specific microbubble&#8221; signal requires proper interaction between signals of the microbubble contrast agent and the insonated US beam.</p>
      <sec>
        <title>8.1. Properties of Ultrasound Contrast Agents</title>
        <p>Unlike contrasts for magnetic resonance imaging (MRI) and computed tomography, which use physical and chemical characteristics of cells to generate their effect, microbubble contrast uses the physical attributes of US, that is, the higher the density difference between media, the greater the reflection of energy emitted and larger the amplitude of US signal. Unquestionably, the gaseous medium provides the greatest difference, corresponding to a signal increase of approximately 30 decibels.</p>
        <p>US contrast agents are microbubbles of gas inside capsules with flexible and stable phospholipid membranes and a defined size. The SonoVue&#174;<xref ref-type="bibr" rid="B127">127</xref> agent (produced by Bracco Imaging S.p.A., Milan, Italy), sold in Europe, the United States, parts of Asia, and South America, is the only product currently authorized in Brazil by the Brazilian Health Regulatory Agency (<italic>Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria</italic> - Anvisa) and members of the National Regulatory Agency for Private Health Insurance and Plans (<italic>Ag&#234;ncia Nacional de Sa&#250;de Suplementar</italic> - ANS). SonoVue&#174; consists of encapsulated microspheres of sulfur hexafluoride gas. Microbubbles have an average diameter of 2.3 &#181;m (a size that prevents them from crossing blood vessel walls and reaching the interstitial space). As a lipophilic gas, its solubility in blood is low, and it does not spread outside the capsule. This protein shell composed of a single layer of phospholipids acts as a surfactant, giving it stability and flexibility along its path in the blood macro- and microcirculation. Therefore, SonoVue&#174; is considered an integral agent of the blood pool and a marker of blood circulation (property that distinguishes it from contrasts used in MRI and computed tomography, which can cross into the extracellular space).</p>
        <p>After the microbubble bursts, the gas is almost entirely exhaled through the lungs during respiration, without undergoing liver metabolism or renal excretion.<xref ref-type="bibr" rid="B124">124</xref> Thus, there is no contraindication to its use in patients with renal failure.</p>
      </sec>
      <sec>
        <title>8.2. Technical Aspects that Influence the Acquisition of Contrast Images</title>
        <p>Currently, most US manufacturers have exclusive software for studies with contrast, which can be included in the original configuration of the machine or purchased separately. However, even equipment without a specific image component for contrast has some parameters the operator can configure. The following concepts and adjustments of the equipment must be known to get the best result during the contrast study:</p>
        <sec>
          <title>8.2.1. Mechanical Index</title>
          <p>A unique characteristic of contrast agents for US (non-existent in those used for MRI and computed tomography) is that they are modified by the waves used to detect them. When exposed to US, microbubble behavior changes according to the US power emitted, that is, the amplitude of the acoustic wave [called mechanical index (MI) in the equipment]. In non-contrast studies, MI ranges from 1.6 to 1.9; under this acoustic power, the microbubble always oscillates vigorously and bursts, causing two unwanted effects: a sudden increase in signal intensity with an excessive blurring of the image, and a significant reduction in contrast concentration, consequently shortening the examination time. This image mode, called &#8220;image by acoustic stimulation,&#8221; does not require equipment with contrast technology (but, on the other hand, it does not use the full potential of the contrast agent, limiting it to its echo-enhancer function).</p>
          <p>After reducing MI to &#8804; 0.1, we can not only keep the integrity of microbubbles but also make them oscillate non-linearly (initial compression followed by expansion) and resonate, emitting different frequencies (known as &#8220;harmonic frequencies&#8221;) from the fundamental one emitted by the transducer. Equipment with this technology can filter signals emitted specifically by microbubbles, leading to a more lasting study that highlights microbubble over tissue signal (virtually nulled in the image, appearing as a dark background).</p>
          <p>This type of study, also called &#8220;contrast study with low MI&#8221;, allows the examiner to evaluate the contrast wash-in continuously in the local studied, the enhancement period, and the concentration of microbubbles in the target structure [essential for situations such as the study of vessels of vessels (<italic>vasa vasorum</italic>), carotid plaques, renal capillary (perfusion) distribution, and masses].<xref ref-type="bibr" rid="B124">124</xref>
					</p>
          <p>An undesired effect of the contrast study with low MI is the depth limitation of the pulse wave, which undergoes greater attenuation as it moves through tissues. Some ways to minimize this effect are: adopting alternative acoustic windows that allow closer proximity with the structure of interest, using broadband transducers with lower frequencies, and, as a last resort, increasing the MI and consequently destroying more bubbles in the proximal field.<xref ref-type="bibr" rid="B128">128</xref>
					</p>
        </sec>
        <sec>
          <title>8.2.2. Image Gain</title>
          <p>A noteworthy equipment control in the contrast study is the image gain, which amplifies the signal received during the post-processing in the equipment. High gain produces a bright image and widespread increase in background noise, obscuring the contrast signal (once the saturation level of the equipment has been reached, there will be no margin to amplify the signal caused by contrast). Therefore, during the contrast study, the equipment gain should be reduced until the image is virtually black, except for highly echogenic structures. Some manufacturers have gain adjustment controls for contrast studies that can easily be turned on and off during the examination. </p>
          <p>When performing a manual adjustment, make sure to have the least amount of acoustic signals before contrast injection and understand if this signal results from an increase in MI (when specific structures are seen in the image) or gain (which causes a widespread rise in noise across the image).<xref ref-type="bibr" rid="B6">6</xref>
					</p>
        </sec>
        <sec>
          <title>8.2.3. Contrast Level</title>
          <p>A last technical aspect worth mentioning is the dose of contrast injected. High doses initially blur (saturation) the signal and attenuate (acoustic shadowing) structures in the distal field until contrast concentrations drop to a proper level. In addition, distinguishing small enhancing differences between structures is not possible, given that the upper limit of dynamic range (grayscale) of the equipment has been exceeded.<xref ref-type="bibr" rid="B128">128</xref> One way of highlighting different enhancing levels caused by contrast in a structure is to adjust the dose of contrast to allow adequate opacification, without blurring or attenuation, and increase the dynamic range of the equipment. In turn, low doses will not reach the opacification level desired.</p>
        </sec>
      </sec>
      <sec>
        <title>8.3. Indications for Contrast in Vascular Ultrasound</title>
        <p><xref ref-type="table" rid="t28">Table 28</xref> lists the main indications for microbubble contrast agents in US studies of different vascular systems (consensus of the European Federation of Societies for Ultrasound in Medicine and Biology, published in 2011).<xref ref-type="bibr" rid="B129">129</xref> The levels of evidence, based on multicenter and/or single-center studies, were classified as A (good), B (moderate), and C (recommended by expert consensus).</p>
        <table-wrap id="t28">
          <label>Table 28</label>
          <caption>
            <title>Indications for contrast agents in vascular ultrasound</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col width="20%"/>
              <col width="40%"/>
              <col width="20%"/>
              <col width="20%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">System</th>
                <th align="center">Application</th>
                <th align="center">Level of evidence</th>
                <th align="center">Probe</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Carotids</td>
                <td align="center">Occlusion or subocclusion<break/> In-stent stenosis<break/>Dissection<break/>Plaque neovascularization</td>
                <td align="center">B<break/>B<break/>C<break/>B</td>
                <td align="center">Linear</td>
              </tr>
              <tr>
                <td align="left" rowspan="2">Aorta</td>
                <td align="center">Dissection, extension of the flap to branches, false lumen patency, re-entry points, and perfusion level of branches that originate from false lumen</td>
                <td align="center">C</td>
                <td align="center" rowspan="2">Convex abdominal or sector cardiac</td>
              </tr>
              <tr>
                <td align="center">Differentiation between an inflammatory aneurysm and contained rupture<break/>Endoleak</td>
                <td align="center">B<break/> A</td>
              </tr>
              <tr>
                <td align="left">Intracerebral vessels</td>
                <td align="center">Signal increase in unsatisfactory basal study<break/> Perfusion in ischemic CVA</td>
                <td align="center">A<break/>C</td>
                <td align="center">Sector cardiac</td>
              </tr>
              <tr>
                <td align="left">Complications in vascular accesses</td>
                <td align="center">Arteriovenous fistulas<break/>Pseudoaneurysms, hematomas</td>
                <td align="center">C<break/>C</td>
                <td align="center">Linear or convex abdominal or sector cardiac</td>
              </tr>
              <tr>
                <td align="left">Kidney</td>
                <td align="center">Signal increase in the renal artery<break/>Renal perfusion</td>
                <td align="center">C<break/>C</td>
                <td align="center">Convex abdominal or sector cardiac</td>
              </tr>
              <tr>
                <td align="left">Lower limbs</td>
                <td align="center">Obstructive atherosclerotic disease (assessment of collateral circulation and microcirculation)<break/>Deep venous thrombosis (signal improvement and inflammatory reaction in perithrombus)</td>
                <td align="center">C<break/>C</td>
                <td align="center">Linear or convex abdominal</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN17">
              <p>
                <italic>CVA: cerebrovascular accident.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>8.4. Preparation, Application, and Dose of Microbubble Contrast</title>
        <p>SonoVue<sup>&#174;</sup> is a kit that includes: a vial with 25 mg of lyophilized powder in an atmosphere of sulfur hexafluoride; a syringe filled with 5 ml of sodium chloride 9 mg/ml (0.9%) solution; a transfer system. The contrast is easy to prepare at the bedside, following the manufacturer&#8217;s instructions. After transferring the content of the syringe to the vial with powder, shake it for 20 seconds to create microbubbles and transform the saline solution into a milky suspension (indicating homogeneous microbubble distribution). In this state, the suspension can be stored for up to 6 hours. If microbubbles accumulate on the surface during rest, shake the solution again, so the microbubbles regain homogeneous distribution before use. </p>
        <p>The usual route of administration is by intravenous bolus injection in a vessel with caliber suitable for puncture with a needle of 20G in diameter (preferably in the antecubital fossa)<italic>.</italic> Administer a small initial volume, followed by a flush of 5 ml of saline solution at 0.9% to push the contrast agent into the central vein (which happens in seconds). </p>
        <p>In most publications, the recommended dose for a single injection in VUS studies is 2.4 ml, ranging from 1 to 4.8 ml, according to the organ studied, the probe used, and the sensitivity of the equipment available (always remembering that probes with higher frequencies need higher doses, in this case, 4.8 ml).<xref ref-type="bibr" rid="B7">7</xref> The first 10 to 40 seconds after bolus injection correspond to the contrast enhancement curve (wash-in and wash-out) and should be continuously recorded for later analysis. In some specific situations, such as the study of late endoleaks, the period of evaluation can reach 5 minutes; in these cases, shorter videos can be recorded. Bear in mind that the higher the MI, the greater the destruction of bubbles, and shorter the duration of contrast. After the bubbles burst, the lungs quickly (2 minutes) and fully eliminate the sulfur hexafluoride (Anvisa).</p>
        <p>SonoVue<sup>&#174;</sup> is a safe agent, with a low complication rate. Reports of anaphylactic reaction correspond to &lt; 0.002% of cases.</p>
      </sec>
      <sec>
        <title>8.5. Basic Protocol for Vascular Ultrasound with Microbubble Contrast</title>
        <p>After defining the indication for microbubble contrast in VUS examination, follow the mandatory basic routine:</p>
        <p>&#8226; Repeat and record the standard CDUS examination of the organ of interest</p>
        <p>&#8226; Secure venous access for injection of contrast solution with microbubbles (peripheral vein puncture or deep vein already in use)</p>
        <p>&#8226; Prepare the contrast solution with microbubbles (SonoVue<sup>&#174;</sup>) following the manufacturer&#8217;s instructions</p>
        <p>&#8226; Activate the specific image component for contrast in US equipment; if there is no specific software, adjust MI (&lt; 0.6 and the closest possible to 0.1), image gain (darken the background), and choose the appropriate windows to reduce the depth of the target-organ under study</p>
        <p>&#8226; Administer the contrast solution, make adjustments to reduce excessive enhancement, and record digital images (videos) for 10 to 40 seconds after the initial bolus injection; in specific longer examinations, record the necessary videos during the procedure (which can reach 5 to 8 minutes) for later analysis.</p>
        <p><bold>Note</bold>: analysis of examination with microbubble contrast is fundamentally dynamic and the duration of the study is short due to the fast destruction of microbubbles by US waves, even when using very low MI. Thus, recording it in digital media is essential for later processing and careful review of images, ensuring a safe diagnosis and permanent storage of results.</p>
      </sec>
      <sec>
        <title>8.6. Limitations of the Use of Contrast in Vascular Ultrasound</title>
        <p>&#8226; Inexperience of the examiner (proper training in ultrasound with contrast is crucial for an effective and safe diagnosis).</p>
        <p>&#8226; Equipment without a specific software for image with contrast makes it difficult (but not impossible) to conduct a conclusive examination.</p>
        <p>&#8226; Access to microbubble contrast in units of the Brazilian public health system.</p>
        <p>&#8226; Complete lack of &#8220;window&#8221; that allows US transmission to the organ of interest (rare).</p>
        <p>&#8226; Hypersensitivity to microbubble contrast (rare).</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other">
        <p>Development: Department of Cardiovascular Imaging (Departamento de Imagem Cardiovascular - DIC) of the Brazilian Society of Cardiology (Sociedade Brasileira de Cardiologia - SBC)</p>
      </fn>
      <fn fn-type="other">
        <p>Norms and Guidelines Council: Fernando Bacal, Leandro Ioschpe Zimerman, Paulo Ricardo Avancini Caramori and Pedro A. Lemos</p>
      </fn>
      <fn fn-type="other">
        <p>Norms and Guidelines Coordinator: Ludhmila Abrah&#227;o Hajjar</p>
      </fn>
      <fn fn-type="other">
        <p>President of the Department of Cardiovascular Imaging: Marcelo Luiz Campos Vieira</p>
      </fn>
      <fn fn-type="other">
        <p>Coordinators: Simone Nascimento dos Santos, Monica Luiza de Alcantara, Cl&#225;udia Maria Vilas Freire</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>This statement shall be referred to as:</bold>
        </p>
        <p> Santos SN, Alcantara ML, Freire CMV, Cantisano AL, Teodoro JAR, Carmen CLL, et al. Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019 Arq Bras Cardiol. 2019; 112(6):809-849.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Note:</bold> These Guidelines are for information purposes and are not to replace the clinical judgment of a physician, who must ultimately determine the appropriate treatment for each patient.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>To the authors and the US Doppler <italic>Escola de Ensino Presencial e a Dist&#226;ncia</italic> for the images. To Rodrigo Tonan for the medical ilustrations.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1 Freire CM, Alc&#226;ntara ML, Santos SN, Amaral SI, Veloso O, Porto CLL, et al. Recomenda&#231;&#245;es para quantifica&#231;&#227;o pelo US da doen&#231;a ateroscler&#243;tica das art&#233;rias car&#243;tidas e vertebrais: grupo de trabalho do departamento de imagem cardiovascular da Sociedade Brasileira de Cardiologia - DIC - SBC. Arq Bras Cardiol: Imagem cardiovasc. 2015;28(n&#250;mero especial):e1-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freire</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Alc&#226;ntara</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Amaral</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Veloso</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Porto</surname>
              <given-names>CLL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recomenda&#231;&#245;es para quantifica&#231;&#227;o pelo US da doen&#231;a ateroscler&#243;tica das art&#233;rias car&#243;tidas e vertebrais: grupo de trabalho do departamento de imagem cardiovascular da Sociedade Brasileira de Cardiologia - DIC - SBC</article-title>
          <source>Arq Bras Cardiol: Imagem cardiovasc</source>
          <year>2015</year>
          <volume>28</volume>
          <issue>n&#250;mero especial</issue>
          <fpage>e1</fpage>
          <lpage>64</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2 Alc&#226;ntara ML, Santos SN, Freire CM, Amaral SI, Veloso O, Porto CL, et al. Recomenda&#231;&#245;es para avalia&#231;&#227;o ultrassonogr&#225;fica da aorta abdominal e ramos: grupo de trabalho do departamento de imagem cardiovascular da Sociedade Brasileira de Cardiologia - DIC - SBC. Arq Bras Cardiol: Imagem cardiovasc. 2016;29(n&#186; especial):e1-68.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alc&#226;ntara</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Freire</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Amaral</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Veloso</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Porto</surname>
              <given-names>CL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recomenda&#231;&#245;es para avalia&#231;&#227;o ultrassonogr&#225;fica da aorta abdominal e ramos: grupo de trabalho do departamento de imagem cardiovascular da Sociedade Brasileira de Cardiologia - DIC - SBC</article-title>
          <source>Arq Bras Cardiol: Imagem cardiovasc</source>
          <year>2016</year>
          <volume>29</volume>
          <issue>n&#186; especial</issue>
          <fpage>e1</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3 Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229(2):340-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grant</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Moneta</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Alexandrov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Bluth</surname>
              <given-names>EI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference</article-title>
          <source>Radiology</source>
          <year>2003</year>
          <volume>229</volume>
          <issue>2</issue>
          <fpage>340</fpage>
          <lpage>346</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4 Oates CP, Naylor AR, Hartshorne T, Charles SM, Fail T, Humphries K, et al. Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg. 2009;37(3):251-61.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oates</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Naylor</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Hartshorne</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Fail</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Humphries</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2009</year>
          <volume>37</volume>
          <issue>3</issue>
          <fpage>251</fpage>
          <lpage>261</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5 World Health Organization (WHO). Noncommunicable diseases [Cited in: 2018 Jun 1] Available in: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs355/en">http://www.who.int/mediacentre/factsheets/fs355/en</ext-link>.</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Noncommunicable diseases</source>
          <date-in-citation content-type="access-date">2018 Jun 1</date-in-citation>
          <comment>Available in: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs355/en">http://www.who.int/mediacentre/factsheets/fs355/en</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6 Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al., Sociedade Brasileira de Cardiologia. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology. Arq Bras Cardiol. 2007;88(Suppl 1):2-19.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sposito</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Caramelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Bertolami</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Afiune</surname>
              <given-names>A</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2007</year>
          <volume>88</volume>
          <issue>Suppl 1</issue>
          <fpage>2</fpage>
          <lpage>19</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7 Xavier HT, Izar MC, Faria Neto Jr, Assad MH, Rocha VZ, Sposito AC, et al., Sociedade Brasileira de Cradiologia. V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xavier</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>Faria</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Assad</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>VZ</given-names>
            </name>
            <name>
              <surname>Sposito</surname>
              <given-names>AC</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cradiologia</collab>
          </person-group>
          <article-title>V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>101</volume>
          <issue>4 Suppl 1</issue>
          <fpage>1</fpage>
          <lpage>20</lpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8 Faludi AA, Izar MC, Saraiva JF, Chacra AP, Bianco HT, Afiune AN, et al. Sociedade Brasileira de Cardiologia. Atualiza&#231;&#227;o da Diretriz Brasileira de Dislipidemias e Preven&#231;&#227;o da Aterosclerose - 2017. Arq Bras Cardiol. 2017;109(2 Suppl 1):1-76.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faludi</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Chacra</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Afiune</surname>
              <given-names>AN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sociedade Brasileira de Cardiologia: Atualiza&#231;&#227;o da Diretriz Brasileira de Dislipidemias e Preven&#231;&#227;o da Aterosclerose - 2017</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2017</year>
          <volume>109</volume>
          <issue>2 Suppl 1</issue>
          <fpage>1</fpage>
          <lpage>76</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9 Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Touboul</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Hennerici</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Meairs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Amarenco</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bornstein</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011): An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011</article-title>
          <source>Cerebrovasc Dis</source>
          <year>2012</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>290</fpage>
          <lpage>296</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10 Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al., American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-111;quiz 89-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Korcarz</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Hurst</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Lonn</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kendall</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>ER</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2008</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>93</fpage>
          <lpage>111</lpage>
          <comment>quiz 89-90</comment>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11 Santos RD, Gagliardi AC, Xavier HT, Casella Filho A, Araujo DB, Cesena FY, et al., Sociedade Brasileira de Cardiologia. First Brazilian guidelines for familial hypercholesterolemia. Arq Bras Cardiol. 2012;99(2 Suppl 2):1-28.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Gagliardi</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Casella</surname>
              <given-names>A</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Cesena</surname>
              <given-names>FY</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>First Brazilian guidelines for familial hypercholesterolemia</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2012</year>
          <volume>99</volume>
          <issue>2 Suppl 2</issue>
          <fpage>1</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12 Simao AF, Precoma DB, Andrade JP, Correa FH, Saraiva JF, Oliveira GM, et al., Sociedade Brasileira de Cardiologia. I Brazilian Guidelines for cardiovascular prevention. Arq Bras Cardiol. 2013;101(6 Suppl 2):1-63.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simao</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Precoma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Correa</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GM</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>I Brazilian Guidelines for cardiovascular prevention</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>101</volume>
          <issue>6 Suppl 2</issue>
          <fpage>1</fpage>
          <lpage>63</lpage>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13 Santos IS, Bittencourt MS, Oliveira IR, Souza AG, Meireles DP, Rundek T, et al. Carotid intima-media thickness value distributions in The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2014;237(1):227-35.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Bittencourt</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Meireles</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Rundek</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Carotid intima-media thickness value distributions in The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)</article-title>
          <source>Atherosclerosis</source>
          <year>2014</year>
          <volume>237</volume>
          <issue>1</issue>
          <fpage>227</fpage>
          <lpage>235</lpage>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14 Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37(1):87-92.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorenz</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>von Kegler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Steinmetz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Markus</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Sitzer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS)</article-title>
          <source>Stroke</source>
          <year>2006</year>
          <volume>37</volume>
          <issue>1</issue>
          <fpage>87</fpage>
          <lpage>92</lpage>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15 Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Int Med. 2008;168(12):1333-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folsom</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Kronmal</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Detrano</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>O'Leary</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Bild</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Bluemke</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA)</article-title>
          <source>Arch Int Med</source>
          <year>2008</year>
          <volume>168</volume>
          <issue>12</issue>
          <fpage>1333</fpage>
          <lpage>1339</lpage>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16 Freire CM, Ribeiro AL, Barbosa FB, Nogueira AI, de Almeida MC, Barbosa MM, et al. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice. Vasc Health Risk Manag. 2009 Sep;5:811-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freire</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>de Almeida</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice</article-title>
          <source>Vasc Health Risk Manag</source>
          <year>2009</year>
          <month>09</month>
          <volume>5</volume>
          <fpage>811</fpage>
          <lpage>817</lpage>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17 Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69(5):377-81.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Woolf</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content</article-title>
          <source>Br Heart J</source>
          <year>1993</year>
          <volume>69</volume>
          <issue>5</issue>
          <fpage>377</fpage>
          <lpage>381</lpage>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18 Widder B, Paulat K, Hackspacher J, Hamann H, Hutschenreiter S, Kreutzer C, et al. Morphological characterization of carotid artery stenoses by ultrasound duplex scanning. Ultrasound Med Biol. 1990;16(4):349-54.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Widder</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Paulat</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hackspacher</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hamann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hutschenreiter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kreutzer</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Morphological characterization of carotid artery stenoses by ultrasound duplex scanning</article-title>
          <source>Ultrasound Med Biol</source>
          <year>1990</year>
          <volume>16</volume>
          <issue>4</issue>
          <fpage>349</fpage>
          <lpage>354</lpage>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19 Wain RA, Lyon RT, Veith FJ, Berdejo GL, Yuan JG, Suggs WD, et al. Accuracy of duplex ultrasound in evaluating carotid artery anatomy before endarterectomy. J Vasc Surg. 1998;27(2):235-42; discussion 42-4.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wain</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Veith</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Berdejo</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Suggs</surname>
              <given-names>WD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Accuracy of duplex ultrasound in evaluating carotid artery anatomy before endarterectomy</article-title>
          <source>J Vasc Surg</source>
          <year>1998</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>235</fpage>
          <lpage>242</lpage>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20 de Bray JM, Baud JM, Dauzat M. Consensus concerning the morphology and the risk of carotid plaques. Cerebrovasc Dis. 1997;7:289-96.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Bray</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Baud</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dauzat</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Consensus concerning the morphology and the risk of carotid plaques</article-title>
          <source>Cerebrovasc Dis</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>289</fpage>
          <lpage>296</lpage>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21 Reilly LM, Lusby RJ, Hughes L, Ferrell LD, Stoney RJ, Ehrenfeld WK. Carotid plaque histology using real-time ultrasonography. Clinical and therapeutic implications. Am J Surg. 1983;146(2):188-93.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reilly</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Lusby</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Stoney</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Ehrenfeld</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
          <article-title>Carotid plaque histology using real-time ultrasonography: Clinical and therapeutic implications</article-title>
          <source>Am J Surg</source>
          <year>1983</year>
          <volume>146</volume>
          <issue>2</issue>
          <fpage>188</fpage>
          <lpage>193</lpage>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22 Muraki M, Mikami T, Yoshimoto T, Fujimoto S, Tokuda K, Kaneko S, et al. New criteria for the sonographic diagnosis of a plaque ulcer in the extracranial carotid artery. AJR Am J Roentgenol. 2012;198(5):1161-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muraki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mikami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tokuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New criteria for the sonographic diagnosis of a plaque ulcer in the extracranial carotid artery</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2012</year>
          <volume>198</volume>
          <issue>5</issue>
          <fpage>1161</fpage>
          <lpage>1166</lpage>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23 Huston J, James EM, Brown RD Jr, Lefsrud RD, Ilstrup DM, Robertson EF, et al. Redefined duplex ultrasonographic criteria for diagnosis of carotid artery stenosis. Mayo Clinic Proceedings. 2000;75(11):1133-40.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huston</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>RD</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Lefsrud</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Ilstrup</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>EF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Redefined duplex ultrasonographic criteria for diagnosis of carotid artery stenosis</article-title>
          <source>Mayo Clinic Proceedings</source>
          <year>2000</year>
          <volume>75</volume>
          <issue>11</issue>
          <fpage>1133</fpage>
          <lpage>1140</lpage>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24 Strandness DE Jr. Duplex scanning in vascular disorders. 3rd ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2002.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Strandness</surname>
              <given-names>DE</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <source>Duplex scanning in vascular disorders</source>
          <year>2002</year>
          <edition>3rd ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25 AbuRahma AF, Robinson PA, Strickler DL, Alberts S, Young L. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg. 1998;12(4):349-58.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>AbuRahma</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Strickler</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Alberts</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials</article-title>
          <source>Ann Vasc Surg</source>
          <year>1998</year>
          <volume>12</volume>
          <issue>4</issue>
          <fpage>349</fpage>
          <lpage>358</lpage>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26 von Reutern GM, Goertler MW, Bornstein NM, Del Sette M, Evans DH, Hetzel A, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43(3):916-21.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Reutern</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Goertler</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Bornstein</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Del Sette</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Hetzel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Grading carotid stenosis using ultrasonic methods</article-title>
          <source>Stroke</source>
          <year>2012</year>
          <volume>43</volume>
          <issue>3</issue>
          <fpage>916</fpage>
          <lpage>921</lpage>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27 Buckenham TM, Wright IA. Ultrasound of the extracranial vertebral artery. Br J Radiol. 2004;77(913):15-20.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buckenham</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>Ultrasound of the extracranial vertebral artery</article-title>
          <source>Br J Radiol</source>
          <year>2004</year>
          <volume>77</volume>
          <issue>913</issue>
          <fpage>15</fpage>
          <lpage>20</lpage>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28 Vicenzini E, Ricciardi MC, Sirimarco G, Di Piero V, Lenzi GL. Extracranial and intracranial sonographic findings in vertebral artery diseases. J Ultrasound Med. 2010;29(12):1811-23.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vicenzini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ricciardi</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Sirimarco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Di Piero</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lenzi</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Extracranial and intracranial sonographic findings in vertebral artery diseases</article-title>
          <source>J Ultrasound Med</source>
          <year>2010</year>
          <volume>29</volume>
          <issue>12</issue>
          <fpage>1811</fpage>
          <lpage>1823</lpage>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29 Cloud GC, Markus HS. Diagnosis and management of vertebral artery stenosis. QJM. 2003;96(1):27-54.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cloud</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Markus</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and management of vertebral artery stenosis</article-title>
          <source>QJM</source>
          <year>2003</year>
          <volume>96</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>54</lpage>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30 Hua Y, Meng XF, Jia LY, Ling C, Miao ZR, Ling F, et al. Color Doppler imaging evaluation of proximal vertebral artery stenosis. AJR Am J Roentgenol. 2009;193(5):1434-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hua</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>XF</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miao</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Color Doppler imaging evaluation of proximal vertebral artery stenosis</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2009</year>
          <volume>193</volume>
          <issue>5</issue>
          <fpage>1434</fpage>
          <lpage>1438</lpage>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31 Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med. 2014;371(22):2101-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kent</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice: Abdominal aortic aneurysms</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>371</volume>
          <issue>22</issue>
          <fpage>2101</fpage>
          <lpage>2108</lpage>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32 LaRoy LL, Cormier PJ, Matalon TA, Patel SK, Turner DA, Silver B. Imaging of abdominal aortic aneurysms. AJR Am J Roentgenol. 1989;152(4):785-92.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LaRoy</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Matalon</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Imaging of abdominal aortic aneurysms</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>1989</year>
          <volume>152</volume>
          <issue>4</issue>
          <fpage>785</fpage>
          <lpage>792</lpage>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation>33 Wild JB, Stather PW, Biancari F, Choke EC, Earnshaw JJ, Grant SW, et al. A multicentre observational study of the outcomes of screening detected sub-aneurysmal aortic dilatation. Eur J Vasc Endovasc Surg. 2013;45(2):128-34.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wild</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Stather</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Biancari</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Choke</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Earnshaw</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>SW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A multicentre observational study of the outcomes of screening detected sub-aneurysmal aortic dilatation</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2013</year>
          <volume>45</volume>
          <issue>2</issue>
          <fpage>128</fpage>
          <lpage>134</lpage>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation>34 Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg. 1996;83(3):404-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koelemay</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>den Hartog</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Prins</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Kromhout</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Legemate</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of arterial disease of the lower extremities with duplex ultrasonography</article-title>
          <source>Br J Surg</source>
          <year>1996</year>
          <volume>83</volume>
          <issue>3</issue>
          <fpage>404</fpage>
          <lpage>409</lpage>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation>35 Uflaker R. Atlas da Anatomia Vascular. Rio de Janeiro: Revinter; 2003.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Uflaker</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>Atlas da Anatomia Vascular</source>
          <year>2003</year>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>Revinter</publisher-name>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation>36 Taylor LM Jr, Moneta GL, Porter JM. Treatment of chronic visceral ischemia. 5th ed. In: Rutherford RB. Vascular surgery. Philadelphia: WB Saunders; 2000. p.1532-41.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>LM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Moneta</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <chapter-title>Treatment of chronic visceral ischemia. 5th ed</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Rutherford</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <source>Vascular surgery</source>
          <year>2000</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>WB Saunders</publisher-name>
          <fpage>1532</fpage>
          <lpage>1541</lpage>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation>37 European Stroke O, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, et al; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851-906.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>European Stroke</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Tendera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aboyans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bartelink</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Baumgartner</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
            <collab>ESC Committee for Practice Guidelines</collab>
          </person-group>
          <article-title>ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)</article-title>
          <source>Eur Heart J</source>
          <year>2011</year>
          <volume>32</volume>
          <issue>22</issue>
          <fpage>2851</fpage>
          <lpage>2906</lpage>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation>38 Pellerito JS, Revzin MV, Tsang JC, Greben CR, Naidich JB. Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis. J Ultrasound Med. 2009;28(5):641-50.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pellerito</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Revzin</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Tsang</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Greben</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Naidich</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis</article-title>
          <source>J Ultrasound Med</source>
          <year>2009</year>
          <volume>28</volume>
          <issue>5</issue>
          <fpage>641</fpage>
          <lpage>650</lpage>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation>39 van Petersen AS, Meerwaldt R, Kolkman JJ, Huisman AB, van der Palen J, van Bockel JH, et al. The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia. J Vasc Surg. 2013;57(6):1603-11.e1-10.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Petersen</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Meerwaldt</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kolkman</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Huisman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>van der Palen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van Bockel</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia</article-title>
          <source>J Vasc Surg</source>
          <year>2013</year>
          <volume>57</volume>
          <issue>6</issue>
          <fpage>1603</fpage>
          <lpage>1611</lpage>
          <comment>e1-10</comment>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation>40 Morais Filho DB, Barros FS. Exame ultrassonogr&#225;fico das art&#233;rias mesent&#233;ricas. In: Engelhorn CA, Moraes Filho D, Barros FS, Coelho NA (eds). Guia pr&#225;tico de ultrassonografia. Rio de Janeiro: Di Livros; 2015.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Morais</surname>
              <given-names>DB</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <chapter-title>Exame ultrassonogr&#225;fico das art&#233;rias mesent&#233;ricas</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Engelhorn</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Moraes</surname>
              <given-names>D</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <source>Guia pr&#225;tico de ultrassonografia</source>
          <year>2015</year>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>Di Livros</publisher-name>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation>41 Gentile AT, Moneta GL, Lee RW, Masser PA, Taylor LM Jr, Porter JM. Usefulness of fasting and postprandial duplex ultrasound examinations for predicting high-grade superior mesenteric artery stenosis. Am J Surg. 1995;169(5):476-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gentile</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Moneta</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Masser</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>LM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Usefulness of fasting and postprandial duplex ultrasound examinations for predicting high-grade superior mesenteric artery stenosis</article-title>
          <source>Am J Surg</source>
          <year>1995</year>
          <volume>169</volume>
          <issue>5</issue>
          <fpage>476</fpage>
          <lpage>479</lpage>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation>42 AbuRahma AF, Scott Dean L. Duplex ultrasound interpretation criteria for inferior mesenteric arteries. Vascular. 2012;20(3):145-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>AbuRahma</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Scott Dean</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Duplex ultrasound interpretation criteria for inferior mesenteric arteries</article-title>
          <source>Vascular</source>
          <year>2012</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>145</fpage>
          <lpage>149</lpage>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation>43 Bowersox JC, Zwolak RM, Walsh DB, Schneider JR, Musson A, LaBombard FE, et al. Duplex ultrasonography in the diagnosis of celiac and mesenteric artery occlusive disease. J Vasc Surg. 1991;14(6):780-6; discussion 6-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bowersox</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Zwolak</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Musson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>LaBombard</surname>
              <given-names>FE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Duplex ultrasonography in the diagnosis of celiac and mesenteric artery occlusive disease</article-title>
          <source>J Vasc Surg</source>
          <year>1991</year>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>780</fpage>
          <lpage>786</lpage>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation>44 Simon N, Franklin SS, Bleifer KH, Maxwell MH. Clinical characteristics of renovascular hypertension. JAMA. 1972;220(9):1209-18.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Bleifer</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Clinical characteristics of renovascular hypertension</article-title>
          <source>JAMA</source>
          <year>1972</year>
          <volume>220</volume>
          <issue>9</issue>
          <fpage>1209</fpage>
          <lpage>1218</lpage>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation>45 Lao D, Parasher PS, Cho KC, Yeghiazarians Y. Atherosclerotic renal artery stenosis--diagnosis and treatment. Mayo Clin Proc. 2011;86(7):649-57.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lao</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Parasher</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Yeghiazarians</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Atherosclerotic renal artery stenosis--diagnosis and treatment</article-title>
          <source>Mayo Clin Proc</source>
          <year>2011</year>
          <volume>86</volume>
          <issue>7</issue>
          <fpage>649</fpage>
          <lpage>657</lpage>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation>46 Liang F, Hu DY, Wu MY, Li TC, Tang CZ, Wang JY, et al. The incidence of renal artery stenosis in the patients referred for coronary artery bypass grafting. Indian J Nephrol. 2012;22(1):13-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>CZ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The incidence of renal artery stenosis in the patients referred for coronary artery bypass grafting</article-title>
          <source>Indian J Nephrol</source>
          <year>2012</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>13</fpage>
          <lpage>17</lpage>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation>47 Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olin</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Froehlich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bacharach</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>BH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients</article-title>
          <source>Circulation</source>
          <year>2012</year>
          <volume>125</volume>
          <issue>25</issue>
          <fpage>3182</fpage>
          <lpage>3190</lpage>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation>48 Zierler RE. Is duplex scanning the best screening test for renal artery stenosis? Semin Vasc Surg. 2001;14(3):177-85.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zierler</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Is duplex scanning the best screening test for renal artery stenosis</article-title>
          <source>Semin Vasc Surg</source>
          <year>2001</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>177</fpage>
          <lpage>185</lpage>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation>49 Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dworkin</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice: Renal-artery stenosis</article-title>
          <source>N Engl J Med</source>
          <year>2009</year>
          <volume>361</volume>
          <issue>20</issue>
          <fpage>1972</fpage>
          <lpage>1978</lpage>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation>50 Borelli FA, Pinto IM, Amodeo C, Smanio PE, Kambara AM, Petisco AC, et al. Analysis of the sensitivity and specificity of noninvasive imaging tests for the diagnosis of renal artery stenosis. Arq Bras Cardiol. 2013;101(5):423-33.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borelli</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Amodeo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Smanio</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Kambara</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Petisco</surname>
              <given-names>AC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of the sensitivity and specificity of noninvasive imaging tests for the diagnosis of renal artery stenosis</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>101</volume>
          <issue>5</issue>
          <fpage>423</fpage>
          <lpage>433</lpage>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation>51 Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(19):2020-45.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rooke</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Misra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sidawy</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Beckman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Findeiss</surname>
              <given-names>LK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2011</year>
          <volume>58</volume>
          <issue>19</issue>
          <fpage>2020</fpage>
          <lpage>2045</lpage>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation>52 Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239-312.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Haskal</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Hertzer</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Bakal</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Halperin</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2006</year>
          <volume>47</volume>
          <issue>6</issue>
          <fpage>1239</fpage>
          <lpage>1312</lpage>
        </element-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation>53 Radermacher J, Chavan A, Schaffer J, Stoess B, Vitzthum A, Kliem V, et al. Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol. 2000;53(5):333-43.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radermacher</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chavan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schaffer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stoess</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vitzthum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kliem</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure</article-title>
          <source>Clin Nephrol</source>
          <year>2000</year>
          <volume>53</volume>
          <issue>5</issue>
          <fpage>333</fpage>
          <lpage>343</lpage>
        </element-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation>54 Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007;11(20):iii-iv,xi-xiii,1-184.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cranny</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aguiar-Ibanez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease</article-title>
          <source>Health Technol Assess</source>
          <year>2007</year>
          <volume>11</volume>
          <issue>20</issue>
          <fpage>iii</fpage>
          <lpage>iiv</lpage>
          <comment>xi-xiii,1-184</comment>
        </element-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation>55 Aboyans V, Ricco JB, Bartelink ME, Bjorck M, Brodmann M, Cohnert T, et al; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboyans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ricco</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bartelink</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Bjorck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brodmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cohnert</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
            <collab>ESC Scientific Document Group</collab>
          </person-group>
          <article-title>2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)</article-title>
          <source>Eur Heart J</source>
          <year>2018</year>
          <volume>39</volume>
          <issue>9</issue>
          <fpage>763</fpage>
          <lpage>816</lpage>
        </element-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation>56 Bradbury AW, Adam DJ. Diagnosis of peripheral arterial disease of the lower limb. BMJ. 2007;334(7606):1229-30.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradbury</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Adam</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of peripheral arterial disease of the lower limb</article-title>
          <source>BMJ</source>
          <year>2007</year>
          <volume>334</volume>
          <issue>7606</issue>
          <fpage>1229</fpage>
          <lpage>1230</lpage>
        </element-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation>57 Collins R, Burch J, Cranny G, Aguiar-Ibanez R, Craig D, Wright K, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334(7606):1257.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cranny</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aguiar-Ibanez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review</article-title>
          <source>BMJ</source>
          <year>2007</year>
          <volume>334</volume>
          <issue>7606</issue>
          <fpage>1257</fpage>
          <lpage>1257</lpage>
        </element-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation>58 de Vries SO, Hunink MG, Polak JF. Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease. Acad Radiol. 1996;3(4):361-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Vries</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Hunink</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease</article-title>
          <source>Acad Radiol</source>
          <year>1996</year>
          <volume>3</volume>
          <issue>4</issue>
          <fpage>361</fpage>
          <lpage>369</lpage>
        </element-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation>59 Eiberg JP, Gronvall Rasmussen JB, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg. 2010;40(4):507-12.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eiberg</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Gronvall Rasmussen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Schroeder</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>Duplex ultrasound scanning of peripheral arterial disease of the lower limb</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2010</year>
          <volume>40</volume>
          <issue>4</issue>
          <fpage>507</fpage>
          <lpage>512</lpage>
        </element-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation>60 Ascher E, Hingorani A, Markevich N, Yorkovich W, Schutzer R, Hou A, et al. Role of duplex arteriography as the sole preoperative imaging modality prior to lower extremity revascularization surgery in diabetic and renal patients. Ann Vasc Surg. 2004;18(4):433-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ascher</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hingorani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Markevich</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yorkovich</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Schutzer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of duplex arteriography as the sole preoperative imaging modality prior to lower extremity revascularization surgery in diabetic and renal patients</article-title>
          <source>Ann Vasc Surg</source>
          <year>2004</year>
          <volume>18</volume>
          <issue>4</issue>
          <fpage>433</fpage>
          <lpage>439</lpage>
        </element-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation>61 Wain RA, Berdejo GL, Delvalle WN, Lyon RT, Sanchez LA, Suggs WD, et al. Can duplex scan arterial mapping replace contrast arteriography as the test of choice before infrainguinal revascularization? J Vasc Surg. 1999;29(1):100-7; discussion 7-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wain</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Berdejo</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Delvalle</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Suggs</surname>
              <given-names>WD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Can duplex scan arterial mapping replace contrast arteriography as the test of choice before infrainguinal revascularization</article-title>
          <source>J Vasc Surg</source>
          <year>1999</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>100</fpage>
          <lpage>107</lpage>
        </element-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation>62 Burke CW, Suk JS, Kim AJ, Hsiang YH, Klibanov AL, Hanes J, et al. Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles. J Control Release. 2012;162(2):414-21.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burke</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Suk</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Hsiang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Klibanov</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hanes</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles</article-title>
          <source>J Control Release</source>
          <year>2012</year>
          <volume>162</volume>
          <issue>2</issue>
          <fpage>414</fpage>
          <lpage>421</lpage>
        </element-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation>63 Mitchell DG, Needleman L, Bezzi M, Goldberg BB, Kurtz AB, Pennell RG, et al. Femoral artery pseudoaneurysm: diagnosis with conventional duplex and color Doppler US. Radiology. 1987;165(3):687-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Needleman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bezzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Kurtz</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Pennell</surname>
              <given-names>RG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Femoral artery pseudoaneurysm: diagnosis with conventional duplex and color Doppler US</article-title>
          <source>Radiology</source>
          <year>1987</year>
          <volume>165</volume>
          <issue>3</issue>
          <fpage>687</fpage>
          <lpage>690</lpage>
        </element-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation>64 Paulson EK, Kliewer MA, Hertzberg BS, O'Malley CM, Washington R, Carroll BA. Color Doppler sonography of groin complications following femoral artery catheterization. AJR Am J Roentgenol. 1995;165(2):439-44.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulson</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Kliewer</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hertzberg</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>O'Malley </surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Washington</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Color Doppler sonography of groin complications following femoral artery catheterization</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>1995</year>
          <volume>165</volume>
          <issue>2</issue>
          <fpage>439</fpage>
          <lpage>444</lpage>
        </element-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation>65 Fasih T, Rudol G, Ashour H, Mudawi A, Bhattacharya V. Surveillance versus nonsurveillance for femoro-popliteal bypass grafts. Angiology. 2004;55(3):251-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fasih</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rudol</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ashour</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mudawi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Surveillance versus nonsurveillance for femoro-popliteal bypass grafts</article-title>
          <source>Angiology</source>
          <year>2004</year>
          <volume>55</volume>
          <issue>3</issue>
          <fpage>251</fpage>
          <lpage>256</lpage>
        </element-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation>66 Ferris BL, Mills JL Sr, Hughes JD, Durrani T, Knox R. Is early postoperative duplex scan surveillance of leg bypass grafts clinically important? J Vasc Surg. 2003;37(3):495-500.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferris</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>JL</given-names>
              <suffix>Sr</suffix>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Durrani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Knox</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Is early postoperative duplex scan surveillance of leg bypass grafts clinically important</article-title>
          <source>J Vasc Surg</source>
          <year>2003</year>
          <volume>37</volume>
          <issue>3</issue>
          <fpage>495</fpage>
          <lpage>500</lpage>
        </element-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation>67 Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ, et al ; American Society of Echocardiography; Society for Vascular Medicine and Biology. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11(3):183-200.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerhard-Herman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Jaff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Roman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Naqvi</surname>
              <given-names>TZ</given-names>
            </name>
            <etal/>
            <collab>American Society of EchocardiographySociety for Vascular Medicine and Biology</collab>
          </person-group>
          <article-title>Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology</article-title>
          <source>Vasc Med</source>
          <year>2006</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>183</fpage>
          <lpage>200</lpage>
        </element-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation>68 Back MR, Novotney M, Roth SM, Elkins D, Farber S, Cuthbertson D, et al. Utility of duplex surveillance following iliac artery angioplasty and primary stenting. J Endovasc Ther. 2001;8(6):629-37.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Back</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Novotney</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Elkins</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cuthbertson</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Utility of duplex surveillance following iliac artery angioplasty and primary stenting</article-title>
          <source>J Endovasc Ther</source>
          <year>2001</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>629</fpage>
          <lpage>637</lpage>
        </element-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation>69 Baril DT, Rhee RY, Kim J, Makaroun MS, Chaer RA, Marone LK. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2009;49(1):133-8; discussion 9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baril</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Rhee</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Makaroun</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Chaer</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Marone</surname>
              <given-names>LK</given-names>
            </name>
          </person-group>
          <article-title>Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery</article-title>
          <source>J Vasc Surg</source>
          <year>2009</year>
          <volume>49</volume>
          <issue>1</issue>
          <fpage>133</fpage>
          <lpage>138</lpage>
        </element-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation>70 Kawarada O, Higashimori A, Noguchi M, Waratani N, Yoshida M, Fujihara M, et al. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81(4):E199-205.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawarada</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Higashimori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Waratani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fujihara</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Duplex criteria for in-stent restenosis in the superficial femoral artery</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2013</year>
          <volume>81</volume>
          <issue>4</issue>
          <fpage>E199</fpage>
          <lpage>E205</lpage>
        </element-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation>71 Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, et al. Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis--findings from a randomized controlled trial. Eur J Radiol. 2012;81(9):2265-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langenberger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schillinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Plank</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sabeti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dick</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cejna</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Agreement of duplex ultrasonography vs: computed tomography angiography for evaluation of native and in-stent SFA re-stenosis--findings from a randomized controlled trial</article-title>
          <source>Eur J Radiol</source>
          <year>2012</year>
          <volume>81</volume>
          <issue>9</issue>
          <fpage>2265</fpage>
          <lpage>2269</lpage>
        </element-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation>72 Wiese P, Nonnast-Daniel B. Colour Doppler ultrasound in dialysis access. Nephrol Dial Transplant. 2004;19(8):1956-63.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wiese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nonnast-Daniel</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Colour Doppler ultrasound in dialysis access</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2004</year>
          <volume>19</volume>
          <issue>8</issue>
          <fpage>1956</fpage>
          <lpage>1963</lpage>
        </element-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation>73 National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis. 2001;37(1 Suppl 1):S137-81.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>National Kidney Foundation</collab>
          </person-group>
          <article-title>NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000</article-title>
          <source>Am J Kidney Dis</source>
          <year>2001</year>
          <volume>37</volume>
          <issue>1 Suppl 1</issue>
          <fpage>S137</fpage>
          <lpage>S181</lpage>
        </element-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation>74 Toregiani JF, Kimura CJ, Rocha AS, Volpiani GG, Bortoncello A, Shirasu K, et al. Avalia&#231;&#227;o da matura&#231;&#227;o das f&#237;stulas arteriovenosas para hemodi&#225;lise pelo eco-Doppler colorido. J Vasc Bras. 2008;7(3):203-13.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toregiani</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Volpiani</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Bortoncello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shirasu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Avalia&#231;&#227;o da matura&#231;&#227;o das f&#237;stulas arteriovenosas para hemodi&#225;lise pelo eco-Doppler colorido</article-title>
          <source>J Vasc Bras</source>
          <year>2008</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>203</fpage>
          <lpage>213</lpage>
        </element-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation>75 Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001;60(5):2013-20.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lockhart</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Lilly</surname>
              <given-names>RZ</given-names>
            </name>
            <name>
              <surname>Gallichio</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients</article-title>
          <source>Kidney Int</source>
          <year>2001</year>
          <volume>60</volume>
          <issue>5</issue>
          <fpage>2013</fpage>
          <lpage>2020</lpage>
        </element-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation>76 Nogueira AI, Leite PL, Mathias ML, Rabischoffsky A, Belem LHJ, Amaral SI, et al. Import&#226;ncia do Eco color Doppler no mapeamento arterial e venoso para confec&#231;&#227;o de fistulas arteriovenosas. Rev Bras Ecocardiogr Imagem Cardiovasc. 2010;23(3):33-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nogueira</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Leite</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Mathias</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Rabischoffsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Belem</surname>
              <given-names>LHJ</given-names>
            </name>
            <name>
              <surname>Amaral</surname>
              <given-names>SI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Import&#226;ncia do Eco color Doppler no mapeamento arterial e venoso para confec&#231;&#227;o de fistulas arteriovenosas</article-title>
          <source>Rev Bras Ecocardiogr Imagem Cardiovasc</source>
          <year>2010</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>33</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation>77 Robbin ML, Chamberlain NE, Lockhart ME, Gallichio MH, Young CJ, Deierhoi MH, et al. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology. 2002;225(1):59-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robbin</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Chamberlain</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Lockhart</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Gallichio</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Deierhoi</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hemodialysis arteriovenous fistula maturity: US evaluation</article-title>
          <source>Radiology</source>
          <year>2002</year>
          <volume>225</volume>
          <issue>1</issue>
          <fpage>59</fpage>
          <lpage>64</lpage>
        </element-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation>78 Grogan J, Castilla M, Lozanski L, Griffin A, Loth F, Bassiouny H. Frequency of critical stenosis in primary arteriovenous fistulae before hemodialysis access: should duplex ultrasound surveillance be the standard of care? J Vasc Surg. 2005;41(6):1000-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grogan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Castilla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lozanski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Loth</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bassiouny</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Frequency of critical stenosis in primary arteriovenous fistulae before hemodialysis access: should duplex ultrasound surveillance be the standard of care?</article-title>
          <source>J Vasc Surg</source>
          <year>2005</year>
          <volume>41</volume>
          <issue>6</issue>
          <fpage>1000</fpage>
          <lpage>1006</lpage>
        </element-citation>
      </ref>
      <ref id="B79">
        <label>79</label>
        <mixed-citation>79 Teodorescu V, Gustavson S, Schanzer H. Duplex ultrasound evaluation of hemodialysis access: a detailed protocol. Int J Nephrol. 2012 Jan;2012:508956.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teodorescu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gustavson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schanzer</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Duplex ultrasound evaluation of hemodialysis access: a detailed protocol</article-title>
          <source>Int J Nephrol</source>
          <year>2012</year>
          <month>01</month>
          <volume>2012</volume>
          <fpage>508956</fpage>
          <lpage>508956</lpage>
        </element-citation>
      </ref>
      <ref id="B80">
        <label>80</label>
        <mixed-citation>80 Planken RN, Keuter XH, Hoeks AP, Kooman JP, van der Sande FM, Kessels AG, et al. Diameter measurements of the forearm cephalic vein prior to vascular access creation in end-stage renal disease patients: graduated pressure cuff versus tourniquet vessel dilatation. Nephrol Dial Transplant. 2006;21(3):802-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Planken</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Keuter</surname>
              <given-names>XH</given-names>
            </name>
            <name>
              <surname>Hoeks</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Kooman</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>van der Sande</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Kessels</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diameter measurements of the forearm cephalic vein prior to vascular access creation in end-stage renal disease patients: graduated pressure cuff versus tourniquet vessel dilatation</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2006</year>
          <volume>21</volume>
          <issue>3</issue>
          <fpage>802</fpage>
          <lpage>806</lpage>
        </element-citation>
      </ref>
      <ref id="B81">
        <label>81</label>
        <mixed-citation>81 Corpataux JM, Haesler E, Silacci P, Ris HB, Hayoz D. Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant. 2002;17(6):1057-62.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corpataux</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Haesler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Silacci</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ris</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Hayoz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2002</year>
          <volume>17</volume>
          <issue>6</issue>
          <fpage>1057</fpage>
          <lpage>1062</lpage>
        </element-citation>
      </ref>
      <ref id="B82">
        <label>82</label>
        <mixed-citation>82 Lin SL, Huang CH, Chen HS, Hsu WA, Yen CJ, Yen TS. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol. 1998;18(2):96-100.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas</article-title>
          <source>Am J Nephrol</source>
          <year>1998</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>96</fpage>
          <lpage>100</lpage>
        </element-citation>
      </ref>
      <ref id="B83">
        <label>83</label>
        <mixed-citation>83 Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, et al. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e351S-418.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bates</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Jaeschke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Goodacre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines</article-title>
          <source>Chest</source>
          <year>2012</year>
          <volume>141</volume>
          <issue>2 Suppl</issue>
          <fpage>e351S</fpage>
          <lpage>e3418</lpage>
        </element-citation>
      </ref>
      <ref id="B84">
        <label>84</label>
        <mixed-citation>84 Hirsh J, Hull RD, Raskob GE. Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol. 1986;8(6 Suppl B):104B-13.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hull</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Raskob</surname>
              <given-names>GE</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology and pathogenesis of venous thrombosis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1986</year>
          <volume>8</volume>
          <issue>6 Suppl B</issue>
          <fpage>104B</fpage>
          <lpage>1013</lpage>
        </element-citation>
      </ref>
      <ref id="B85">
        <label>85</label>
        <mixed-citation>85 Andrews EJ Jr, Fleischer AC. Sonography for deep venous thrombosis: current and future applications. Ultrasound Q. 2005;21(4):213-25.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrews</surname>
              <given-names>EJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fleischer</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Sonography for deep venous thrombosis: current and future applications</article-title>
          <source>Ultrasound Q</source>
          <year>2005</year>
          <volume>21</volume>
          <issue>4</issue>
          <fpage>213</fpage>
          <lpage>225</lpage>
        </element-citation>
      </ref>
      <ref id="B86">
        <label>86</label>
        <mixed-citation>86 Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. J Blood Med. 2011 Apr;2:59-69.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kesieme</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kesieme</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jebbin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Irekpita</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dongo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Deep vein thrombosis: a clinical review</article-title>
          <source>J Blood Med</source>
          <year>2011</year>
          <month>04</month>
          <volume>2</volume>
          <fpage>59</fpage>
          <lpage>69</lpage>
        </element-citation>
      </ref>
      <ref id="B87">
        <label>87</label>
        <mixed-citation>87 Meissner MH, Wakefield TW, Ascher E, Caprini JA, Comerota AJ, Eklof B, et al. Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg. 2007;46(Suppl S):25S-53.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meissner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Wakefield</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Ascher</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Caprini</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Comerota</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Eklof</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute venous disease: venous thrombosis and venous trauma</article-title>
          <source>J Vasc Surg</source>
          <year>2007</year>
          <volume>46</volume>
          <issue>Suppl S</issue>
          <fpage>25S</fpage>
          <lpage>253</lpage>
        </element-citation>
      </ref>
      <ref id="B88">
        <label>88</label>
        <mixed-citation>88 Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH. Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg. 2002;23(4):344-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labropoulos</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Mansour</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Giannoukas</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Moutzouros</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Early thrombus remodelling of isolated calf deep vein thrombosis</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2002</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>344</fpage>
          <lpage>348</lpage>
        </element-citation>
      </ref>
      <ref id="B89">
        <label>89</label>
        <mixed-citation>89 Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130(18):1636-61.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Comerota</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Ginsberg</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Goldenberg</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association</article-title>
          <source>Circulation</source>
          <year>2014</year>
          <volume>130</volume>
          <issue>18</issue>
          <fpage>1636</fpage>
          <lpage>1661</lpage>
        </element-citation>
      </ref>
      <ref id="B90">
        <label>90</label>
        <mixed-citation>90 De Maeseneer MG, Bochanen N, van Rooijen G, Neglen P. Analysis of 1,338 patients with acute lower limb Deep Venous Thrombosis (DVT) supports the inadequacy of the term "Proximal DVT". Eur J Vasc Endovasc Surg. 2016;51(3):415-20.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Maeseneer</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Bochanen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>van Rooijen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Neglen</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Analysis of 1,338 patients with acute lower limb Deep Venous Thrombosis (DVT) supports the inadequacy of the term "Proximal DVT"</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2016</year>
          <volume>51</volume>
          <issue>3</issue>
          <fpage>415</fpage>
          <lpage>420</lpage>
        </element-citation>
      </ref>
      <ref id="B91">
        <label>91</label>
        <mixed-citation>91 Langford N, Stansby G, Avital L. The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144. Acute Med. 2012;11(3):138-42.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langford</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stansby</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Avital</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144</article-title>
          <source>Acute Med</source>
          <year>2012</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>138</fpage>
          <lpage>142</lpage>
        </element-citation>
      </ref>
      <ref id="B92">
        <label>92</label>
        <mixed-citation>92 Caprini JA. Risk assessment as a guide to thrombosis prophylaxis. Curr Opin Pulm Med. 2010;16(5):448-52.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caprini</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Risk assessment as a guide to thrombosis prophylaxis</article-title>
          <source>Curr Opin Pulm Med</source>
          <year>2010</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>448</fpage>
          <lpage>452</lpage>
        </element-citation>
      </ref>
      <ref id="B93">
        <label>93</label>
        <mixed-citation>93 Fitzgerald SJ, McAndrew CM, Kraay MJ, Goldberg VM. Incidence of postthrombotic syndrome in patients undergoing primary total hip arthroplasty for osteoarthritis. Clin Orthop Relat Res. 2011;469(2):530-4.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fitzgerald</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>McAndrew</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kraay</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>Incidence of postthrombotic syndrome in patients undergoing primary total hip arthroplasty for osteoarthritis</article-title>
          <source>Clin Orthop Relat Res</source>
          <year>2011</year>
          <volume>469</volume>
          <issue>2</issue>
          <fpage>530</fpage>
          <lpage>534</lpage>
        </element-citation>
      </ref>
      <ref id="B94">
        <label>94</label>
        <mixed-citation>94 Pesavento R, Villalta S, Prandoni P. The postthrombotic syndrome. Intern Emerg Med. 2010;5(3):185-92.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pesavento</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Villalta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Prandoni</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The postthrombotic syndrome</article-title>
          <source>Intern Emerg Med</source>
          <year>2010</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>185</fpage>
          <lpage>192</lpage>
        </element-citation>
      </ref>
      <ref id="B95">
        <label>95</label>
        <mixed-citation>95 Kahn SR, Desmarais S, Ducruet T, Arsenault L, Ginsberg JS. Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux. J Thromb Haemost. 2006;4(4):907-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Desmarais</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ducruet</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arsenault</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ginsberg</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux</article-title>
          <source>J Thromb Haemost</source>
          <year>2006</year>
          <volume>4</volume>
          <issue>4</issue>
          <fpage>907</fpage>
          <lpage>908</lpage>
        </element-citation>
      </ref>
      <ref id="B96">
        <label>96</label>
        <mixed-citation>96 Wakefield TW, Caprini J, Comerota AJ. Thromboembolic diseases. Curr Probl Surg. 2008;45(12):844-99.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wakefield</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Caprini</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Comerota</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Thromboembolic diseases</article-title>
          <source>Curr Probl Surg</source>
          <year>2008</year>
          <volume>45</volume>
          <issue>12</issue>
          <fpage>844</fpage>
          <lpage>899</lpage>
        </element-citation>
      </ref>
      <ref id="B97">
        <label>97</label>
        <mixed-citation>97 Lee JJ, Pope JE. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases. Arthritis Res Ther. 2014;16(5):435.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Pope</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases</article-title>
          <source>Arthritis Res Ther</source>
          <year>2014</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>435</fpage>
          <lpage>435</lpage>
        </element-citation>
      </ref>
      <ref id="B98">
        <label>98</label>
        <mixed-citation>98 Bounameaux H, Perrier A, Righini M. Diagnosis of venous thromboembolism: an update. Vasc Med. 2010;15(5):399-406.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bounameaux</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Perrier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Righini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of venous thromboembolism: an update</article-title>
          <source>Vasc Med</source>
          <year>2010</year>
          <volume>15</volume>
          <issue>5</issue>
          <fpage>399</fpage>
          <lpage>406</lpage>
        </element-citation>
      </ref>
      <ref id="B99">
        <label>99</label>
        <mixed-citation>99 Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2012;55(5):1449-62.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meissner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Gloviczki</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Comerota</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Dalsing</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Eklof</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>DL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum</article-title>
          <source>J Vasc Surg</source>
          <year>2012</year>
          <volume>55</volume>
          <issue>5</issue>
          <fpage>1449</fpage>
          <lpage>1462</lpage>
        </element-citation>
      </ref>
      <ref id="B100">
        <label>100</label>
        <mixed-citation>100 Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997;82(4):423-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prandoni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Villalta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bagatella</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Marchiori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piccioli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The clinical course of deep-vein thrombosis: Prospective long-term follow-up of 528 symptomatic patients</article-title>
          <source>Haematologica</source>
          <year>1997</year>
          <volume>82</volume>
          <issue>4</issue>
          <fpage>423</fpage>
          <lpage>428</lpage>
        </element-citation>
      </ref>
      <ref id="B101">
        <label>101</label>
        <mixed-citation>101 Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A, et al. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002;88(3):402-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prandoni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lensing</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Bernardi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Villalta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bagatella</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Girolami</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis</article-title>
          <source>Thromb Haemost</source>
          <year>2002</year>
          <volume>88</volume>
          <issue>3</issue>
          <fpage>402</fpage>
          <lpage>406</lpage>
        </element-citation>
      </ref>
      <ref id="B102">
        <label>102</label>
        <mixed-citation>102 Eichinger S, Heinze G, Kyrle PA. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. J Am Heart Assoc. 2014;3(1):e000467.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eichinger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heinze</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kyrle</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model</article-title>
          <source>J Am Heart Assoc</source>
          <year>2014</year>
          <volume>3</volume>
          <issue>1</issue>
          <elocation-id>e000467</elocation-id>
        </element-citation>
      </ref>
      <ref id="B103">
        <label>103</label>
        <mixed-citation>103 Linkins LA, Pasquale P, Paterson S, Kearon C. Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis. Arch Intern Med. 2004;164(16):1793-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linkins</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Pasquale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Paterson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kearon</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis</article-title>
          <source>Arch Intern Med</source>
          <year>2004</year>
          <volume>164</volume>
          <issue>16</issue>
          <fpage>1793</fpage>
          <lpage>1796</lpage>
        </element-citation>
      </ref>
      <ref id="B104">
        <label>104</label>
        <mixed-citation>104 Porto CL, Milhomens AL, Pires CE, Xavier SS, Sicuro F, Bottino DA, et al. Changes on venous diameter and leg perimeter with different clinical treatments for moderate chronic venous disease: evaluation using Duplex scanning and perimeter measurements. Int Angiol. 2009;28(3):222-31.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porto</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Milhomens</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Sicuro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bottino</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changes on venous diameter and leg perimeter with different clinical treatments for moderate chronic venous disease: evaluation using Duplex scanning and perimeter measurements</article-title>
          <source>Int Angiol</source>
          <year>2009</year>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>222</fpage>
          <lpage>231</lpage>
        </element-citation>
      </ref>
      <ref id="B105">
        <label>105</label>
        <mixed-citation>105 Sivananthan G, Halin NJ, Estes JM, Alessi-Chinetti JM, Polak JF. Value of complete full-length lower extremity sonography in patients undergoing computed tomographic pulmonary angiography. J Ultrasound Med. 2014;33(12):2137-43.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sivananthan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Halin</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Estes</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Alessi-Chinetti</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Value of complete full-length lower extremity sonography in patients undergoing computed tomographic pulmonary angiography</article-title>
          <source>J Ultrasound Med</source>
          <year>2014</year>
          <volume>33</volume>
          <issue>12</issue>
          <fpage>2137</fpage>
          <lpage>2143</lpage>
        </element-citation>
      </ref>
      <ref id="B106">
        <label>106</label>
        <mixed-citation>106 Bernardi E, Camporese G, Buller HR, Siragusa S, Imberti D, Berchio A, et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. JAMA. 2008;300(14):1653-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernardi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Camporese</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Buller</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Siragusa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imberti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berchio</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial</article-title>
          <source>JAMA</source>
          <year>2008</year>
          <volume>300</volume>
          <issue>14</issue>
          <fpage>1653</fpage>
          <lpage>1659</lpage>
        </element-citation>
      </ref>
      <ref id="B107">
        <label>107</label>
        <mixed-citation>107 Mumoli N, Vitale J, Giorgi-Pierfranceschi M, Sabatini S, Tulino R, Cei M, et al. General practitioner-performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: a multicenter, prospective cohort study. Ann Fam Med. 2017;15(6):535-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mumoli</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Vitale</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giorgi-Pierfranceschi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tulino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cei</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>General practitioner-performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: a multicenter, prospective cohort study</article-title>
          <source>Ann Fam Med</source>
          <year>2017</year>
          <volume>15</volume>
          <issue>6</issue>
          <fpage>535</fpage>
          <lpage>539</lpage>
        </element-citation>
      </ref>
      <ref id="B108">
        <label>108</label>
        <mixed-citation>108 Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A, et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles. Vasa. 2007;36(1):53-61.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coleridge-Smith</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Labropoulos</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Partsch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nicolaides</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cavezzi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document: Part I. Basic principles</article-title>
          <source>Vasa</source>
          <year>2007</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>53</fpage>
          <lpage>61</lpage>
        </element-citation>
      </ref>
      <ref id="B109">
        <label>109</label>
        <mixed-citation>109 Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57(6):769-74.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aaslid</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Markwalder</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Nornes</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries</article-title>
          <source>J Neurosurg</source>
          <year>1982</year>
          <volume>57</volume>
          <issue>6</issue>
          <fpage>769</fpage>
          <lpage>774</lpage>
        </element-citation>
      </ref>
      <ref id="B110">
        <label>110</label>
        <mixed-citation>110 Lindegaard KF, Bakke SJ, Grolimund P, Aaslid R, Huber P, Nornes H. Assessment of intracranial hemodynamics in carotid artery disease by transcranial Doppler ultrasound. J Neurosurg. 1985;63(6):890-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindegaard</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Bakke</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Grolimund</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aaslid</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nornes</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Assessment of intracranial hemodynamics in carotid artery disease by transcranial Doppler ultrasound</article-title>
          <source>J Neurosurg</source>
          <year>1985</year>
          <volume>63</volume>
          <issue>6</issue>
          <fpage>890</fpage>
          <lpage>898</lpage>
        </element-citation>
      </ref>
      <ref id="B111">
        <label>111</label>
        <mixed-citation>111 Hassler W, Steinmetz H, Pirschel J. Transcranial Doppler study of intracranial circulatory arrest. J Neurosurg. 1989;71(2):195-201.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassler</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Steinmetz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pirschel</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Transcranial Doppler study of intracranial circulatory arrest</article-title>
          <source>J Neurosurg</source>
          <year>1989</year>
          <volume>71</volume>
          <issue>2</issue>
          <fpage>195</fpage>
          <lpage>201</lpage>
        </element-citation>
      </ref>
      <ref id="B112">
        <label>112</label>
        <mixed-citation>112 Biniek R, Ringelstein EB, Br&#252;ckmann H, Leonhardt G, Ammeling B, Nolte P. Recanalization of acute middle cerebral artery occlusion monitored by transcranial doppler sonography. In: Hacke W, del Zoppo GJ, Hirschberg M. (eds). Thrombolytic therapy in acute ischemic stroke. Berlin: Springer-Heidelberg; 1991. p.221-3.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Biniek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ringelstein</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Br&#252;ckmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leonhardt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ammeling</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nolte</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <chapter-title>Recanalization of acute middle cerebral artery occlusion monitored by transcranial doppler sonography</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Hacke</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>del Zoppo</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Hirschberg</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <source>Thrombolytic therapy in acute ischemic stroke</source>
          <year>1991</year>
          <publisher-loc>Berlin</publisher-loc>
          <publisher-name>Springer-Heidelberg</publisher-name>
          <fpage>221</fpage>
          <lpage>223</lpage>
        </element-citation>
      </ref>
      <ref id="B113">
        <label>113</label>
        <mixed-citation>113 Labiche LA, Malkoff M, Alexandrov AV. Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging. 2003;13:28-33.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labiche</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Malkoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alexandrov</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Residual flow signals predict complete recanalization in stroke patients treated with TPA</article-title>
          <source>J Neuroimaging</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>28</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="B114">
        <label>114</label>
        <mixed-citation>114 Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg. 1984;60(1):37-41.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aaslid</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nornes</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound</article-title>
          <source>J Neurosurg</source>
          <year>1984</year>
          <volume>60</volume>
          <issue>1</issue>
          <fpage>37</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="B115">
        <label>115</label>
        <mixed-citation>115 Angeli S, Del Sette M, Beelke M, Anzola GP, Zanette E. Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol Sci. 2001;22(5):353-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Angeli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Del Sette</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beelke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Anzola</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Zanette</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Transcranial Doppler in the diagnosis of cardiac patent foramen ovale</article-title>
          <source>Neurol Sci</source>
          <year>2001</year>
          <volume>22</volume>
          <issue>5</issue>
          <fpage>353</fpage>
          <lpage>356</lpage>
        </element-citation>
      </ref>
      <ref id="B116">
        <label>116</label>
        <mixed-citation>116 Adams RJ, McKie VC, Carl EM, Nichols FT, Perry R, Brock K, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42(5):699-704.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>McKie</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Carl</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brock</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler</article-title>
          <source>Ann Neurol</source>
          <year>1997</year>
          <volume>42</volume>
          <issue>5</issue>
          <fpage>699</fpage>
          <lpage>704</lpage>
        </element-citation>
      </ref>
      <ref id="B117">
        <label>117</label>
        <mixed-citation>117 Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>McKie</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Files</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vichinsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pegelow</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography</article-title>
          <source>N Engl J Med</source>
          <year>1998</year>
          <volume>339</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>11</lpage>
        </element-citation>
      </ref>
      <ref id="B118">
        <label>118</label>
        <mixed-citation>118 Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004;103(10):3689-94.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Granger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vichinsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Abboud</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <issue>10</issue>
          <fpage>3689</fpage>
          <lpage>3694</lpage>
        </element-citation>
      </ref>
      <ref id="B119">
        <label>119</label>
        <mixed-citation>119 Chernyshev OY, Vein AM, Mathew NT, Kolosova OA, Kailasam J, Frolov A, et al. Blood flow velocity and pulsatility index differences in patients with unilateral migraine. Headache. 2001;41(7):704-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chernyshev</surname>
              <given-names>OY</given-names>
            </name>
            <name>
              <surname>Vein</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Kolosova</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Kailasam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frolov</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Blood flow velocity and pulsatility index differences in patients with unilateral migraine</article-title>
          <source>Headache</source>
          <year>2001</year>
          <volume>41</volume>
          <issue>7</issue>
          <fpage>704</fpage>
          <lpage>709</lpage>
        </element-citation>
      </ref>
      <ref id="B120">
        <label>120</label>
        <mixed-citation>120 Spencer MP, Thomas GI, Nicholls SC, Sauvage LR. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 1990;21(3):415-23.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Nicholls</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Sauvage</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <article-title>Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography</article-title>
          <source>Stroke</source>
          <year>1990</year>
          <volume>21</volume>
          <issue>3</issue>
          <fpage>415</fpage>
          <lpage>423</lpage>
        </element-citation>
      </ref>
      <ref id="B121">
        <label>121</label>
        <mixed-citation>121 Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, et al. Consensus on microembolus detection by TCD. International consensus group on microembolus detection. Stroke. 1998;29(3):725-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ringelstein</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Droste</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Babikian</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Grosset</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Kaps</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Consensus on microembolus detection by TCD: International consensus group on microembolus detection</article-title>
          <source>Stroke</source>
          <year>1998</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>725</fpage>
          <lpage>729</lpage>
        </element-citation>
      </ref>
      <ref id="B122">
        <label>122</label>
        <mixed-citation>122 Lange MC, Zetola VH, Miranda-Alves M, Moro CH, Silvado CE, Rodrigues DL, et al. Brazilian guidelines for the application of transcranial ultrasound as a diagnostic test for the confirmation of brain death. Arq Neuropsiquiatr. 2012;70(5):373-80.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lange</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Zetola</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Miranda-Alves</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moro</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Silvado</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>DL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brazilian guidelines for the application of transcranial ultrasound as a diagnostic test for the confirmation of brain death</article-title>
          <source>Arq Neuropsiquiatr</source>
          <year>2012</year>
          <volume>70</volume>
          <issue>5</issue>
          <fpage>373</fpage>
          <lpage>380</lpage>
        </element-citation>
      </ref>
      <ref id="B123">
        <label>123</label>
        <mixed-citation>123 Lobo CL, Cancado RD, Leite AC, Dos Anjos AC, Pinto AC, Matta AP, et al. Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease. Rev Bras Hematol Hemoter. 2011;33(1):43-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobo</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Cancado</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Leite</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Dos Anjos</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Matta</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease</article-title>
          <source>Rev Bras Hematol Hemoter</source>
          <year>2011</year>
          <volume>33</volume>
          <issue>1</issue>
          <fpage>43</fpage>
          <lpage>48</lpage>
        </element-citation>
      </ref>
      <ref id="B124">
        <label>124</label>
        <mixed-citation>124 Greis C. Ultrasound contrast agents as markers of vascularity and microcirculation. Clin Hemorheol Microcirc. 2009;43(1-2):1-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ultrasound contrast agents as markers of vascularity and microcirculation</article-title>
          <source>Clin Hemorheol Microcirc</source>
          <year>2009</year>
          <volume>43</volume>
          <issue>1-2</issue>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="B125">
        <label>125</label>
        <mixed-citation>125 Jung EM, Wiggermann P, Greis C, Eder F, Ehrich J, Jung W, et al. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results. Clin Hemorheol Microcirc. 2012;52(2-4):167-77.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Wiggermann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Greis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Eder</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ehrich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results</article-title>
          <source>Clin Hemorheol Microcirc</source>
          <year>2012</year>
          <volume>52</volume>
          <issue>2-4</issue>
          <fpage>167</fpage>
          <lpage>177</lpage>
        </element-citation>
      </ref>
      <ref id="B126">
        <label>126</label>
        <mixed-citation>126 Jung EM, Clevert DA, Schreyer AG, Schmitt S, Rennert J, Kubale R, et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study. World J Gastroenterol. 2007;13(47):6356-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Clevert</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Schreyer</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Schmitt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rennert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kubale</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study</article-title>
          <source>World J Gastroenterol</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>47</issue>
          <fpage>6356</fpage>
          <lpage>6364</lpage>
        </element-citation>
      </ref>
      <ref id="B127">
        <label>127</label>
        <mixed-citation>127 Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol. 1999;9(Suppl 3):S347-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>SonoVue, a new ultrasound contrast agent</article-title>
          <source>Eur Radiol</source>
          <year>1999</year>
          <volume>9</volume>
          <supplement>Suppl 3</supplement>
          <fpage>S347</fpage>
          <lpage>S348</lpage>
        </element-citation>
      </ref>
      <ref id="B128">
        <label>128</label>
        <mixed-citation>128 Greis C. Technical aspects of contrast-enhanced ultrasound (CEUS) examinations: tips and tricks. Clin Hemorheol Microcirc. 2014;58(1):89-95.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Technical aspects of contrast-enhanced ultrasound (CEUS) examinations: tips and tricks</article-title>
          <source>Clin Hemorheol Microcirc</source>
          <year>2014</year>
          <volume>58</volume>
          <issue>1</issue>
          <fpage>89</fpage>
          <lpage>95</lpage>
        </element-citation>
      </ref>
      <ref id="B129">
        <label>129</label>
        <mixed-citation>129 Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33-59.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piscaglia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nolsoe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Cosgrove</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Gilja</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Bachmann Nielsen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications</article-title>
          <source>Ultraschall Med</source>
          <year>2012</year>
          <volume>33</volume>
          <issue>1</issue>
          <fpage>33</fpage>
          <lpage>59</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="s1" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Posicionamento</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Posicionamento de Ultrassonografia Vascular do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia - 2019</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Simone Nascimento dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff20">1</xref>
          <xref ref-type="aff" rid="aff21">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alcantara</surname>
            <given-names>Monica Luiza de</given-names>
          </name>
          <xref ref-type="aff" rid="aff22">3</xref>
          <xref ref-type="aff" rid="aff23">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freire</surname>
            <given-names>Cl&#225;udia Maria Vilas</given-names>
          </name>
          <xref ref-type="aff" rid="aff24">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cantisano</surname>
            <given-names>Armando Luis</given-names>
          </name>
          <xref ref-type="aff" rid="aff25">6</xref>
          <xref ref-type="aff" rid="aff26">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teodoro</surname>
            <given-names>Jos&#233; Aldo Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff27">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porto</surname>
            <given-names>Carmen Lucia Lascasas</given-names>
          </name>
          <xref ref-type="aff" rid="aff28">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amaral</surname>
            <given-names>Salomon Israel do</given-names>
          </name>
          <xref ref-type="aff" rid="aff22">3</xref>
          <xref ref-type="aff" rid="aff23">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Veloso</surname>
            <given-names>Orlando</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albricker</surname>
            <given-names>Ana Cristina Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff30">11</xref>
          <xref ref-type="aff" rid="aff31">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Petisco</surname>
            <given-names>Ana Cl&#225;udia Gomes Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff32">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>Fanilda Souto</given-names>
          </name>
          <xref ref-type="aff" rid="aff33">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>M&#225;rcio Vin&#237;cius Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff34">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleh</surname>
            <given-names>Mohamed Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="aff32">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>Marcelo Luiz Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff35">16</xref>
          <xref ref-type="aff" rid="aff36">17</xref>
          <xref ref-type="aff" rid="aff37">18</xref>
        </contrib>
      </contrib-group>
      <aff id="aff20">
        <label>1</label>
        <institution content-type="original">Hospital Bras&#237;lia, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff21">
        <label>2</label>
        <institution content-type="original">Eccos Diagn&#243;stico Cardiovascular, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff22">
        <label>3</label>
        <institution content-type="original">Americas Medical City, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff23">
        <label>4</label>
        <institution content-type="original">Hospital Samaritano, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff24">
        <label>5</label>
        <institution content-type="original">Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff25">
        <label>6</label>
        <institution content-type="original">Ecovitall, Rio de Janeiro, RJ - Brazil </institution>
      </aff>
      <aff id="aff26">
        <label>7</label>
        <institution content-type="original">Hospital Barra Dor, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff27">
        <label>8</label>
        <institution content-type="original">Provato Medicina Diagn&#243;stica, Ribeir&#227;o Preto, SP - Brazil</institution>
      </aff>
      <aff id="aff28">
        <label>9</label>
        <institution content-type="original">Hospital Universit&#225;rio Pedro Ernesto, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff29">
        <label>10</label>
        <institution content-type="original">USDOPPLER, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff30">
        <label>11</label>
        <institution content-type="original">IMEDE, Instituto de Ultrassom, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff31">
        <label>12</label>
        <institution content-type="original">UniBH, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff32">
        <label>13</label>
        <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff33">
        <label>14</label>
        <institution content-type="original">Angiolab, Laborat&#243;rio Cardiovascular, Vit&#243;ria, ES - Brazil</institution>
      </aff>
      <aff id="aff34">
        <label>15</label>
        <institution content-type="original">Hospital Mater Dei, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff35">
        <label>16</label>
        <institution content-type="original">Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff36">
        <label>17</label>
        <institution content-type="original">Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff37">
        <label>18</label>
        <institution content-type="original">Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas da Faculdade de Medicina da USP, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c2"><bold>Correspond&#234;ncia:</bold> Sociedade Brasileira de Cardiologia - Av. Marechal C&#226;mara, 360/330 - Centro - Rio de Janeiro - CEP: 20020-907. E-mail: <email>sbc@cardiol.br</email>.</corresp>
      </author-notes>
    </front-stub>
    <body>
      <table-wrap id="t58">
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
          </colgroup>
          <thead>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <th align="center" colspan="8">Declara&#231;&#227;o de potencial conflito de interesses dos autores/colaboradores do Posicionamento de Ultrassonografia Vascular do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia &#8211; 2019</th>
            </tr>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <th align="center" colspan="8">Se nos &#250;ltimos 3 anos o autor/colaborador do Posicionamento:</th>
            </tr>
            <tr>
              <th align="center">Nomes Integrantes do Posicionamento</th>
              <th align="center">Participou de estudos cl&#237;nicos e/ou experimentais subvencionados pela ind&#250;stria farmac&#234;utica ou de equipamentos relacionados &#224; diretriz em quest&#227;o</th>
              <th align="center">Foi palestrante em eventos ou atividades patrocinadas pela ind&#250;stria relacionados &#224; diretriz em quest&#227;o</th>
              <th align="center">Foi (&#233;) membro do conselho consultivo ou diretivo da ind&#250;stria farmac&#234;utica ou de equipamentos</th>
              <th align="center">Participou de comit&#234;s normativos de estudos cient&#237;ficos patrocinados pela ind&#250;stria</th>
              <th align="center">Recebeu aux&#237;lio pessoal ou institucional da ind&#250;stria</th>
              <th align="center">Elaborou textos cient&#237;ficos em peri&#243;dicos patrocinados pela ind&#250;stria</th>
              <th align="center">Tem a&#231;&#245;es da ind&#250;stria</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Cl&#225;udia Maria Vilas Freire</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Jos&#233; Aldo Ribeiro Teodoro</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Carmen Lucia Lascasas Porto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Orlando Veloso</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Ana Cl&#225;udia Gomes Pereira Petisco</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Fanilda Souto Barros</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">M&#225;rcio Vin&#237;cius Lins Barros</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Mohamed Hassan Saleh</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Marcelo Luiz Campos Vieira</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Simone Nascimento dos Santos</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Monica Luiza de Alcantara</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Salomon Israel do Amaral</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Ana Cristina Lopes Albricker</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Armando Luis Cantisano</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <sec sec-type="intro">
        <title>1. Introdu&#231;&#227;o e Equipamento</title>
        <sec>
          <title>1.1. Introdu&#231;&#227;o</title>
          <p>O uso do ultrassom (US) xem medicina foi iniciado nos anos 1940 e, desde ent&#227;o, vem tendo papel importante no diagn&#243;stico das doen&#231;as cardiovasculares (DCV). Trata-se de uma tecnologia diversificada que segue basicamente os princ&#237;pios f&#237;sicos da propaga&#231;&#227;o das ondas de US em meios diversos. Devido a sua ampla aplicabilidade, relativo baixo custo e reprodutibilidade, o US tem seu papel estabelecido no aux&#237;lio diagn&#243;stico. Esta diretriz foi elaborada por membros do Departamento de Imagem Cardiovascular (DIC), especialistas em ultrassonografia vascular (USV), com o objetivo de orientar a melhor utiliza&#231;&#227;o desta t&#233;cnica, dentro dos conhecimentos recomendados na literatura m&#233;dica atual. Optamos por incluir os principais aspectos relacionados aos componentes do equipamento, <italic>softwares</italic>, transdutores e sua evolu&#231;&#227;o desde a &#250;ltima diretriz, seguidos por abordagem dos temas mais relevantes na &#225;rea do diagn&#243;stico de doen&#231;as vasculares. A fundamenta&#231;&#227;o do diagn&#243;stico pela USV de importantes patologias, como doen&#231;a ateroscler&#243;tica das art&#233;rias car&#243;tidas, afe&#231;&#245;es das art&#233;rias vertebrais, da aorta abdominal e de seus ramos, foi embasada nas recomenda&#231;&#245;es do painel de especialistas do DIC de 2015 e 2016.<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B2">2</xref>
					</p>
          <p>A diretriz n&#227;o tem o objetivo de comparar a USV com outras modalidades de exames de imagem, nem discorrer sobre a utiliza&#231;&#227;o da USV no acompanhamento das doen&#231;as vasculares ap&#243;s o diagn&#243;stico inicial. Para isso, o leitor dever&#225; recorrer a publica&#231;&#245;es mais amplas e espec&#237;ficas sobre o tema. </p>
          <p>Nosso objetivo &#233; difundir as melhores pr&#225;ticas da USV nos diversos servi&#231;os do pa&#237;s, homogeneizar a interpreta&#231;&#227;o dos exames e contribuir para um aproveitamento adequado dessa ferramenta n&#227;o invasiva, amplamente dispon&#237;vel e de baixo custo.</p>
        </sec>
        <sec>
          <title>1.2. Equipamentos</title>
          <p>Em um pa&#237;s com dimens&#245;es continentais como o Brasil e com diversas realidades econ&#244;micas, torna-se dif&#237;cil estabelecer o que seja um equipamento ideal. N&#227;o se pode exigir que um pequeno laborat&#243;rio no interior do pa&#237;s trabalhe com equipamentos que disponham dos mesmos recursos tecnol&#243;gicos de um laborat&#243;rio que atenda um grande n&#250;mero de pacientes. Esta normativa pretende sugerir o que &#233; um equipamento com os recursos m&#237;nimos adequados e o que &#233; o ideal para realizar, com seguran&#231;a e acur&#225;cia, os exames cujos protocolos ser&#227;o expostos a seguir, sempre lembrando que esta &#225;rea est&#225; em constante evolu&#231;&#227;o. </p>
          <sec>
            <title>1.2.1. Console</title>
            <p>O equipamento deve ser capaz de realizar os seguintes tipos de imagem e Doppler: (a) imagem bidimensional; (b) mapeamento de fluxo a cores (MFC); (c) Doppler espectral puls&#225;til; (d) Doppler espectral cont&#237;nuo (para alguns tipos de transdutores, n&#227;o sendo fundamental para exames vasculares); (e) <italic>power</italic> Doppler, tamb&#233;m conhecido como <italic>power</italic> angio e Doppler energia, forma de mapeamento de fluxos sem indicar a dire&#231;&#227;o, baseado na amplitude do sinal (recurso ideal, mas n&#227;o fundamental para o exame).</p>
            <p>Recursos mais avan&#231;ados, como imagem em segunda harm&#244;nica, <italic>B-Flow</italic>, sequ&#234;ncias de pulso invertido para utiliza&#231;&#227;o de contraste com microbolhas e at&#233; mesmo transdutores capazes de realizar imagens tridimensionais, s&#227;o de utilidade em exames complexos, mas ainda n&#227;o fazem parte de nossa pr&#225;tica di&#225;ria. Estes tamb&#233;m ser&#227;o abordados em car&#225;ter informativo e como forma de incentivar o avan&#231;o tecnol&#243;gico que traga benef&#237;cios adicionais para os pacientes.</p>
          </sec>
          <sec>
            <title>
              <bold>1.2.2. Aplicativos (<italic>Softwares</italic>)</bold>
            </title>
            <p>O equipamento dever&#225; ter, entre as suas op&#231;&#245;es de aplicativos, configura&#231;&#245;es (<italic>presets</italic>) preestabelecidas, espec&#237;ficas para cada tipo de estudo, agilizando e facilitando a tarefa do examinador. </p>
          </sec>
          <sec>
            <title>1.2.3. Transdutores Multifrequenciais ou de Banda Larga</title>
            <p>&#8226; <bold>Transdutor linear:</bold> frequ&#234;ncia ideal entre 5 e 10 MHz (em algumas circunst&#226;ncias, frequ&#234;ncias de 4 ou 12 MHz podem ser &#250;teis); para estudos de estruturas superficiais, pois o transdutor de maior frequ&#234;ncia tem melhor resolu&#231;&#227;o axial da imagem, por&#233;m sua utiliza&#231;&#227;o &#233; limitada pela grande atenua&#231;&#227;o que o som sofre ao viajar pelos tecidos.</p>
            <p>&#8226; <bold>Transdutor convexo:</bold> frequ&#234;ncia ideal entre 2 e 5 MHz, utilizado nos estudos cujas estruturas de interesse estejam localizadas mais profundamente, como as estruturas abdominais, com a vantagem de abordar maior campo de vis&#227;o em rela&#231;&#227;o aos transdutores setoriais de frequ&#234;ncias semelhantes.</p>
            <p>&#8226; <bold>Transdutor setorial de baixa frequ&#234;ncia:</bold> 2 a 4 MHz; &#250;til quando h&#225; necessidade de Doppler cont&#237;nuo em estudos arteriais abdominais.</p>
            <p>&#8226; <bold>Transdutor setorial de alta frequ&#234;ncia:</bold> 4 a 10 MHz; &#250;til quando a janela ac&#250;stica &#233; limitada por estruturas &#243;sseas. </p>
            <p>&#8226; <bold>Transdutores microconvexos:</bold> frequ&#234;ncia de 4 a 8 MHz; adapt&#225;veis a locais com janela limitada como, por exemplo, estrutura &#243;ssea, curativos, feridas ou outras situa&#231;&#245;es em que a superf&#237;cie de contato dispon&#237;vel para a sonda seja reduzida, sem ocorrer perda de resolu&#231;&#227;o lateral nos campos distais, apresentada pelos transdutores setoriais.</p>
            <p>
              <bold>
                <italic>1.2.3.1. Orienta&#231;&#227;o da Imagem</italic>
              </bold>
            </p>
            <p>A maioria dos guias para obten&#231;&#227;o de imagens vasculares recomenda que, nas imagens longitudinais, as estruturas craniais sejam representadas &#224; esquerda da tela, e as estruturas caudais &#224; direita. Nos cortes transversais, as estruturas &#224; esquerda da tela devem estar concordantes com a marca&#231;&#227;o no canto superior esquerdo do monitor. Dessa forma, nos cortes transversais, as estruturas laterais do dim&#237;dio direito, bem como as estruturas mediais do dim&#237;dio esquerdo ser&#227;o representadas &#224; esquerda da tela do monitor.<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B4">4</xref>
						</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>2. Art&#233;rias Car&#243;tidas e Vertebrais</title>
        <p>Segundo a Organiza&#231;&#227;o Mundial da Sa&#250;de (OMS), as DCV s&#227;o as principais causas de morbidade e mortalidade em todo o mundo. Em 2012, 17,5 milh&#245;es de pessoas morreram devido &#224;s DCV, o equivalente a 31% de todas as mortes que ocorreram no mesmo per&#237;odo, sendo estimado que 7,4 milh&#245;es foram por doen&#231;a arterial coron&#225;ria (DAC) e 6,7 milh&#245;es por acidente vascular encef&#225;lico (AVE).<xref ref-type="bibr" rid="B5">5</xref>
				</p>
        <p>A ultrassonografia das art&#233;rias car&#243;tidas &#233; de grande valia e largamente utilizada na avalia&#231;&#227;o do risco cardiovascular, pela medida da espessura do complexo mediointimal e detec&#231;&#227;o da presen&#231;a das placas ateroscler&#243;ticas, bem como pela capacidade de avaliar a morfologia das placas e o grau de estenose, caracter&#237;sticas associadas &#224; ocorr&#234;ncia de eventos cerebrovasculares.</p>
        <sec>
          <title>2.1. Espessura Mediointimal e Detec&#231;&#227;o de Placas das Art&#233;rias Car&#243;tidas para Avalia&#231;&#227;o do Risco Cardiovascular</title>
          <p>Com a publica&#231;&#227;o das diretrizes brasileiras de dislipidemia e preven&#231;&#227;o da aterosclerose de 2007 e 2013,<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B6">6</xref><sup>-</sup><xref ref-type="bibr" rid="B8">8</xref> dos documentos de consenso de Mannheim 2004-2011<xref ref-type="bibr" rid="B9">9</xref> e do consenso da American Society of Echocardiography,<xref ref-type="bibr" rid="B10">10</xref> os especialistas brasileiros na &#225;rea da US vascular se mobilizaram para difundir a pr&#225;tica correta da medida da espessura mediointimal (EMI) e da detec&#231;&#227;o da placa ateroscler&#243;tica das art&#233;rias car&#243;tidas. Na &#250;ltima atualiza&#231;&#227;o da diretriz brasileira em 2017,<xref ref-type="bibr" rid="B8">8</xref> a medida da EMI n&#227;o foi inclu&#237;da isoladamente na estratifica&#231;&#227;o do risco cardiovascular, mas na caracteriza&#231;&#227;o da placa ateroscler&#243;tica como sendo a EMI &gt; 1,5 mm. Outro aspecto importante para a correta realiza&#231;&#227;o dessa medida &#233; o fato de ser utilizada em diversos protocolos de pesquisa. Como os consensos de especialidades americanos e europeus utilizam a EMI como fator agravante de risco cardiovascular, optou-se pela inclus&#227;o da t&#233;cnica de medida nesse posicionamento. Esta se&#231;&#227;o tem como finalidade a normatiza&#231;&#227;o da t&#233;cnica para a medida da EMI e para a detec&#231;&#227;o de placas carot&#237;deas.</p>
        </sec>
        <sec>
          <title>2.2. Defini&#231;&#227;o Ultrassonogr&#225;fica da Espessura Mediointimal e da Placa Carot&#237;dea</title>
          <p>A EMI &#233; caracterizada, ao modo bidimensional, por uma dupla linha com defini&#231;&#227;o das interfaces l&#250;men-&#237;ntima e m&#233;dia-advent&#237;cia. A dist&#226;ncia entre as duas interfaces ac&#250;sticas &#233; considerada a medida da EMI. A placa carot&#237;dea (PC) ateromatosa pode ser definida como uma estrutura focal estendendo-se no m&#237;nimo 0,5 mm para o l&#250;men do vaso e/ou medindo mais do que 50% do valor da medida da EMI adjacente, e/ou ainda a medida de EMI &gt; 1,5 mm.<xref ref-type="bibr" rid="B9">9</xref> A <xref ref-type="fig" rid="f18">figura 1</xref> exemplifica esquematicamente a medida da EMI e das tr&#234;s formas de defini&#231;&#227;o da PC. </p>
          <p>
            <fig id="f18">
              <label>Figura 1</label>
              <caption>
                <title>Ilustra&#231;&#227;o esquem&#225;tica demonstrando exemplos de medida da EMI e de placas. Medida da EMI (A). Medidas diferentes de 3 placas carot&#237;deas: protrus&#227;o &#8805; 0,5 mm para o l&#250;men do vaso (B); medida &gt; 50% do valor da medida da EMI adjacente (C); placa extensa (D).</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf01-pt.jpg"/></fig>
          </p>
          <sec>
            <title>2.2.1. Indica&#231;&#245;es</title>
            <p>Os consensos europeu e americano<xref ref-type="bibr" rid="B9">9</xref><sup>,</sup><xref ref-type="bibr" rid="B10">10</xref> recomendam a realiza&#231;&#227;o da medida da EMI em grupos espec&#237;ficos (<xref ref-type="table" rid="t30">Tabela 1</xref>). Nesses grupos de indiv&#237;duos, a medida da EMI &#233; considerada aumentada se acima do percentil 75 para faixa et&#225;ria, sexo e ra&#231;a, de acordo com uma das tabelas normativas, auxiliando na discuss&#227;o do tratamento cl&#237;nico e modifica&#231;&#227;o de estilo de vida. Recomenda-se que, na presen&#231;a de PC, independentemente do grau de obstru&#231;&#227;o, n&#227;o &#233; necess&#225;ria a descri&#231;&#227;o da medida da EMI, com exce&#231;&#227;o para os exames solicitados especificamente para esta finalidade. Nesses casos, a PC, se presente no local da medida da EMI, deve ser inclu&#237;da na medida. </p>
            <table-wrap id="t30">
              <label>Tabela 1</label>
              <caption>
                <title>Quando medir a espessura mediointimal</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="100%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">1. Risco cardiovascular intermedi&#225;rio: utilizar a medida da EMI como fator agravante para a reclassifica&#231;&#227;o em alto risco<xref ref-type="bibr" rid="B10">10</xref>
										</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">2. Pacientes conhecidamente em maior risco de evento cardiovascular e de dif&#237;cil classifica&#231;&#227;o cl&#237;nica:</td>
                  </tr>
                  <tr>
                    <td align="left"> &#8226; Pacientes com hipercolesterolemia familiar<xref ref-type="bibr" rid="B11">11</xref>
										</td>
                  </tr>
                  <tr>
                    <td align="left"> &#8226; Portadores de doen&#231;as autoimunes ou em uso de imunossupressores, corticosteroides e antirretrovirais, ou outros medicamentos que induzam a eleva&#231;&#227;o do colesterol<xref ref-type="bibr" rid="B12">12</xref>
										</td>
                  </tr>
                  <tr>
                    <td align="left"> &#8226; Hist&#243;ria de doen&#231;a cardiovascular precoce em parentes de primeiro grau<xref ref-type="bibr" rid="B10">10</xref>
										</td>
                  </tr>
                  <tr>
                    <td align="left"> &#8226; Indiv&#237;duos &lt; 60 anos, com anormalidade grave em um fator de risco<xref ref-type="bibr" rid="B10">10</xref>
										</td>
                  </tr>
                  <tr>
                    <td align="left"> &#8226; Mulheres &lt; 60 anos, com no m&#237;nimo dois fatores de risco<xref ref-type="bibr" rid="B10">10</xref>
										</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN18">
                  <p>EMI: espessura mediointimal.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec>
            <title>2.2.2. Protocolo de Medidas</title>
            <p>O protocolo recomendado &#233; semelhante ao descrito pelo estudo ELSA-Brasil<xref ref-type="bibr" rid="B13">13</xref> (<xref ref-type="table" rid="t31">Tabela 2</xref>).</p>
            <table-wrap id="t31">
              <label>Tabela 2</label>
              <caption>
                <title>Protocolo de medida da espessura mediointimal</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="100%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">&#8226; Imagem fundamental ao modo bidimensional</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&#8226; N&#227;o utilizar o <italic>zoom</italic></td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Transdutor com frequ&#234;ncia &gt; 7 MHz</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Ajuste adequado de ganho; profundidade entre 3,0 e 4,0 cm</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Corte longitudinal da car&#243;tida comum e bifurca&#231;&#227;o carot&#237;dea</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Obter imagens nos acessos anterior, posterior ou no esternocleidomast&#243;ideo, com a imagem mais retil&#237;nea poss&#237;vel e com o padr&#227;o de dupla linha bem definido, e escolher a melhor imagem</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Medir na parede posterior das car&#243;tidas comuns &#224; direita e &#224; esquerda, a 1 cm da bifurca&#231;&#227;o, de forma autom&#225;tica/semiautom&#225;tica</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>Ap&#243;s aquisi&#231;&#227;o dos dados num&#233;ricos da EMI, os valores m&#233;dios ser&#227;o comparados com valores de refer&#234;ncia j&#225; existentes, de acordo com as tabelas normativas dos estudos ELSA-Brasil<xref ref-type="bibr" rid="B13">13</xref>, CAPS<xref ref-type="bibr" rid="B14">14</xref> ou MESA.<xref ref-type="bibr" rid="B15">15</xref> A decis&#227;o sobre qual tabela utilizar depender&#225; de g&#234;nero, idade e etnia do indiv&#237;duo.</p>
            <p>Muito embora a medida manual ponto a ponto seja menos reprodut&#237;vel, levando-se em considera&#231;&#227;o a variabilidade dos equipamentos ultrassonogr&#225;ficos utilizados em nosso pa&#237;s, foi consenso que, nos equipamentos em que a medida autom&#225;tica da EMI n&#227;o esteja dispon&#237;vel, a medida manual ponto a ponto pode ser realizada, respeitando-se estritamente as recomenda&#231;&#245;es t&#233;cnicas. Especial aten&#231;&#227;o deve ser dada aos pontos de coloca&#231;&#227;o do cursor nas interfaces &#237;ntima-l&#250;men e m&#233;dia-advent&#237;cia, onde o examinador deve ser bastante cauteloso em n&#227;o superestimar os valores. Neste caso, devem ser realizadas no m&#237;nimo cinco medidas de cada lado para se obter um valor m&#233;dio (EMI m&#233;dia).<xref ref-type="bibr" rid="B16">16</xref>
						</p>
          </sec>
          <sec>
            <title>2.2.3. Interpreta&#231;&#227;o dos Resultados</title>
            <p>EMI m&#233;dia [m&#233;dia das medidas na art&#233;ria car&#243;tida comum direita (CCD) ou esquerda [CCE]: a maioria dos equipamentos fornece essa medida de forma autom&#225;tica ou semiautom&#225;tica (neste &#250;ltimo caso, o examinador pode fazer pequenos ajustes em cima da medida autom&#225;tica). Uma vez obtidos os dois valores m&#233;dios da EMI de cada lado, deve-se compar&#225;-los com a tabela, para a obten&#231;&#227;o do percentil equivalente. O maior percentil deve ser considerado o percentil no qual se encontra o indiv&#237;duo estudado. </p>
            <p>Para a determina&#231;&#227;o do percentil da medida da EMI, deve-se consultar os <xref ref-type="table" rid="t32">tabelas 3</xref> a <xref ref-type="table" rid="t34">5</xref>, de acordo com a faixa et&#225;ria do indiv&#237;duo estudado.</p>
            <table-wrap id="t32">
              <label>Tabela 3</label>
              <caption>
                <title>ELSA-Brasil13 utilizada para indiv&#237;duos de ambos os sexos, na faixa et&#225;ria entre 40 e 65 anos, de etnia branca, parda ou negra</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="1%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                  <col width="6%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="center" colspan="9"> EMI m&#233;dia CCE (mm)</th>
                    <th align="center">
										</th>
                    <th align="center" colspan="9"> EMI m&#233;dia CCD (mm)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="left" rowspan="13">
                      <bold>Homem</bold>
                    </td>
                    <td align="center">
                      <bold>Etnia</bold>
                    </td>
                    <td align="center">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center">
                      <bold>40a</bold>
                    </td>
                    <td align="center">
                      <bold>45a</bold>
                    </td>
                    <td align="center">
                      <bold>50a</bold>
                    </td>
                    <td align="center">
                      <bold>55a</bold>
                    </td>
                    <td align="center">
                      <bold>60a</bold>
                    </td>
                    <td align="center">
                      <bold>65a</bold>
                    </td>
                    <td align="center">
                      <bold>&#160;</bold>
                    </td>
                    <td align="center" rowspan="13">
                      <bold>Homem</bold>
                    </td>
                    <td align="center">
                      <bold>Etnia</bold>
                    </td>
                    <td align="center">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center">
                      <bold>40a</bold>
                    </td>
                    <td align="center">
                      <bold>45a</bold>
                    </td>
                    <td align="center">
                      <bold>50a</bold>
                    </td>
                    <td align="center">
                      <bold>55a</bold>
                    </td>
                    <td align="center">
                      <bold>60a</bold>
                    </td>
                    <td align="center">
                      <bold>65a</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Branco</td>
                    <td align="center">P 25</td>
                    <td align="center">0,47</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,54</td>
                    <td align="center">0,57</td>
                    <td align="center">0,60</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Branco</td>
                    <td align="center">P 25</td>
                    <td align="center">0,45</td>
                    <td align="center">0,48</td>
                    <td align="center">0,51</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,57</td>
                    <td align="center">0,60</td>
                    <td align="center">0,64</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,51</td>
                    <td align="center">0,54</td>
                    <td align="center">0,58</td>
                    <td align="center">0,61</td>
                    <td align="center">0,65</td>
                    <td align="center">0,69</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,60</td>
                    <td align="center">0,65</td>
                    <td align="center">0,69</td>
                    <td align="center">0,73</td>
                    <td align="center">0,77</td>
                    <td align="center">0,81</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">0,75</td>
                    <td align="center">0,79</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,70</td>
                    <td align="center">0,75</td>
                    <td align="center">0,80</td>
                    <td align="center">0,85</td>
                    <td align="center">0,90</td>
                    <td align="center">0,95</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,66</td>
                    <td align="center">0,71</td>
                    <td align="center">0,76</td>
                    <td align="center">0,81</td>
                    <td align="center">0,85</td>
                    <td align="center">0,90</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Pardo</td>
                    <td align="center">P 25</td>
                    <td align="center">0,48</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,58</td>
                    <td align="center">0,61</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Pardo</td>
                    <td align="center">P 25</td>
                    <td align="center">0,44</td>
                    <td align="center">0,47</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,60</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,57</td>
                    <td align="center">0,61</td>
                    <td align="center">0,65</td>
                    <td align="center">0,69</td>
                    <td align="center">0,73</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,50</td>
                    <td align="center">0,54</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,66</td>
                    <td align="center">0,69</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,60</td>
                    <td align="center">0,65</td>
                    <td align="center">0,70</td>
                    <td align="center">0,75</td>
                    <td align="center">0,80</td>
                    <td align="center">0,85</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,58</td>
                    <td align="center">0,63</td>
                    <td align="center">0,68</td>
                    <td align="center">0,73</td>
                    <td align="center">0,77</td>
                    <td align="center">0,82</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,69</td>
                    <td align="center">0,75</td>
                    <td align="center">0,80</td>
                    <td align="center">0,86</td>
                    <td align="center">0,92</td>
                    <td align="center">0,97</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,69</td>
                    <td align="center">0,74</td>
                    <td align="center">0,79</td>
                    <td align="center">0,84</td>
                    <td align="center">0,89</td>
                    <td align="center">0,94</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Negro</td>
                    <td align="center">P 25</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,55</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,65</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Negro</td>
                    <td align="center">P 25</td>
                    <td align="center">0,46</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,57</td>
                    <td align="center">0,60</td>
                    <td align="center">0,64</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">0,75</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,54</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,66</td>
                    <td align="center">0,70</td>
                    <td align="center">0,74</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,64</td>
                    <td align="center">0,68</td>
                    <td align="center">0,72</td>
                    <td align="center">0,77</td>
                    <td align="center">0,81</td>
                    <td align="center">0,86</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,61</td>
                    <td align="center">0,67</td>
                    <td align="center">0,73</td>
                    <td align="center">0,78</td>
                    <td align="center">0,84</td>
                    <td align="center">0,90</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,71</td>
                    <td align="center">0,78</td>
                    <td align="center">0,84</td>
                    <td align="center">0,91</td>
                    <td align="center">0,97</td>
                    <td align="center">1,03</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,70</td>
                    <td align="center">0,77</td>
                    <td align="center">0,83</td>
                    <td align="center">0,89</td>
                    <td align="center">0,95</td>
                    <td align="center">1,02</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid;border-top-width:thin;border-top-style:solid">
                    <td align="left" rowspan="13">
                      <bold>Mulher</bold>
                    </td>
                    <td align="center">
                      <bold>Etnia</bold>
                    </td>
                    <td align="center">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center">
                      <bold>40a</bold>
                    </td>
                    <td align="center">
                      <bold>45a</bold>
                    </td>
                    <td align="center">
                      <bold>50a</bold>
                    </td>
                    <td align="center">
                      <bold>55a</bold>
                    </td>
                    <td align="center">
                      <bold>60a</bold>
                    </td>
                    <td align="center">
                      <bold>65a</bold>
                    </td>
                    <td align="center">
                      <bold>&#160;</bold>
                    </td>
                    <td align="center" rowspan="13">
                      <bold>Mulher</bold>
                    </td>
                    <td align="center">
                      <bold>Etnia</bold>
                    </td>
                    <td align="center">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center">
                      <bold>40a</bold>
                    </td>
                    <td align="center">
                      <bold>45a</bold>
                    </td>
                    <td align="center">
                      <bold>50a</bold>
                    </td>
                    <td align="center">
                      <bold>55a</bold>
                    </td>
                    <td align="center">
                      <bold>60a</bold>
                    </td>
                    <td align="center">
                      <bold>65a</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Branco</td>
                    <td align="center">P 25</td>
                    <td align="center">0,44</td>
                    <td align="center">0,47</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Branco</td>
                    <td align="center">P 25</td>
                    <td align="center">0,44</td>
                    <td align="center">0,47</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,55</td>
                    <td align="center">0,58</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,66</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,48</td>
                    <td align="center">0,52</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,66</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,54</td>
                    <td align="center">0,58</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">0,75</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,53</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,66</td>
                    <td align="center">0,70</td>
                    <td align="center">0,75</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,61</td>
                    <td align="center">0,66</td>
                    <td align="center">0,71</td>
                    <td align="center">0,76</td>
                    <td align="center">0,81</td>
                    <td align="center">0,86</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,59</td>
                    <td align="center">0,64</td>
                    <td align="center">0,69</td>
                    <td align="center">0,74</td>
                    <td align="center">0,79</td>
                    <td align="center">0,84</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Pardo</td>
                    <td align="center">P 25</td>
                    <td align="center">0,45</td>
                    <td align="center">0,48</td>
                    <td align="center">0,51</td>
                    <td align="center">0,54</td>
                    <td align="center">0,57</td>
                    <td align="center">0,60</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Pardo</td>
                    <td align="center">P 25</td>
                    <td align="center">0,44</td>
                    <td align="center">0,47</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,50</td>
                    <td align="center">0,53</td>
                    <td align="center">0,57</td>
                    <td align="center">0,60</td>
                    <td align="center">0,64</td>
                    <td align="center">0,67</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,56</td>
                    <td align="center">0,60</td>
                    <td align="center">0,64</td>
                    <td align="center">0,68</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,56</td>
                    <td align="center">0,60</td>
                    <td align="center">0,64</td>
                    <td align="center">0,68</td>
                    <td align="center">0,72</td>
                    <td align="center">0,77</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,55</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,68</td>
                    <td align="center">0,72</td>
                    <td align="center">0,76</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,63</td>
                    <td align="center">0,68</td>
                    <td align="center">0,73</td>
                    <td align="center">0,78</td>
                    <td align="center">0,83</td>
                    <td align="center">0,88</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,62</td>
                    <td align="center">0,67</td>
                    <td align="center">0,72</td>
                    <td align="center">0,77</td>
                    <td align="center">0,82</td>
                    <td align="center">0,87</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Negro</td>
                    <td align="center">P 25</td>
                    <td align="center">0,46</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,55</td>
                    <td align="center">0,58</td>
                    <td align="center">0,61</td>
                    <td align="center">
										</td>
                    <td align="center" rowspan="4">Negro</td>
                    <td align="center">P 25</td>
                    <td align="center">0,46</td>
                    <td align="center">0,49</td>
                    <td align="center">0,53</td>
                    <td align="center">0,56</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                  </tr>
                  <tr>
                    <td align="left">P 50</td>
                    <td align="center">0,51</td>
                    <td align="center">0,55</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,70</td>
                    <td align="center">
										</td>
                    <td align="center">P 50</td>
                    <td align="center">0,51</td>
                    <td align="center">0,55</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                  </tr>
                  <tr>
                    <td align="left">P 75</td>
                    <td align="center">0,57</td>
                    <td align="center">0,62</td>
                    <td align="center">0,66</td>
                    <td align="center">0,70</td>
                    <td align="center">0,75</td>
                    <td align="center">0,79</td>
                    <td align="center">
										</td>
                    <td align="center">P 75</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">0,76</td>
                    <td align="center">0,80</td>
                  </tr>
                  <tr>
                    <td align="left">P 90</td>
                    <td align="center">0,64</td>
                    <td align="center">0,70</td>
                    <td align="center">0,76</td>
                    <td align="center">0,82</td>
                    <td align="center">0,88</td>
                    <td align="center">0,94</td>
                    <td align="center">
										</td>
                    <td align="center">P 90</td>
                    <td align="center">0,64</td>
                    <td align="center">0,71</td>
                    <td align="center">0,77</td>
                    <td align="center">0,83</td>
                    <td align="center">0,90</td>
                    <td align="center">0,96</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN19">
                  <p>
                    <italic>CCD: art&#233;ria car&#243;tida comum direita; CCE: art&#233;ria car&#243;tida comum direita; EMI: espessura mediointimal.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="t33">
              <label>Tabela 4</label>
              <caption>
                <title>Tabela CAPS14 utilizada para indiv&#237;duos de ambos os sexos, na faixa et&#225;ria entre 25 e 45 anos. N&#227;o existe classifica&#231;&#227;o por etnia</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="1%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                </colgroup>
                <tbody>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="left" rowspan="5">
                      <bold>Homem</bold>
                    </td>
                    <td align="center" rowspan="2" style="border-bottom-width:thin;border-bottom-style:solid">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="7">
                      <bold>Idade</bold>
                    </td>
                    <td align="center">
                      <bold>&#160;</bold>
                    </td>
                    <td align="center" rowspan="5">
                      <bold>Mulher</bold>
                    </td>
                    <td align="center" rowspan="2" style="border-bottom-width:thin;border-bottom-style:solid">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="7">
                      <bold>Idade</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="left">
                      <bold>25</bold>
                    </td>
                    <td align="center">
                      <bold>35</bold>
                    </td>
                    <td align="center">
                      <bold>45</bold>
                    </td>
                    <td align="center">
                      <bold>55</bold>
                    </td>
                    <td align="center">
                      <bold>65</bold>
                    </td>
                    <td align="center">
                      <bold>75</bold>
                    </td>
                    <td align="center">
                      <bold>85</bold>
                    </td>
                    <td align="center">
                      <bold>&#160;</bold>
                    </td>
                    <td align="center">
                      <bold>25</bold>
                    </td>
                    <td align="center">
                      <bold>35</bold>
                    </td>
                    <td align="center">
                      <bold>45</bold>
                    </td>
                    <td align="center">
                      <bold>55</bold>
                    </td>
                    <td align="center">
                      <bold>65</bold>
                    </td>
                    <td align="center">
                      <bold>75</bold>
                    </td>
                    <td align="center">
                      <bold>85</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left">%25</td>
                    <td align="center">0,515</td>
                    <td align="center">0,585</td>
                    <td align="center">0,634</td>
                    <td align="center">0,68</td>
                    <td align="center">0,745</td>
                    <td align="center">0,814</td>
                    <td align="center">0,83</td>
                    <td align="center">
										</td>
                    <td align="center">%25</td>
                    <td align="center">0,524</td>
                    <td align="center">0,575</td>
                    <td align="center">0,619</td>
                    <td align="center">0,665</td>
                    <td align="center">0,718</td>
                    <td align="center">0,771</td>
                    <td align="center">0,807</td>
                  </tr>
                  <tr>
                    <td align="left">%50</td>
                    <td align="center">0,567</td>
                    <td align="center">0,633</td>
                    <td align="center">0,686</td>
                    <td align="center">0,746</td>
                    <td align="center">0,83</td>
                    <td align="center">0,914</td>
                    <td align="center">0,937</td>
                    <td align="center">
										</td>
                    <td align="center">%50</td>
                    <td align="center">0,567</td>
                    <td align="center">0,615</td>
                    <td align="center">0,665</td>
                    <td align="center">0,719</td>
                    <td align="center">0,778</td>
                    <td align="center">0,837</td>
                    <td align="center">0,880</td>
                  </tr>
                  <tr>
                    <td align="left">%75</td>
                    <td align="center">0,633</td>
                    <td align="center">0,682</td>
                    <td align="center">0,756</td>
                    <td align="center">0,837</td>
                    <td align="center">0,921</td>
                    <td align="center">1,028</td>
                    <td align="center">1,208</td>
                    <td align="center">
										</td>
                    <td align="center">%75</td>
                    <td align="center">0,612</td>
                    <td align="center">0,66</td>
                    <td align="center">0,713</td>
                    <td align="center">0,776</td>
                    <td align="center">0,852</td>
                    <td align="center">0,921</td>
                    <td align="center">0,935</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap id="t34">
              <label>Tabela 5</label>
              <caption>
                <title>Tabela MESA15 utilizada para indiv&#237;duos de ambos os sexos, na faixa et&#225;ria entre 65 e 84 anos, de etnia branca, negra, chinesa ou hisp&#226;nica</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                  <col width="5%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="center" colspan="17">EMI m&#233;dia CCD</th>
                  </tr>
                </thead>
                <tbody>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" rowspan="3">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem branco</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher branca</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem negro</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher negra</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center">%25</td>
                    <td align="center">0,52</td>
                    <td align="center">0,57</td>
                    <td align="center">0,65</td>
                    <td align="center">0,72</td>
                    <td align="center">0,51</td>
                    <td align="center">0,55</td>
                    <td align="center">0,65</td>
                    <td align="center">0,72</td>
                    <td align="center">0,58</td>
                    <td align="center">0,61</td>
                    <td align="center">0,71</td>
                    <td align="center">0,74</td>
                    <td align="center">0,55</td>
                    <td align="center">0,60</td>
                    <td align="center">0,65</td>
                    <td align="center">0,71</td>
                  </tr>
                  <tr>
                    <td align="center">%50</td>
                    <td align="center">0,62</td>
                    <td align="center">0,68</td>
                    <td align="center">0,77</td>
                    <td align="center">0,83</td>
                    <td align="center">0,58</td>
                    <td align="center">0,65</td>
                    <td align="center">0,75</td>
                    <td align="center">0,83</td>
                    <td align="center">0,67</td>
                    <td align="center">0,74</td>
                    <td align="center">0,85</td>
                    <td align="center">0,85</td>
                    <td align="center">0,64</td>
                    <td align="center">0,71</td>
                    <td align="center">0,76</td>
                    <td align="center">0,83</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">%75</td>
                    <td align="center">0,71</td>
                    <td align="center">0,81</td>
                    <td align="center">0,92</td>
                    <td align="center">0,97</td>
                    <td align="center">0,67</td>
                    <td align="center">0,76</td>
                    <td align="center">0,87</td>
                    <td align="center">0,93</td>
                    <td align="center">0,80</td>
                    <td align="center">0,92</td>
                    <td align="center">0,99</td>
                    <td align="center">1,02</td>
                    <td align="center">0,74</td>
                    <td align="center">0,81</td>
                    <td align="center">0,92</td>
                    <td align="center">0,96</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" rowspan="3">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem chin&#234;s</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher chinesa</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem hisp&#226;nico</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher hisp&#226;nica</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center">%25</td>
                    <td align="center">0,54</td>
                    <td align="center">0,56</td>
                    <td align="center">0,62</td>
                    <td align="center">0,66</td>
                    <td align="center">0,55</td>
                    <td align="center">0,54</td>
                    <td align="center">0,59</td>
                    <td align="center">0,67</td>
                    <td align="center">0,53</td>
                    <td align="center">0,60</td>
                    <td align="center">0,65</td>
                    <td align="center">0,71</td>
                    <td align="center">0,51</td>
                    <td align="center">0,57</td>
                    <td align="center">0,65</td>
                    <td align="center">0,63</td>
                  </tr>
                  <tr>
                    <td align="center">%50</td>
                    <td align="center">0,64</td>
                    <td align="center">0,70</td>
                    <td align="center">0,73</td>
                    <td align="center">0,79</td>
                    <td align="center">0,60</td>
                    <td align="center">0,63</td>
                    <td align="center">0,71</td>
                    <td align="center">0,77</td>
                    <td align="center">0,62</td>
                    <td align="center">0,67</td>
                    <td align="center">0,78</td>
                    <td align="center">0,81</td>
                    <td align="center">0,58</td>
                    <td align="center">0,69</td>
                    <td align="center">0,76</td>
                    <td align="center">0,78</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">%75</td>
                    <td align="center">0,73</td>
                    <td align="center">0,83</td>
                    <td align="center">0,92</td>
                    <td align="center">0,98</td>
                    <td align="center">0,70</td>
                    <td align="center">0,77</td>
                    <td align="center">0,84</td>
                    <td align="center">0,96</td>
                    <td align="center">0,73</td>
                    <td align="center">0,82</td>
                    <td align="center">0,90</td>
                    <td align="center">0,92</td>
                    <td align="center">0,67</td>
                    <td align="center">0,77</td>
                    <td align="center">0,87</td>
                    <td align="center">0,92</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" colspan="17">
                      <bold>EMI m&#233;dia CCE</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" rowspan="3">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem branco</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher branca</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem negro</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher negra</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center">%25</td>
                    <td align="center">0,54</td>
                    <td align="center">0,57</td>
                    <td align="center">0,67</td>
                    <td align="center">0,71</td>
                    <td align="center">0,50</td>
                    <td align="center">0,55</td>
                    <td align="center">0,63</td>
                    <td align="center">0,70</td>
                    <td align="center">0,56</td>
                    <td align="center">0,63</td>
                    <td align="center">0,69</td>
                    <td align="center">0,72</td>
                    <td align="center">0,54</td>
                    <td align="center">0,59</td>
                    <td align="center">0,63</td>
                    <td align="center">0,68</td>
                  </tr>
                  <tr>
                    <td align="center">%50</td>
                    <td align="center">0,63</td>
                    <td align="center">0,69</td>
                    <td align="center">0,81</td>
                    <td align="center">0,85</td>
                    <td align="center">0,58</td>
                    <td align="center">0,64</td>
                    <td align="center">0,73</td>
                    <td align="center">0,80</td>
                    <td align="center">0,69</td>
                    <td align="center">0,75</td>
                    <td align="center">0,82</td>
                    <td align="center">0,85</td>
                    <td align="center">0,63</td>
                    <td align="center">0,67</td>
                    <td align="center">0,76</td>
                    <td align="center">0,78</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">%75</td>
                    <td align="center">0,78</td>
                    <td align="center">0,82</td>
                    <td align="center">0,95</td>
                    <td align="center">1,00</td>
                    <td align="center">0,67</td>
                    <td align="center">0,75</td>
                    <td align="center">0,85</td>
                    <td align="center">0,94</td>
                    <td align="center">0,81</td>
                    <td align="center">0,92</td>
                    <td align="center">0,99</td>
                    <td align="center">1,02</td>
                    <td align="center">0,73</td>
                    <td align="center">0,80</td>
                    <td align="center">0,90</td>
                    <td align="center">0,91</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" rowspan="3">
                      <bold>Percentil</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem chin&#234;s</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher chinesa</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Homem hisp&#226;nico</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Mulher hisp&#226;nica</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                    <td align="center" colspan="4">
                      <bold>Idade</bold>
                    </td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid">
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                    <td align="center">
                      <bold>45-54</bold>
                    </td>
                    <td align="center">
                      <bold>55-64</bold>
                    </td>
                    <td align="center">
                      <bold>65-74</bold>
                    </td>
                    <td align="center">
                      <bold>75-84</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center">%25</td>
                    <td align="center">0,55</td>
                    <td align="center">0,57</td>
                    <td align="center">0,62</td>
                    <td align="center">0,69</td>
                    <td align="center">0,49</td>
                    <td align="center">0,52</td>
                    <td align="center">0,58</td>
                    <td align="center">0,64</td>
                    <td align="center">0,55</td>
                    <td align="center">0,61</td>
                    <td align="center">0,68</td>
                    <td align="center">0,72</td>
                    <td align="center">0,51</td>
                    <td align="center">0,58</td>
                    <td align="center">0,62</td>
                    <td align="center">0,68</td>
                  </tr>
                  <tr>
                    <td align="center">%50</td>
                    <td align="center">0,63</td>
                    <td align="center">0,70</td>
                    <td align="center">0,72</td>
                    <td align="center">0,84</td>
                    <td align="center">0,58</td>
                    <td align="center">0,63</td>
                    <td align="center">0,71</td>
                    <td align="center">0,76</td>
                    <td align="center">0,64</td>
                    <td align="center">0,72</td>
                    <td align="center">0,80</td>
                    <td align="center">0,86</td>
                    <td align="center">0,58</td>
                    <td align="center">0,68</td>
                    <td align="center">0,72</td>
                    <td align="center">0,77</td>
                  </tr>
                  <tr>
                    <td align="center">%75</td>
                    <td align="center">0,73</td>
                    <td align="center">0,84</td>
                    <td align="center">0,86</td>
                    <td align="center">0,97</td>
                    <td align="center">0,67</td>
                    <td align="center">0,72</td>
                    <td align="center">0,87</td>
                    <td align="center">0,94</td>
                    <td align="center">0,75</td>
                    <td align="center">0,85</td>
                    <td align="center">0,98</td>
                    <td align="center">0,97</td>
                    <td align="center">0,68</td>
                    <td align="center">0,79</td>
                    <td align="center">0,86</td>
                    <td align="center">0,91</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN20">
                  <p>
                    <italic>CCD: art&#233;ria car&#243;tida comum direita; CCE: art&#233;ria car&#243;tida comum direita; EMI: espessura mediointimal.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec>
            <title>2.2.4. Como Descrever no Laudo</title>
            <p>Descrever a medida da EMI m&#233;dia de cada lado, em mm, no corpo do laudo. Al&#233;m disso, deve-se acrescentar na conclus&#227;o se a medida encontra-se acima ou abaixo do percentil 75, e a tabela utilizada, com sua refer&#234;ncia bibliogr&#225;fica.</p>
            <p>Descrever a presen&#231;a das placas carot&#237;deas, com suas determinadas caracter&#237;sticas e quantifica&#231;&#245;es, de acordo com os crit&#233;rios recomendados pelo recente consenso brasileiro.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
          </sec>
        </sec>
        <sec>
          <title>2.3. Avalia&#231;&#227;o Morfol&#243;gica das Placas Ateroscler&#243;ticas Carot&#237;deas</title>
          <p>A morfologia da PC tem um papel importante na ocorr&#234;ncia de eventos cerebrovasculares e pode tamb&#233;m ser um importante preditor de eventos.<xref ref-type="bibr" rid="B17">17</xref><sup>,</sup><xref ref-type="bibr" rid="B18">18</xref>
					</p>
          <p>O reconhecimento das caracter&#237;sticas ultrassonogr&#225;ficas da placa pode facilitar a identifica&#231;&#227;o de uma placa inst&#225;vel. As caracter&#237;sticas da placa que devemos descrever s&#227;o: localiza&#231;&#227;o, extens&#227;o da placa, ecogenicidade, textura, superf&#237;cie, presen&#231;a de componentes m&#243;veis e de zona anecoica junto &#224; c&#225;psula fibr&#243;tica. Estas caracter&#237;sticas devem ser descritas nas placas mais importantes, principalmente naquelas com mais de 50% de estenose.</p>
          <p>&#8226; <bold>Localiza&#231;&#227;o da placa:</bold> quanto &#224; localiza&#231;&#227;o, recomendamos subdividir as car&#243;tidas em: car&#243;tida comum proximal e distal, bifurca&#231;&#227;o, ramo externo e ramo interno proximal e m&#233;dio (<xref ref-type="fig" rid="f19">Figura 2</xref>). </p>
          <p>
            <fig id="f19">
              <label>Figura 2</label>
              <caption>
                <title>Car&#243;tida direita e suas subdivis&#245;es anat&#244;micas recomendadas pelo grupo (adaptada do estudo Mannheim).9 CC: car&#243;tida comum; RI: ramo interno; TBC: tronco braquicef&#225;lico.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf02-pt.jpg"/></fig>
          </p>
          <p>&#8226; <bold>Extens&#227;o da placa:</bold> a extens&#227;o da placa deve ser medida, pois pode correlacionar-se com a possibilidade de eventos e tem implica&#231;&#227;o na escolha da abordagem do tratamento cir&#250;rgico e endovascular.<xref ref-type="bibr" rid="B19">19</xref>
					</p>
          <p>&#8226; <bold>Ecogenicidade:</bold> define-se a ecogenicidade da placa comparando-a com a ecogenicidade de estruturas adjacentes &#224; mesma (sangue, m&#250;sculo, advent&#237;cia do vaso e osso) classificando-as em:<xref ref-type="bibr" rid="B20">20</xref>
					</p>
          <p>- Hipoecog&#234;nica ou ecolucente: mais escura, ou seja, ecogenicidade similar &#224; do sangue e menos ecog&#234;nica do que o m&#250;sculo esternocleidomast&#243;ideo.</p>
          <p>- Isoecog&#234;nica: ecogenicidade pr&#243;xima &#224; do m&#250;sculo. </p>
          <p>- Hiperecog&#234;nica: mais branca que o m&#250;sculo adjacente.</p>
          <p>- Calcificada: muito ecog&#234;nica, gerando sombra ac&#250;stica, devido ao dep&#243;sito de c&#225;lcio. Ecogenicidade compar&#225;vel &#224; do osso.</p>
          <p>&#8226; <bold>Ecotextura:</bold> quanto &#224; textura da placa, Reilly et al.,<xref ref-type="bibr" rid="B21">21</xref> as classificou como homog&#234;neas ou heterog&#234;neas.</p>
          <p>- Homog&#234;neas: uniformes com baixo n&#237;vel de ecos e uniformes com alto n&#237;vel de ecos.</p>
          <p>- Heterog&#234;neas: compostas por uma mistura de alto, m&#233;dio e baixo n&#237;vel de ecos.</p>
          <p>- Superf&#237;cie: a superf&#237;cie luminal &#233; classificada em tr&#234;s classes:<xref ref-type="bibr" rid="B20">20</xref><sup>,</sup><xref ref-type="bibr" rid="B22">22</xref>
					</p>
          <p>- Regular: irregularidades inferiores a 0,4 mm de profundidade.</p>
          <p>- Irregular: de 0,4 a 2 mm de profundidade.</p>
          <p>- Ulcera&#231;&#227;o: depress&#227;o superior a 2,0 mm de profundidade.</p>
        </sec>
        <sec>
          <title>2.4. Quantifica&#231;&#227;o das Estenoses das Art&#233;rias Car&#243;tidas</title>
          <p>V&#225;rios crit&#233;rios de avalia&#231;&#227;o das estenoses carot&#237;deas foram publicados por diversas institui&#231;&#245;es, com algumas diferen&#231;as em sua interpreta&#231;&#227;o.<xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B23">23</xref><sup>-</sup><xref ref-type="bibr" rid="B25">25</xref> Por&#233;m, em 2003, nos EUA, foi publicado um documento de consenso para oferecer recomenda&#231;&#245;es na realiza&#231;&#227;o dos exames de USV das art&#233;rias car&#243;tidas. Em 2009 o mesmo foi feito pelo Reino Unido e em 2015 pelo DIC da Sociedade Brasileira de Cardiologia (SBC).<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B3">3</xref><sup>,</sup><xref ref-type="bibr" rid="B4">4</xref>
					</p>
          <sec>
            <title>2.4.1. T&#233;cnicas de Medidas para a Quantifica&#231;&#227;o das Estenoses</title>
            <p>A avalia&#231;&#227;o da estenose carot&#237;dea pela USV baseia-se em medidas da velocidade do fluxo e suas rela&#231;&#245;es a partir do Doppler espectral, associadas &#224; avalia&#231;&#227;o da imagem ao bidimensional e ao <italic>color</italic> Doppler. Com o paciente em dec&#250;bito dorsal, s&#227;o realizados cortes ultrassonogr&#225;ficos transversais e longitudinais que permitem a visualiza&#231;&#227;o do sistema carot&#237;deo direito e esquerdo.</p>
            <p>A <xref ref-type="fig" rid="f20">figura 3</xref> demonstra a recomenda&#231;&#227;o do DIC-SBC para a sequ&#234;ncia da avalia&#231;&#227;o das estenoses carot&#237;deas.</p>
            <p>
              <fig id="f20">
                <label>Figura 3</label>
                <caption>
                  <title>Recomenda&#231;&#227;o do Departamento de Imagem cardiovasculas da Sociedade Brasileira de Cardiologia para a sequ&#234;ncia da avalia&#231;&#227;o das estenoses carot&#237;deas. VPS: velocidade de pico sist&#243;lico.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf03-pt.jpg"/></fig>
            </p>
            <p>
              <bold>
                <italic>2.4.1.1. Quantifica&#231;&#227;o das Estenoses Carot&#237;deas por Par&#226;metros Hemodin&#226;micos</italic>
              </bold>
            </p>
            <p>A velocidade do fluxo arterial medida pelo Doppler &#233; apresentada como ondas de velocidade de fluxo (espectro) em cada local examinado. As caracter&#237;sticas das ondas dependem do tipo de fluxo no local, bem como de altera&#231;&#245;es produzidas na velocidade do sangue por condi&#231;&#245;es proximais e distais ao local de medida. Na art&#233;ria car&#243;tida interna (ACI) as ondas de velocidade de fluxo s&#227;o normalmente de baixa resist&#234;ncia. Na art&#233;ria car&#243;tida externa (ACE) o padr&#227;o da onda de velocidade &#233; de alta resist&#234;ncia, enquanto na art&#233;ria car&#243;tida comum (ACC) &#233; do tipo intermedi&#225;rio entre as car&#243;tidas interna e externa<xref ref-type="bibr" rid="B13">13</xref> (<xref ref-type="fig" rid="f21">Figura 4</xref>).</p>
            <p>
              <fig id="f21">
                <label>Figura 4</label>
                <caption>
                  <title>Padr&#245;es de fluxo normais das art&#233;rias car&#243;tidas. (A) Art&#233;ria car&#243;tida comum. (B) Art&#233;ria car&#243;tida interna. (C) Art&#233;ria car&#243;tida externa.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf04-pt.jpg"/></fig>
            </p>
            <p>A medida das velocidades deve ser realizada nos segmentos proximal e distal da ACC e, para a avalia&#231;&#227;o da raz&#227;o de velocidades na quantifica&#231;&#227;o das estenoses da ACI, a ACC deve ser avaliada a aproximadamente 2 cm da bifurca&#231;&#227;o, preferencialmente em um segmento retil&#237;neo, sem placas.<xref ref-type="bibr" rid="B4">4</xref> A ACI deve ser avaliada nos segmentos proximal e m&#233;dio, pois as les&#245;es ateroscler&#243;ticas usualmente afetam os 2 cm proximais. O cursor deve estar paralelo &#224; parede do vaso, com amostra de volume menor do que o l&#250;men e posicionada no seu centro e em dire&#231;&#227;o ao fluxo, de modo que o &#226;ngulo de insona&#231;&#227;o seja &#8804; 60&#186; (<xref ref-type="fig" rid="f22">Figura 5</xref>).<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B26">26</xref>
						</p>
            <p>
              <fig id="f22">
                <label>Figura 5</label>
                <caption>
                  <title>(1) Esquema ilustrando a coloca&#231;&#227;o do cursor e o &#226;ngulo de insona&#231;&#227;o. (A) Paralelo ao jato no caso de estenose. (B) Paralelo ao vaso. (2) Cursor e &#226;ngulo de insona&#231;&#227;o na dire&#231;&#227;o ao jato de fluxo no caso de estenose (seta).</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf05-pt.jpg"/></fig>
            </p>
            <p>Identificada a estenose ao modo B e/ou ao <italic>color</italic> Doppler, deve ser documentado o tra&#231;ado espectral neste ponto, nas regi&#245;es pr&#233;-esten&#243;tica e p&#243;s-esten&#243;tica. A avalia&#231;&#227;o das velocidades fornecidas pelo tra&#231;ado espectral deve compreender a velocidade do pico sist&#243;lico (VPS) e a velocidade diast&#243;lica final (VDF) nas ACC e ACI. A partir da velocidade sist&#243;lica e diast&#243;lica obtemos as rela&#231;&#245;es (raz&#245;es): VPS ACI/VPS ACC, VPS ACI/VDF ACC e VDF ACI/VDF ACC. </p>
            <p>As suboclus&#245;es t&#234;m seu diagn&#243;stico baseado na demonstra&#231;&#227;o do estreitamento do l&#250;men do vaso ao color/power Doppler, com fluxo filiforme (<italic>string sign</italic> ou <italic>trickle flow</italic>), por&#233;m pode estar associada a velocidades altas, baixas ou indetect&#225;veis, o que eventualmente dificulta o diagn&#243;stico.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
            <p>As oclus&#245;es carot&#237;deas, por sua vez, podem ser diagnosticadas pela ultrassonografia como a aus&#234;ncia de l&#250;men patente na escala de cinza e aus&#234;ncia de detec&#231;&#227;o de fluxo ao <italic>color/power</italic> Doppler e/ou Doppler espectral, assim como a presen&#231;a de fluxo de alta resist&#234;ncia na ACC, e do fluxo staccato - fluxo com velocidade muito reduzida e de alt&#237;ssima resist&#234;ncia no ponto da oclus&#227;o ou pr&#233;-oclus&#227;o.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
            <p>O grupo de estudos do DIC-SBC sugere a tabela apresentada no <xref ref-type="table" rid="t35">tabela 6</xref> para a quantifica&#231;&#227;o das estenoses da ACI.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
            <table-wrap id="t35">
              <label>Tabela 6</label>
              <caption>
                <title>Quantifica&#231;&#227;o das estenoses da art&#233;ria car&#243;tida interna (Departamento de Imagem cardiovascular da Sociedade Brasileira de cardiologia)</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="16%"/>
                  <col width="16%"/>
                  <col width="16%"/>
                  <col width="16%"/>
                  <col width="16%"/>
                  <col width="16%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">% Est Anat Dist (Nascet)</th>
                    <th align="center">VPS cm/s</th>
                    <th align="center">VDF cm/s</th>
                    <th align="center">VPS Cl/ VPS cc</th>
                    <th align="center">VPS Cl/ VDF CC</th>
                    <th align="center">VDF Cl/ VDF CC</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&lt; 50%</td>
                    <td align="center" style="background-color:#339C6D">&lt; 140</td>
                    <td align="center" style="background-color:#ffff00">&lt; 40</td>
                    <td align="center" style="background-color:#ffff00">&lt; 2,0</td>
                    <td align="center" style="background-color:#FFC926">&lt; 8</td>
                    <td align="center" style="background-color:#FFC926">&lt; 2,6</td>
                  </tr>
                  <tr>
                    <td align="left">50 a 59%</td>
                    <td align="center" style="background-color:#339C6D">140 a 230</td>
                    <td align="center" style="background-color:#ffff00">40 a 69</td>
                    <td align="center" style="background-color:#ffff00">2,0 a 3,1</td>
                    <td align="center" style="background-color:#FFC926">8 a 10</td>
                    <td align="center" style="background-color:#FFC926">2,6 a 5,5</td>
                  </tr>
                  <tr>
                    <td align="left">60 a 69%</td>
                    <td align="center" style="background-color:#339C6D">&#8211;</td>
                    <td align="center" style="background-color:#ffff00">70 a 100</td>
                    <td align="center" style="background-color:#ffff00">3,2 a 4,0</td>
                    <td align="center" style="background-color:#FFC926">11 a 13</td>
                    <td align="center" style="background-color:#FFC926">&#8211;</td>
                  </tr>
                  <tr>
                    <td align="left">70 a 79%</td>
                    <td align="center" style="background-color:#339C6D">&gt; 230</td>
                    <td align="center" style="background-color:#ffff00">&gt; 100</td>
                    <td align="center" style="background-color:#ffff00">&gt; 4,0</td>
                    <td align="center" style="background-color:#FFC926">14 a 21</td>
                    <td align="center" style="background-color:#FFC926">&#8211;</td>
                  </tr>
                  <tr>
                    <td align="left">80 a 89%</td>
                    <td align="center" style="background-color:#339C6D">&#8211;</td>
                    <td align="center" style="background-color:#ffff00">&gt; 140</td>
                    <td align="center" style="background-color:#ffff00">&#8211;</td>
                    <td align="center" style="background-color:#FFC926">22 a 29</td>
                    <td align="center" style="background-color:#FFC926">&gt; 5,5</td>
                  </tr>
                  <tr>
                    <td align="left">&gt; 90%</td>
                    <td align="center" style="background-color:#339C6D">&gt; 400</td>
                    <td align="center" style="background-color:#ffff00">&#8211;</td>
                    <td align="center" style="background-color:#ffff00">&gt; 5,0</td>
                    <td align="center" style="background-color:#FFC926">&gt; 30</td>
                    <td align="center" style="background-color:#FFC926">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Suboclus&#227;o</td>
                    <td align="center">Vari&#225;vel - fluxo filiforme</td>
                    <td align="center">Vari&#225;vel - fluxo filiforme</td>
                    <td align="center">Vari&#225;vel - fluxo filiforme</td>
                    <td align="center">Vari&#225;vel - fluxo filiforme</td>
                    <td align="center">Vari&#225;vel - fluxo filiforme</td>
                  </tr>
                  <tr>
                    <td align="left">Oclus&#227;o</td>
                    <td align="center">Aus&#234;ncia de fluxo</td>
                    <td align="center">Aus&#234;ncia de fluxo</td>
                    <td align="center">N&#227;o se aplica</td>
                    <td align="center">N&#227;o se aplica</td>
                    <td align="center">N&#227;o se aplica</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN21">
                  <p>
                    <italic>As cores representam, da esquerda para a direita, os crit&#233;rios mais relevantes segundo a literatura. CC: car&#243;tida comum; CI: car&#243;tida interna; VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>
              <bold>
                <italic>2.4.1.2. Quantifica&#231;&#227;o das Estenoses Carot&#237;deas por Par&#226;metros Anat&#244;micos</italic>
              </bold>
            </p>
            <p>O crit&#233;rio anat&#244;mico (<xref ref-type="fig" rid="f23">Figura 6</xref>) baseia-se na avalia&#231;&#227;o da redu&#231;&#227;o luminal e deve ser usado para caracterizar, em especial, as estenoses inferiores a 50% (sem repercuss&#227;o hemodin&#226;mica), por&#233;m, tamb&#233;m &#233; grande adjuvante nas estenoses maiores que 50%, em que o crit&#233;rio hemodin&#226;mico pode falhar na quantifica&#231;&#227;o adequada da estenose (p. ex., estenose a&#243;rtica grave, estenose carot&#237;dea contralateral significativa, entre outros). D&#225;-se prefer&#234;ncia &#224; medida da redu&#231;&#227;o luminal pelo di&#226;metro, devendo-se informar o resultado da faixa de estenose carot&#237;dea em intervalos de 10%. A fim de evitar poss&#237;veis diferen&#231;as na medida da redu&#231;&#227;o do di&#226;metro quando se inclui a &#237;ntima espessada ou quando se deixa de inclu&#237;-la, recomenda-se n&#227;o medir as placas menores que 20%.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
            <p>
              <fig id="f23">
                <label>Figura 6</label>
                <caption>
                  <title>Medida da redu&#231;&#227;o luminal. (A) Placa ateromatosa de l&#250;men regular. (B) Placa ateromatosa de l&#250;men irregular.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf06-pt.jpg"/></fig>
            </p>
          </sec>
          <sec>
            <title>2.4.2. Circunst&#226;ncias que Podem Alterar a Medida das Velocidades do Fluxo e A Avalia&#231;&#227;o Anat&#244;mica</title>
            <p>A avalia&#231;&#227;o das velocidades pode estar comprometida em algumas condi&#231;&#245;es que afetam as medidas da an&#225;lise espectral. Elas podem estar localizadas na bifurca&#231;&#227;o carot&#237;dea, distal ou proximal &#224; mesma ou, ainda, na car&#243;tida contralateral. Dentre as condi&#231;&#245;es proximais &#224; bifurca&#231;&#227;o ressaltamos as valvopatias a&#243;rticas (estenose ou insufici&#234;ncia), estenoses de origem ateroscler&#243;tica ou arterites com envolvimento do arco a&#243;rtico, ramos e car&#243;tida comum<xref ref-type="bibr" rid="B1">1</xref> (<xref ref-type="table" rid="t36">Tabela 7</xref>).</p>
            <table-wrap id="t36">
              <label>Tabela 7</label>
              <caption>
                <title>Circunst&#226;ncias que podem alterar a medida das velocidades de fluxo</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="33%"/>
                  <col width="33%"/>
                  <col width="33%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Patologia</th>
                    <th align="center">Altera&#231;&#245;es &#224; USV</th>
                    <th align="center">Alternativas de avalia&#231;&#227;o</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Estenose proximal da art&#233;ria car&#243;tida comum ou tronco braquicef&#225;lico</td>
                    <td align="center">Redu&#231;&#227;o das velocidades absolutas de fluxo (VPS e VDF)</td>
                    <td align="center">Utilizar as raz&#245;es de velocidade e avalia&#231;&#227;o por crit&#233;rio anat&#244;mico</td>
                  </tr>
                  <tr>
                    <td align="left">Estenose significativa ou oclus&#227;o carot&#237;dea contralateral</td>
                    <td align="center">Eleva&#231;&#227;o das velocidades do fluxo de forma compensat&#243;ria</td>
                    <td align="center">Utilizar as raz&#245;es de velocidade e avalia&#231;&#227;o por crit&#233;rio anat&#244;mico</td>
                  </tr>
                  <tr>
                    <td align="left">Arritmias (fibrila&#231;&#227;o atrial)</td>
                    <td align="center">Picos de velocidade vari&#225;veis</td>
                    <td align="center">Aguardar per&#237;odo mais regular, ou usar m&#233;dia de cinco batimentos e crit&#233;rio anat&#244;mico</td>
                  </tr>
                  <tr>
                    <td align="left">Estenose valvar a&#243;rtica</td>
                    <td align="center">Redu&#231;&#227;o das velocidades absolutas de fluxo (VPS e VDF)</td>
                    <td align="center">Utilizar as raz&#245;es de velocidade e avalia&#231;&#227;o por crit&#233;rio anat&#244;mico</td>
                  </tr>
                  <tr>
                    <td align="left">Insufici&#234;ncia valvar a&#243;rtica</td>
                    <td align="center">Eleva&#231;&#227;o da VPS de fluxo, podendo haver fluxo diast&#243;lico reverso</td>
                    <td align="center">Utilizar crit&#233;rio anat&#244;mico ou raz&#227;o de velocidade que n&#227;o envolva a VDF</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN22">
                  <p>
                    <italic>USV: ultrassonografia vascular; VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>A avalia&#231;&#227;o anat&#244;mica pode ser prejudicada em circunst&#226;ncias como calcifica&#231;&#227;o arterial com sombra ac&#250;stica, ajustes inadequados do equipamento, entre outros.</p>
          </sec>
          <sec>
            <title>2.4.3. Descri&#231;&#227;o do Laudo</title>
            <p>Informa&#231;&#245;es importantes para o laudo s&#227;o: </p>
            <p>&#8226; Especificar o tipo de transdutor utilizado.</p>
            <p>&#8226; Qualidade t&#233;cnica do exame (citar situa&#231;&#245;es que possam prejudicar a qualidade do mesmo - p. ex., presen&#231;a de cateteres). </p>
            <p>&#8226; Descrever a presen&#231;a de placas ateroscler&#243;ticas, sua localiza&#231;&#227;o, extens&#227;o, caracter&#237;sticas morfol&#243;gicas e grau de estenose, esta quantificada em decis segundo a recomenda&#231;&#227;o do DIC-SBC.<xref ref-type="bibr" rid="B1">1</xref>
						</p>
            <p>&#8226; Descrever outros achados das art&#233;rias car&#243;tidas ou relacionados &#224;s mesmas (p. ex., tortuosidades, dissec&#231;&#245;es, tumores, arterites). </p>
          </sec>
        </sec>
        <sec>
          <title>2.5. Avalia&#231;&#227;o Ultrassonogr&#225;fica P&#243;s-Interven&#231;&#227;o Carot&#237;dea</title>
          <p>O tratamento da doen&#231;a ateroscler&#243;tica carot&#237;dea sintom&#225;tica e assintom&#225;tica tem sido motivo de debate multidisciplinar. O tratamento intervencionista pode ser feito pela endarterectomia carot&#237;dea ou pelo implante de <italic>stent</italic> carot&#237;deo.</p>
          <p>A ultrassonografia &#233; o exame de escolha para o seguimento p&#243;s-interven&#231;&#227;o carot&#237;dea e o protocolo do exame cumpre a mesma sequ&#234;ncia do exame das art&#233;rias car&#243;tidas sem interven&#231;&#227;o, com algumas peculiaridades no local da interven&#231;&#227;o. Para maiores informa&#231;&#245;es sobre o que documentar no local da interven&#231;&#227;o vascular, o protocolo b&#225;sico de seguimento ultrassonogr&#225;fico e as tabelas de par&#226;metros velocim&#233;tricos, orientamos consultar as recomenda&#231;&#245;es do DIC publicadas recentemente.<xref ref-type="bibr" rid="B1">1</xref>
					</p>
        </sec>
        <sec>
          <title>2.6. Avalia&#231;&#227;o Ultrassonogr&#225;fica das Art&#233;rias Vertebrais</title>
          <p>A avalia&#231;&#227;o das art&#233;rias vertebrais extracranianas pela USV &#233; adjuvante ao estudo das car&#243;tidas. Dividem-se em quatro segmentos: tr&#234;s extracranianos e um intracraniano (<xref ref-type="fig" rid="f24">Figura 7</xref>).<xref ref-type="bibr" rid="B27">27</xref><sup>,</sup><xref ref-type="bibr" rid="B28">28</xref>
					</p>
          <p>
            <fig id="f24">
              <label>Figura 7</label>
              <caption>
                <title>Segmentos extracranianos da art&#233;ria vertebral (V0-V3).</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf07-pt.jpg"/></fig>
          </p>
          <sec>
            <title>2.6.1. Metodologia de Realiza&#231;&#227;o do Exame</title>
            <p>A posi&#231;&#227;o do paciente &#233; a mesma adotada para o estudo das car&#243;tidas. </p>
            <p>Para a avalia&#231;&#227;o da por&#231;&#227;o extracraniana das art&#233;rias vertebrais recomenda-se iniciar o exame pelo segmento V2. Nesse ponto, com aux&#237;lio do Doppler colorido e pequenos movimentos de angula&#231;&#227;o, procura-se identificar a art&#233;ria (acompanhada de sua veia) e passa-se a registrar as curvas espectrais, adequando a escala e o &#226;ngulo de insona&#231;&#227;o do vaso. A partir desse ponto, a art&#233;ria &#233; visualizada em dire&#231;&#227;o &#224; sua origem. O segmento V3 da vertebral situa-se abaixo do processo mastoide do osso temporal (marco anat&#244;mico para o estudo). Nesta regi&#227;o, observa-se a sa&#237;da do vaso do forame transverso e seu curso em torno do processo mastoide (tamb&#233;m chamada de &#8220;al&#231;a do atlas&#8221; em raz&#227;o da rela&#231;&#227;o anat&#244;mica com esse corpo vertebral).<xref ref-type="bibr" rid="B3">3</xref> Os par&#226;metros de normalidade esperados s&#227;o:</p>
            <p>Di&#226;metro: varia de 2 a 4 mm. Assimetria de calibre entre as vertebrais &#233; frequente (73% dos casos), sendo a esquerda mais calibrosa em 50% dos casos.<xref ref-type="bibr" rid="B28">28</xref><sup>,</sup><xref ref-type="bibr" rid="B29">29</xref> Ao Doppler puls&#225;til o padr&#227;o normal &#233; de ondas com fluxo laminar, anter&#243;grado, de baixa resist&#234;ncia, VPS entre 20 e 60 cm/s no segmento V2 e podendo variar de 30 a 100 cm/s na origem da vertebral. Em raz&#227;o da frequente assimetria de di&#226;metro, h&#225; consider&#225;vel diferen&#231;a de VPS e &#237;ndice de resist&#234;ncia (IR) entre vertebrais normais de um mesmo indiv&#237;duo.<xref ref-type="bibr" rid="B27">27</xref>
						</p>
            <p>A hipoplasia de vertebral &#233; definida como di&#226;metro do vaso igual ou inferior a 2,0 mm (ou assimetria de calibre entre as vertebrais com rela&#231;&#227;o &gt; 1:1,7).<xref ref-type="bibr" rid="B28">28</xref>
						</p>
          </sec>
          <sec>
            <title>2.6.2. Quantifica&#231;&#227;o das Estenoses</title>
            <p>As estenoses proximais (V0-V1) t&#234;m seu diagn&#243;stico no aumento de velocidades de fluxo no local da les&#227;o. A normatiza&#231;&#227;o do DIC-SBC<xref ref-type="bibr" rid="B3">3</xref> sugere os valores apresentados no <xref ref-type="table" rid="t37">tabela 8</xref>, adaptado do estudo de Hua et al.,<xref ref-type="bibr" rid="B30">30</xref> Estenoses dos demais segmentos devem ser avaliadas pela USV baseando-se em an&#225;lise multiparam&#233;trica como turbul&#234;ncia ao <italic>color</italic> Doppler, aumento localizado das velocidades de fluxo, aumento dos &#237;ndices de velocidade e amortecimento do fluxo distal, uma vez que n&#227;o existem tabelas de quantifica&#231;&#227;o das estenoses para esses segmentos.</p>
            <table-wrap id="t37">
              <label>Tabela 8</label>
              <caption>
                <title>Valores de corte para velocidades nas estenoses proximais da art&#233;ria vertebral</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="25%"/>
                  <col width="25%"/>
                  <col width="25%"/>
                  <col width="25%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Estenose</th>
                    <th align="center">&lt; 50%</th>
                    <th align="center">50 a 69%</th>
                    <th align="center">70 a 99%</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">V<sub>max</sub></td>
                    <td align="center">&#8805; 85 cm/s</td>
                    <td align="center">&#8805; 140 cm/s</td>
                    <td align="center">&#8805; 210 cm/s</td>
                  </tr>
                  <tr>
                    <td align="left">IVV</td>
                    <td align="center">&#8805; 1,3</td>
                    <td align="center">&#8805; 2,1</td>
                    <td align="center">&#8805; 4</td>
                  </tr>
                  <tr>
                    <td align="left">VDF</td>
                    <td align="center">&#8805; 27 cm/s</td>
                    <td align="center">&#8805; 35 cm/s</td>
                    <td align="center">&#8805; 55 cm/s</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN23">
                  <p>
                    <italic>IVV: &#237;ndice de velocidade m&#225;xima no ponto de estenose e o segmento V2; VDF: velocidade diast&#243;lica final.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>3. Aorta abdominal e ramos</title>
        <sec>
          <title>3.1. Aneurisma da Aorta Abdominal</title>
          <sec>
            <title>3.1.1. Considera&#231;&#245;es Gerais</title>
            <p>Os aneurismas s&#227;o definidos como dilata&#231;&#245;es localizadas iguais ou superiores a 50% do di&#226;metro arterial proximal ou normal, envolvendo obrigatoriamente todas as camadas do vaso. Apesar de o di&#226;metro da aorta abdominal variar com a idade, o sexo e o biotipo, o di&#226;metro m&#233;dio da aorta infrarrenal &#233; de aproximadamente 2,0 cm, sendo o limite superior da normalidade &lt; 3,0 cm. Assim, considera-se um aneurisma de aorta abdominal (AAA) uma aorta que mede &gt; 3,0 cm. Os AAA est&#227;o localizados entre o diafragma e a bifurca&#231;&#227;o a&#243;rtica e podem ser classificados como suprarrenal, justarrenal e infrarrenal. Aproximadamente 85% dos aneurismas da aorta abdominal s&#227;o infrarrenais e 5% envolvem a aorta suprarrenal.<xref ref-type="bibr" rid="B31">31</xref> Cerca de 25% dos pacientes portadores de AAA t&#234;m aneurisma de art&#233;rias il&#237;acas associado.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>Os aneurismas podem ser fusiformes, saculares ou com geometrias exc&#234;ntricas. O tipo de assimetria pode influenciar significativamente o risco de ruptura e, &#224; medida que os aneurismas crescem, podem se formar trombos laminados que preservam o l&#250;men arterial.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>A USV &#233; o exame mais utilizado para rastreamento e diagn&#243;stico em pacientes assintom&#225;ticos, nas unidades de emerg&#234;ncia sem diagn&#243;stico pr&#233;vio e nos pacientes sintom&#225;ticos. A angiotomografia computadorizada (angio-TC) &#233; o exame de elei&#231;&#227;o para a avalia&#231;&#227;o pr&#233; e p&#243;s-operat&#243;ria; entretanto, a USV n&#227;o perde o seu valor por ser mais dispon&#237;vel, ter menor custo e n&#227;o utilizar contraste nefrot&#243;xico. A disponibilidade atual do contraste com microbolhas torna a USV bastante atraente, especialmente na avalia&#231;&#227;o p&#243;s-operat&#243;ria.<xref ref-type="bibr" rid="B32">32</xref>
						</p>
          </sec>
          <sec>
            <title>
              <bold>3.1.2. Indica&#231;&#245;es Cl&#237;nicas</bold>
              <xref ref-type="bibr" rid="B2">2</xref>
            </title>
            <p>&#8226; Rastreamento (<xref ref-type="table" rid="t38">Tabela 9</xref>).</p>
            <table-wrap id="t38">
              <label>Tabela 9</label>
              <caption>
                <title>Recomenda&#231;&#227;o do Departamento de Imagem Cardiovascular para rastreamento e acompanhamento do aneurisma de aorta abdominal</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="100%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Rastreamento</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&#8226; Homens de 65 a 75 anos</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Homens de 55 a 75 anos com hist&#243;rico familiar de AAA e/ou tabagismo</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Mulheres de 55 a 75 anos com hist&#243;rico familiar de AAA e/ou tabagismo</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid;border-top-width:thin;border-top-style:solid">
                    <td align="left">
                      <bold>Intervalo de acompanhamento</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; 2,6 a 2,9 cm &#8211; reavaliar em 5 anos (dilata&#231;&#227;o subaneurism&#225;tica)</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; 3,0 a 3,9 cm &#8211; 24 meses</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; 4,0 a 4,5 cm &#8211; 12 meses</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; 4,6 a 5,0 cm &#8211; 6 meses</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; &gt; 5,0 cm &#8211; 3 meses</td>
                  </tr>
                  <tr style="border-bottom-width:thin;border-bottom-style:solid;border-top-width:thin;border-top-style:solid">
                    <td align="left">
                      <bold>Indica&#231;&#227;o de interven&#231;&#227;o</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; &#8805; 5,5 cm</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Sintomas relacionados ao AAA</td>
                  </tr>
                  <tr>
                    <td align="left">&#8226; Taxa de crescimento &gt; 1,0 cm ao ano</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN24">
                  <p>
                    <italic>AAA: aneurisma de aorta abdominal.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>&#8226; Seguimento: acompanhar o crescimento e definir o momento cir&#250;rgico adequado.<xref ref-type="bibr" rid="B33">33</xref>
						</p>
            <p>&#8226; Avalia&#231;&#227;o de massa abdominal puls&#225;til, sinais de ruptura ou crescimento. </p>
            <p>&#8226; Exame pr&#233;-operat&#243;rio do AAA: informar dados sobre a via de acesso, altera&#231;&#245;es em art&#233;rias il&#237;acas, s&#237;tio de fixa&#231;&#227;o da endopr&#243;tese, aspecto e medidas do saco aneurism&#225;tico, e presen&#231;a trombos parietais.</p>
            <p>&#8226; Exame p&#243;s-operat&#243;rio do AAA.</p>
          </sec>
          <sec>
            <title>3.1.3. Orienta&#231;&#245;es e Protocolos de Exame (<xref ref-type="table" rid="t39">Tabela 10</xref>)</title>
            <table-wrap id="t39">
              <label>Tabela 10</label>
              <caption>
                <title>Recomenda&#231;&#227;o do Departamento de Imagem Cardiovascular para realiza&#231;&#227;o dos exames abdominais vasculares</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="30%"/>
                  <col width="17%"/>
                  <col width="17%"/>
                  <col width="17%"/>
                  <col width="17%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Orienta&#231;&#245;es para exame</th>
                    <th align="center">Aorta abdominal</th>
                    <th align="center">Segmento aortoil&#237;aco</th>
                    <th align="center">Art&#233;rias mesent&#233;ricas e tronco cel&#237;aco</th>
                    <th align="center">Art&#233;rias renais</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Transdutores convexos ou setoriais de baixa frequ&#234;ncia (2 a 5 MHz)</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Preferencialmente pela manh&#227; com jejum de 6 a 8 h</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">N&#227;o fumar, n&#227;o usar goma de mascar, n&#227;o ingerir bebidas gasosas</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Antifis&#233;tico opcional</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Posi&#231;&#227;o supina com cabeceira elevada a 30<sup>o</sup></td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Posi&#231;&#227;o de dec&#250;bito lateral</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">&#8211;</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Cortes transversal, coronal e longitudinal</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">O que avaliar:</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Modo B:</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left"> Dimens&#245;es</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> Varia&#231;&#245;es anat&#244;micas</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> Morfologia de paredes e placas</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> Presen&#231;a de trombos</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">&#8211;</td>
                    <td align="center">&#8211;</td>
                  </tr>
                  <tr>
                    <td align="left"><italic>Color</italic> Doppler:</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left"> Aliasing</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> Aus&#234;ncia de fluxo (oclus&#227;o)</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left">Doppler espectral:</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left"> VPS</td>
                    <td align="center">&#8211;</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> Raz&#227;o de VPS (V2/V1)</td>
                    <td align="center">&#8211;</td>
                    <td align="center">x</td>
                    <td align="center">&#8211;</td>
                    <td align="center">&#8211;</td>
                  </tr>
                  <tr>
                    <td align="left"> VDF</td>
                    <td align="center">&#8211;</td>
                    <td align="center">&#8211;</td>
                    <td align="center">x</td>
                    <td align="center">x</td>
                  </tr>
                  <tr>
                    <td align="left"> &#205;ndice renal a&#243;rtico</td>
                    <td align="center">&#8211;</td>
                    <td align="center">&#8211;</td>
                    <td align="center">&#8211;</td>
                    <td align="center">x</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN25">
                  <p>
                    <italic>VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec>
            <title>3.1.4. Protocolo de exame do aneurisma de aorta abdominal de acordo com as recomenda&#231;&#245;es do Departamento de Imagem cardiovascular<xref ref-type="bibr" rid="B2">2</xref>
						</title>
            <p>O exame deve ser realizado desde a regi&#227;o subxifoide at&#233; a bifurca&#231;&#227;o a&#243;rtica e, a seguir, estudam-se as art&#233;rias il&#237;acas comuns direita e esquerda e seus ramos externo e interno.</p>
            <p>A avalia&#231;&#227;o &#233; feita pelo modo B, utilizando-se cortes transversais, coronais e longitudinais para detectar placas de ateroma e medir os di&#226;metros, principalmente se houver dilata&#231;&#245;es. A medida anteroposterior (AP) do aneurisma deve ser realizada durante a expans&#227;o sist&#243;lica m&#225;xima, referenciando se a medida foi feita da parede externa &#224; parede externa (EAE) ou parede interna &#224; parede interna (IAI).</p>
            <p>&#8226; <bold>Rastreamento:</bold> utiliza-se o modo B durante a etapa subxifoide do ecocardiograma ou durante ultrassonografia abdominal de rotina.</p>
            <p>&#8226; <bold>Diagn&#243;stico e seguimento:</bold> rastreia-se a aorta desde a regi&#227;o subxifoide at&#233; a sua bifurca&#231;&#227;o e, a seguir, estudam-se as art&#233;rias il&#237;acas e ramos. </p>
            <p>&#8226; <bold>Avalia&#231;&#227;o pr&#233;-operat&#243;ria:</bold> descri&#231;&#245;es, medidas necess&#225;rias e dados relevantes est&#227;o descritos na <xref ref-type="fig" rid="f25">figura 8</xref>.</p>
            <p>
              <fig id="f25">
                <label>Figura 8</label>
                <caption>
                  <title>Avalia&#231;&#227;o pr&#233;-operat&#243;ria do aneurisma de aorta abdominal (AAA).</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf08-pt.jpg"/></fig>
            </p>
            <p>&#8226; <bold>Avalia&#231;&#227;o p&#243;s-operat&#243;ria:</bold> torna-se necess&#225;rio o conhecimento das t&#233;cnicas cir&#250;rgicas utilizadas. Estas encontram-se descritas detalhadamente nas recomenda&#231;&#245;es do DIC.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>Informa&#231;&#245;es consideradas fundamentais para o relat&#243;rio m&#233;dico (<xref ref-type="fig" rid="f25">Figura 8</xref>):</p>
            <p>&#8226; <bold>Exame diagn&#243;stico:</bold></p>
            <p>- Relatar dificuldades t&#233;cnicas.</p>
            <p>- Medir o maior di&#226;metro da aorta.</p>
            <p>- Informar a presen&#231;a de tortuosidades ou alongamento da aorta.</p>
            <p>- Definir a localiza&#231;&#227;o do aneurisma: supra, justa ou infrarrenal.</p>
            <p>- Definir a forma anat&#244;mica do aneurisma: sacular, fusiforme ou outras. </p>
            <p>- Informar a presen&#231;a ou n&#227;o de trombos murais, o di&#226;metro intraluminal e sinais de ruptura, quando presentes.</p>
            <p>&#8226; <bold>Informa&#231;&#245;es adicionais para o exame pr&#233;-operat&#243;rio:</bold></p>
            <p>- Di&#226;metros:</p>
            <p>&#9675; Colo no plano da art&#233;ria renal mais baixa.</p>
            <p>&#9675; Colo 15 mm abaixo da origem da art&#233;ria renal mais baixa.</p>
            <p>&#9675; M&#225;ximo do AAA - corte transversal AP (IAI ou EAE).</p>
            <p>&#9675; No plano da bifurca&#231;&#227;o (quando presente).</p>
            <p>&#9675; De ambas as art&#233;rias il&#237;acas comuns.</p>
            <p>&#9675; Da bifurca&#231;&#227;o da art&#233;ria il&#237;aca.</p>
            <p>- Extens&#227;o longitudinal do colo proximal.</p>
            <p>- &#194;ngulo do colo com eixo do aneurisma.</p>
            <p>- Extens&#227;o longitudinal do AAA.</p>
          </sec>
        </sec>
        <sec>
          <title>3.2. Doen&#231;a Ateroscler&#243;tica do Segmento Aortoil&#237;aco</title>
          <p>A USV permite identifica&#231;&#227;o, localiza&#231;&#227;o e extens&#227;o anat&#244;mica das les&#245;es ateroscler&#243;ticas, al&#233;m de avaliar a parede da aorta de forma a documentar n&#227;o s&#243; a presen&#231;a de les&#227;o ateroscler&#243;tica, mas a presen&#231;a de ulcera&#231;&#227;o, calcifica&#231;&#227;o, trombo, dissec&#231;&#227;o e dilata&#231;&#227;o. Esta t&#233;cnica, quando realizada por profissionais treinados e experientes, tem boa acur&#225;cia diagn&#243;stica na doen&#231;a ateroscler&#243;tica aortoil&#237;aca (DAAoI), com 86% de sensibilidade e 97% de especificidade para les&#245;es &gt; 50% de estenose.<xref ref-type="bibr" rid="B34">34</xref>
					</p>
          <sec>
            <title>3.2.1. Indica&#231;&#245;es Cl&#237;nicas da Ultrassonografia Venosa na Doen&#231;a Ateroscler&#243;tica Aortoil&#237;aca</title>
            <p>&#8226; Sintomas de claudica&#231;&#227;o intermitente com pulso femoral diminu&#237;do ou ausente, claudica&#231;&#227;o de gl&#250;teos, disfun&#231;&#227;o er&#233;til, dor em repouso e sintomas de isquemia aguda (embolia distal).</p>
            <p>&#8226; Sinais cl&#237;nicos como sopro abdominal e redu&#231;&#227;o do &#237;ndice tornozelo-braquial.</p>
            <p>&#8226; USV pr&#233;via demonstrando altera&#231;&#245;es do padr&#227;o de curva de velocidade nas art&#233;rias femorais.</p>
            <p>&#8226; Acompanhamento de enxertos e endopr&#243;teses para tratamento de obstru&#231;&#227;o em territ&#243;rio aortoil&#237;aco.*</p>
            <p>&#8226; Suspeita diagn&#243;stica de dissec&#231;&#227;o da aorta.</p>
            <p>&#8226; Suspeita diagn&#243;stica de arterites.</p>
          </sec>
          <sec>
            <title>3.2.2. Protocolo do Exame da Doen&#231;a Ateroscler&#243;tica Aortoil&#237;aca de Acordo com as Recomenda&#231;&#245;es do DIC (<xref ref-type="table" rid="t35">Tabela 10</xref>)</title>
            <p>
              <bold>
                <italic>3.2.2.1. Crit&#233;rios diagn&#243;sticos</italic>
              </bold>
            </p>
            <p>Estenose: medir a VPS no local da les&#227;o (V2) e 1 a 2 cm proximal &#224; les&#227;o (V1) e calcular a raz&#227;o dessas velocidades (V2/V1). A curva espectral deve ser obtida com um &#226;ngulo &#8804; 60&#186; paralelo ao eixo do fluxo turbilhonado (<xref ref-type="fig" rid="f26">Figura 9</xref>). A classifica&#231;&#227;o do grau de estenose deve ser realizada de acordo com o apresentado no <xref ref-type="table" rid="t40">tabela 11</xref>.</p>
            <p>
              <fig id="f26">
                <label>Figura 9</label>
                <caption>
                  <title>Mapeamento de fluxo em cores demonstrando o fluxo proximal &#224; les&#227;o em vermelho e o fluxo turbilhonado no ponto da les&#227;o (seta). Os esquemas A C mostram o espectro das velocidades ao Doppler. (A) Cursor proximal &#224; les&#227;o para a medida de V1. (B) Cursor no local da les&#227;o para a medida de V2. (C) Cursor distal &#224; les&#227;o com padr&#227;o de onda amortecida.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf09-pt.jpg"/></fig>
            </p>
            <table-wrap id="t40">
              <label>Tabela 11</label>
              <caption>
                <title>Classifica&#231;&#227;o do grau de estenose pelo Doppler pulsado</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="50%"/>
                  <col width="50%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Classifica&#231;&#227;o</th>
                    <th align="center">Raz&#227;o de velocidades sist&#243;licas</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Estenose &lt; 50%</td>
                    <td align="center">V2/V1 &lt; 2,0</td>
                  </tr>
                  <tr>
                    <td align="left">Estenose &#8805; 50%</td>
                    <td align="center">V2/V1 &#8805; 2,0</td>
                  </tr>
                  <tr>
                    <td align="left">Estenose &#8805; 70%</td>
                    <td align="center">V2/V1 &#8805; 4,0</td>
                  </tr>
                  <tr>
                    <td align="left">Oclus&#227;o</td>
                    <td align="center">Aus&#234;ncia de fluxo</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>&#8226; <bold>Oclus&#227;o:</bold> aus&#234;ncia de fluxo em qualquer segmento do territ&#243;rio aortoil&#237;aco, mesmo com par&#226;metros de varredura para obten&#231;&#227;o de fluxos de baixas velocidades. Presen&#231;a de onda pr&#233;-oclusiva t&#237;pica (alta resist&#234;ncia perif&#233;rica, pico sist&#243;lico de baixa velocidade e aus&#234;ncia de fluxo diast&#243;lico). Vasos colaterais podem ser observados pr&#233; e p&#243;s-segmento oclu&#237;do (ponto de reentrada). O espectro p&#243;s-oclusivo &#233; caracterizado por onda monof&#225;sica, com VPS reduzida e tempo de acelera&#231;&#227;o prolongado - <italic>parvus/tardus</italic> (<xref ref-type="fig" rid="f26">Figura 9</xref>). Na presen&#231;a de imagem hipoecoica com interface c&#244;ncava ao fluxo colorido e espectro com padr&#227;o pr&#233;-oclusivo em staccato, este achado sugere oclus&#227;o tromboemb&#243;lica. </p>
            <p>&#8226; Informa&#231;&#245;es consideradas fundamentais para constar no relat&#243;rio m&#233;dico:</p>
            <p>- Exame diagn&#243;stico: </p>
            <p>&#9675; Relatar se o exame foi realizado com dificuldade t&#233;cnica.</p>
            <p>&#9675; Informar o maior di&#226;metro da aorta e/ou art&#233;rias il&#237;acas na presen&#231;a de dilata&#231;&#245;es.</p>
            <p>- Informa&#231;&#245;es adicionais para o exame pr&#233;-operat&#243;rio: </p>
            <p>&#8226; Informar presen&#231;a, aspecto e localiza&#231;&#227;o das placas ateroscler&#243;ticas, assim com o grau de estenose das les&#245;es. As limita&#231;&#245;es gerais do exame de USV s&#227;o listadas na <xref ref-type="table" rid="t41">tabela 12</xref>.</p>
            <table-wrap id="t41">
              <label>Tabela 12</label>
              <caption>
                <title>Limita&#231;&#245;es do exame de ultrassonografia vascular na avalia&#231;&#227;o de aorta abdominal e ramos</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="33%"/>
                  <col width="33%"/>
                  <col width="33%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Aorta e il&#237;acas</th>
                    <th align="left">Art&#233;rias mesent&#233;ricas/Tronco cel&#237;aco</th>
                    <th align="left">Art&#233;rias renais</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&#9679; Abdome hostil</td>
                    <td align="left">&#9679; Abdome hostil</td>
                    <td align="left">&#9679; Abdome hostil</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Obesidade</td>
                    <td align="left">&#9679; Obesidade</td>
                    <td align="left">&#9679; Obesidade</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Meteorismo intestinal</td>
                    <td align="left">&#9679; Meteorismo intestinal</td>
                    <td align="left">&#9679; Meteorismo intestinal</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Examinador-dependente</td>
                    <td align="left">&#9679; Paciente com dor abdominal intensa &#8211; na isquemia aguda</td>
                    <td align="left">&#9679; Varia&#231;&#245;es anat&#244;micas</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Equipamento de baixa qualidade</td>
                    <td align="left">&#9679; Examinador-dependente</td>
                    <td align="left">&#9679; Examinador-dependente</td>
                  </tr>
                  <tr>
                    <td align="left">
										</td>
                    <td align="left">&#9679; Equipamento de baixa qualidade</td>
                    <td align="left">&#9679; Equipamento de baixa qualidade</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
        </sec>
        <sec>
          <title>3.3. Art&#233;rias Mesent&#233;ricas</title>
          <sec>
            <title>3.3.1. Considera&#231;&#245;es Gerais</title>
            <p>Os vasos mesent&#233;ricos s&#227;o representados pelo tronco cel&#237;aco (TC) e art&#233;rias mesent&#233;ricas superior (AMS) e inferior (AMI). Anatomicamente o TC origina-se logo abaixo do hiato a&#243;rtico do diafragma, dando origem &#224;s art&#233;rias hep&#225;tica e espl&#234;nica. </p>
            <p>Cerca de 0,5 a 2 cm abaixo do TC e 4 a 5 cm acima da bifurca&#231;&#227;o a&#243;rtica, originam-se as AMS e inferior, respectivamente (<xref ref-type="fig" rid="f27">Figura 10</xref>).<xref ref-type="bibr" rid="B35">35</xref>
						</p>
            <p>
              <fig id="f27">
                <label>Figura 10</label>
                <caption>
                  <title>Aorta abdominal e ramos. AE: art&#233;ria espl&#234;nica; AH: art&#233;ria hep&#225;tica; AICD: art&#233;ria il&#237;aca comum direita; AICE: art&#233;ria il&#237;aca comum esquerda; AMI: art&#233;ria mesent&#233;rica inferior; ARD: art&#233;ria renal direita; ARE: art&#233;ria renal esquerda; MAS: art&#233;ria mesent&#233;rica superior; TC: tronco cel&#237;aco.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf10-pt.jpg"/></fig>
            </p>
            <p>A doen&#231;a obstrutiva das art&#233;rias mesent&#233;ricas evolui de forma cr&#244;nica e assintom&#225;tica. A manifesta&#231;&#227;o cl&#237;nica representada por dor abdominal p&#243;s-prandial (angina mesent&#233;rica) e/ou perda progressiva de peso ocorre quando dois ou mais vasos mesent&#233;ricos s&#227;o envolvidos. Os indiv&#237;duos idosos do sexo masculino s&#227;o mais frequentemente acometidos. A aterosclerose &#233; respons&#225;vel por mais de 90% das doen&#231;as que acometem as art&#233;rias mesent&#233;ricas e, geralmente, &#233; uma propaga&#231;&#227;o do processo ateromatoso que envolve toda a aorta.<xref ref-type="bibr" rid="B36">36</xref>
						</p>
            <p>A arteriografia &#233; considerada o m&#233;todo de diagn&#243;stico padr&#227;o; no entanto, a USV, por ser n&#227;o invasiva e isenta de risco, &#233; o primeiro exame indicado na investiga&#231;&#227;o da isquemia intestinal cr&#244;nica sintom&#225;tica.<xref ref-type="bibr" rid="B37">37</xref>
						</p>
            <p>A USV tem como objetivo determinar a presen&#231;a, a localiza&#231;&#227;o, a extens&#227;o e a gravidade da les&#227;o esten&#243;tica. O estudo deve incluir a AMS, o TC e a AMI, sendo a avalia&#231;&#227;o da AMS e do TC de maior import&#226;ncia.<xref ref-type="bibr" rid="B38">38</xref>
						</p>
          </sec>
          <sec>
            <title>3.3.2. Indica&#231;&#245;es Cl&#237;nicas</title>
            <p>&#8226; Dor abdominal recorrente p&#243;s-prandial (angina mesent&#233;rica).</p>
            <p>&#8226; Emagrecimento sem causa conhecida.</p>
            <p>&#8226; Sopro abdominal. </p>
            <p>Os protocolos de seguimento ap&#243;s o tratamento cir&#250;rgico ou endovascular, al&#233;m dos protocolos para avalia&#231;&#227;o das s&#237;ndromes compressivas, est&#227;o descritos detalhadamente nas recomenda&#231;&#245;es do DIC.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
          </sec>
          <sec>
            <title>3.3.3. Preparo e Protocolo Geral de Exame (<xref ref-type="table" rid="t39">Tabela 10</xref>)</title>
            <p>&#8226; Protocolo espec&#237;fico de exame:<xref ref-type="bibr" rid="B39">39</xref><sup>,</sup><xref ref-type="bibr" rid="B40">40</xref>
						</p>
            <p>- Posicionar o transdutor na regi&#227;o epig&#225;strica; utilizando-se o corte transversal, identifica-se a AMS anteriormente, a aorta posteriormente e a veia renal entre esses dois vasos (<xref ref-type="fig" rid="f28">Figura 11A</xref>). Nessa mesma regi&#227;o, utilizando-se o corte longitudinal da aorta, identificam-se o TC e a AMS (<xref ref-type="fig" rid="f28">Figura 11B</xref>).</p>
            <p>
              <fig id="f28">
                <label>Figura 11</label>
                <caption>
                  <title>Vasos mesent&#233;ricos e aorta abdominal. (A) Corte transversal ao modo B evidenciando a art&#233;ria mesent&#233;rica superior (AMS) anteriormente e a aorta abdominal (AO) posteriormente. (B) Corte longitudinal da aorta abdominal e emerg&#234;ncia do tronco cel&#237;aco e AMS.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf11-pt.jpg"/></fig>
            </p>
            <p>- Modo B: tem como objetivo avaliar a presen&#231;a da doen&#231;a ateroscler&#243;tica ou aneurism&#225;tica.</p>
            <p>- Mapeamento de fluxo em cores: avalia a perviedade dos vasos e indica turbul&#234;ncia do fluxo, sugerindo prov&#225;vel local de estenose.</p>
            <p>- An&#225;lise espectral: usada para analisar a VPS e a VDF. Recomenda-se que estas medidas de velocidades sejam feitas na origem do vaso e/ou nos locais onde haja suspeita de estenose. O &#226;ngulo de insona&#231;&#227;o deve ser posicionado em dire&#231;&#227;o ao fluxo sangu&#237;neo.</p>
            <p>- As velocidades dos vasos mesent&#233;ricos sofrem influ&#234;ncia da respira&#231;&#227;o; portanto, &#233; recomendado que o paciente fa&#231;a uma r&#225;pida apneia no momento em que elas sejam medidas. </p>
            <p>&#8226; Os crit&#233;rios ultrassonogr&#225;ficos para avalia&#231;&#227;o do fluxo no TC e na AMS s&#227;o apresentados na <xref ref-type="table" rid="t42">tabela 13</xref>.<xref ref-type="bibr" rid="B2">2</xref><sup>,</sup><xref ref-type="bibr" rid="B41">41</xref><sup>-</sup><xref ref-type="bibr" rid="B43">43</xref>
						</p>
            <table-wrap id="t42">
              <label>Tabela 13</label>
              <caption>
                <title>Crit&#233;rios ultrassonogr&#225;ficos para avalia&#231;&#227;o de tronco cel&#237;aco e art&#233;ria mesent&#233;rica superior nativos</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="20%"/>
                  <col width="20%"/>
                  <col width="20%"/>
                  <col width="20%"/>
                  <col width="20%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Art&#233;ria</th>
                    <th align="center">Doppler normal</th>
                    <th align="center">Estenose &#8805; 50%</th>
                    <th align="center">Estenose &#8805; 70%</th>
                    <th align="center">Oclus&#227;o</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">TC</td>
                    <td align="center">Baixa resist&#234;ncia</td>
                    <td align="center">VPS &gt; 240 cm/s<break/>VDF &gt; 40 cm/s</td>
                    <td align="center">VPS &gt; 320 cm/s<break/>VDF&gt; 100 cm/s</td>
                    <td align="center">Aus&#234;ncia de fluxo<break/>Fluxo retr&#243;grado AHC</td>
                  </tr>
                  <tr>
                    <td align="left">AMS Jejum</td>
                    <td align="center">Alta resist&#234;ncia</td>
                    <td align="center">VPS &gt; 295 cm/s<break/>VDF &gt; 45 cm/s</td>
                    <td align="center">VPS &gt; 400 cm/s<break/>VDF &gt; 70 cm/s</td>
                    <td align="center">Aus&#234;ncia de fluxo</td>
                  </tr>
                  <tr>
                    <td align="left">AMS p&#243;s-prandial</td>
                    <td align="center">Baixa resist&#234;ncia</td>
                    <td align="center">VPS &gt; 295 cm/s VDF &gt; 45 cm/s</td>
                    <td align="center">VPS &gt; 400 cm/s VDF &gt; 70 cm/s</td>
                    <td align="center">Aus&#234;ncia de fluxo</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN26">
                  <p>
                    <italic>AHC: art&#233;ria hep&#225;tica comum; AMS: art&#233;ria mesent&#233;rica superior; TC: tronco cel&#237;aco; VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec>
            <title>3.3.4. Informa&#231;&#245;es Consideradas Fundamentais para Constar no Relat&#243;rio M&#233;dico</title>
            <p>&#8226; Relatar se o exame foi realizado com dificuldade t&#233;cnica.</p>
            <p>&#8226; Presen&#231;a ou n&#227;o de doen&#231;a ateroscler&#243;tica.</p>
            <p>&#8226; Localiza&#231;&#227;o da les&#227;o.</p>
            <p>&#8226; Mensura&#231;&#227;o da estenose.</p>
            <p>&#8226; Medidas das velocidades de pico sist&#243;lico e VDF.</p>
          </sec>
          <sec>
            <title>3.3.5. Limita&#231;&#245;es do Exame</title>
            <p>As limita&#231;&#245;es do exame est&#227;o listadas na <xref ref-type="table" rid="t41">tabela 12</xref>.</p>
          </sec>
        </sec>
        <sec>
          <title>3.4. Art&#233;rias Renais</title>
          <sec>
            <title>3.4.1. Considera&#231;&#245;es Gerais</title>
            <p>A preval&#234;ncia de estenose da art&#233;ria renal (EAR) varia conforme a popula&#231;&#227;o estudada. Na popula&#231;&#227;o geral de hipertensos, a EAR &#233; a causa mais comum de hipertens&#227;o secund&#225;ria e responde por cerca de 1 a 6% dos casos.<xref ref-type="bibr" rid="B44">44</xref><sup>,</sup><xref ref-type="bibr" rid="B45">45</xref>
						</p>
            <p>A causa mais comum da EAR &#233; a aterosclerose (85% a 90% dos casos), acomete mais frequentemente a origem e/ou o segmento proximal da art&#233;ria renal, podendo ser uni ou bilateral. Sua preval&#234;ncia aumenta com a idade, o diabetes e com a presen&#231;a de aterosclerose em outros s&#237;tios arteriais. &#201; considerada um preditor independente de eventos adversos como infarto agudo do mioc&#225;rdio, AVE e morte por causa cardiovascular.<xref ref-type="bibr" rid="B45">45</xref><sup>,</sup><xref ref-type="bibr" rid="B46">46</xref>
						</p>
            <p>A displasia fibromuscular, doen&#231;a n&#227;o inflamat&#243;ria, responde por 10% dos casos de EAR. Sua frequ&#234;ncia na popula&#231;&#227;o geral &#233; desconhecida, sendo descrita mais comumente em mulheres jovens. O envolvimento da art&#233;ria renal ocorre em seu segmento mesodistal, e &#233; geralmente bilateral.<xref ref-type="bibr" rid="B47">47</xref>
						</p>
            <p>Com o avan&#231;o na qualidade dos m&#233;todos de imagem, o diagn&#243;stico da EAR tornou-se fact&#237;vel, assim como de grande interesse, no intuito de identificar pacientes que se beneficiariam n&#227;o somente da terapia medicamentosa, mas tamb&#233;m de procedimentos de revasculariza&#231;&#227;o renal. Dentre os exames de imagem, a USV &#233; o m&#233;todo de escolha inicial para a investiga&#231;&#227;o da EAR por vantagens como n&#227;o invasividade, aus&#234;ncia de riscos de radia&#231;&#227;o, baixo custo e, principalmente, aus&#234;ncia de contraindica&#231;&#245;es relacionadas ao uso de contraste nefrot&#243;xico. A avalia&#231;&#227;o ultrassonogr&#225;fica das art&#233;rias renais possui alta especificidade em laborat&#243;rios competentes, mostrando que, quando os vasos s&#227;o corretamente avaliados, os resultados raramente divergem dos resultados da arteriografia.<xref ref-type="bibr" rid="B45">45</xref><sup>,</sup><xref ref-type="bibr" rid="B48">48</xref><sup>-</sup><xref ref-type="bibr" rid="B50">50</xref>
						</p>
            <p>As principais indica&#231;&#245;es para a investiga&#231;&#227;o da EAR, de acordo com as principais diretrizes americanas, s&#227;o apresentadas na <xref ref-type="table" rid="t43">tabela 14</xref>.<xref ref-type="bibr" rid="B51">51</xref><sup>,</sup><xref ref-type="bibr" rid="B52">52</xref>
						</p>
            <table-wrap id="t43">
              <label>Tabela 14</label>
              <caption>
                <title>Indica&#231;&#245;es cl&#237;nicas para a investiga&#231;&#227;o da estenose de art&#233;ria renal</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="100%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">&#9679; In&#237;cio da hipertens&#227;o arterial em pacientes com idade &#8804; 30 anos</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&#9679; In&#237;cio de hipertens&#227;o grave em pacientes com idade &#8805; 55 anos</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com hipertens&#227;o acelerada (piora s&#250;bita ou persistente da hipertens&#227;o arterial previamente controlada)</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com hipertens&#227;o resistente (falha do tratamento com doses plenas de tr&#234;s classes de anti-hipertensivos, incluindo diur&#233;ticos)</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com hipertens&#227;o maligna (cursando com les&#227;o de &#243;rg&#227;o-alvo: insufici&#234;ncia renal aguda, insufici&#234;ncia card&#237;aca congestiva aguda, novo dist&#250;rbio visual ou neurol&#243;gico, e /ou retinopatia avan&#231;ada)</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com piora da fun&#231;&#227;o renal ap&#243;s administra&#231;&#227;o de inibidor da enzima de convers&#227;o da angiotensina ou bloqueador do receptor de angiotensina</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com atrofia renal inexplic&#225;vel ou discrep&#226;ncia &gt; 1,5 cm do tamanho dos rins</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com edema pulmonar s&#250;bito e inexplicado (flash pulmonary edema)</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com insufici&#234;ncia renal ou insufici&#234;ncia card&#237;aca congestiva inexplicada</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com angina refrat&#225;ria</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com doen&#231;a arterial coron&#225;ria de m&#250;ltiplos vasos</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Pacientes com aneurisma de aorta abdominal</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>O estudo das art&#233;rias renais tem como principais objetivos:</p>
            <p>&#8226; Identificar as art&#233;rias renais principais e, se poss&#237;vel, as art&#233;rias renais acess&#243;rias.</p>
            <p>&#8226; Localizar e graduar as les&#245;es esten&#243;ticas consequentes a doen&#231;a ateroscler&#243;tica ou n&#227;o.</p>
            <p>&#8226; Acompanhar a progress&#227;o da EAR.</p>
            <p>&#8226; Seguimento ap&#243;s a revasculariza&#231;&#227;o da art&#233;ria renal.</p>
          </sec>
          <sec>
            <title>3.4.2. Protocolo de Exame (<xref ref-type="table" rid="t35">Tabela 10</xref>)</title>
            <p>&#8226; Posi&#231;&#227;o do paciente: Dec&#250;bito dorsal, utilizando os cortes ultrassonogr&#225;ficos transversal e longitudinal, para an&#225;lise da aorta abdominal e origem das art&#233;rias renais.</p>
            <p>&#8226; Em dec&#250;bito lateral, utilizando o corte coronal, devem ser avaliados todos os segmentos m&#233;dios e distais das art&#233;rias renais. Nesse corte deve-se mensurar o di&#226;metro longitudinal do rim e analisar o fluxo intrarrenal nas art&#233;rias segmentares ou interlobares.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>&#8226; Modo B: &#233; utilizado para a identifica&#231;&#227;o de placas de ateroma na art&#233;ria renal, bem como avaliar a ecogenicidade e a dimens&#227;o do rim.</p>
            <p>&#8226; Mapeamento do fluxo em cores e/ou Doppler de amplitude: avaliam a perviedade das art&#233;rias. O Doppler de amplitude orienta para poss&#237;veis locais de estenose pela turbul&#234;ncia do fluxo ou pela redu&#231;&#227;o do l&#250;men do vaso.</p>
            <p>&#8226; An&#225;lise espectral: Indispens&#225;vel para a aquisi&#231;&#227;o das medidas de velocidades sist&#243;lica e diast&#243;lica (VPS e VDF). Deve-se utilizar o corte ultrassonogr&#225;fico transversal ou o coronal, mantendo o cursor em dire&#231;&#227;o ao jato de fluxo, com um &#226;ngulo de insona&#231;&#227;o &lt; 60&#176; na art&#233;ria renal e de 0&#176; nas art&#233;rias intraparenquimatosas.<xref ref-type="bibr" rid="B53">53</xref>
						</p>
            <p>&#8226; As velocidades de pico sist&#243;lico e a velocidade diast&#243;lica final devem ser mensuradas na origem da art&#233;ria renal ou em qualquer segmento em que haja suspeita de estenose.</p>
            <p>&#8226; A medida da VPS na aorta para o c&#225;lculo do &#237;ndice renal a&#243;rtico (IRA) deve ser feita com a aorta em corte longitudinal e pr&#243;ximo &#224; origem da AMS.</p>
          </sec>
          <sec>
            <title>3.4.3. Crit&#233;rios para o Diagn&#243;stico de Estenose da Art&#233;ria Renal</title>
            <p>Os crit&#233;rios para o diagn&#243;stico de EAR s&#227;o classificados em diretos e indiretos. O primeiro consiste na avalia&#231;&#227;o da art&#233;ria renal desde a sua origem na aorta e, se poss&#237;vel, em toda a sua extens&#227;o. O segundo tem como fundamento analisar a repercuss&#227;o hemodin&#226;mica da les&#227;o proximal da art&#233;ria renal, nas art&#233;rias intraparenquimatosas.</p>
            <p>O crit&#233;rio direto &#233; representado pelas VPS e VDF na art&#233;ria renal e pela VPS na aorta para c&#225;lculo do IRA (VPS da art&#233;ria renal/VPS aorta). O padr&#227;o de onda considerado normal para a art&#233;ria renal &#233; uma onda de baixa resist&#234;ncia. A VPS &#233; considerada o par&#226;metro mais fiel para graduar a EAR e os valores variam de estudo para estudo entre 180 e 250 m/s. A VDF e o IRA s&#227;o utilizados como adjuvantes para avalia&#231;&#227;o das EAR. O IRA varia entre 3,2 e 3,7 de acordo com v&#225;rios estudos, para estimar uma estenose hemodinamicamente significativa. Situa&#231;&#245;es como coarcta&#231;&#227;o da aorta, disfun&#231;&#227;o ventricular esquerda grave, dissec&#231;&#227;o ou aneurisma da aorta e velocidades sist&#243;licas na aorta &gt; 100 cm/s ou &lt; 40 cm/s podem alterar os valores das velocidades nas art&#233;rias renais e suas rela&#231;&#245;es.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>Os crit&#233;rios indiretos, representados pela mensura&#231;&#227;o do tamanho do rim e da an&#225;lise do fluxo nas art&#233;rias intraparenquimatosas, devem ser utilizados em combina&#231;&#227;o com os crit&#233;rios diretos para a otimiza&#231;&#227;o dos resultados. A diferen&#231;a de 1,5 cm no tamanho dos rins pode ser consequente a estenose hemodinamicamente significativa ou at&#233; oclus&#227;o da art&#233;ria renal. Em rela&#231;&#227;o &#224; an&#225;lise do fluxo em art&#233;rias intraparenquimatosas, inicialmente observam-se a redu&#231;&#227;o do pico sist&#243;lico inicial (PSI), prolongamento do tempo de acelera&#231;&#227;o (TA), com redu&#231;&#227;o do &#237;ndice de acelera&#231;&#227;o (IA) e achatamento da onda sist&#243;lica at&#233; que o padr&#227;o <italic>parvus/tardus</italic> seja encontrado. TA &gt; 70 ms relaciona-se com a presen&#231;a de EAR de 60%, enquanto o fluxo parvus/tardus est&#225; presente nas estenoses mais graves (80%).<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <p>A <xref ref-type="table" rid="t44">tabela 15</xref> resume os crit&#233;rios recomendados pelo DIC da SBC para a estenose hemodinamicamente significativa (&gt; 60%) da art&#233;ria renal. Todas as refer&#234;ncias para esses crit&#233;rios est&#227;o detalhadas na refer&#234;ncia.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
            <table-wrap id="t44">
              <label>Tabela 15</label>
              <caption>
                <title>Crit&#233;rios velocim&#233;tricos para a quantifica&#231;&#227;o das estenoses de art&#233;ria renal nativa e ap&#243;s o implante de stent</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="14%"/>
                  <col width="14%"/>
                  <col width="14%"/>
                  <col width="14%"/>
                  <col width="14%"/>
                  <col width="14%"/>
                  <col width="14%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Grau de estenose</th>
                    <th align="center">VPS na art&#233;ria renal</th>
                    <th align="center">Indice renal/aorta</th>
                    <th align="center">VDF na art&#233;ria renal</th>
                    <th align="center">Fluxo intrarrenal</th>
                    <th align="center">VPS art&#233;ria renal <italic>stent</italic></th>
                    <th align="center">Indice renal/aorta <italic>stent</italic></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Normal</td>
                    <td align="center">&lt; 200 cm/s</td>
                    <td align="center">&lt; 3,5</td>
                    <td align="center">&lt; 150 cm/s</td>
                    <td align="center">TA &lt; 70 ms</td>
                    <td align="center">&lt; 390 cm/s</td>
                    <td align="center">&lt; 5</td>
                  </tr>
                  <tr>
                    <td align="left">&lt; 60%</td>
                    <td align="center">&#8805; 200 cm/s</td>
                    <td align="center">&lt; 3,5</td>
                    <td align="center">&lt; 150 cm/s</td>
                    <td align="center">TA &lt; 70 ms</td>
                    <td align="center">&lt; 390 cm/s</td>
                    <td align="center">&lt; 5</td>
                  </tr>
                  <tr>
                    <td align="left">&#8805; 60%</td>
                    <td align="center">&#8805; 200 cm/s</td>
                    <td align="center">&#8805; 3,5</td>
                    <td align="center">&lt; 150 cm/s</td>
                    <td align="center">TA &lt; ou &#8805; 70ms</td>
                    <td align="center">&gt; 390 cm/s</td>
                    <td align="center">&#8805; 5</td>
                  </tr>
                  <tr>
                    <td align="left">&#8805; 80%</td>
                    <td align="center">&#8805; 200 cm/s</td>
                    <td align="center">&#8805; 3,5</td>
                    <td align="center">&#8805; 150 cm/s</td>
                    <td align="center">TA &#8805; 70 ms fluxo tardus/parvus</td>
                    <td align="center">&#8805; 390 cm/s</td>
                    <td align="center">&#8805; 5</td>
                  </tr>
                  <tr>
                    <td align="left">Oclus&#227;o</td>
                    <td align="center">-</td>
                    <td align="center">-</td>
                    <td align="center">-</td>
                    <td align="center">Pode ter fluxo tardus/parvus</td>
                    <td align="center">-</td>
                    <td align="center">-</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN27">
                  <p>
                    <italic>TA: tempo de acelera&#231;&#227;o; VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>Oclus&#227;o da art&#233;ria renal pode ser sugerida pela n&#227;o visualiza&#231;&#227;o de fluxo no interior do vaso ao mapeamento de fluxo em cores e/ou pelo Doppler de amplitude, e pela n&#227;o detec&#231;&#227;o de fluxo pelo Doppler pulsado, associada a di&#226;metro longitudinal do rim ipsolateral &lt; 8,5 cm. </p>
            <p>Acompanhamento ap&#243;s a revasculariza&#231;&#227;o renal n&#227;o faz parte do escopo desta publica&#231;&#227;o e pode ser encontrado nas diretrizes do DIC.<xref ref-type="bibr" rid="B2">2</xref>
						</p>
          </sec>
          <sec>
            <title>3.4.4. Limita&#231;&#245;es do Estudo das Art&#233;rias Renais</title>
            <p>Est&#227;o listadas na <xref ref-type="table" rid="t41">tabela 12</xref>. </p>
          </sec>
          <sec>
            <title>3.4.5. Informa&#231;&#245;es Consideradas Fundamentais para Constar no Relat&#243;rio M&#233;dico</title>
            <p>&#8226; Relatar se o exame foi realizado com dificuldade t&#233;cnica.</p>
            <p>&#8226; Informar a presen&#231;a ou n&#227;o de doen&#231;a ateroscler&#243;tica ou sinais de displasia fibromuscular.</p>
            <p>&#8226; Localiza&#231;&#227;o da les&#227;o. </p>
            <p>&#8226; Mensura&#231;&#227;o da estenose.</p>
            <p>&#8226; Medida das VPS e VDF na art&#233;ria renal.</p>
            <p>&#8226; Medida da VPS na aorta.</p>
            <p>&#8226; Medida dos &#237;ndices de pulsatilidade (IP) e IR nas art&#233;rias intraparenquimatosas (de prefer&#234;ncia a art&#233;ria segmentar).</p>
            <p>&#8226; Medida do tamanho do rim.</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>4. Art&#233;rias dos membros inferiores</title>
        <p>A USV permite a avalia&#231;&#227;o das arteriopatias perif&#233;ricas com elevada acur&#225;cia, proporcionando a avalia&#231;&#227;o anat&#244;mica e funcional das les&#245;es arteriais, al&#233;m de identificar localiza&#231;&#227;o, extens&#227;o e repercuss&#227;o hemodin&#226;mica da estenose ou oclus&#227;o.<xref ref-type="bibr" rid="B54">54</xref><sup>,</sup><xref ref-type="bibr" rid="B55">55</xref>
				</p>
        <sec>
          <title>4.1. Indica&#231;&#245;es Cl&#237;nicas</title>
          <p>&#8226; Diagn&#243;stico anat&#244;mico de estenoses ou oclus&#245;es na arteriopatia estenosante perif&#233;rica, em pacientes sintom&#225;ticos, nos quais a revasculariza&#231;&#227;o seja considerada.<xref ref-type="bibr" rid="B56">56</xref><sup>-</sup><xref ref-type="bibr" rid="B59">59</xref>
					</p>
          <p>&#8226; Seguimento de progress&#227;o de doen&#231;a estenosante diagnosticada previamente.</p>
          <p>&#8226; Planejamento terap&#234;utico cir&#250;rgico em pacientes com diagn&#243;stico de doen&#231;a arterial perif&#233;rica (DAP).<xref ref-type="bibr" rid="B60">60</xref><sup>,</sup><xref ref-type="bibr" rid="B61">61</xref>
					</p>
          <p>&#8226; Diagn&#243;stico e acompanhamento de aneurismas arteriais perif&#233;ricos.<xref ref-type="bibr" rid="B62">62</xref>
					</p>
          <p>&#8226; Diagn&#243;stico, acompanhamento e tratamento de pseudoaneurismas.<xref ref-type="bibr" rid="B63">63</xref><sup>,</sup><xref ref-type="bibr" rid="B64">64</xref>
					</p>
          <p>&#8226; Avalia&#231;&#227;o de enxertos vasculares aut&#243;genos ou sint&#233;ticos, com acompanhamento e diagn&#243;stico de complica&#231;&#245;es.<xref ref-type="bibr" rid="B65">65</xref><sup>-</sup><xref ref-type="bibr" rid="B67">67</xref>
					</p>
          <p>&#8226; Monitoramento de s&#237;tios arteriais submetidos a interven&#231;&#227;o percut&#226;nea, como angioplastia, tromb&#243;lise, trombectomia, aterectomia e implante de <italic>stent</italic>.<xref ref-type="bibr" rid="B68">68</xref><sup>-</sup><xref ref-type="bibr" rid="B71">71</xref>
					</p>
          <p>&#8226; Confirma&#231;&#227;o de anormalidades arteriais significativas detectadas por outro m&#233;todo de imagem.</p>
          <p>&#8226; Avalia&#231;&#227;o de anormalidades vasculares e perivasculares, como massas, aneurismas, pseudoaneurismas, dissec&#231;&#245;es, tromboses, embolias, malforma&#231;&#227;o vasculares, f&#237;stulas arteriovenosas (FAV).</p>
          <p>&#8226; Avalia&#231;&#227;o da integridade arterial no trauma.</p>
          <p>&#8226; Avalia&#231;&#227;o das s&#237;ndromes compressivas arteriais, como o aprisionamento da art&#233;ria popl&#237;tea.</p>
        </sec>
        <sec>
          <title>4.2. Protocolo do Exame (<xref ref-type="table" rid="t45">Tabela 16</xref>)</title>
          <table-wrap id="t45">
            <label>Tabela 16</label>
            <caption>
              <title>Protocolo de exame diagn&#243;stico e mapeamento pr&#233;-operat&#243;rio</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="5%"/>
                <col width="19%"/>
                <col width="19%"/>
                <col width="19%"/>
                <col width="19%"/>
                <col width="19%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="2">Art&#233;ria</th>
                  <th align="center" colspan="2">Modo B</th>
                  <th align="center" colspan="2">Doppler Pulsado</th>
                  <th align="center" rowspan="2">Mapeamento em Cores</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Normal</td>
                  <td align="center">Alterado</td>
                  <td align="center">Normal</td>
                  <td align="center">Alterado</td>
                </tr>
                <tr>
                  <td align="left">AFC</td>
                  <td align="center" rowspan="9">Transversal: avaliar di&#226;metro e aspecto da parede<break/>Longitudinal: avaliar aspecto da parede e di&#226;metro intraluminal</td>
                  <td align="center" rowspan="9">Transversal: medir as dilata&#231;&#245;es, se poss&#237;vel medir as estenoses intraluminais<break/>Longitudinal: medir extens&#227;o da les&#227;o</td>
                  <td align="center" rowspan="9">Longitudinal: utilizar &#226;ngulo &#8804; 60 graus, fluxo laminar, curva multif&#225;sica (trif&#225;sica)</td>
                  <td align="center" rowspan="9">Longitudinal: avaliar fluxo na estenose, proximal e distal &#224; estenose<break/>Considerar a medida da velocidade de pico sist&#243;lico no local de maior velocidade (V2), com &#226;ngulo &#8804;60 graus e 1 a 4 cm proximal &#224; les&#227;o (V1) para realizar a raz&#227;o de velocidades (V2/V1)<break/>Fluxo no segmento p&#243;s-esten&#243;tico: turbul&#234;ncia ou queda da velocidade<break/>Curva de velocidade p&#243;s-esten&#243;tica tipo parvus-tardus significa repercuss&#227;o hemodin&#226;mica</td>
                  <td align="center" rowspan="9">Avaliar perviedade do vaso com preenchimento da cor intraluminal<break/>Oclus&#227;o: aus&#234;ncia de preenchimento da cor<break/>Demonstra turbilhonamento do fluxo &#8211; aspecto de mosaico (<italic>aliasing</italic>)<break/>Guiar varredura do volume de amostra para detectar ponto de maior velocidade</td>
                </tr>
                <tr>
                  <td>AFS proximal</td>
                </tr>
                <tr>
                  <td>AFS m&#233;dia</td>
                </tr>
                <tr>
                  <td>AFS distal</td>
                </tr>
                <tr>
                  <td>AP</td>
                </tr>
                <tr>
                  <td>ATP</td>
                </tr>
                <tr>
                  <td>ATA</td>
                </tr>
                <tr>
                  <td>AF</td>
                </tr>
                <tr>
                  <td>TTF</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN28">
                <p>
                  <italic>AF: art&#233;ria fibular; AFC: art&#233;ria femoral comum; AFP: art&#233;ria femoral profunda; AFS: art&#233;ria femoral superficial; AP: art&#233;ria popl&#237;tea; ATA: art&#233;ria tibial anterior; ATP: art&#233;ria tibial posterior; TTF: tronco tibiofibular.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>4.3. Crit&#233;rios Diagn&#243;sticos</title>
          <p>Estenose: medir a VPS no local da les&#227;o (V2) e 1 a 4 cm proximal &#224; les&#227;o (V1), calculando a raz&#227;o dessas velocidades (V2/V1). A curva espectral deve ser obtida com um &#226;ngulo menor ou igual a 60o paralelo ao eixo do fluxo turbilhonado (<xref ref-type="fig" rid="f26">Figura 9</xref>). A classifica&#231;&#227;o do grau de estenose deve ser realizada de acordo com o apresentado na <xref ref-type="table" rid="t46">tabela 17</xref>.<xref ref-type="bibr" rid="B60">60</xref><sup>,</sup><xref ref-type="bibr" rid="B61">61</xref> Outros crit&#233;rios que podem auxiliar na gradua&#231;&#227;o da estenose s&#227;o: presen&#231;a de TA prolongado em art&#233;rias distais, podendo indicar les&#245;es hemodinamicamente significativas em segmento proximal.</p>
          <table-wrap id="t46">
            <label>Tabela 17</label>
            <caption>
              <title>Classifica&#231;&#227;o do grau de estenose nas art&#233;rias nativas pelo Doppler pulsadao</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="50%"/>
                <col width="50%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Classifica&#231;&#227;o</th>
                  <th align="center">Raz&#227;o de velocidades sist&#243;licas</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Estenose &lt; 50%</td>
                  <td align="center">V2/V1 &lt; 2,0</td>
                </tr>
                <tr>
                  <td align="left">Estenose &#8805; 50%</td>
                  <td align="center">V2/V1 &#8805; 2,0</td>
                </tr>
                <tr>
                  <td align="left">Estenose &#8805; 70%</td>
                  <td align="center">V2/V1 &#8805; 4,0</td>
                </tr>
                <tr>
                  <td align="left">Oclus&#227;o</td>
                  <td align="center">Aus&#234;ncia de fluxo</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Oclus&#227;o: aus&#234;ncia de fluxo em qualquer segmento das art&#233;rias dos membros inferiores, mesmo com par&#226;metros de varredura para obten&#231;&#227;o de fluxos de baixas velocidades. Presen&#231;a de onda pr&#233;-oclusiva t&#237;pica (alta resist&#234;ncia perif&#233;rica, pico sist&#243;lico de baixa velocidade e aus&#234;ncia de fluxo diast&#243;lico). Vasos colaterais podem ser observados pr&#233; e p&#243;s-segmento oclu&#237;do (ponto de reenchimento). O espectro p&#243;s-oclusivo &#233; caracterizado por onda monof&#225;sica, com VPS reduzida e TA prolongado (padr&#227;o <italic>parvus/tardus</italic>). Quando se observa imagem hipoecoica com interface c&#244;ncava ao fluxo colorido e espectro com padr&#227;o pr&#233;-oclusivo em <italic>staccato</italic>, sugere tromboembolismo (<xref ref-type="table" rid="t47">Tabela 18</xref>).</p>
          <table-wrap id="t47">
            <label>Tabela 18</label>
            <caption>
              <title>Padr&#245;es de fluxo arterial em diversas situa&#231;&#245;es</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">
									</th>
                  <th align="center">Denomina&#231;&#227;o</th>
                  <th align="center">Significado cl&#237;nico</th>
                  <th align="center">Situa&#231;&#227;o de ocorr&#234;ncia</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/8c62f4408a506c42d717effe466528b988c93061.svg"/>
                  </th>
                  <td align="center">Trif&#225;sico</td>
                  <td align="center">Encontrado em indiv&#237;duos jovens e normais</td>
                  <td align="center">Normal</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/7590739e1145a548c9161633254f727c182e8a14.svg"/>
                  </th>
                  <td align="center">Trif&#225;sico sem o componente el&#225;stico</td>
                  <td align="center">Encontrado em idosos com diminui&#231;&#227;o da elasticidade do vaso</td>
                  <td align="center">&#9679; Idosos normais &#9679; Mal alinhamentodo feixe de US</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/3ff587b715cd43d9fcf3c750bd82b9ad3410042a.svg"/>
                  </th>
                  <td align="center">Bif&#225;sico hiper&#234;mico</td>
                  <td align="center">Sem componente reverso, por&#233;m toca na linha de base. Velocidades aumentadas</td>
                  <td align="center">&#9679; Processos inflamat&#243;rios &#9679; Vasodilata&#231;&#227;o reativa normal</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/c65ba3d5531e790173232e93402cf2271631bf1c.svg"/>
                  </th>
                  <td align="center">Bif&#225;sico p&#243;s-obstrutivo</td>
                  <td align="center">Sem componente reverso, por&#233;m toca na linha de base. Velocidades baixas</td>
                  <td align="center">Ap&#243;s obstru&#231;&#245;es moderadas</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/43be11ea47d2bb881f6dcf284e05100979b4e6c9.svg"/>
                  </th>
                  <td align="center">Bif&#225;sico com componente pandiast&#243;lico reverso</td>
                  <td align="center">Componente reverso pandiast&#243;lico. Normalmente com velocidades normais</td>
                  <td align="center">Vasos que fornecem colaterais para outras art&#233;rias com estenose. Na maioria dos casos, vasos sem les&#245;es proximais</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/675242914f37bec8a0e24701349fc50259629cae.svg"/>
                  </th>
                  <td align="center">Bif&#225;sico "<italic>to and fro</italic>"</td>
                  <td align="center">Componente reverso pandiast&#243;lico acentuado</td>
                  <td align="center">&#9679; Pseudonaneurisma &#9679; <italic>Endoleak</italic> do tipo II</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/25c0f14324f45ed298d313beb116c73c7cf132d2.svg"/>
                  </th>
                  <td align="center">Monof&#225;sico agudo</td>
                  <td align="center">Velocidade baixa, com tempo de acelera&#231;&#227;o pouco aumentado</td>
                  <td align="center">P&#243;s-estenoses moderadas e moderadas a importantes, COM reserva de vasodilata&#231;&#227;o</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/2f583405386c5aad2380446343be6517beb04a7e.svg"/>
                  </th>
                  <td align="center">Monof&#225;sico amortecido</td>
                  <td align="center">Velocidade baixa, com tempo de acelera&#231;&#227;o aumentado</td>
                  <td align="center">P&#243;s-estenoses importantes ou p&#243;s-oclus&#227;o, COM reserva de vasodilata&#231;&#227;o</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/651219b13f7128221529c8a6ebfa897de386ec2a.svg"/>
                  </th>
                  <td align="center">Monof&#225;sico extremamente amortecido</td>
                  <td align="center">Velocidade muito baixa, com tempo de acelera&#231;&#227;o muito aumentado</td>
                  <td align="center">P&#243;s-oclus&#227;o, COM reserva de vasodilata&#231;&#227;o</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/10fbed5cdec29c1eee2b5e4efa6c7925ac43b313.svg"/>
                  </th>
                  <td align="center">Monof&#225;sico sem di&#225;stole</td>
                  <td align="center">Velocidade extremamente baixa, com tempo de acelera&#231;&#227;o aumentado, sem fluxo na di&#225;stole</td>
                  <td align="center">P&#243;s-oclus&#227;o, SEM reserva de vasodilata&#231;&#227;o. Les&#245;es multissegmentares graves.</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/6e820012a5ddf1de5c1c7c0ef123568795ab1dd3.svg"/>
                  </th>
                  <td align="center">Cont&#237;nuo</td>
                  <td align="center">Velocidade extremamente baixa, com tempo de acelera&#231;&#227;o t&#227;o aumentado que n&#227;o distingue VPS de VDF</td>
                  <td align="center">P&#243;s-oclus&#227;o, COM reserva de vasodilata&#231;&#227;o. Les&#245;es multissegmentares graves</td>
                </tr>
                <tr>
                  <th align="left">
                    <inline-graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/PJjC79yRvgyGqtwGVWCNvpv/71de0020c1dc8ec4c1025c4f21cfbf1fe02bf4dd.svg"/>
                  </th>
                  <td align="center">Reverso</td>
                  <td align="center">Velocidade baixa, pode ou n&#227;o estar amortecido, e pode at&#233; ter componente reverso</td>
                  <td align="center">Enchimento retr&#243;grado de um vaso com oclus&#227;o proximal</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN29">
                <p>
                  <italic>VDF: velocidade diast&#243;lica final; VPS: velocidade de pico sist&#243;lico.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Aneurisma: a identifica&#231;&#227;o e a localiza&#231;&#227;o do aneurisma deve ser documentada. O maior di&#226;metro deve ser medido englobando a camada advent&#237;cia (<italic>out-out</italic>) pelo modo bidimensional em corte transversal. Deve-se investigar a presen&#231;a de trombo intraluminal e este dever&#225; ser documentado pelo mapeamento de fluxo em cores.</p>
          <p>Pseudoaneurisma: caracteriza-se por dilata&#231;&#227;o que n&#227;o compromete todas as camadas da art&#233;ria e possuir um canal de liga&#231;&#227;o com o l&#250;men arterial. Todas essas estruturas devem ser avaliadas por modo bidimensional e mapeamento em cores, realizando as medidas dos calibres. O Doppler espectral deve ser obtido no canal de liga&#231;&#227;o, onde se observa fluxo t&#237;pico &#8220;<italic>to-and-fro</italic>&#8221; (<xref ref-type="table" rid="t47">Tabela 18</xref>). Nos casos de interven&#231;&#245;es terap&#234;uticas, o mapeamento em cores e o Doppler pulsado devem ser usados como guia terap&#234;utico, avaliando o fluxo sangu&#237;neo na art&#233;ria nativa, bem como auxiliando na pun&#231;&#227;o, nos casos de terap&#234;utica com trombina, e verificando a trombose do pseudoaneurisma em todas as modalidades de tratamento.<xref ref-type="bibr" rid="B63">63</xref>
					</p>
          <p>A <xref ref-type="table" rid="t47">tabela 18</xref> exemplifica os diferentes tipos de padr&#245;es de fluxo arterial, com suas denomina&#231;&#245;es, significados cl&#237;nicos e principais situa&#231;&#245;es de ocorr&#234;ncia.</p>
        </sec>
        <sec>
          <title>4.4. Informa&#231;&#245;es Consideradas Fundamentais para Constar no Relat&#243;rio M&#233;dico</title>
          <p>&#8226; Relatar se o exame foi realizado com dificuldade t&#233;cnica.</p>
          <p>&#8226; Aspecto das paredes e di&#226;metro de todas as art&#233;rias estudadas, quando necess&#225;rio.</p>
          <p>&#8226; Presen&#231;a, aspecto, localiza&#231;&#227;o e grau de estenose das placas ateroscler&#243;ticas.</p>
          <p>&#8226; Velocidades nas estenoses e aspecto das curvas de velocidade no segmento p&#243;s-esten&#243;tico.</p>
          <p>&#8226; Sinais de oclus&#227;o arterial segmentar ou total.</p>
        </sec>
        <sec>
          <title>4.5. Limita&#231;&#245;es Gerais do Exame de Ultrassonografia Arterial Perif&#233;rica</title>
          <p>&#8226; Examinador-dependente.</p>
          <p>&#8226; Equipamento de baixa qualidade t&#233;cnica.</p>
          <p>&#8226; Edema dos membros inferiores.</p>
          <p>&#8226; &#218;lcera n&#227;o cicatrizada.</p>
        </sec>
      </sec>
      <sec>
        <title>5. F&#237;stulas arteriovenosas para hemodi&#225;lise</title>
        <sec>
          <title>5.1. Introdu&#231;&#227;o</title>
          <p>As FAV podem ser cong&#234;nitas, traum&#225;ticas ou criadas especificamente para serem utilizadas em hemodi&#225;lise. Nesta diretriz abordaremos apenas os aspectos t&#233;cnicos para avalia&#231;&#227;o com a USV das FAV para hemodi&#225;lise (FAVH), que podem ser de dois tipos: </p>
          <p>1. Aut&#243;genas, do tipo f&#237;stula radiocef&#225;lica ou braquiocef&#225;lica (Brescia-Cimino). Na <xref ref-type="fig" rid="f29">figura 12</xref> observa-se, em A, a fixa&#231;&#227;o laterolateral entre art&#233;ria e veia; em B, a fixa&#231;&#227;o terminal da art&#233;ria e lateral da veia; em C, a fixa&#231;&#227;o terminal da veia e lateral da art&#233;ria; e em D, a fixa&#231;&#227;o terminoterminal em art&#233;ria e veia.<xref ref-type="bibr" rid="B72">72</xref>
					</p>
          <p>
            <fig id="f29">
              <label>Figura 12</label>
              <caption>
                <title>Tipos de f&#237;stulas braquiocef&#225;licas (Brescia-Cimino). (A) Posi&#231;&#227;o laterolateral art&#233;ria e veia. (B) Posi&#231;&#227;o terminal art&#233;ria &#8211; lateral veia. (C) Posi&#231;&#227;o terminal veia - lateral art&#233;ria. (D) Posi&#231;&#227;o terminoterminal art&#233;ria e veia.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf12-pt.jpg"/></fig>
          </p>
          <p>2. F&#237;stulas de politetrafluoretileno (PTFE). Na <xref ref-type="fig" rid="f30">figura 13</xref> observa-se, em A, um exemplo de ponte de PTFE entre a veia bas&#237;lica e a art&#233;ria radial; em B, h&#225; uma al&#231;a de PTFE entre a veia bas&#237;lica e a art&#233;ria radial; em C, h&#225; uma ponte de PTFE entre a art&#233;ria e a veia braquial; e em D, exemplifica-se no membro inferior uma al&#231;a de PTFE entre a veia safena magna e a art&#233;ria femoral.<xref ref-type="bibr" rid="B73">73</xref>
					</p>
          <p>
            <fig id="f30">
              <label>Figura 13</label>
              <caption>
                <title>Tipos de f&#237;stulas de politetrafluoretileno (PTFE). (A) Ponte PTFE entre veia bas&#237;lica e art&#233;ria radial. (B) Al&#231;a de PTFE entre veia bas&#237;lica e art&#233;ria radial. (C) Ponte entre art&#233;ria e veia braquiais. (D) Al&#231;a entre veia safena magna e art&#233;ria femoral.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf13-pt.jpg"/></fig>
          </p>
          <p>As FAVH mais comuns s&#227;o as dos tipos radiocef&#225;lico e braquiocef&#225;lico,<xref ref-type="bibr" rid="B73">73</xref> por&#233;m, como alternativa, podem ser confeccionadas entre outros vasos, tais como entre a art&#233;ria ulnar e a veia bas&#237;lica, ou, ainda, entre a art&#233;ria braquial e a veia bas&#237;lica, devendo ser superficializadas.</p>
        </sec>
        <sec>
          <title>5.2. Indica&#231;&#245;es do Exame</title>
          <p>As principais indica&#231;&#245;es para a USV nas FAVH s&#227;o:</p>
          <p>&#8226; Mapeamento vascular pr&#233;-operat&#243;rio, com planejamento para confec&#231;&#227;o, incluindo avalia&#231;&#227;o de vasos centrais.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B75">75</xref>
					</p>
          <p>&#8226; Avalia&#231;&#227;o da matura&#231;&#227;o, principalmente em pacientes obesos. A matura&#231;&#227;o ocorre quando a FAVH &#233; capaz de suportar sucessivas pun&#231;&#245;es venosas com agulhas de grosso calibre. As falhas nesse processo podem ocorrer em at&#233; 60% dos casos.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B76">76</xref><sup>,</sup><xref ref-type="bibr" rid="B77">77</xref>
					</p>
          <p>&#8226; Seguimento funcional da FAVH para detec&#231;&#227;o precoce de complica&#231;&#245;es.</p>
          <p>&#8226; Recomenda&#231;&#227;o: fazer um exame pr&#233;-confec&#231;&#227;o para planejamento e dois exames p&#243;s-confec&#231;&#227;o para reduzir a sua taxa de fal&#234;ncia.<xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B78">78</xref>
					</p>
          <p>&#8226; Contraindica&#231;&#245;es para confec&#231;&#227;o: s&#237;ndrome de Paget-Schroetter e trombose venosa profunda (TVP).</p>
        </sec>
        <sec>
          <title>5.3. T&#233;cnica<xref ref-type="bibr" rid="B79">79</xref>
					</title>
          <p>&#8226; Equipamento de alta tecnologia - com sonda linear de alta frequ&#234;ncia e/ou frequ&#234;ncia vari&#225;vel.</p>
          <p>&#8226; Paciente em repouso, com a sala em temperatura ambiente, posicionando-se o membro superior estendido paralelamente ao corpo.</p>
          <p>&#8226; Medir os di&#226;metros anteroposteriores dos vasos em cortes transversais.</p>
          <p>&#8226; Os poss&#237;veis s&#237;tios para a medida do volume do fluxo s&#227;o: aferente - medir na art&#233;ria, de 1 a 2 cm antes da anastomose; e eferente - medir na veia, de 1 a 2 cm ap&#243;s a anastomose.</p>
          <p>&#8226; Observar as altera&#231;&#245;es aos cortes bidimensionais e analisar os fluxos com turbul&#234;ncia ao mapeamento de fluxo em cores.</p>
          <p>&#8226; A angula&#231;&#227;o do Doppler deve ser orientada paralelamente ao fluxo sangu&#237;neo (mais pr&#243;ximo a 60&#176;).<xref ref-type="bibr" rid="B79">79</xref>
					</p>
          <p>&#8226; As caracter&#237;sticas ao Doppler espectral observadas s&#227;o: art&#233;ria - fluxo de baixa resist&#234;ncia; veia - fluxo de padr&#227;o &#8220;arterializado&#8221;.</p>
        </sec>
        <sec>
          <title>5.4. Crit&#233;rios Diagn&#243;sticos</title>
          <sec>
            <title>5.4.1. Protocolo para Confec&#231;&#227;o de F&#237;stulas Arteriovenosas para Hemodi&#225;lise</title>
            <p>&#8226; Escolher o membro n&#227;o dominante, se satisfat&#243;rio.</p>
            <p>&#8226; Observar as ordens: 1<sup>a</sup> op&#231;&#227;o punho; 2<sup>a</sup> op&#231;&#227;o cotovelo; 3<sup>a</sup> op&#231;&#227;o pr&#243;tese.</p>
            <p>&#8226; Medir os di&#226;metros arteriais e venosos (podendo ser utilizado o garrote do membro para avaliar a distensibilidade venosa).<xref ref-type="bibr" rid="B80">80</xref><sup>,</sup><xref ref-type="bibr" rid="B81">81</xref>
						</p>
            <p>- Di&#226;metros ideais na veia ou na art&#233;ria: cotovelo - 4 mm; punho - 3 mm.</p>
            <p>- Di&#226;metros m&#237;nimos funcionais: cotovelo - 2 mm; punho - 1,8 mm.<xref ref-type="bibr" rid="B72">72</xref>
						</p>
            <p>&#8226; Medir a profundidade entre os vasos e a superf&#237;cie da pele, sendo a ideal para pun&#231;&#227;o &lt; 5 mm.<xref ref-type="bibr" rid="B79">79</xref>
						</p>
            <p>&#8226; Medir a dist&#226;ncia entre a art&#233;ria e a veia a serem utilizadas (<xref ref-type="fig" rid="f31">Figura 14</xref>).</p>
            <p>
              <fig id="f31">
                <label>Figura 14</label>
                <caption>
                  <title>Medida da dist&#226;ncia entre a art&#233;ria braquial e a veia bas&#237;lica pr&#233;-confec&#231;&#227;o de f&#237;stulas arteriovenosas alternativa.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf14-pt.jpg"/></fig>
            </p>
          </sec>
          <sec>
            <title>5.4.2. Protocolo ap&#243;s Confec&#231;&#227;o<xref ref-type="bibr" rid="B77">77</xref><sup>,</sup><xref ref-type="bibr" rid="B79">79</xref><sup>,</sup><xref ref-type="bibr" rid="B81">81</xref>
						</title>
            <p>&#8226; Medidas da art&#233;ria, veia e anastomose: </p>
            <p>- Di&#226;metros ideais de veia ou art&#233;ria: cotovelo - 4 mm; punho - 3 mm.</p>
            <p>- Di&#226;metro m&#237;nimo funcional: 2 mm.</p>
            <p>&#8226; C&#225;lculo do volume de fluxo: para se aferir o volume efetivo do fluxo atrav&#233;s de uma FAVH deve-se medir o di&#226;metro da veia de drenagem pelas bordas internas (em cm), preferencialmente por corte transversal, com a finalidade de se calcular o seu raio (R) e, por conseguinte, sua &#225;rea (em cm&#178;). Essa medida deve ser feita em uma regi&#227;o mais afastada do local da anastomose da f&#237;stula, onde n&#227;o haja mais turbul&#234;ncia de fluxo ao mapeamento de fluxo em cores, geralmente entre 2 e 5 cm da anastomose. No local da veia onde se fez a avalia&#231;&#227;o de di&#226;metro, obt&#233;m-se o fluxo pelo Doppler pulsado. O volume de amostra &#233; posicionado no centro do vaso e o &#226;ngulo de fluxo do Doppler deve ser corrigido para at&#233; 60&#176;. Com o Doppler pulsado calcula-se a velocidade m&#233;dia do fluxo (V<sub>M&#201;DIA</sub>) em cm/s. Deve-se obter a m&#233;dia de 3 a 5 ciclos card&#237;acos. Aplica-se ent&#227;o, a f&#243;rmula seguinte:</p>
            <disp-formula id="e2">
              <mml:math id="e02">
                <mml:semantics>
                  <mml:mstyle mathsize="12.0pt">
                    <mml:mi mathvariant="italic">Fluxo</mml:mi>
                    <mml:mspace width="0.33em"/>
                    <mml:mi mathvariant="italic">medio</mml:mi>
                    <mml:mspace width="0.33em"/>
                    <mml:mi>(</mml:mi>
                    <mml:mi mathvariant="italic">ml</mml:mi>
                    <mml:mo>/</mml:mo>
                    <mml:mi>min</mml:mi>
                    <mml:mi>)</mml:mi>
                    <mml:mspace width="0.33em"/>
                    <mml:mo>=</mml:mo>
                    <mml:mspace width="0.33em"/>
                    <mml:msub>
                      <mml:mi mathvariant="italic">V</mml:mi>
                      <mml:mrow>
                        <mml:mi mathsize="50.0%" mathvariant="italic">MEDIA</mml:mi>
                        <mml:mspace width="0.33em"/>
                      </mml:mrow>
                    </mml:msub>
                    <mml:mi>(</mml:mi>
                    <mml:mi mathvariant="italic">cm</mml:mi>
                    <mml:mo>/</mml:mo>
                    <mml:mi mathvariant="italic">s</mml:mi>
                    <mml:mi>)</mml:mi>
                    <mml:mspace width="0.33em"/>
                    <mml:mo>&#215;</mml:mo>
                    <mml:mspace width="0.33em"/>
                    <mml:msup>
                      <mml:mi mathvariant="italic">R</mml:mi>
                      <mml:mn mathsize="50.0%">2</mml:mn>
                    </mml:msup>
                    <mml:mspace width="0.33em"/>
                    <mml:mi>(</mml:mi>
                    <mml:msup>
                      <mml:mi mathvariant="italic">cm</mml:mi>
                      <mml:mn mathsize="50.0%">2</mml:mn>
                    </mml:msup>
                    <mml:mi>)</mml:mi>
                    <mml:mspace width="0.33em"/>
                    <mml:mo mathvariant="italic">&#960;</mml:mo>
                    <mml:mspace width="0.33em"/>
                    <mml:mo>&#215;</mml:mo>
                    <mml:mspace width="0.33em"/>
                    <mml:mn>60</mml:mn>
                    <mml:mi>(</mml:mi>
                    <mml:mi mathvariant="italic">s</mml:mi>
                    <mml:mi>)</mml:mi>
                  </mml:mstyle>
                </mml:semantics>
              </mml:math>
            </disp-formula>
            <p>Os valores a seguir s&#227;o considerados para volume de fluxo normal, para as FAVH hom&#243;logas ou heter&#243;logas:</p>
            <p>&#8226; F&#237;stula Brescia-Cimino (radiocef&#225;lica) = 614 &#177; 242 ml/min.</p>
            <p>&#8226; PTFE = 464 &#177; 199 ml/min. </p>
            <p>&#8226; Valor m&#233;dio normal = 514 ml/min.</p>
            <p>As f&#237;stulas com volume de fluxo &lt; 450 ml/min apresentam alto risco de trombose em 2 a 6 semanas.</p>
            <p>O volume de fluxo m&#237;nimo funcional para as FAVH em cotovelo &#233; &#8805; 200 ml/min, e em punho &#8805; 150 ml/min.</p>
            <p>O hiperfluxo &#233; considerado quando o volume de fluxo &#233; &gt; 3.000 ml/min.</p>
            <p>&#8226; Protocolo na matura&#231;&#227;o:<xref ref-type="bibr" rid="B73">73</xref><sup>,</sup><xref ref-type="bibr" rid="B74">74</xref><sup>,</sup><xref ref-type="bibr" rid="B77">77</xref> a matura&#231;&#227;o da FAVH consiste nos aumentos dos calibres e dos fluxos nos vasos utilizados. </p>
            <p>Deve-se avaliar o di&#226;metro e a estrutura dos vasos (&#8805; 6 mm), o volume de fluxo (&#8805; 600 ml/min) e dist&#226;ncia da veia at&#233; a superf&#237;cie da pele &#8804; 6 mm.</p>
            <p>Aguardar um tempo m&#237;nimo de 14 dias, sendo o ideal a individualiza&#231;&#227;o com seguimento para cada paciente e tempo superior a 30 dias. Recomenda-se, se poss&#237;vel, aguardar por 60, ou at&#233; 90 dias, antes da primeira canaliza&#231;&#227;o. </p>
            <p>Os principais objetivos para os achados &#224; USV est&#227;o resumidos na <xref ref-type="table" rid="t48">tabela 19</xref>.</p>
            <table-wrap id="t48">
              <label>Tabela 19</label>
              <caption>
                <title>Objetivos para a f&#237;stulas arteriovenosas para hemodi&#225;lise adequada (95%)77a</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="100%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">&#9679; Di&#226;metro vascular: &gt; 4 mm</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">&#9679; Volume de fluxo: &gt; 500 ml/min</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Tempo de matura&#231;&#227;o: &gt; 30 dias</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Di&#226;metros &lt; 3 mm e volumes de fluxo &lt; 400 ml/min = alta probabilidade de fal&#234;ncia</td>
                  </tr>
                  <tr>
                    <td align="left">&#9679; Os di&#226;metros dos vasos devem aumentar com o passar do tempo</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
          <sec>
            <title>
              <bold>5.4.3. Causas e Tipos de Fal&#234;ncias (Aut&#243;genas e Prot&#233;ticas)</bold>
              <xref ref-type="bibr" rid="B74">74</xref>
              <sup>,</sup>
              <xref ref-type="bibr" rid="B76">76</xref>
              <sup>,</sup>
              <xref ref-type="bibr" rid="B79">79</xref>
              <sup>,</sup>
              <xref ref-type="bibr" rid="B82">82</xref>
            </title>
            <p>&#9679; Arterial: diabetes melito e presen&#231;a de ateromatose significativa.</p>
            <p>&#9679; Venosa: fibrose.</p>
            <p>&#9679; Local da anastomose: turbul&#234;ncia e hiperplasia intimal.</p>
            <p>&#9679; Escapes significativos por veias tribut&#225;rias.</p>
            <p>&#9679; Fen&#244;meno de roubo, em que se observa fluxo retr&#243;grado na art&#233;ria radial distal &#224; FAVH (<xref ref-type="fig" rid="f32">Figura 15</xref>).</p>
            <p>
              <fig id="f32">
                <label>Figura 15</label>
                <caption>
                  <title>Fen&#244;meno de roubo com fluxo retr&#243;grado na art&#233;ria radial (em azul), no segmento distal &#224; anastomose da f&#237;stulas arteriovenosas para hemodi&#225;lise.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf15-pt.jpg"/></fig>
            </p>
            <p>&#9679; Tortuosidades acentuadas.</p>
            <p>&#9679; Hiperplasia intimal (valvas).</p>
            <p>&#9679; Trombose (dissec&#231;&#227;o por pun&#231;&#227;o).</p>
            <p>&#9679; Idiop&#225;ticos: pun&#231;&#227;o e t&#233;cnica cir&#250;rgica.</p>
            <p>&#9679; Estenose significativa com V2/V1 &#8805; 4 (se &#8805; 2 indica estenose &gt; 50%; em caso de anormalidades cl&#237;nicas e/ou hemodin&#226;micas associadas, recomenda-se angioplastia).</p>
            <p>&#9679; Oclus&#227;o.</p>
            <p>&#9679; Aneurisma, dilata&#231;&#227;o por degenera&#231;&#227;o das pr&#243;teses e pseudoaneurisma.</p>
            <p>&#9679; Infec&#231;&#227;o.</p>
            <p>&#9679; Hematoma, seroma e linfocele.</p>
          </sec>
          <sec>
            <title>5.4.4. Limita&#231;&#245;es para o Exame</title>
            <p>Inexistentes, com raras exce&#231;&#245;es em edemas muito significativos, cicatrizes com fibrose e presen&#231;a de aparelhos ortop&#233;dicos.</p>
          </sec>
          <sec>
            <title>5.4.5. Sugest&#245;es para Elabora&#231;&#227;o do Laudo e Conclus&#227;o</title>
            <p>1. Exame pr&#233;-confec&#231;&#227;o (<xref ref-type="table" rid="t49">Tabela 20</xref>): </p>
            <table-wrap id="t49">
              <label>Tabela 20</label>
              <caption>
                <title>Mapeamento pr&#233;-confec&#231;&#227;o da f&#237;stulas arteriovenosas para hemodi&#225;lise</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">
										</th>
                    <th align="center" colspan="3">Di&#226;metros art&#233;rias &#8211; mm</th>
                    <th align="center" colspan="5"> Di&#226;metros veias &#8211; mm</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Axilar</td>
                    <td align="center">Braquial</td>
                    <td align="center">Radial</td>
                    <td align="center">Ulnar</td>
                    <td align="center">Braquial</td>
                    <td align="center">Radial</td>
                    <td align="center">Ulnar</td>
                    <td align="center">Cef&#225;lica</td>
                    <td align="center">Bas&#237;lica</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/antebra&#231;o proximal</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/antebra&#231;o m&#233;dio</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/antebra&#231;o distal</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Cotovelo/punho</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Profundidade pele-vaso</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Dist&#226;ncia A-V</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>&#8226; Informar sobre TVP e superficial; altera&#231;&#245;es no sistema arterial; e presen&#231;a de varia&#231;&#245;es anat&#244;micas an&#244;malas, tais como n&#250;mero de vasos, trajetos e vasos do antebra&#231;o que seguem no bra&#231;o.</p>
            <p>&#8226; Informar as medidas de calibres e fluxos adequados.</p>
            <p>2. Exame p&#243;s-confec&#231;&#227;o (<xref ref-type="table" rid="t50">Tabela 21</xref>):</p>
            <table-wrap id="t50">
              <label>Tabela 21</label>
              <caption>
                <title>Mapeamento p&#243;s-confec&#231;&#227;o da f&#237;stula arteriovenosa para hemodi&#225;lise</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                  <col width="11%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Anastomose:</th>
                    <th align="center" colspan="3">Di&#226;metros art&#233;rias &#8211; mm</th>
                    <th align="center" colspan="5"> Di&#226;metros veias &#8211; mm</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Axilar</td>
                    <td align="center">Braquial</td>
                    <td align="center">Radial</td>
                    <td align="center">Ulnar</td>
                    <td align="center">Braquial</td>
                    <td align="center">Radial</td>
                    <td align="center">Ulnar</td>
                    <td align="center">Cef&#225;lica</td>
                    <td align="center">Bas&#237;lica</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/antebra&#231;o proximal</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/Antebra&#231;o m&#233;dio</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Bra&#231;o/antebra&#231;o distal</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Cotovelo/punho</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                  <tr>
                    <td align="left">Profundidade pele-vaso</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                    <td align="center">
										</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>&#8226; Descrever o tipo de FAVH e sua localiza&#231;&#227;o; informar se funcional, disfuncional ou n&#227;o funcional, citando a causa, a localiza&#231;&#227;o e a extens&#227;o do acometimento</p>
            <p>&#8226; Informar os volumes aferente e eferente (ml/min).</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>6. Trombose Venosa Profunda</title>
        <sec>
          <title>6.1. Introdu&#231;&#227;o</title>
          <p>A TVP e a embolia pulmonar (EP) fazem parte de um mesmo espectro de doen&#231;a: o tromboembolismo venoso (TEV). Aproximadamente dois ter&#231;os dos casos s&#227;o constitu&#237;dos por TVP e um ter&#231;o por EP. Entre 85% e 90% dos casos a TVP ocorrem nos membros inferiores.<xref ref-type="bibr" rid="B83">83</xref>
					</p>
          <p>O TEV &#233; patologia grave e preven&#237;vel, de alta incid&#234;ncia, sendo a terceira DCV mais comum, depois do infarto agudo do mioc&#225;rdio e do AVE. O TEV &#233;, portanto, uma condi&#231;&#227;o s&#233;ria e potencialmente letal que pode atingir tanto pacientes internados quanto ambulatoriais. Ap&#243;s o primeiro epis&#243;dio de TEV, h&#225; grande chance de recorr&#234;ncia.<xref ref-type="bibr" rid="B84">84</xref><sup>,</sup><xref ref-type="bibr" rid="B85">85</xref>
					</p>
          <p>O trombo venoso se inicia frequentemente no n&#237;vel das c&#250;spides venosas (<xref ref-type="fig" rid="f33">Figura 16</xref>), seja das veias superficiais, seja das veias profundas, e se estende proximalmente em 13% das vezes, retrogradamente em 4% das vezes e em ambas as dire&#231;&#245;es em 10% das vezes.<xref ref-type="bibr" rid="B86">86</xref><sup>-</sup><xref ref-type="bibr" rid="B88">88</xref> Ele pode ser parcial, se ocupar parcialmente o l&#250;men da veia envolvida, ou total. Se a localiza&#231;&#227;o do trombo ocorrer no sistema superficial, determinar&#225; o quadro de trombose venosa superficial; se envolver o sistema venoso profundo, ser&#225; uma TVP, podendo acometer uma ou mais veias.<xref ref-type="bibr" rid="B89">89</xref> A TVP nos membros inferiores &#233; considerada proximal se envolver a veia popl&#237;tea e/ou veias proximais, com ou sem o envolvimento de outras veias da perna e distal se envolver as veias profundas infrapatelares.<xref ref-type="bibr" rid="B87">87</xref><sup>,</sup><xref ref-type="bibr" rid="B90">90</xref>
					</p>
          <p>
            <fig id="f33">
              <label>Figura 16</label>
              <caption>
                <title>Trombo parcial recente (agudo) localizado no seio valvar da veia femoral comum, visto pelo modo bidimensional, atrav&#233;s dos cortes longitudinal (A) e transversal (B). N&#227;o h&#225; colabamento total da veia durante a compress&#227;o (C).</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf16-pt.jpg"/></fig>
          </p>
          <p>O exame objetivo &#233; crucial porque o diagn&#243;stico cl&#237;nico isolado n&#227;o &#233; confi&#225;vel. As consequ&#234;ncias do erro diagn&#243;stico s&#227;o s&#233;rias. O resultado, na fase precoce, pode ser a morte e, na fase tardia, dependendo da fisiopatologia (obstru&#231;&#227;o, refluxo ou ambos), pode instalar-se quadro de hipertens&#227;o venosa cr&#244;nica, levando a condi&#231;&#245;es incapacitantes como a s&#237;ndrome p&#243;s-tromb&#243;tica (SPT) e, no caso do acometimento pulmonar, a hipertens&#227;o pulmonar.<xref ref-type="bibr" rid="B83">83</xref><sup>,</sup><xref ref-type="bibr" rid="B85">85</xref><sup>,</sup><xref ref-type="bibr" rid="B91">91</xref> Al&#233;m disso, embora a terapia anticoagulante seja efetiva, seu uso desnecess&#225;rio implica gastos e risco de hemorragia maior.<xref ref-type="bibr" rid="B92">92</xref>
					</p>
        </sec>
        <sec>
          <title>6.2. S&#237;ndrome P&#243;s-Tromb&#243;tica</title>
          <p>A SPT &#233; definida como combina&#231;&#227;o dos sintomas e dos achados objetivos em pacientes acometidos pela TVP nos membros inferiores ou superiores. A SPT &#233; doen&#231;a debilitante e &#233; a consequ&#234;ncia mais comum da TVP e a menos reconhecida.<xref ref-type="bibr" rid="B93">93</xref><sup>,</sup><xref ref-type="bibr" rid="B94">94</xref> Sabe-se que, ap&#243;s um per&#237;odo de um a cinco anos do epis&#243;dio de TVP, cerca de 30% a 50% dos pacientes desenvolver&#227;o a SPT, sendo que, nestes, a forma grave estar&#225; presente em 5% a 10% dos casos, mesmo que tratados corretamente.<xref ref-type="bibr" rid="B94">94</xref><sup>,</sup><xref ref-type="bibr" rid="B95">95</xref>
					</p>
          <p>A SPT &#233; o resultado da combina&#231;&#227;o da hipertens&#227;o venosa secund&#225;ria &#224; obstru&#231;&#227;o ao fluxo ou &#224; incompet&#234;ncia valvular, junto &#224;s altera&#231;&#245;es microcirculat&#243;rias e linf&#225;ticas.</p>
          <sec>
            <title>6.2.1. Diagn&#243;stico da Trombose Venosa Profunda</title>
            <p>Como o diagn&#243;stico cl&#237;nico da TVP tem baixa acur&#225;cia (&lt; 50%), poucos pacientes avaliados com suspeita de TVP ter&#227;o efetivamente a doen&#231;a (12% a 31%). Em virtude disto, um teste exato e objetivo que possa confirmar ou excluir TVP &#233; indicado.<xref ref-type="bibr" rid="B87">87</xref><sup>,</sup><xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B96">96</xref> O atual padr&#227;o-ouro para o diagn&#243;stico de TVP &#233; a USV de compress&#227;o.<xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B97">97</xref>
						</p>
            <p>Tr&#234;s categorias de exames s&#227;o utilizadas para determinar a probabilidade de TVP:<xref ref-type="bibr" rid="B92">92</xref><sup>,</sup><xref ref-type="bibr" rid="B98">98</xref>
						</p>
            <p>1. Probabilidade cl&#237;nica baseada na anamnese e no exame cl&#237;nico.</p>
            <p>2. Dosagem do D-d&#237;mero.</p>
            <p>3. Estudos de imagem, sendo o mais comumente usado a USV venosa e os menos frequentemente utilizados a flebografia, a angiotomografia e a angiorresson&#226;ncia venosa. Esta diretriz abordar&#225; apenas o exame de USV.</p>
          </sec>
          <sec>
            <title>6.2.2. Ultrassonografia Vascular</title>
            <p>A USV tem sido considerada o padr&#227;o-ouro da atualidade para o diagn&#243;stico da TVP aguda.<xref ref-type="bibr" rid="B99">99</xref> O estudo PIOPED II mostrou 95,5% de concord&#226;ncia entre angio-TC e ultrassonografia para o diagn&#243;stico ou exclus&#227;o de TVP. Al&#233;m disso, devemos lembrar que a USV &#233; &#250;til n&#227;o s&#243; para o diagn&#243;stico de TVP em pacientes sintom&#225;ticos ou assintom&#225;ticos (com alto risco de TVP), mas tamb&#233;m para identificar outras condi&#231;&#245;es que causem sinais e sintomas indistingu&#237;veis da TVP. </p>
            <p>&#201; imprescind&#237;vel o conhecimento da anatomia vascular e de suas varia&#231;&#245;es, pois &#233; alta a frequ&#234;ncia de variabilidade do n&#250;mero de veias, podendo estar apenas uma delas acometidas, al&#233;m dos diferentes n&#237;veis de conflu&#234;ncias e trajetos.</p>
            <p>Para o diagn&#243;stico de trombose utilizamos v&#225;rios crit&#233;rios, listados a seguir.</p>
            <p>1. Compress&#227;o venosa: a veia normal tem paredes finas, lisas e regulares e &#233; totalmente colab&#225;vel &#224; compress&#227;o realizada com o transdutor (<xref ref-type="fig" rid="f34">Figura 17</xref>).</p>
            <p>
              <fig id="f34">
                <label>Figura 17</label>
                <caption>
                  <title>Manobra de compress&#227;o venosa. (A) Art&#233;ria e veia sem compress&#227;o. (B) Veia normal com compress&#227;o total. (C) Veia dilatada e incompress&#237;vel, com trombo recente. (D) Veia incompress&#237;vel, com trombo antigo (cr&#244;nico). (E) Retrombose.</title>
                </caption>
                <graphic xlink:href="1678-4170-abc-112-06-0809-90106-gf17-pt.jpg"/></fig>
            </p>
            <p>A incompressibilidade &#233; o principal crit&#233;rio para o diagn&#243;stico de TVP (<xref ref-type="fig" rid="f33">Figura 16</xref>).</p>
            <p>Algumas condi&#231;&#245;es podem dificultar essa compressibilidade, sendo algumas vezes necess&#225;rias manobras especiais. S&#227;o elas: </p>
            <p>&#8226; Presen&#231;a de forte grupamento muscular no trajeto a ser comprimido, por exemplo, a compress&#227;o no canal adutor exige que se fa&#231;a a compress&#227;o pela face externa da coxa.</p>
            <p>&#8226; Bexiga neurog&#234;nica, em que se faz necess&#225;rio o esvaziamento por meio de cateterismo vesical.</p>
            <p>&#8226; Proximidade de estruturas &#243;sseas, por exemplo, veias infrapatelares, em que a compress&#227;o &#233; limitada pela dimens&#227;o do transdutor.</p>
            <p>2. Calibre da veia: normalmente a veia tem o dobro do calibre da art&#233;ria adjacente. Na trombose venosa aguda h&#225; uma grande distens&#227;o da parede do vaso, com aumento do calibre da veia e perda desta rela&#231;&#227;o. Com o passar do tempo, com o processo de recanaliza&#231;&#227;o, a veia vai diminuindo de calibre em alguns segmentos de forma desordenada, perdendo a uniformidade normalmente observada ao longo dos vasos. Pode ocorrer, na fase mais cr&#244;nica, a completa retra&#231;&#227;o da veia, assumindo calibres menores que os das art&#233;rias e, por vezes, dificultando o reconhecimento ao exame.</p>
            <p>3. Caracter&#237;sticas da parede venosa: irregularidades parietais ou espessamento parietal difuso, trabecula&#231;&#245;es ou sinequias intraluminais, altera&#231;&#245;es valvulares estruturais, perda da rela&#231;&#227;o anat&#244;mica com estruturas adjacentes, mesmo que t&#234;nues, podem denotar TVP pr&#233;via j&#225; recanalizada. </p>
            <p>Presen&#231;a de ecos intraluminais indicam a presen&#231;a do trombo e sua ecogenicidade pode ou n&#227;o caracterizar a idade do trombo.</p>
            <p>4. Mapeamento em cores: o mapeamento de fluxo em cores &#233; importante ferramenta na trombose venosa.</p>
            <p>Enquanto o preenchimento de todo o l&#250;men pelo fluxo colorido nos cortes longitudinal e transverso &#233; indicativo de normalidade, aus&#234;ncia de cor ou falhas do enchimento do vaso podem indicar trombose total ou parcial, sobretudo nos trombos recentes parciais de baixa ecogenicidade.</p>
            <p>Presen&#231;a de fluxo ao redor do vaso &#233; fortemente indicativa de TVP em fase aguda. J&#225; a presen&#231;a de fluxo de permeio ao trombo indica recanaliza&#231;&#227;o e cronicidade do processo.</p>
            <p>Cuidados devem ser tomados quanto &#224; escala e ao ganho do aparelho e a realiza&#231;&#227;o adequada das manobras que aumentem o fluxo venoso, gerando sinal de cor.</p>
            <p>5. An&#225;lise espectral: o fluxo venoso normal ao Doppler espectral &#233; espont&#226;neo e f&#225;sico com a respira&#231;&#227;o, aumenta com a manobra de compress&#227;o distal e cessa com as manobras de Valsalva (veias proximais) ou compress&#227;o proximal.<xref ref-type="bibr" rid="B85">85</xref> A espontaneidade do fluxo pode n&#227;o ser observada nas veias distais em pacientes em dec&#250;bito, sendo necess&#225;rias manobras de compress&#227;o distal e/ou mobiliza&#231;&#227;o do membro para o deslocamento da coluna sangu&#237;nea. A perda da fasicidade, com padr&#227;o cont&#237;nuo do fluxo, &#233; sinal indireto indicativo de oclus&#227;o ou compress&#227;o proximal. J&#225; a resposta amortecida &#224; compress&#227;o distal denota obstru&#231;&#227;o entre o local de compress&#227;o e o local de amostra do fluxo.</p>
            <p>Quando h&#225; dano valvular, ocorre fluxo retr&#243;grado. Refluxo valvular &#233;, ent&#227;o, sinal patol&#243;gico, que pode alertar para a presen&#231;a de trombose pr&#233;via, devendo-se descartar as agenesias valvulares ou o refluxo venoso secund&#225;rio ao hiperfluxo.</p>
            <p>Na <xref ref-type="table" rid="t51">tabela 22</xref>, est&#227;o descritas caracter&#237;sticas &#224; USV para auxiliar no diagn&#243;stico das fases da trombose venosa.</p>
            <table-wrap id="t51">
              <label>Tabela 22</label>
              <caption>
                <title>Caracter&#237;sticas das diferentes fases da trombose venosa profunda &#224; ultrassonografia vascular</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="25%"/>
                  <col width="25%"/>
                  <col width="25%"/>
                  <col width="25%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Fase</th>
                    <th align="center">Aguda</th>
                    <th align="center">Intermedi&#225;ria (subaguda)</th>
                    <th align="center">Cr&#244;nica</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Tempo do evento</td>
                    <td align="center">At&#233; 14 dias</td>
                    <td align="center">14 a 28 dias</td>
                    <td align="center">&gt; 28 dias</td>
                  </tr>
                  <tr>
                    <td align="left">Calibre do vaso</td>
                    <td align="center">Dilatado</td>
                    <td align="center">Ainda dilatado ou normal ou leve redu&#231;&#227;o</td>
                    <td align="center">Geralmente reduzido</td>
                  </tr>
                  <tr>
                    <td align="left">Incompressibilidade</td>
                    <td align="center">Total ou parcial</td>
                    <td align="center">Total ou parcial</td>
                    <td align="center">Parcial ou ausente</td>
                  </tr>
                  <tr>
                    <td align="left">Aspecto do trombo</td>
                    <td align="center">Hipoecog&#234;nico</td>
                    <td align="center">Isoecoico</td>
                    <td align="center">Hiperecog&#234;nico Irregularidades parietais Res&#237;duos fibr&#243;ticos Trombo residual: calibre &gt; 2 mm ap&#243;s compress&#227;o m&#225;xima em 6 meses ou &gt; 3 mm em dois exames consecutivos</td>
                  </tr>
                  <tr>
                    <td align="left">Fluxo</td>
                    <td align="center">Ausente ou parcial</td>
                    <td align="center">Canais de fluxo de permeio &#224; massa tromb&#243;tica Pode encontrar microf&#237;stula</td>
                    <td align="center">M&#250;ltiplos canais de fluxo permeando o trombo Preenchendo totalmente o l&#250;men Presen&#231;a de colaterais Espectro de fluxo cont&#237;nuo ou de amplitude reduzida Pode haver refluxo ao ortostatismo</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>A realiza&#231;&#227;o das manobras de Valsalva e respirat&#243;rias de inspira&#231;&#227;o e expira&#231;&#227;o auxilia e agrega informa&#231;&#245;es (<xref ref-type="table" rid="t52">Tabela 23</xref>). </p>
            <table-wrap id="t52">
              <label>Tabela 23</label>
              <caption>
                <title>Varia&#231;&#245;es do fluxo venoso de acordo com a fase do ciclo respirat&#243;rio</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="33%"/>
                  <col width="33%"/>
                  <col width="33%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Fluxo</th>
                    <th align="center">Inspira&#231;&#227;o</th>
                    <th align="center">Expira&#231;&#227;o</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Membros inferiores</td>
                    <td align="center">&#8595;</td>
                    <td align="center">&#8593;</td>
                  </tr>
                  <tr>
                    <td align="left">Membros superiores</td>
                    <td align="center">&#8593;</td>
                    <td align="center">&#8595;</td>
                  </tr>
                  <tr>
                    <td align="left">Subcl&#225;vias</td>
                    <td align="center">&#8593;</td>
                    <td align="center">&#8595;</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
        </sec>
        <sec>
          <title>6.3. Retrombose</title>
          <p>Alto risco de doen&#231;a tromboemb&#243;lica venosa recorrente persiste ap&#243;s o per&#237;odo de tratamento da TVP, com incid&#234;ncia cumulativa dessas complica&#231;&#245;es de cerca de 30% em oito anos de acompanhamento; nestes, a mortalidade chega a 30%, principalmente por doen&#231;a maligna.<xref ref-type="bibr" rid="B100">100</xref><sup>,</sup><xref ref-type="bibr" rid="B101">101</xref> O sexo masculino, a localiza&#231;&#227;o do trombo e o D-d&#237;mero s&#227;o os fatores preditores relevantes do risco de recorr&#234;ncia.<xref ref-type="bibr" rid="B102">102</xref> Outros fatores de risco menos conhecidos s&#227;o o trombo residual ocupando 50% do di&#226;metro do l&#250;men do vaso ap&#243;s o tratamento e a falha na normaliza&#231;&#227;o da compress&#227;o pela USV.<xref ref-type="bibr" rid="B101">101</xref>
					</p>
          <p>Como o diagn&#243;stico n&#227;o invasivo da recorr&#234;ncia &#233; dif&#237;cil, alguns crit&#233;rios ultrassonogr&#225;ficos podem ser utilizados, como:</p>
          <p>&#8226; Medida da massa do trombo residual.</p>
          <p>&#8226; Altera&#231;&#245;es na extens&#227;o do trombo.</p>
          <p>&#8226; Caracter&#237;sticas ultrassonogr&#225;ficas do trombo (baixa ecogenicidade, suave compressibilidade, presen&#231;a de cauda, ader&#234;ncia &#224; parede e aumento no di&#226;metro da veia (&#8805; 2 vezes o da veia contralateral, ou em rela&#231;&#227;o ao di&#226;metro da art&#233;ria que a acompanha).<xref ref-type="bibr" rid="B100">100</xref><sup>,</sup><xref ref-type="bibr" rid="B101">101</xref><sup>,</sup><xref ref-type="bibr" rid="B103">103</xref>
					</p>
        </sec>
        <sec>
          <title>6.4. T&#233;cnica do Exame</title>
          <p>Para membros inferiores o paciente deve ser posicionado em dec&#250;bito dorsal, com o tronco e cabe&#231;a elevados at&#233; 30&#176;, em posi&#231;&#227;o confort&#225;vel, pr&#243;ximo da borda do leito, do mesmo lado do examinador, fazendo uma leve rota&#231;&#227;o lateral da articula&#231;&#227;o coxofemoral e leve flex&#227;o do joelho. </p>
          <p>Para membros superiores o paciente deve ser posicionado em dec&#250;bito dorsal, com o membro estendido paralelamente ao corpo e discretamente afastado do mesmo.</p>
          <p>O sistema venoso profundo deve ser examinado desde a prega inguinal, fazendo-se delicadamente a compress&#227;o das veias com o transdutor, por meio de cortes transversais.<xref ref-type="bibr" rid="B85">85</xref><sup>,</sup><xref ref-type="bibr" rid="B104">104</xref><sup>,</sup><xref ref-type="bibr" rid="B105">105</xref> O objetivo &#233; constatar a aus&#234;ncia ou a presen&#231;a de trombos recentes ou residuais, a cada 5 cm, ao longo de toda a &#225;rvore troncular venosa no segmento femoropopl&#237;teo pela face medial da coxa, segmento infrapatelar para a popl&#237;tea e trifurca&#231;&#227;o, na face posteromedial da perna para as veias musculares da panturrilha (gastrocn&#234;mias, soleares, intergemelares), veias tibiais posteriores e fibulares at&#233; o tornozelo, al&#233;m das veias superficiais (safenas magna e parva ao longo de toda a extens&#227;o). </p>
          <p>Existem protocolos que avaliam apenas o segmento proximal (femoropopl&#237;teo) ou a USV de compress&#227;o de dois pontos (veia femoral comum e veia popl&#237;tea). Esses protocolos, conhecidos como <italic>point of care</italic> facilitam a realiza&#231;&#227;o do exame por m&#233;dicos emergencistas, e vem se mostrando uma alternativa na sala de emerg&#234;ncia.<xref ref-type="bibr" rid="B106">106</xref> Por&#233;m, a avalia&#231;&#227;o de todo o sistema venoso &#233; importante para o diagn&#243;stico correto da TVP, para melhor avalia&#231;&#227;o nos casos de recorr&#234;ncia, e auxilia no diagn&#243;stico diferencial com outras patologias. Esta diretriz orienta a realiza&#231;&#227;o sempre do exame completo.<xref ref-type="bibr" rid="B107">107</xref><sup>,</sup><xref ref-type="bibr" rid="B108">108</xref>
					</p>
          <p>As veias fibulares e soleares, que nela drenam, podem ser visualizadas pela face lateral da perna, tendo-se como refer&#234;ncia anat&#244;mica a f&#237;bula. Neste caso, as veias fibulares ficam mais superficiais em rela&#231;&#227;o ao transdutor e as veias tibiais posteriores, mais profundas. Para isso a posi&#231;&#227;o do paciente deve ser modificada, com flex&#227;o do joelho e apoio do p&#233; na maca. Esta manobra n&#227;o deve ser negligenciada mesmo em pacientes internados, j&#225; que h&#225; uma grande preval&#234;ncia de TVP nos segmentos proximais das veias fibulares neste grupo de pacientes.</p>
          <p>Raramente as veias tibiais anteriores e as veias do p&#233; s&#227;o investigadas, a n&#227;o ser que haja algum sinal indicativo de acometimento localizado. </p>
          <p>Por outro lado, as veias il&#237;acas devem ser investigadas quando ocorrer TVP das veias femorais comuns e n&#227;o for poss&#237;vel a identifica&#231;&#227;o do final do trombo, ou quando o fluxo detectado nelas for cont&#237;nuo ou de baixa amplitude.</p>
          <p>Alternamos as imagens transversas com as longitudinais utilizando o modo <italic>color</italic> para avalia&#231;&#227;o do fluxo e, quando necess&#225;rio, o registro do Doppler espectral. </p>
          <p>Todas as etapas do exame (clipes e imagens est&#225;ticas) devem ser arquivadas digitalmente. Atualmente, nos protocolos de pesquisas cl&#237;nicas de estudos multic&#234;ntricos internacionais, recomenda-se que a manobra de compress&#227;o da veia seja registrada na mesma foto, com e sem compress&#227;o (imagem duplicada - dual). Caso haja trombo, devem ser feitas as medidas do di&#226;metro da veia, em locais informados, para avalia&#231;&#227;o da massa tromb&#243;tica residual.<xref ref-type="bibr" rid="B107">107</xref>
					</p>
          <p>O mesmo protocolo de avalia&#231;&#227;o deve ser seguido para os sistemas venosos profundo e superficial dos membros superiores, nos segmentos m&#233;dio e distal das veias subcl&#225;vias e para as veias jugulares.</p>
          <p>Durante o acompanhamento dos pacientes com TVP, em que j&#225; haja recanaliza&#231;&#227;o, o paciente dever&#225; ser colocado em posi&#231;&#227;o ortost&#225;tica preferencialmente e/ou sentado quando n&#227;o for poss&#237;vel, para a pesquisa de refluxo venoso.</p>
          <p>N&#227;o podemos nos esquecer de que a temperatura da sala pode influenciar sobremaneira a facilidade da realiza&#231;&#227;o desses exames. O frio induz &#224; vasoconstri&#231;&#227;o, devendo, portanto, ser evitado. A temperatura ideal seria de 22 a 25&#176;C.</p>
          <sec>
            <title>6.4.1. Transdutores</title>
            <p>Em geral utilizam-se os transdutores lineares de alta frequ&#234;ncia (5 a 12 MHz) para pacientes normais e magros. Em pacientes com sobrepeso/obesos, para o estudo do canal adutor e at&#233; mesmo para veias da perna em pacientes com edema moderado/intenso, pode-se lan&#231;ar m&#227;o de transdutores com maior alcance de profundidade, como, por exemplo, os transdutores abdominais convexos, cuja frequ&#234;ncia varia de 3 a 5 MHz.<xref ref-type="bibr" rid="B108">108</xref>
						</p>
          </sec>
          <sec>
            <title>6.4.2. Informa&#231;&#245;es para o Laudo</title>
            <p>&#8226; H&#225; ou n&#227;o sinais de TVP e/ou superficial. </p>
            <p>&#8226; Informa&#231;&#245;es sobre as caracter&#237;sticas do trombo. </p>
            <p>&#8226; Extens&#227;o da trombose: fundamental e, se poss&#237;vel, com medidas aproximadas de pontos anat&#244;micos de refer&#234;ncia, tais como espinha il&#237;aca anterossuperior, prega inguinal, joelho, mal&#233;olo ou regi&#227;o plantar, prega axilar, prega do cotovelo e prega do punho.</p>
            <p>&#8226; Em caso de trombose cr&#244;nica:</p>
            <p>- As medidas das massas tromb&#243;ticas residuais podem estar no laudo e/ou nas imagens, com suas devidas localiza&#231;&#245;es, para que possam ser comparadas posteriormente</p>
            <p>- Presen&#231;a de refluxo ao ortostatismo.</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>7. Doppler Transcraniano</title>
        <p>O objetivo primordial do estudo denominado Doppler transcraniano (DTC) &#233; obter informa&#231;&#245;es hemodin&#226;micas em art&#233;rias tronculares intracranianas, de maneira n&#227;o invasiva, por meio da insona&#231;&#227;o de fluxos pelo Doppler puls&#225;til.<xref ref-type="bibr" rid="B109">109</xref><sup>,</sup><xref ref-type="bibr" rid="B110">110</xref> O cr&#226;nio sempre representou uma barreira ao alcance dos vasos, pois o US n&#227;o atravessa o c&#225;lcio contido no tecido &#243;sseo e existem &#225;reas limitadas (as &#8220;janelas&#8221; transorbitais, transtemporais e o forame magno) para o exame. Al&#233;m disso, a localiza&#231;&#227;o profunda das art&#233;rias no enc&#233;falo dificulta a obten&#231;&#227;o de imagens adequadas e a coleta segura de amostra capaz de fornecer curvas espectrais necess&#225;rias &#224; interpreta&#231;&#227;o do estado hemodin&#226;mico registrado em dado momento. Essas caracter&#237;sticas desfavor&#225;veis definem que o transdutor capaz de insonar fluxos em todas as art&#233;rias tronculares das circula&#231;&#245;es anterior e posterior tenha, obrigatoriamente, pequeno tamanho e baixa frequ&#234;ncia (2,0 MHz ou menos). O advento do mapeamento de MFC trouxe seguran&#231;a para identifica&#231;&#227;o dos vasos e an&#225;lise de fluxos.</p>
        <sec>
          <title>7.1. Tipos de Doppler Transcraniano</title>
          <p>&#8226; <bold>DTC &#8220;cego&#8221;:</bold> utiliza apenas transdutor com Doppler puls&#225;til, sem imagem modo B (<xref ref-type="table" rid="t53">Tabela 24</xref>).</p>
          <table-wrap id="t53">
            <label>Tabela 24</label>
            <caption>
              <title>Identifica&#231;&#227;o das art&#233;rias tronculares intracranianas pelo Doppler transcraniano &#8220;cego&#8221;<xref ref-type="bibr" rid="B114">114</xref>
							</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Art&#233;ria</th>
                  <th align="center">Profundidade</th>
                  <th align="center">Vm de Fluxo</th>
                  <th align="center">Dire&#231;&#227;o de fluxo em rela&#231;&#227;o ao transdutor</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Sif&#227;o carot&#237;deo</td>
                  <td align="center">55 a 70 mm</td>
                  <td align="center">40 a 50 cm/s</td>
                  <td align="center">Positiva ou negativa</td>
                </tr>
                <tr>
                  <td align="left">Oft&#225;lmica</td>
                  <td align="center">40 a 60 mm</td>
                  <td align="center">20 cm/s</td>
                  <td align="center">Positiva</td>
                </tr>
                <tr>
                  <td align="left">Car&#243;tida interna distal</td>
                  <td align="center">55 a 70 mm</td>
                  <td align="center">45 cm/s</td>
                  <td align="center">Positiva</td>
                </tr>
                <tr>
                  <td align="left">Cerebral anterior</td>
                  <td align="center">60 a 70 mm</td>
                  <td align="center">60 cm/s</td>
                  <td align="center">Negativa</td>
                </tr>
                <tr>
                  <td align="left">Cerebral m&#233;dia</td>
                  <td align="center">35 a 60 mm</td>
                  <td align="center">70 cm/s</td>
                  <td align="center">Positiva</td>
                </tr>
                <tr>
                  <td align="left">Cerebral posterior</td>
                  <td align="center">55 a 70 mm</td>
                  <td align="center">40 cm/s</td>
                  <td align="center">Positiva (P1), negativa (P2)</td>
                </tr>
                <tr>
                  <td align="left">Vertebral</td>
                  <td align="center">55 a 70 mm</td>
                  <td align="center">40 cm/s</td>
                  <td align="center">Negativa</td>
                </tr>
                <tr>
                  <td align="left">Basilar</td>
                  <td align="center">70 a 120 mm</td>
                  <td align="center">45 cm/s</td>
                  <td align="center">Negativa</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>&#8226; <bold>DTC com Doppler colorido:</bold> (transdutor com imagem em modo B, Doppler puls&#225;til e MFC associados). </p>
          <p>&#8226; <bold>DTC com contraste de microbolhas:</bold> DTC colorido associado &#224; infus&#227;o venosa de contraste com microbolhas.</p>
          <p>&#8226; <bold>DTC com macrobolhas:</bold> DTC colorido associado &#224; infus&#227;o venosa perif&#233;rica de solu&#231;&#227;o salina ou glicosada misturada com ar ambiente e agitada (macrobolhas).</p>
        </sec>
        <sec>
          <title>7.2. T&#233;cnica e Protocolo de Exame</title>
          <p>O foco principal de qualquer exame de DTC deve ser a identifica&#231;&#227;o segura de todas as art&#233;rias tronculares e o registro da curva espectral de fluxo correspondente a cada um dos vasos. Portanto, a utilidade do MFC &#233; indiscut&#237;vel. O uso de aparelhos dedicados exclusivamente ao Doppler &#8220;cego&#8221; justifica-se, atualmente, no monitoramento cont&#237;nuo de fluxo durante cirurgias e em unidades neurointensivas.</p>
          <p>O protocolo b&#225;sico de um exame de DTC deve incluir o uso de todas as janelas poss&#237;veis &#224; transmiss&#227;o do US at&#233; as art&#233;rias intracranianas:<xref ref-type="bibr" rid="B109">109</xref> a) transorbitais (direita e esquerda), para insona&#231;&#227;o de sif&#245;es carot&#237;deos e oft&#225;lmicas); (b) transtemporais (direita e esquerda), para visualiza&#231;&#227;o de car&#243;tidas internas distais, cerebrais anteriores (segmentos A1 e A2), cerebrais m&#233;dias (segmentos M1 em toda extens&#227;o e in&#237;cio de M2), topo de basilar e cerebrais posteriores (segmentos P1 e P2 em toda extens&#227;o); (c) transforaminal, para estudo de segmentos V4 de art&#233;rias vertebrais e basilar (segmentos proximal e m&#233;dio), sendo poss&#237;vel, ainda, insona&#231;&#227;o de ramos cerebelares posteroinferiores das vertebrais.</p>
          <p>O paciente pode ser posicionado em dec&#250;bito dorsal ou sentado. A cabe&#231;a ser&#225; girada de acordo com a janela utilizada em determinado momento. A sequ&#234;ncia do exame fica a crit&#233;rio do examinador, sendo obrigat&#243;rio o registro de imagens das curvas espectrais de fluxo de cada vaso examinado, com identifica&#231;&#227;o do mesmo, de acordo com padr&#227;o internacional. A inclus&#227;o de fotos ou &#8220;clipes&#8221; com MFC garante seguran&#231;a para confirma&#231;&#227;o da identifica&#231;&#227;o e tamb&#233;m de poss&#237;veis variantes anat&#244;micas (muito frequentes) ou dificuldades t&#233;cnicas durante o exame.</p>
          <p>A visualiza&#231;&#227;o de estruturas encef&#225;licas ao modo B define a capacidade de o US atravessar a parede &#243;ssea na janela escolhida e a usabilidade da mesma para o exame. O MFC evidenciar&#225; (ou n&#227;o) fluxo nos lumens das art&#233;rias regionais, guiando com precis&#227;o o volume amostral do Doppler puls&#225;til at&#233; o segmento do l&#250;men a ser insonado para obten&#231;&#227;o da curva espectral de fluxo. Al&#233;m da morfologia das ondas de fluxo de cada vaso, a rotina de mensura&#231;&#227;o da integral de velocidades tem que ser executada, pois isso garante a aquisi&#231;&#227;o de valores indispens&#225;veis &#224; an&#225;lise hemodin&#226;mica necess&#225;ria nas diversas patologias em que h&#225; indica&#231;&#227;o do DTC: velocidade sist&#243;lica m&#225;xima, velocidade diast&#243;lica final, velocidade m&#233;dia, IR e IP (atentar para que esses c&#225;lculos estejam inclu&#237;dos no preset do aparelho).</p>
          <p>As indica&#231;&#245;es cl&#237;nicas do DTC est&#227;o listadas na <xref ref-type="table" rid="t54">tabela 25</xref>.</p>
          <table-wrap id="t54">
            <label>Tabela 25</label>
            <caption>
              <title>Indica&#231;&#245;es cl&#237;nicas do Doppler transcraniano115,116</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Patologia</th>
                  <th align="center">Objetivo</th>
                  <th align="center">Observa&#231;&#227;o</th>
                  <th align="center">Achados</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Morte encef&#225;lica<xref ref-type="table-fn" rid="TFN31">*</xref>
									</td>
                  <td align="center">Exame complementar juridicamente validado para atestar parada de circula&#231;&#227;o cerebral</td>
                  <td align="center">Obrigat&#243;rio o estudo padr&#227;o de art&#233;rias da circula&#231;&#227;o anterior e posterior. Em caso de fluxo sangu&#237;neo residual, repetir em 12 horas</td>
                  <td align="center">Curva espectral com padr&#227;o de pico sist&#243;lico curto (&lt; 50 cm/s) com aus&#234;ncia de fluxo diast&#243;lico; ou padr&#227;o &#8220;alternante&#8221; (fluxo sist&#243;lico anter&#243;grado e diast&#243;lico retr&#243;grado)</td>
                </tr>
                <tr>
                  <td align="left">Hipertens&#227;o intracraniana<xref ref-type="bibr" rid="B111">111</xref>
									</td>
                  <td align="center">Monitoramento indireto adjuvante, inclusive ap&#243;s craniectomia descompressiva</td>
                  <td align="center">An&#225;lise qualitativa do padr&#227;o da curva, que pode variar de forma din&#226;mica (a invers&#227;o do componente diast&#243;lico delimita o est&#225;gio irrevers&#237;vel)</td>
                  <td align="center">Redu&#231;&#227;o progressiva do componente diast&#243;lico da curva espectral de fluxo de acordo com gravidade da hipertens&#227;o</td>
                </tr>
                <tr>
                  <td align="left">Acidente vascular encef&#225;lico isqu&#234;mico (fase aguda)<xref ref-type="bibr" rid="B112">112</xref><sup>,</sup><xref ref-type="bibr" rid="B113">113</xref>
									</td>
                  <td align="center">Monitoramento da reperfus&#227;o do vaso nos casos de tromb&#243;lise (at&#233; 4,5 horas do in&#237;cio do evento), que dura cerca de 40 minutos (mas pode prolongar-se por mais de 1 hora)</td>
                  <td align="center">Monitoramento pode ser intermitente (aparelho convencional) ou cont&#237;nuo (transdutor com Doppler &#8220;cego&#8221; fixado em capacete ajust&#225;vel ao cr&#226;nio do paciente)</td>
                  <td align="center">Reaparecimento gradual de fluxo de acordo com grau de reperfus&#227;o (escala TIBI de padr&#227;o de curvas espectrais)</td>
                </tr>
                <tr>
                  <td align="left">Hemorragia subaracn&#243;idea<sup>**</sup><xref ref-type="bibr" rid="B114">114</xref> (<xref ref-type="table" rid="t55">Tabela 26</xref>)</td>
                  <td align="center">Diagn&#243;stico, avalia&#231;&#227;o de gravidade e monitoramento do vasospasmo, orientando a interven&#231;&#227;o precoce</td>
                  <td align="center">Realizar exame na interna&#231;&#227;o e repetir diariamente em caso de vasospasmo (per&#237;odo cr&#237;tico: 4 a 14 dias ap&#243;s o evento). Todas as art&#233;rias devem ser insonadas a cada exame</td>
                  <td align="center">Aumento de velocidade m&#233;dia de fluxo, de acordo com a gravidade. O &#237;ndice de Lindegaard (raz&#227;o de velocidade entre cerebral m&#233;dia e car&#243;tida interna ipsolateral) diferencia espasmo verdadeiro e hiperemia</td>
                </tr>
                <tr>
                  <td align="left">Forame oval patente<sup>***</sup><xref ref-type="bibr" rid="B115">115</xref>
									</td>
                  <td align="center">Pesquisa de <italic>shunt</italic> em paciente com acidente vascular encef&#225;lico isqu&#234;mico (transit&#243;rio ou fixo)</td>
                  <td align="center">Infus&#227;o venosa de solu&#231;&#227;o salina agitada (&#8220;macrobolhas&#8221;) associada a manobra de Valsalva</td>
                  <td align="center">HITS (&#234;mbolos gasosos) registrados nas curvas espectrais s&#227;o contados e classificados pela escala de Spencer</td>
                </tr>
                <tr>
                  <td align="left">Doen&#231;a falciforme<sup>****</sup><xref ref-type="bibr" rid="B116">116</xref><sup>-</sup><xref ref-type="bibr" rid="B118">118</xref> (<xref ref-type="table" rid="t56">Tabela 27</xref>)</td>
                  <td align="center">Diagn&#243;stico e gradua&#231;&#227;o de estenose intraluminal, para estratificar o risco de AVE isqu&#234;mico e defini&#231;&#227;o de conduta terap&#234;utica. Monitoramento de resposta terap&#234;utica</td>
                  <td align="center">Obrigat&#243;ria realiza&#231;&#227;o em falc&#234;micos entre 2 e 16 anos de idade</td>
                  <td align="center">Velocidade m&#233;dia de fluxo obtida definir&#225; a periodicidade do acompanhamento e conduta (troca sangu&#237;nea)</td>
                </tr>
                <tr>
                  <td align="left">Migr&#226;nea (enxaqueca)<xref ref-type="bibr" rid="B119">119</xref>
									</td>
                  <td align="center">Apoio ao diagn&#243;stico cl&#237;nico e diferencia&#231;&#227;o de outras cefaleias</td>
                  <td align="center">Pode ser realizado no per&#237;odo intercr&#237;tico ou durante a crise &#225;lgica (resultados diferentes)</td>
                  <td align="center">Medida de &#237;ndice de pulsatilidade e velocidade m&#233;dia de fluxo em todos os vasos</td>
                </tr>
                <tr>
                  <td align="left">Monitoramento transoperat&#243;rio<xref ref-type="bibr" rid="B120">120</xref><sup>,</sup><xref ref-type="bibr" rid="B121">121</xref>
									</td>
                  <td align="center">Avalia&#231;&#227;o pr&#233;-operat&#243;ria de risco para AVE (monitoramento de microembolia espont&#226;nea; estudo da reserva de fluxo cerebral) e monitoramento peroperat&#243;rio de &#234;mbolos e redu&#231;&#227;o de fluxo cerebral durante cirurgias neurol&#243;gicas e cardiovasculares</td>
                  <td align="center">Monitoramento cont&#237;nuo de fluxo em art&#233;rias cerebrais m&#233;dias com uso de 2 transdutores de Doppler &#8220;cego&#8221; fixados em capacete ajust&#225;vel ao cr&#226;nio do paciente. O monitoramento deve ser mantido no p&#243;s-operat&#243;rio (em raz&#227;o de microembolia neste per&#237;odo)</td>
                  <td align="center">Registro da taxa de &#234;mbolos (s&#243;lidos e/ou gasosos) e redu&#231;&#227;o da velocidade m&#233;dia do fluxo em rela&#231;&#227;o ao valor basal (&gt; 15%) definem risco de ocorr&#234;ncia de acidente vascular encef&#225;lico isqu&#234;mico no p&#243;s-operat&#243;rio imediato<sup>*****</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN30">
                <p>AVE: acidente vascular cerebral; HITS: high intensity transient signals (sinais transit&#243;rios de alta intensidade); TIBI: Thrombolysis in Brain Ischemia [tromb&#243;lise na isquemia cerebral (escala)]. As informa&#231;&#245;es seguidas por asteriscos</p>
              </fn>
              <fn id="TFN31">
                <label>(*)</label>
                <p>contam com dados adicionais, apresentados no texto a seguir.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="t55">
            <label>*Tabela 26</label>
            <caption>
              <title>Classifica&#231;&#227;o de vasospasmo</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Art&#233;ria: ACM</th>
                  <th align="center">VMF (cm/s)</th>
                  <th align="center">&#205;ndice de Lindegaard</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Leve</td>
                  <td align="center">120 a 130</td>
                  <td align="center">3 a 6</td>
                </tr>
                <tr>
                  <td align="left">Moderado</td>
                  <td align="center">130 a 200</td>
                  <td align="center">3 a 6</td>
                </tr>
                <tr>
                  <td align="left">Grave</td>
                  <td align="center">&gt; 200</td>
                  <td align="center">&gt; 6</td>
                </tr>
                <tr>
                  <td align="left">Art&#233;ria: ACA</td>
                  <td align="center">&gt; 50% da VMF em 24h</td>
                  <td align="center">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">Art&#233;ria: ACP</td>
                  <td align="center">&gt; 110</td>
                  <td align="center">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">Art&#233;ria: AV</td>
                  <td align="center">&gt; 80</td>
                  <td align="center">&#8211;</td>
                </tr>
                <tr>
                  <td align="left">Art&#233;ria: basilar</td>
                  <td align="center">
									</td>
                  <td align="center">&#205;ndice de Soustiel</td>
                </tr>
                <tr>
                  <td align="left">Leve</td>
                  <td align="center">80 a 95</td>
                  <td align="center">2 a 2,49</td>
                </tr>
                <tr>
                  <td align="left">Moderado</td>
                  <td align="center">&gt; 85</td>
                  <td align="center">2,5 2,99</td>
                </tr>
                <tr>
                  <td align="left">Grave</td>
                  <td align="center">&gt; 115</td>
                  <td align="center">&gt; 3</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN32">
                <p>
                  <italic>ACM: art&#233;ria cerebral m&#233;dia; ACA: art&#233;ria cerebral anterior; ACP: art&#233;ria cerebral posterior; AV: art&#233;ria vertebral. Observa&#231;&#227;o: &#205;ndice de Lindegaard &#233; a raz&#227;o entre a maior velocidade m&#233;dia de fluxo (VMF) em cerebral m&#233;dia (M1) e VMF na car&#243;tida interna extracraniana ipsolateral. O &#237;ndice de Soustiel &#233; a raz&#227;o entre a VMF da vertebral e a VMF da basilar.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="t56">
            <label>****Tabela 27</label>
            <caption>
              <title>Recomenda&#231;&#245;es da Diretriz Brasileira de Doppler Transcraniano em Crian&#231;as e Adolescentes com Doen&#231;a Falciforme (2010)<xref ref-type="bibr" rid="B123">123</xref>
							</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="50%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Velocidade m&#233;dia de fluxo</th>
                  <th align="center">Grupo de risco de AVE</th>
                  <th align="center">Conduta</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Janelas ultrass&#244;nicas inadequadas</td>
                  <td align="center">Inconclusivo</td>
                  <td align="center">Utilizar outro m&#233;todo de imagem para avalia&#231;&#227;o de eventos cerebrovasculares</td>
                </tr>
                <tr>
                  <td align="left">Dif&#237;cil execu&#231;&#227;o: n&#227;o coopera&#231;&#227;o do paciente</td>
                  <td align="center">Inconclusivo</td>
                  <td align="center">Repetir em 3 meses, se poss&#237;vel com examinador diferente</td>
                </tr>
                <tr>
                  <td align="left">&lt; 70 cm/s</td>
                  <td align="center">Baixo fluxo</td>
                  <td align="center">Repetir exame em 30 dias</td>
                </tr>
                <tr>
                  <td align="left">&lt; 170 cm/s</td>
                  <td align="center">Normal</td>
                  <td align="center">Repetir exame em 12 meses</td>
                </tr>
                <tr>
                  <td align="left">170 a 184 cm/s</td>
                  <td align="center">&#8220;Condicional baixo&#8221;</td>
                  <td align="center">Repetir exame em 3 meses: se &lt; 170 cm/s, repetir em 12 meses</td>
                </tr>
                <tr>
                  <td align="left">184 a 199 cm/s</td>
                  <td align="center">&#8220;Condicional alto&#8221;</td>
                  <td align="center">Repetir exame em 30 dias: se &lt; 170 cm/s, repetir DTC a cada 3 meses; se dois exames consecutivos anormais, considerar troca sangu&#237;nea de longo prazo</td>
                </tr>
                <tr>
                  <td align="left">200 a 220 cm/s</td>
                  <td align="center">Anormal</td>
                  <td align="center">Repetir exame em 30 dias: se &gt; 200 cm/s, troca sangu&#237;nea; se &#8220;condicional alto&#8221;, repetir DTC em 3 meses; se &#8220;condicional baixo&#8221;, repetir em 6 meses</td>
                </tr>
                <tr>
                  <td align="left">&gt; 220 cm/s</td>
                  <td align="center">Anormal</td>
                  <td align="center">Risco iminente de AVE e considerar troca sangu&#237;nea de longo prazo</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN33">
                <p>AVE: acidente vascular encef&#225;lico; DTC: Doppler transcraniano.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>*De acordo com as Diretrizes Brasileiras para o Uso do Ultrassom Transcraniano como Teste Confirmat&#243;rio (definidas por um grupo de especialistas do Departamento de Neurossonologia da Academia Brasileira de Neurologia em 2012), os crit&#233;rios<xref ref-type="bibr" rid="B122">122</xref> s&#227;o:</p>
          <p>&#8226; Um &#250;nico exame de DTC &#233; suficiente como teste para confirma&#231;&#227;o de morte encef&#225;lica.</p>
          <p>&#8226; O DTC deve ser realizado somente em paciente com diagn&#243;stico cl&#237;nico previamente estabelecido, de acordo com as regula&#231;&#245;es brasileiras correntes; al&#233;m disso, o paciente tem que apresentar condi&#231;&#245;es hemodin&#226;micas est&#225;veis (com ou sem uso de f&#225;rmacos) e press&#227;o arterial sist&#234;mica sist&#243;lica m&#237;nima de 90 mmHg (se inferior a esse valor, o exame n&#227;o ter&#225; validade diagn&#243;stica).</p>
          <p>&#8226; &#201; obrigat&#243;ria a realiza&#231;&#227;o de estudo padr&#227;o completo de DTC, com registro de imagens em modo B e mapeamento de fluxo em cores (se dispon&#237;veis) e das curvas espectrais de fluxo de todas as art&#233;rias tronculares intracranianas.</p>
          <p>&#8226; Achados caracter&#237;sticos de parada circulat&#243;ria encef&#225;lica ao DTC: curvas espectrais de fluxo com onda sist&#243;lica de baixa amplitude (&lt; 50 cm/s de velocidade) ou curvas com padr&#227;o de fluxo alternante (ondas com componente sist&#243;lico anter&#243;grado seguido de componente diast&#243;lico reverso).</p>
          <p>&#8226; Aus&#234;ncia de fluxo nas art&#233;rias tronculares intracranianas n&#227;o &#233; crit&#233;rio para morte encef&#225;lica, exceto nos casos em que tenha sido realizado DTC pr&#233;vio, na mesma hospitaliza&#231;&#227;o do paciente, com registro de fluxo nas art&#233;rias analisadas.</p>
          <p>&#8226; Circula&#231;&#227;o anterior: nos casos de janelas transtemporais inadequadas, torna-se obrigat&#243;rio o registro de crit&#233;rios de &#8220;colapso vascular&#8221; em ambos os sif&#245;es carot&#237;deos para diagn&#243;stico de morte encef&#225;lica.</p>
          <p>&#8226; Circula&#231;&#227;o posterior: em caso de impossibilidade de detec&#231;&#227;o de fluxo em basilar, os achados de &#8220;colapso vascular&#8221; em ambas as vertebrais intracranianas s&#227;o indispens&#225;veis ao diagn&#243;stico de morte encef&#225;lica; por outro lado, achado correspondente a &#8220;colapso vascular&#8221; em basilar na presen&#231;a de fluxo sangu&#237;neo residual em pelo menos uma das vertebrais invalidar&#225; o diagn&#243;stico conclusivo do exame como uma indica&#231;&#227;o de morte encef&#225;lica neste territ&#243;rio.</p>
          <p>&#8226; Fluxo sangu&#237;neo residual pode ser detectado em quase 20% dos pacientes, principalmente em car&#243;tidas intracranianas e em pacientes com craniotomia (mas esse achado tende a desaparecer em poucas horas). </p>
          <p>&#8226; Laudo referente ao exame precisa conter relato detalhado dos achados registrados em cada art&#233;ria das circula&#231;&#245;es anterior e posterior e ser conclusivo em rela&#231;&#227;o &#224; presen&#231;a ou n&#227;o de crit&#233;rios para parada circulat&#243;ria encef&#225;lica que corroborem o diagn&#243;stico cl&#237;nico de morte encef&#225;lica.</p>
          <p>
            <bold>***Classifica&#231;&#227;o de Spencer</bold>
          </p>
          <p>O n&#250;mero de esp&#237;culas emb&#243;licas registradas na tela do aparelho constitui tamb&#233;m informa&#231;&#227;o &#250;til, pois quanto maior o n&#250;mero de macrobolhas, mais significativa a dimens&#227;o do(s) orif&#237;cio(s) de passagem atrav&#233;s do forame oval (classifica&#231;&#227;o de Spencer): grau 0 - aus&#234;ncia de HITS; grau 1 - 1 a 10HITS; grau 2 - 11 a 30 HITS; grau 3 - 31 a 100HITS; grau 4 - 101 a 300 HITS; grau 5 - &gt; 300 HITS (&#8220;efeito cortina&#8221;). Acima do grau 2 o shunt card&#237;aco direita-esquerda &#233; considerado significativo. Nos casos de incont&#225;veis esp&#237;culas (&#8220;efeito cortina&#8221;), a possibilidade de FAV pulmonar deve ser considerada.</p>
          <p>Protocolo do exame: infus&#227;o venosa perif&#233;rica de solu&#231;&#227;o com &#8220;macrobolhas&#8221; (8 ml de soro fisiol&#243;gico ou solu&#231;&#227;o glicosada misturada com 2 ml de ar ambiente e agitada at&#233; homogeneiza&#231;&#227;o), seguida imediatamente de manobra de Valsava vigorosa realizada pelo paciente durante 5 segundos e insona&#231;&#227;o simult&#226;nea de curvas espectrais de fluxo (Doppler puls&#225;til) em art&#233;rias cerebrais e basilar. O teste deve ser realizado em condi&#231;&#245;es basais (registro de fluxo com Valsalva em cerebrais m&#233;dias direita e esquerda e em basilar) e ap&#243;s infus&#227;o de &#8220;macrobolhas&#8221; (ou seja, 6 vezes no total). Em caso de registro com padr&#227;o &#8220;em cortina&#8221;, deve-se interromper o estudo (que ser&#225; considerado positivo).</p>
          <p>*****Sinais de microemboliza&#231;&#227;o s&#227;o detectados em at&#233; 70% dos casos durante a primeira hora ap&#243;s endarterectomias. Taxa de 50 &#8220;sinais de microemboliza&#231;&#227;o&#8221;/hora ocorre em at&#233; 10% dos casos, sendo preditiva de isquemia focal ipsolateral.<xref ref-type="bibr" rid="B121">121</xref>
					</p>
        </sec>
        <sec>
          <title>7.3. Limita&#231;&#245;es do Doppler Transcraniano Colorido</title>
          <p>As limita&#231;&#245;es do DTC s&#227;o basicamente decorrentes da barreira ao US representada pela calota &#243;ssea craniana. O uso de agentes de contraste (&#8220;microbolhas&#8221;) reduziu muito os casos de exames inconclusivos em raz&#227;o de &#8220;aus&#234;ncia de janelas adequadas&#8221;. A inexperi&#234;ncia do m&#233;dico examinador tamb&#233;m &#233; um fator limitante fundamental; a curva de aprendizado &#233; relativamente longa e exige dedica&#231;&#227;o. </p>
          <sec>
            <title>7.3.1. Informa&#231;&#245;es Indispens&#225;veis em Laudos de Doppler Transcraniano</title>
            <p>A estrutura b&#225;sica de qualquer exame complementar deve conter: </p>
            <p>&#8226; Identifica&#231;&#227;o do paciente (nome completo e idade).</p>
            <p>&#8226; Indica&#231;&#227;o cl&#237;nica (a finalidade do exame definir&#225; o tipo de DTC necess&#225;rio).</p>
            <p>&#8226; Qualidade t&#233;cnica do exame (referindo poss&#237;veis dificuldades com interfer&#234;ncia na obten&#231;&#227;o das imagens necess&#225;rias ao estudo).</p>
            <p>&#8226; Registro de todas as janelas ultrassonogr&#225;ficas utilizadas e os vasos examinados (justificando os casos de impossibilidade de estudo).</p>
            <p>&#8226; Descri&#231;&#227;o das caracter&#237;sticas espec&#237;ficas detectadas em cada recurso t&#233;cnico utilizado:</p>
            <p>- Mapeamento de fluxo em cores (pat&#234;ncia ou oclus&#227;o do l&#250;men, padr&#227;o laminar ou turbilhonar (&#8220;mosaico&#8221;), dire&#231;&#227;o (anter&#243;grada ou invertida).</p>
            <p>- Doppler puls&#225;til (padr&#227;o laminar ou turbilhonar, dire&#231;&#227;o (anter&#243;grada ou invertida), registro das medidas de velocidades das curvas espectrais de fluxo (sist&#243;lica m&#225;xima, diast&#243;lica final e m&#233;dia) e IP e resist&#234;ncia de acordo com a indica&#231;&#227;o cl&#237;nica do exame (exemplo: doen&#231;a falciforme exige velocidade m&#233;dia).</p>
            <p>- Solu&#231;&#227;o contrastante de &#8220;macrobolhas&#8221; (registro e contagem de HITS na pesquisa de forame oval patente e embolia paradoxal).</p>
            <p>- Uso de agente de contraste com &#8220;microbolhas&#8221; (SonoVue<sup>&#174;</sup>).</p>
            <p>- No monitoramento intraoperat&#243;rio, descrever a ocorr&#234;ncia e a contagem de HITS/hora e as varia&#231;&#245;es de velocidades de fluxo com potencial de risco para AVE isqu&#234;mico no p&#243;s-operat&#243;rio.</p>
            <p><bold>Conclus&#227;o:</bold> evitar diagn&#243;stico etiol&#243;gico (DTC &#233; estudo da hemodin&#226;mica cerebral e os achados devem ser correlacionados &#224; indica&#231;&#227;o cl&#237;nica do exame: por exemplo, presen&#231;a ou aus&#234;ncia de crit&#233;rios para vasospasmo, com classifica&#231;&#227;o do grau e refer&#234;ncia temporal &#224; data de in&#237;cio dos sintomas da hemorragia subaracn&#243;idea). </p>
            <p><bold>Observa&#231;&#227;o:</bold> na doen&#231;a falciforme h&#225; obrigatoriedade de especificar, ap&#243;s conclus&#227;o, a data recomendada para repeti&#231;&#227;o do exame de reavalia&#231;&#227;o (de acordo com as Diretrizes Brasileiras de Doppler Transcraniano em Crian&#231;as e Adolescentes, 2010).<xref ref-type="bibr" rid="B123">123</xref> Nas demais patologias essa sugest&#227;o est&#225; proibida pela &#233;tica profissional.</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>8. Contraste em Ultrassonografia Vascular</title>
        <p>A introdu&#231;&#227;o de agentes de contraste para exames de ultrassonografia ampliou muito o valor cl&#237;nico deste m&#233;todo. A ultrassonografia em modo B &#233; uma excelente modalidade para se demonstrarem caracter&#237;sticas anat&#244;micas e morfol&#243;gicas de par&#234;nquima tecidual, mas n&#227;o fornece qualquer informa&#231;&#227;o sobre viabilidade e integridade da microcircula&#231;&#227;o. A ultrassonografia com Doppler colorido (USDC) adicionou informa&#231;&#245;es sobre velocidade de fluxo sangu&#237;neo, mas n&#227;o &#233; capaz de quantificar o volume e demonstrar com sensibilidade suficiente o fluxo sangu&#237;neo na microcircula&#231;&#227;o,<xref ref-type="bibr" rid="B124">124</xref><sup>-</sup><xref ref-type="bibr" rid="B126">126</xref> onde a velocidade &#233; muito baixa para ser detectada sem que artefatos gerados pelos movimentos do tecido e do transdutor predominem. Al&#233;m disso, a resolu&#231;&#227;o espacial da USDC &#233; limitada, a representa&#231;&#227;o de velocidade &#233; &#226;ngulo-dependente e h&#225; in&#250;meros artefatos que podem influenciar a interpreta&#231;&#227;o diagn&#243;stica das imagens. A ultrassonografia com Doppler melhorada com contraste aumentou substancialmente a sensibilidade da USDC e reduziu algumas das limita&#231;&#245;es.</p>
        <p>A inova&#231;&#227;o t&#233;cnica foi a introdu&#231;&#227;o de m&#243;dulos de imagem espec&#237;ficos para contraste nos aparelhos de US, possibilitando a visualiza&#231;&#227;o direta de sinais emitidos por agentes de contraste com microbolhas, independentemente de suas velocidades. Devido &#224;s caracter&#237;sticas pr&#243;prias dos sinais das microbolhas (que s&#227;o fundamentalmente diferentes daqueles provenientes dos tecidos), s&#227;o criadas imagens &#8220;espec&#237;ficas das microbolhas&#8221; (somente contraste) que podem exibir volume e perfus&#227;o de par&#234;nquimas teciduais com sensibilidade e resolu&#231;&#227;o espacial extremamente elevadas.<xref ref-type="bibr" rid="B124">124</xref> A cria&#231;&#227;o de cada sinal &#8220;espec&#237;fico de microbolha&#8221; requer intera&#231;&#227;o adequada dos sinais do agente de contraste carreador da microbolha com o feixe de US insonado.</p>
        <sec>
          <title>8.1. Propriedades dos Agentes de Contraste de Ultrassom</title>
          <p>O contraste com microbolhas, ao contr&#225;rio daqueles empregados para a resson&#226;ncia magn&#233;tica (RM) e a tomografia computadorizada, que utilizam as caracter&#237;sticas f&#237;sicas e qu&#237;micas das c&#233;lulas para o seu efeito, usa as caracter&#237;sticas f&#237;sicas do pr&#243;prio US; ou seja, quanto maior a diferen&#231;a de densidade entre os meios, maior a reflex&#227;o da energia emitida e maior a amplitude do sinal de US. Indiscutivelmente, o meio gasoso &#233; o que promove a maior diferen&#231;a, correspondendo a um aumento do sinal da ordem de 30 decib&#233;is.</p>
          <p>Os agentes de contraste para US s&#227;o microbolhas de g&#225;s contidas em c&#225;psulas com membrana fosfolip&#237;dica que possuem flexibilidade e estabilidade, al&#233;m de um tamanho definido. O agente SonoVue<sup>&#174;127</sup> (produzido pela Bracco Imaging S.p.A., Mil&#227;o, It&#225;lia), comercializado na Europa, nos Estados Unidos, em parte da &#193;sia e na Am&#233;rica do Sul, &#233; o &#250;nico produto liberado atualmente no Brasil pela Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (Anvisa) e pelo rol da Ag&#234;ncia Nacional de Sa&#250;de Suplementar (ANS). O SonoVue<sup>&#174;</sup> consiste em microesferas de g&#225;s hexafluoreto de enxofre encapsuladas. As microbolhas possuem di&#226;metro m&#233;dio de 2,3 &#181;m (tamanho que as impede de atravessar as paredes dos vasos sangu&#237;neos e alcan&#231;ar o espa&#231;o intersticial). Por ser um g&#225;s lipof&#237;lico, tem baixa solubilidade no sangue e n&#227;o se difunde para fora da c&#225;psula. Essa capa proteica composta de camada &#250;nica de fosfolip&#237;dios atua como surfactante, conferindo-lhe estabilidade e flexibilidade ao longo de seu trajeto na macro e microcircula&#231;&#227;o sangu&#237;nea. O SonoVue<sup>&#174;</sup> &#233;, portanto, considerado um agente integrante do <italic>pool</italic> de sangue e um marcador da circula&#231;&#227;o sangu&#237;nea (propriedade que o distingue dos contrastes utilizados na RM e na tomografia computadorizada, que podem atravessar para o espa&#231;o extracelular).</p>
          <p>Ap&#243;s ruptura da microbolha, o g&#225;s &#233; exalado na respira&#231;&#227;o atrav&#233;s dos pulm&#245;es em sua quase totalidade, n&#227;o sofrendo qualquer metaboliza&#231;&#227;o hep&#225;tica ou excre&#231;&#227;o renal.<xref ref-type="bibr" rid="B124">124</xref> Assim, n&#227;o h&#225; contraindica&#231;&#227;o ao uso em pacientes com insufici&#234;ncia renal.</p>
        </sec>
        <sec>
          <title>8.2. Aspectos T&#233;cnicos que Influenciam a Obten&#231;&#227;o de Imagem com Contraste</title>
          <p>Atualmente, a maioria dos fabricantes de aparelhos de US possui <italic>software</italic> espec&#237;fico para estudo com contraste, que pode estar inclu&#237;do na configura&#231;&#227;o original da m&#225;quina ou ser adquirido &#224; parte. Entretanto, mesmo naqueles sem o m&#243;dulo de imagem espec&#237;fico para contraste, alguns par&#226;metros podem ser configurados pelo pr&#243;prio operador. Para a obten&#231;&#227;o de melhor resultado durante o estudo contrastado, alguns conceitos e regulagens do equipamento devem obrigatoriamente ser conhecidos:</p>
          <sec>
            <title>
              <bold>8.2.1. &#205;ndice Mec&#226;nico (<italic>Mechanical Index</italic>)</bold>
            </title>
            <p>Uma caracter&#237;stica exclusiva dos agentes de contraste para US (inexistente naqueles usados para RM e tomografia computadorizada) &#233; que eles s&#227;o modificados pelas ondas usadas para detect&#225;-los. O comportamento da microbolha, quando exposta ao US, varia de acordo com a pot&#234;ncia de US emitida, ou seja, a amplitude da onda ac&#250;stica [que nos equipamentos &#233; denominada de &#237;ndice mec&#226;nico (MI)]. Em estudos n&#227;o contrastados o MI encontra-se na faixa de 1,6 a 1,9; sob essa pot&#234;ncia ac&#250;stica, a microbolha invariavelmente entra em oscila&#231;&#227;o vigorosa e se rompe, gerando dois efeitos indesejados: aumento abrupto da intensidade do sinal com borramento excessivo na imagem e marcada redu&#231;&#227;o da concentra&#231;&#227;o de contraste, com consequente encurtamento do tempo de exame. Esse modo de imagem, chamado de &#8220;imagem por estimula&#231;&#227;o ac&#250;stica&#8221;, n&#227;o necessita de equipamentos com tecnologia para contraste (mas, por outro lado, n&#227;o utiliza todo o potencial do agente de contraste, limitando-se &#224; fun&#231;&#227;o de ecorreal&#231;ador).</p>
            <p>Ao reduzirmos o MI para &#8804; 0,1 conseguimos n&#227;o somente manter a integridade das microbolhas, mas tamb&#233;m fazer com que elas oscilem de forma n&#227;o linear (compress&#227;o inicial seguida de expans&#227;o) e entrem em resson&#226;ncia, emitindo frequ&#234;ncias (as chamadas &#8220;frequ&#234;ncias harm&#244;nicas&#8221;) diferentes da frequ&#234;ncia fundamental emitida pelo transdutor. Os equipamentos dotados desta tecnologia conseguem filtrar esses sinais emitidos especificamente pela microbolhas, obtendo um estudo mais duradouro e que destaca o sinal das microbolhas em detrimento dos tecidos (estes praticamente anulados na imagem que aparece como fundo escuro).</p>
            <p>Esta forma de estudo, chamada tamb&#233;m de &#8220;estudo contrastado com baixo MI&#8221;, permite avaliar de forma cont&#237;nua o tempo de chegada do contraste (<italic>wash in</italic>) ao local de estudo, o per&#237;odo de realce e a concentra&#231;&#227;o das microbolhas na estrutura-alvo [muito importante para situa&#231;&#245;es como o estudo dos vasos dos vasos (<italic>vasa vasorum</italic>), das placas carot&#237;deas, da distribui&#231;&#227;o capilar (perfus&#227;o) renal e de massas].<xref ref-type="bibr" rid="B124">124</xref>
						</p>
            <p>Um efeito indesejado no estudo contrastado com baixo MI &#233; a limita&#231;&#227;o da profundidade atingida pela onda de pulso, que sofre maior atenua&#231;&#227;o &#224; medida que caminha pelos tecidos. Algumas formas de minimizar esse efeito s&#227;o: ado&#231;&#227;o de janelas ac&#250;sticas alternativas que permitam aproximar a estrutura de interesse, utilizar transdutores de banda larga com frequ&#234;ncias menores e, em &#250;ltimo caso, aumentar o MI, tendo como consequ&#234;ncia maior destrui&#231;&#227;o de bolhas no campo proximal.<xref ref-type="bibr" rid="B128">128</xref>
						</p>
          </sec>
          <sec>
            <title>8.2.2. Ganho de Imagem</title>
            <p>Um controle do equipamento que merece aten&#231;&#227;o no estudo contrastado &#233; o ganho da imagem, que amplifica o sinal recebido durante o p&#243;s-processamento no equipamento. Ganho elevado produz imagem brilhante e aumento generalizado no ru&#237;do de fundo, obscurecendo o sinal do contraste (uma vez que o n&#237;vel de satura&#231;&#227;o do equipamento tenha sido atingido, n&#227;o haver&#225; margem para aumento do sinal provocado pelo contraste). Durante o estudo com contraste deve-se, portanto, reduzir o ganho do equipamento at&#233; que a imagem fique virtualmente de cor preta, exceto para estruturas altamente ecog&#234;nicas. Alguns fabricantes possuem controles de ajuste de ganho para estudos contrastados que podem facilmente ser ativados e desativados durante o estudo. </p>
            <p>Quando se realiza um ajuste manual, deve-se ter a menor quantidade de sinais ac&#250;sticos antes da inje&#231;&#227;o de contraste e entender se esse sinal &#233; provocado por aumento do MI (quando s&#227;o visualizadas estruturas espec&#237;ficas na imagem) ou do ganho (que provoca aumento generalizado do ru&#237;do em toda a imagem).<xref ref-type="bibr" rid="B6">6</xref>
						</p>
          </sec>
          <sec>
            <title>8.2.3. Quantidade de Contraste</title>
            <p>Um &#250;ltimo aspecto t&#233;cnico a ser mencionado &#233; a dose do contraste a ser injetada. Doses altas provocam inicialmente borramento (satura&#231;&#227;o) do sinal e atenua&#231;&#227;o (sombra ac&#250;stica) das estruturas no campo distal, at&#233; que haja queda para concentra&#231;&#245;es adequadas do n&#237;vel de contraste. Al&#233;m disso, n&#227;o ser&#225; poss&#237;vel distinguir pequenas diferen&#231;as de realce entre estruturas, uma vez que o limite superior da faixa din&#226;mica (escala de cinza) do equipamento foi ultrapassado.<xref ref-type="bibr" rid="B128">128</xref> Uma forma de se destacarem os diferentes n&#237;veis de realce provocados pelo contraste em uma estrutura &#233; ajustar a dose de contraste para n&#237;veis que permitam opacifica&#231;&#227;o adequada, sem borramento ou atenua&#231;&#227;o, e aumentar o n&#237;vel da faixa din&#226;mica (<italic>dynamic range</italic>) do equipamento. Doses baixas, por sua vez, n&#227;o alcan&#231;ar&#227;o o n&#237;vel de opacifica&#231;&#227;o desejado.</p>
          </sec>
        </sec>
        <sec>
          <title>8.3. Indica&#231;&#245;es para Uso de Contraste em Ultrassonografia Vascular</title>
          <p>A <xref ref-type="table" rid="t57">tabela 28</xref> lista as principais indica&#231;&#245;es para uso de agentes de contraste com microbolhas em estudos de US nos diversos sistemas vasculares (consenso da Sociedade Europeia de Ultrassom, publicado em 2011).<xref ref-type="bibr" rid="B129">129</xref> Os n&#237;veis de evid&#234;ncia com base em estudos multic&#234;ntricos e/ou unic&#234;ntricos foram caracterizados como A (boa), B (moderada) e C (quando a recomenda&#231;&#227;o se d&#225; via um consenso de especialistas).</p>
          <table-wrap id="t57">
            <label>Tabela 28</label>
            <caption>
              <title>Indica&#231;&#245;es para o uso de agentes de contraste na ultrassonografia vascular</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="20%"/>
                <col width="40%"/>
                <col width="20%"/>
                <col width="20%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Sistema</th>
                  <th align="center">Aplica&#231;&#227;o</th>
                  <th align="center">N&#237;vel de evid&#234;ncia</th>
                  <th align="center">Sonda</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Car&#243;tidas</td>
                  <td align="center">Oclus&#227;o ou suboclus&#227;o<break/>Estenose de <italic>stent</italic><break/>Dissec&#231;&#227;o<break/>Neovasculariza&#231;&#227;o de placas</td>
                  <td align="center">B<break/>B<break/>C<break/>B</td>
                  <td align="center">Linear</td>
                </tr>
                <tr>
                  <td align="left" rowspan="2">Aorta</td>
                  <td align="center">Dissec&#231;&#227;o, extens&#227;o do <italic>flap</italic> para ramos, perviedade do falso l&#250;men, pontos de reentrada e n&#237;vel de perfus&#227;o dos ramos que se originam do falso l&#250;men</td>
                  <td align="center">C</td>
                  <td align="center" rowspan="2">Abdominal convexa ou setorial card&#237;aca</td>
                </tr>
                <tr>
                  <td align="center">Diferencia&#231;&#227;o entre aneurisma inflamat&#243;rio e ruptura contida <italic>Endoleak</italic></td>
                  <td align="center">B<break/>A</td>
                </tr>
                <tr>
                  <td align="left">Vasos intracerebrais</td>
                  <td align="center">Aumento do sinal em estudo basal insatisfat&#243;rio Perfus&#227;o no AVE isqu&#234;mico</td>
                  <td align="center">A<break/>C</td>
                  <td align="center">Setorial card&#237;aca</td>
                </tr>
                <tr>
                  <td align="left">Complica&#231;&#245;es de acessos vasculares</td>
                  <td align="center">F&#237;stulas arteriovenosas Pseudoaneurismas, hematomas</td>
                  <td align="center">C<break/>C</td>
                  <td align="center">Linear ou abdominal convexa ou setorial card&#237;aca</td>
                </tr>
                <tr>
                  <td align="left">Rim</td>
                  <td align="center">Aumento do sinal da art&#233;ria renal Perfus&#227;o renal</td>
                  <td align="center">C<break/>C</td>
                  <td align="center">Abdominal convexa ou setorial card&#237;aca</td>
                </tr>
                <tr>
                  <td align="left">Membros inferiores</td>
                  <td align="center">Doen&#231;a ateroscler&#243;tica obstrutiva (avalia&#231;&#227;o da circula&#231;&#227;o colateral e microcircula&#231;&#227;o)<break/>Trombose venosa profunda (melhora do sinal e rea&#231;&#227;o inflamat&#243;ria peritrombos)</td>
                  <td align="center">C<break/>C</td>
                  <td align="center">Linear ou abdominal convexa</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN34">
                <p>
                  <italic>AVE: acidente vascular encef&#225;lico.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>8.4. Modo de Preparo, Aplica&#231;&#227;o e Dose do Contraste com Microbolhas</title>
          <p>SonoVue<sup>&#174;</sup> &#233; composto por um <italic>kit</italic> que inclui: um frasco-ampola com 25 mg de p&#243; liofilizado em uma atmosfera de hexafluoreto de enxofre; uma seringa preenchida com 5 ml de solu&#231;&#227;o de cloreto de s&#243;dio 9 mg/ml (0,9%); um sistema de transfer&#234;ncia. O contraste &#233; de f&#225;cil preparo &#224; beira do leito, seguindo-se as instru&#231;&#245;es do fabricante. Ap&#243;s transferir o conte&#250;do da seringa para o frasco com p&#243;, o mesmo dever&#225; ser agitado durante 20 segundos para forma&#231;&#227;o das microbolhas e a solu&#231;&#227;o salina transformar-se em uma suspens&#227;o com aspecto leitoso (indicando distribui&#231;&#227;o homog&#234;nea das microbolhas). Neste estado, a suspens&#227;o pode ser armazenada por at&#233; 6 horas. Se as microbolhas se acumularem na superf&#237;cie durante o repouso, a solu&#231;&#227;o poder&#225; ser novamente agitada para que as microbolhas readquiram distribui&#231;&#227;o homog&#234;nea antes do uso. </p>
          <p>A via usual de administra&#231;&#227;o &#233; uma inje&#231;&#227;o intravenosa em <italic>bolus</italic> em vaso de calibre adequado para pun&#231;&#227;o com agulha de 20G de di&#226;metro (preferencialmente em fossa antecubital). Um pequeno volume inicial deve ser administrado, seguido de um <italic>flush</italic> com 5 ml de solu&#231;&#227;o salina a 0,9% para empurrar o agente de contraste at&#233; a veia central (o que ocorre em segundos). </p>
          <p>A dose recomendada na maioria das publica&#231;&#245;es para inje&#231;&#227;o &#250;nica nos estudos de USV &#233; de 2,4 ml, podendo variar de 1 a 4,8 ml, de acordo com o &#243;rg&#227;o a ser estudado, a sonda empregada e a sensibilidade do equipamento dispon&#237;vel (lembrando sempre que sondas com frequ&#234;ncia mais elevada necessitam de doses maiores, no caso 4,8 ml).<xref ref-type="bibr" rid="B7">7</xref> Os primeiros 10 a 40 segundos ap&#243;s o bolus correspondem &#224; curva de realce do contraste (<italic>wash in</italic> e <italic>wash out</italic>) e devem ser registrados continuamente para posterior an&#225;lise. Em alguns casos espec&#237;ficos, como na pesquisa de <italic>endoleaks</italic> tardios, o tempo de avalia&#231;&#227;o pode chegar a 5 minutos; nesses casos, clipes menores podem ser registrados. Deve-se ter em mente que, quanto maior o MI, maior a destrui&#231;&#227;o de bolhas e menor o tempo de dura&#231;&#227;o do contraste. Ap&#243;s ruptura das bolhas o hexafluoreto de enxofre &#233; r&#225;pida (2 minutos) e integralmente eliminado pelos pulm&#245;es (Anvisa).</p>
          <p>SonoVue<sup>&#174;</sup> &#233; um agente seguro, com baixo &#237;ndice de complica&#231;&#245;es. H&#225; relatos de rea&#231;&#227;o anafil&#225;tica em &lt; 0,002% dos casos.</p>
        </sec>
        <sec>
          <title>8.5. Protocolo B&#225;sico de Exame de Ultrassonografia Vascular com Contraste de Microbolhas</title>
          <p>Definida a indica&#231;&#227;o de uso de contraste com microbolhas em exame de US vascular, a rotina b&#225;sica obrigat&#243;ria requer:</p>
          <p>&#8226; Repeti&#231;&#227;o e registro de exame de USDC padr&#227;o do &#243;rg&#227;o de interesse.</p>
          <p>&#8226; Garantia de acesso venoso para inje&#231;&#227;o de solu&#231;&#227;o de contraste com microbolhas (pun&#231;&#227;o de veia perif&#233;rica ou uso de veia profunda j&#225; em uso).</p>
          <p>&#8226; Prepara&#231;&#227;o da solu&#231;&#227;o de contraste com microbolhas (SonoVue<sup>&#174;</sup>) de acordo com as orienta&#231;&#245;es do fabricante do produto.</p>
          <p>&#8226; Acionamento do modo de imagem espec&#237;fico para contraste no equipamento de US; caso n&#227;o haja <italic>software</italic> espec&#237;fico, ajuste de IM (&lt; 0,6 e o mais pr&#243;ximo poss&#237;vel de 0,1), ganho de imagem (escurecer o fundo) e escolha de janelas adequadas que reduzam a profundidade do &#243;rg&#227;o-alvo do estudo.</p>
          <p>&#8226; Administra&#231;&#227;o da solu&#231;&#227;o com contraste, ajustes para reduzir excesso de realce e registro de imagens (clipes) digitais durante os 10 a 40 segundos ap&#243;s <italic>bolus</italic> inicial; nos casos de exames espec&#237;ficos com maior dura&#231;&#227;o, registrar clipes necess&#225;rios no decorrer do tempo (que pode alcan&#231;ar 5 a 8 minutos) para an&#225;lise posterior.</p>
          <p><bold>Observa&#231;&#227;o:</bold> a an&#225;lise do exame com contraste de microbolhas &#233; fundamentalmente din&#226;mica e a dura&#231;&#227;o do estudo &#233; curta em raz&#227;o da r&#225;pida destrui&#231;&#227;o das microbolhas pelas ondas de US, mesmo quando se utiliza IM muito baixo. Portanto, o registro em m&#237;dia digital &#233; essencial para posterior processamento e reavalia&#231;&#227;o cuidadosa das imagens, garantindo diagn&#243;stico seguro e armazenamento perene dos resultados.</p>
        </sec>
        <sec>
          <title>
					</title>
        </sec>
        <sec>
          <title>8.6. Limita&#231;&#245;es do Uso de Contraste em Ultrassonografia Vascular</title>
          <p>&#8226; Inexperi&#234;ncia do examinador (treinamento adequado em exames de ultrassonografia com contraste &#233; indispens&#225;vel para um diagn&#243;stico efetivo e seguro).</p>
          <p>&#8226; Aparelhagem sem <italic>software</italic> espec&#237;fico para imagem com contraste dificulta (mas n&#227;o inviabiliza) a realiza&#231;&#227;o de um exame conclusivo.</p>
          <p>&#8226; Acesso ao contraste com microbolhas nas unidades da rede p&#250;blica de sa&#250;de do pa&#237;s.</p>
          <p>&#8226; Aus&#234;ncia completa de &#8220;janela&#8221; que permita transmiss&#227;o do US at&#233; &#243;rg&#227;o de interesse (raro).</p>
          <p>&#8226; Hipersensibilidade ao contraste com microbolhas (rara).</p>
        </sec>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <p>Realiza&#231;&#227;o: Departamento de Imagem Cardiovascular (DIC) da Sociedade Brasileira de Cardiologia (SBC)</p>
        </fn>
        <fn fn-type="other">
          <p>Conselho de Normatiza&#231;&#245;es e Diretrizes: Fernando Bacal, Leandro Ioschpe Zimerman, Paulo Ricardo Avancini Caramori e Pedro A. Lemos</p>
        </fn>
        <fn fn-type="other">
          <p>Coordenador de Normatiza&#231;&#245;es e Diretrizes: Ludhmila Abrah&#227;o Hajjar</p>
        </fn>
        <fn fn-type="other">
          <p>Presidente do Departamento de Imagem Cardiovascular (DIC): Marcelo Luiz Campos Vieira</p>
        </fn>
        <fn fn-type="other">
          <p>Coordenadoras: Simone Nascimento dos Santos, Monica Luiza de Alcantara, Cl&#225;udia Maria Vilas Freire</p>
        </fn>
        <fn fn-type="other">
          <p>
            <bold>Este posicionamento dever&#225; ser citado como:</bold>
          </p>
          <p> Santos SN, Alcantara ML, Freire CMV, Cantisano AL, Teodoro JAR, Carmen CLL, et al. Posicionamento de Ultrassonografia Vascular do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia - 2019. Arq Bras Cardiol. 2019; 112(6):809-849.</p>
        </fn>
        <fn fn-type="other">
          <p><bold>Nota:</bold> Estas Diretrizes se prestam a informar e n&#227;o a substituir o julgamento cl&#237;nico do m&#233;dico que, em &#250;ltima an&#225;lise, deve determinar o tratamento apropriado para seus pacientes.</p>
        </fn>
      </fn-group>
      <ack>
        <title>Agradecimentos</title>
        <p>Aos autores e &#224; US Doppler Escola de Ensino Presencial e a Dist&#226;ncia, pelas imagens cedidas. Ao Rodrigo Tonan, pelas ilustra&#231;&#245;es m&#233;dicas.</p>
      </ack>
    </back>
  </sub-article>
</article>
